data_2ai5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ai5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.5 m -76.71 -28.86 56.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 110.0 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.57 -15.66 7.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -24.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.008 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.9 m -136.44 -37.05 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.002 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.407 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.6 m-70 -71.49 -179.66 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 110.344 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER 176.55 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.834 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 79' ' ' ILE . 26.6 mt -42.66 -67.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -121.98 42.37 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.349 -0.844 . . . . 0.0 110.041 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -139.0 87.39 2.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 110.117 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pttt -55.51 85.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 110.06 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -96.63 -143.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 36.4 t -51.96 -31.4 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.0 161.01 15.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.87 120.06 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.705 2.27 . . . . 0.0 110.262 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.51 130.16 5.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.98 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.594 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 6.7 m-85 -51.02 -33.25 24.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -66.14 -42.67 88.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.15 -52.37 59.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 53.6 t -56.37 -43.38 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.878 . . . . 0.0 109.973 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -51.5 -57.9 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -45.14 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.933 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 9.3 mttt -58.13 -34.83 70.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.87 4.01 31.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -68.48 -29.27 67.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.6 19.91 34.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -112.72 174.08 6.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.13 . . . . 0.0 110.16 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -122.26 -12.68 8.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.79 19.04 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.062 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.01 -21.02 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 19.6 t -71.38 -56.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.98 -52.72 64.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 109.993 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 45.2 t80 -52.18 -66.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.478 ' CD1' ' HB1' ' A' ' 73' ' ' ALA . 59.9 mt -43.21 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.577 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.54 -35.92 1.21 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.411 -0.805 . . . . 0.0 110.108 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.29 -35.98 81.01 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -93.94 -11.87 30.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -1.17 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.452 HD11 ' CD1' ' A' ' 72' ' ' LEU . 13.6 mt -72.01 -44.26 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 110.07 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -102.1 -44.15 5.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.96 -162.01 48.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.45 -136.37 12.78 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.92 -170.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 0.0 110.074 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.4 -19.55 5.65 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 53' ' ' VAL . 98.8 t -101.5 -20.2 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -1.134 . . . . 0.0 110.078 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 86.8 m95 -121.77 -27.59 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.022 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.38 -136.65 2.28 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 22.5 p -129.53 -35.06 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.074 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 56' ' ' SER . 3.4 p -42.19 102.66 0.28 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.131 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.8 87.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.203 . . . . 0.0 110.27 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.5 ttt -45.02 139.87 3.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.684 2.256 . . . . 0.0 110.281 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.22 162.93 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 110.172 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 22.0 mm-40 -134.56 163.54 29.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 110.096 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -103.81 72.75 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.436 HG23 HG23 ' A' ' 46' ' ' ILE . 3.6 m -124.31 155.89 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ASP . 66.7 p -104.14 169.92 8.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.948 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' THR . 14.0 t0 -43.43 -58.0 2.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.05 -58.92 3.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -54.4 -41.29 69.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.577 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -58.48 -35.49 72.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.815 . . . . 0.0 109.858 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -65.17 -52.08 57.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.9 -30.03 57.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.998 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' CD1' HD11 ' A' ' 46' ' ' ILE . 24.0 mt -70.24 -50.69 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' CD1' ' A' ' 42' ' ' LEU . . . -70.13 -30.79 68.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.471 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.24 -37.09 58.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.459 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.464 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 22.8 t90 -80.28 -36.83 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.594 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 54.9 mt -74.34 -37.22 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 24.7 mt -68.36 -46.91 68.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -57.42 -25.99 60.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.989 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 75' ' ' TRP . 16.8 mt -75.44 130.59 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.025 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.107 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 11.8 m -72.47 -29.01 63.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -1.214 . . . . 0.0 109.962 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -16.38 9.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.94 -28.02 6.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.4 m -132.27 -34.15 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.513 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 89.1 m-70 -75.51 -179.22 4.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 169.39 124.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.75 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.482 ' CD2' HG21 ' A' ' 79' ' ' ILE . 23.2 mt -42.25 -66.47 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 42.71 3.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.943 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -147.73 45.75 1.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.02 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 10.6 pttt -42.4 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -89.73 -89.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 t -82.11 -31.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.872 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.22 170.26 15.59 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 3.0 Cg_endo -61.28 127.54 22.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.715 2.277 . . . . 0.0 110.273 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -51.08 133.36 27.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.218 -0.926 . . . . 0.0 109.939 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.513 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 4.6 m-85 -49.54 -32.19 11.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.14 -45.93 62.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.55 -44.71 95.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.529 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 34.7 t -57.68 -45.83 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 77' ' ' LEU . . . -52.86 -53.12 53.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.886 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . 20.7 ttmt -55.27 -45.39 76.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.976 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.74 66.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 41.6 m-85 -102.99 -1.25 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.081 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.35 -29.93 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.74 15.37 52.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -126.02 153.6 44.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -1.133 . . . . 0.0 110.038 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -20.71 13.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.016 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -96.52 14.65 23.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -59.53 -21.89 60.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.8 -56.91 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.984 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -52.92 63.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.0 t80 -51.8 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.519 HD13 ' CB ' ' A' ' 73' ' ' ALA . 78.2 mt -43.08 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.913 . . . . 0.0 110.123 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.74 -41.83 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.036 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.69 -40.61 88.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.08 -13.67 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.076 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 41.1 mt -69.24 -46.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.027 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -83.22 -12.51 56.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.066 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -96.21 -37.28 10.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.61 -162.18 54.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 95.29 -141.09 15.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.76 -175.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -1.146 . . . . 0.0 110.05 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.43 -12.33 3.5 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 53' ' ' VAL . 98.8 t -105.1 -23.53 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.105 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.529 ' CZ2' HG21 ' A' ' 28' ' ' VAL . 92.4 m95 -112.3 -24.77 9.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.89 28.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -110.09 54.4 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.24 96.82 49.23 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.047 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.51 88.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.325 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.9 ttt -60.08 139.41 91.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.872 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 144.09 91.44 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.652 2.235 . . . . 0.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.66 165.42 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.69 2.26 . . . . 0.0 110.151 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.432 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 31.1 mm-40 -136.62 164.58 27.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.82 62.1 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 46' ' ' ILE . 3.7 m -114.34 155.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.9 p -103.67 169.02 8.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 109.967 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 25.3 t0 -43.38 -58.23 2.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -47.97 -55.38 10.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.85 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.45 -42.63 74.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.911 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -57.78 -34.87 70.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.845 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 1.6 mtmt -65.6 -52.59 50.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.19 -30.1 48.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.999 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.05 -51.39 32.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.892 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 42' ' ' LEU . . . -69.59 -31.8 70.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.418 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.27 -36.55 61.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.475 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.0 t90 -79.76 -38.31 33.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.835 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.484 HG12 ' CD1' ' A' ' 25' ' ' TYR . 79.1 mt -70.72 -39.7 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 14.8 mt -67.54 -44.62 77.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.041 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -31.86 70.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG21 ' CD2' ' A' ' 16' ' ' LEU . 39.5 mt -67.84 114.99 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.086 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -103.36 -28.71 11.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.089 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.7 mmt -59.08 -14.5 10.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.13 -25.43 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.478 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -135.95 -36.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.8 m-70 -70.63 -179.14 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER 172.73 124.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.524 ' CD2' HG23 ' A' ' 79' ' ' ILE . 24.2 mt -42.15 -63.3 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.344 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 42.51 3.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.0 110.06 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -142.83 86.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -60.31 78.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.166 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 17.7 mttt -88.42 -141.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 110.011 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 38.9 t -50.17 -31.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.12 157.65 16.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.89 124.71 15.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.73 2.287 . . . . 0.0 110.271 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -45.01 132.91 6.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 109.952 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.2 m-85 -52.12 -32.26 34.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.57 -47.2 76.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.151 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -47.3 83.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 38.0 t -57.45 -45.25 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.999 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -53.15 -50.23 64.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -53.47 -44.74 69.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.055 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -38.08 65.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.034 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -100.85 -0.48 36.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.133 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.6 -26.46 67.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.049 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.26 24.27 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.33 154.13 47.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -1.193 . . . . 0.0 110.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -36.67 9.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.017 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.461 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 22.5 t70 -88.41 34.26 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.94 -24.57 67.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.02 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.86 -54.72 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.461 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -58.33 -55.97 28.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' LEU . 8.5 t80 -50.82 -65.19 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 73' ' ' ALA . 25.6 mt -43.01 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.584 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.25 -42.01 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 110.078 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.23 58.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' LEU . 1.6 mmtp -97.43 -7.61 31.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 49.5 mt -75.98 -47.91 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 110.067 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -73.8 -15.24 61.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.05 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 44.06 -144.01 2.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 94.6 -134.0 11.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.3 p 169.75 -170.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -1.184 . . . . 0.0 110.013 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.21 6.56 6.24 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.34 -11.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.492 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 96.3 m95 -124.72 -9.14 7.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.56 -128.58 2.37 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.87 51.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.2 t -114.01 94.94 36.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.041 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.431 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 3.0 Cg_exo -60.86 87.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.776 2.317 . . . . 0.0 110.281 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.6 ttt -59.17 139.42 88.0 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.95 141.03 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.636 2.224 . . . . 0.0 110.301 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.35 164.94 18.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.669 2.246 . . . . 0.0 110.065 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -134.8 163.19 30.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.132 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -104.4 57.05 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 110.005 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 3.5 m -114.33 155.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.232 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -107.13 174.58 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.896 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -43.66 -50.37 7.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.001 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.31 -63.26 1.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 0.0 109.906 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 6.2 mt-10 -53.88 -39.79 66.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.786 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.584 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -60.31 -34.45 73.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.63 57.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 110.005 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.8 -30.62 61.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.996 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 46' ' ' ILE . 19.8 mt -70.01 -49.82 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.36 -32.13 69.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.105 -0.997 . . . . 0.0 109.398 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -75.24 -36.88 61.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.472 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.9 t90 -79.79 -37.95 34.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.815 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.15 -40.42 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.0 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 29' ' ' ALA . 21.7 mt -68.84 -39.96 79.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.933 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -64.66 -28.63 69.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.855 . . . . 0.0 110.035 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.524 HG23 ' CD2' ' A' ' 16' ' ' LEU . 28.5 mt -69.67 116.79 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.003 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.054 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.446 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 10.6 m -79.23 -29.08 42.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -1.15 . . . . 0.0 110.018 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.08 -15.64 14.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.928 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.5 m -127.83 -30.24 2.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.505 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -80.27 -179.37 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.06 123.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.449 -0.782 . . . . 0.0 109.785 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.506 ' CD2' HG22 ' A' ' 79' ' ' ILE . 2.0 mt -42.01 -64.12 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -122.85 42.77 3.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 109.991 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -148.3 45.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.016 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.87 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.343 -0.848 . . . . 0.0 110.224 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 5.6 mtpt -91.6 -89.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 28.3 t -80.58 -31.54 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.903 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.79 169.22 15.92 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.574 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -60.98 126.98 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.759 2.306 . . . . 0.0 110.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -51.19 131.45 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.897 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.505 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.36 -32.22 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.135 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.56 -45.45 68.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -48.86 79.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 37.7 t -56.53 -43.5 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 77' ' ' LEU . . . -52.55 -54.53 31.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.952 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -46.1 69.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -55.55 -35.3 65.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 31.8 m-85 -101.42 0.21 36.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.927 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -63.43 -25.87 68.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.05 16.8 54.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -139.43 153.62 47.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -1.165 . . . . 0.0 110.185 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -105.47 -29.02 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 0.0 110.111 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -76.69 1.81 16.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 110.117 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -55.93 -24.19 36.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.022 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 96.1 t -67.62 -55.53 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.71 -54.83 42.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -52.32 -63.16 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.063 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 38' ' ' ALA . 50.5 mt -43.24 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 110.087 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.67 -41.04 2.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -56.83 -41.11 90.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.26 -15.38 40.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 39.7 mt -67.28 -46.83 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.878 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 5.46 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -123.82 -6.64 7.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.103 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 44.24 -149.04 0.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.41 -146.72 18.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.69 177.05 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -1.119 . . . . 0.0 110.106 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.54 -14.8 3.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.79 -30.8 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.03 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.574 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.3 m95 -107.89 -26.21 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.08 -155.94 24.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 t -108.05 57.39 0.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -1.15 . . . . 0.0 110.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.7 t -117.59 96.26 49.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.61 78.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.741 2.294 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.2 ttt -52.15 138.98 35.81 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.68 142.24 82.63 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.627 2.218 . . . . 0.0 110.383 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.423 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.8 Cg_endo -63.83 161.92 30.72 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.649 2.233 . . . . 0.0 110.17 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 27.1 mm-40 -135.04 163.57 29.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 110.104 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.09 69.1 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.002 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.457 HG23 HG22 ' A' ' 46' ' ' ILE . 3.3 m -114.7 155.8 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.1 m -101.28 165.09 11.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.915 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 4.5 m-20 -43.41 -57.75 2.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.008 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.21 -55.11 11.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.51 -43.05 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' CB ' ' HB1' ' A' ' 43' ' ' ALA . . . -57.4 -36.63 71.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.825 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -65.28 -52.32 55.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -0.833 . . . . 0.0 110.026 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -53.94 -28.97 40.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.462 HD11 HG23 ' A' ' 46' ' ' ILE . 17.3 mt -70.19 -52.05 26.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.935 . . . . 0.0 109.822 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.445 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -69.29 -31.38 69.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 0.0 109.38 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.23 -37.06 61.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.476 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.5 t90 -79.57 -38.44 34.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.78 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.482 HG12 ' CD1' ' A' ' 25' ' ' TYR . 47.2 mt -70.6 -42.4 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 24.5 mt -65.41 -42.82 92.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 109.99 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.3 t -61.95 -33.09 73.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 110.031 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.506 HG22 ' CD2' ' A' ' 16' ' ' LEU . 42.0 mt -64.63 103.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.146 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 16.6 m -97.6 -30.42 12.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -1.164 . . . . 0.0 110.134 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.9 mmt -61.16 -12.61 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.64 58.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.473 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 m -123.86 -19.01 5.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.7 m-70 -91.26 -179.18 5.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.948 . . . . 0.0 110.343 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.52 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 170.66 122.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.916 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -42.52 -64.23 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.16 41.9 3.2 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -139.42 86.06 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.45 -0.781 . . . . 0.0 110.073 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 3.7 ptpt -55.24 86.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 18' ' ' ALA . 2.8 tptt -95.01 -147.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.02 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 35.9 t -50.89 -31.28 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 109.924 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -120.07 166.14 13.58 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.573 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.15 129.35 28.22 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.776 2.317 . . . . 0.0 110.252 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -50.76 127.16 17.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.9 m-85 -47.95 -33.55 7.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.004 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -68.12 -44.44 76.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -49.53 76.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.051 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.621 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 61.9 t -56.97 -44.72 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -51.21 -62.51 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.943 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -40.92 67.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.788 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -61.63 -32.06 72.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CB ' HD21 ' A' ' 77' ' ' LEU . 6.5 m-85 -91.64 2.07 56.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.17 -25.4 61.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.082 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.71 -3.88 68.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -118.26 164.67 14.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -1.135 . . . . 0.0 110.045 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 -11.01 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.67 21.78 16.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.033 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -59.37 -15.81 18.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 49.2 t -73.77 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.033 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.87 -51.4 69.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.2 -64.34 0.84 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 109.997 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 73' ' ' ALA . 55.8 mt -43.52 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . . . -42.53 -37.62 1.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.494 -0.754 . . . . 0.0 110.095 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.73 -41.13 93.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 49' ' ' GLY . 4.7 mmtp -87.9 -9.47 53.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 25.7 mt -73.49 -51.52 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.004 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -17.5 62.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.03 -18.18 13.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 55.53 -140.32 40.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 92.35 -139.44 14.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.7 p 169.92 -170.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -1.142 . . . . 0.0 110.034 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.23 4.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.83 -21.32 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -1.145 . . . . 0.0 110.131 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.621 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 93.0 m95 -115.81 -28.39 6.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 110.096 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 -155.85 25.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.9 p -107.89 65.34 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.039 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 51' ' ' SER . 60.4 t -129.97 96.33 26.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.59 87.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.736 2.291 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.406 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 8.9 ttt -59.43 140.28 88.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 2.9 Cg_endo -63.28 141.5 82.26 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.577 2.185 . . . . 0.0 110.375 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.8 163.91 23.3 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.571 2.181 . . . . 0.0 110.029 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 20.0 mm-40 -134.95 163.33 30.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -0.982 . . . . 0.0 110.064 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -104.83 64.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.953 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -113.83 155.72 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 p -100.06 166.78 10.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 109.901 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.36 -55.29 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.069 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.79 -57.95 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.47 -40.99 68.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.9 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -58.58 -35.47 72.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.811 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HE3' HG11 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.56 -52.25 53.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.339 -0.85 . . . . 0.0 110.088 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.52 -30.19 52.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 110.082 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.7 mt -70.24 -50.33 40.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.87 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.39 -30.99 68.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.253 -0.905 . . . . 0.0 109.455 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -76.27 -36.56 58.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.56 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CE2' HD11 ' A' ' 79' ' ' ILE . 23.7 t90 -80.79 -36.97 31.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 109.835 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.487 HG12 ' CD1' ' A' ' 25' ' ' TYR . 47.6 mt -74.13 -34.87 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.947 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.522 HD21 ' CB ' ' A' ' 32' ' ' TYR . 20.1 mt -72.34 -41.88 66.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.4 t -64.14 -27.78 69.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 75' ' ' TRP . 37.8 mt -69.65 100.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.018 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.051 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.6 m -73.04 -28.99 62.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 0.0 109.991 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.7 mmt -59.39 -14.33 11.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.197 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.28 -25.31 3.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 110.106 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 9.7 m -135.76 -36.82 0.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.023 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -69.47 -178.84 1.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 175.63 129.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.75 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.522 ' CD1' HG23 ' A' ' 79' ' ' ILE . 3.9 mm? -42.75 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.137 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.26 42.55 3.12 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 110.009 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.41 87.76 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.12 156.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.061 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 178.73 -145.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 55.1 t -50.15 -29.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 0.0 109.848 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.81 20.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.567 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.67 121.37 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.745 2.296 . . . . 0.0 110.316 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 135.06 3.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.937 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.556 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.4 m-85 -53.07 -31.87 44.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.42 -47.2 67.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.85 -46.14 91.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 36.3 t -57.51 -45.47 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.975 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 76' ' ' ILE . . . -52.34 -57.25 10.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.9 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -54.51 -43.29 71.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.59 -34.95 71.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.057 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 6.3 m-85 -102.44 4.68 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.9 -23.42 59.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.22 10.58 60.63 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 167.69 14.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.098 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -113.62 -10.67 13.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -110.81 28.79 8.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.075 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -70.8 -24.81 62.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG12 ' HD3' ' A' ' 70' ' ' LYS . 83.9 t -68.89 -56.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 110.045 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 1.3 m-20 -59.18 -53.2 61.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.0 t80 -51.32 -63.05 1.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 73' ' ' ALA . 56.8 mt -43.17 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.046 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.62 -41.09 2.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.14 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.48 -39.67 84.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -88.57 -16.62 32.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -1.155 . . . . 0.0 110.093 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 44.5 mt -65.65 -47.68 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.883 . . . . 0.0 110.063 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 2.9 ttmm -80.09 6.2 12.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.82 -28.97 4.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.2 -156.95 33.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.75 -129.67 9.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.82 -170.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -1.172 . . . . 0.0 110.028 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -2.29 8.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 ' CD1' ' A' ' 54' ' ' TRP . 37.6 t -119.95 -14.84 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.148 . . . . 0.0 110.094 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.567 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.5 m95 -133.79 9.45 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.32 -149.78 20.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 21.5 m -118.13 51.42 1.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -1.194 . . . . 0.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.454 ' O ' ' OG ' ' A' ' 51' ' ' SER . 49.6 t -110.26 95.13 20.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.922 . . . . 0.0 110.098 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.86 72.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.798 2.332 . . . . 0.0 110.286 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 57' ' ' VAL . 8.1 ttt -43.98 139.41 3.02 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.883 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.85 141.23 83.85 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.642 2.228 . . . . 0.0 110.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.35 160.21 36.24 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.615 2.21 . . . . 0.0 110.135 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 23.5 mm-40 -133.01 162.92 30.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.072 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -103.93 68.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 46' ' ' ILE . 3.4 m -115.13 155.94 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.132 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.6 p -101.91 167.93 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' THR . 8.8 t0 -43.39 -61.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.082 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.47 -54.98 6.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.41 -43.23 75.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.853 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.504 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . . . -57.56 -36.28 71.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.784 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HD3' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.26 -52.19 55.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 110.046 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.07 -29.37 44.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.929 . . . . 0.0 110.019 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.2 mt -70.12 -51.73 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.895 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' A' ' 42' ' ' LEU . . . -69.31 -31.54 70.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -0.988 . . . . 0.0 109.39 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.12 -37.27 61.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.843 . . . . 0.0 109.619 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.47 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.4 t90 -79.33 -38.21 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.803 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.556 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.8 mt -71.48 -41.66 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.962 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 21.7 mt -64.53 -46.68 81.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 109.96 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -56.65 -27.95 59.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 109.977 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.522 HG23 ' CD1' ' A' ' 16' ' ' LEU . 6.8 mt -75.46 121.82 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.096 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 m -95.06 -28.83 14.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -16.18 6.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.872 . . . . 0.0 110.117 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -23.57 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.186 -0.946 . . . . 0.0 109.945 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m -137.51 -38.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.424 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 89.2 m-70 -70.01 -179.53 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 110.33 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 173.31 123.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.827 . . . . 0.0 109.802 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 79' ' ' ILE . 31.6 mt -42.52 -66.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -122.47 42.63 3.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -141.46 84.11 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.17 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -61.7 76.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 110.111 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -79.21 -90.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.028 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 34.6 t -99.44 -39.51 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.989 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.93 166.45 12.3 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.576 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.82 118.61 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.785 2.323 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.35 128.79 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' HD11 ' A' ' 76' ' ' ILE . 5.5 m-85 -48.34 -35.7 12.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -63.32 -41.87 98.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.08 -48.38 71.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 32' ' ' TYR . 98.1 t -58.13 -46.3 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -51.88 -53.94 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -45.48 73.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.949 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 6.1 mttp -56.66 -34.43 67.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 110.048 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.569 ' CE2' HG13 ' A' ' 28' ' ' VAL . 19.3 m-85 -103.96 -1.36 27.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.59 -28.56 60.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.31 19.55 34.95 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG3' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -128.23 149.5 50.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.156 . . . . 0.0 110.023 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.52 -14.57 15.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 35' ' ' ARG . 7.1 p-10 -102.55 4.37 38.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.085 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -54.38 -20.89 8.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.04 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.508 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 72.7 t -69.66 -54.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.049 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.4 -53.63 55.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.092 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 70.4 t80 -50.88 -64.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 73' ' ' ALA . 72.3 mt -43.18 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . . . -42.35 -41.63 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.73 -39.24 75.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -89.76 -5.96 56.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.052 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 31.2 mt -78.02 -47.68 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -9.1 58.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -100.37 -42.58 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.033 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.43 -169.03 52.2 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.38 -138.37 13.83 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER 169.7 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 110.07 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.84 3.22 5.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -121.69 -18.05 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 110.02 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 93.8 m95 -120.01 -11.72 9.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.46 -141.02 7.61 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.03 60.01 1.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -1.201 . . . . 0.0 110.061 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 59' ' ' MET . 22.8 t -122.82 96.37 45.31 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.915 . . . . 0.0 110.106 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.55 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.697 2.265 . . . . 0.0 110.279 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' VAL . 7.1 ttt -49.77 138.39 17.57 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.511 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 143.47 90.09 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.685 2.256 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.43 165.68 17.07 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.716 2.277 . . . . 0.0 110.145 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 27.8 mm-40 -135.08 163.89 28.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.117 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -104.34 64.25 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.058 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.61 155.82 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.109 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.54 167.42 10.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 m-20 -43.36 -59.01 2.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.117 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.5 -56.35 7.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.897 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -54.87 -41.87 71.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.235 -0.916 . . . . 0.0 109.92 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.519 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -57.95 -37.74 74.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -64.7 -51.82 60.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -53.92 -29.26 41.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.016 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 46' ' ' ILE . 45.2 mt -70.1 -52.75 21.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 39' ' ' VAL . . . -68.55 -32.47 72.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.496 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.12 -36.93 64.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.475 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 19.0 t90 -78.64 -40.06 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.817 . . . . 0.0 109.74 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.571 HD11 ' CE1' ' A' ' 25' ' ' TYR . 20.9 mt -71.11 -43.77 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.93 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 20.6 mt -62.22 -44.68 96.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 t -59.58 -36.02 75.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 75' ' ' TRP . 26.2 mt -59.6 108.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.964 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.04 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.8 m -106.55 -29.13 9.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 110.017 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mmt -58.51 -14.99 9.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.27 -24.75 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.982 . . . . 0.0 109.988 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' HG12 ' A' ' 21' ' ' VAL . 11.2 m -136.15 -36.91 0.73 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.577 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.7 m-70 -71.73 -179.9 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 110.378 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.06 121.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.873 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 15' ' ' ASP . 1.6 mp -42.13 -62.31 0.96 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.303 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.13 42.37 3.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.36 -0.838 . . . . 0.0 110.038 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -147.05 45.76 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -47.49 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.134 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -96.54 -89.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 0.0 109.954 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 13' ' ' CYS . 35.4 t -78.12 -31.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 109.901 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.15 168.32 18.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.566 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.04 124.73 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.728 2.285 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -49.32 127.57 15.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 109.893 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.594 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 3.3 m-85 -45.97 -31.22 2.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.081 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.31 -44.47 75.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.035 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -63.59 -49.12 74.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 39.7 t -57.8 -45.79 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 77' ' ' LEU . . . -51.21 -63.72 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.29 -38.67 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -60.24 -35.65 75.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.881 . . . . 0.0 110.042 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.61 2.89 26.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.033 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -65.87 -26.62 67.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.024 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.71 16.71 49.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.39 154.51 36.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.064 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -100.54 -14.34 18.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' CG ' ' OD2' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -108.7 29.37 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.07 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.524 HG13 ' CE ' ' A' ' 70' ' ' LYS . 22.0 t -73.31 -61.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD2' ' CG ' ' A' ' 37' ' ' ASP . 3.2 p-10 -59.27 -50.33 74.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -51.75 -58.23 7.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.047 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 73' ' ' ALA . 45.5 mt -48.3 -73.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 110.125 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.67 -43.07 3.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.25 -41.23 86.4 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.68 -9.88 54.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.123 . . . . 0.0 110.042 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 34.0 mt -73.21 -50.55 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.51 -11.57 60.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.053 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -100.83 -13.67 18.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 45.31 -165.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 108.0 -137.39 14.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.85 -172.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.146 . . . . 0.0 110.101 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.12 -10.59 5.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 53' ' ' VAL . 82.1 t -106.72 -22.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -1.144 . . . . 0.0 110.047 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.566 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.6 m95 -120.37 -22.12 6.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.53 -169.61 42.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -98.14 46.36 1.01 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.095 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -111.39 96.24 30.41 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 59' ' ' MET . 3.0 Cg_exo -60.75 76.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 0.0 110.346 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' PRO . 7.5 ttt -43.24 139.59 2.34 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 3.0 Cg_endo -62.64 142.59 90.22 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.674 2.25 . . . . 0.0 110.309 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.8 Cg_endo -63.27 166.8 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.626 2.217 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 29.8 mm-40 -136.03 164.64 27.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 110.075 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -104.62 58.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.6 155.96 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.014 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.8 p -100.39 168.53 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.995 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 56.5 t0 -43.32 -53.31 5.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.41 -58.77 4.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -54.27 -40.71 68.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.781 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.548 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -58.69 -36.38 74.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' HG13 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.71 -51.86 60.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 110.0 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.0 -29.7 57.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.4 mt -70.21 -50.28 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.949 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.72 -30.3 66.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 109.398 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.5 mt-30 -76.63 -37.2 56.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.507 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.473 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 24.7 t90 -80.6 -36.45 32.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.842 . . . . 0.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.594 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 55.6 mt -74.64 -33.65 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.914 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 21.9 mt -71.61 -45.39 62.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -60.64 -25.81 66.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 75' ' ' TRP . 39.1 mt -71.3 119.84 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.107 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 m -99.13 -28.86 13.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -1.182 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.6 mmt -54.89 -17.46 3.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.34 -23.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.967 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.1 m -138.63 -37.75 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.897 . . . . 0.0 110.041 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.452 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.6 m-70 -70.12 -179.25 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.852 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 170.77 126.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 79' ' ' ILE . 28.8 mt -42.17 -67.85 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 42.77 3.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 110.019 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -139.44 83.6 1.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -62.33 74.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 57.2 mmtt -77.68 -90.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 26.5 t -97.67 -45.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.97 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.7 167.52 14.03 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.07 119.28 6.35 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.68 2.254 . . . . 0.0 110.242 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 134.58 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.607 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 5.0 m-85 -50.49 -32.07 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 79' ' ' ILE . . . -67.72 -44.88 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.017 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.59 -48.83 79.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 71.4 t -57.16 -44.51 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.993 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -51.69 -59.7 3.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.904 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.75 -43.07 72.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -34.04 73.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 110.048 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' HB3' HD22 ' A' ' 77' ' ' LEU . 16.6 m-85 -94.5 -12.76 27.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -52.12 -28.77 19.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 0.0 110.009 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.63 17.25 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -122.86 121.98 37.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.106 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -72.97 -31.06 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.034 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.67 37.01 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 110.054 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.463 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.37 -25.11 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.62 -50.91 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.099 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -55.67 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 110.076 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.7 t80 -50.61 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.066 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 38' ' ' ALA . 1.4 mt -43.27 -73.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.079 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 69' ' ' ALA . . . -42.19 -41.75 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.805 . . . . 0.0 110.058 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.5 -41.89 89.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.8 OUTLIER -84.98 -16.91 39.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 32.8 mt -65.21 -49.46 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 10.3 tttt -80.83 -0.06 37.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -7.01 10.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 47.77 -155.86 1.06 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.9 -149.64 16.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.3 p 169.68 -167.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.15 . . . . 0.0 110.071 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -18.08 7.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 53' ' ' VAL . 64.2 t -100.03 -3.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.571 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 99.6 m95 -137.88 6.45 2.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.44 -153.06 23.8 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -118.37 52.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.108 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.91 96.2 40.57 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.069 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.65 80.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.689 2.259 . . . . 0.0 110.225 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.4 ttt -51.48 138.58 29.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.95 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.75 144.84 90.04 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.682 2.255 . . . . 0.0 110.394 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.96 168.19 10.97 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.693 2.262 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.427 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 33.7 mm-40 -137.06 164.83 27.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.155 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.05 60.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.027 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.66 155.89 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -103.77 170.59 7.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.001 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' THR . 13.1 m-20 -43.35 -57.27 3.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.993 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.83 -57.96 4.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -41.02 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' CB ' ' HB1' ' A' ' 43' ' ' ALA . . . -59.46 -34.77 72.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -65.41 -51.24 61.64 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -56.2 -30.69 62.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.078 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HB3' HD12 ' A' ' 46' ' ' ILE . 38.1 mt -70.41 -48.9 53.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -71.22 -29.6 65.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -37.43 48.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.495 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.471 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 25.3 t90 -81.03 -34.21 32.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.607 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 56.6 mt -76.84 -35.74 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 24.4 mt -71.36 -45.38 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.973 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 t -59.06 -33.42 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.008 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 75' ' ' TRP . 14.1 mt -69.29 95.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.979 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 6.2 mmmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.017 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.3 m -73.7 -28.98 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -1.182 . . . . 0.0 110.04 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.66 -13.3 13.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.34 -35.51 51.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 m -125.15 -25.49 3.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.55 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.99 -179.25 7.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.463 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 169.48 122.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.784 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.55 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 1.2 mp -41.84 -64.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.7 42.69 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 110.072 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -136.54 82.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.83 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.46 113.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.046 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -134.51 -143.55 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 t -50.98 -30.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.61 158.91 19.23 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.67 122.54 11.41 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.769 2.313 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 126.35 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 109.981 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.55 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.6 m-85 -46.29 -37.27 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.085 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -61.05 -50.72 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.02 92.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.041 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 90.6 t -57.08 -45.45 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 77' ' ' LEU . . . -53.04 -58.97 5.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -55.77 -40.93 73.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.756 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -34.25 74.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -100.7 1.8 40.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.17 62.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 17.79 44.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -132.17 147.62 52.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 110.096 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -90.75 -33.83 15.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -91.12 28.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -62.72 -20.24 64.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.29 -57.45 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -57.64 -56.59 19.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' A' ' 42' ' ' LEU . 42.8 t80 -49.45 -63.98 0.94 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.98 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.437 HD12 ' CB ' ' A' ' 73' ' ' ALA . 10.7 mt -43.11 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.585 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.45 -38.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -56.93 -39.96 89.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -89.18 -7.52 55.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 110.059 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 46.2 mt -77.78 -39.48 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -3.52 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -102.51 -34.77 9.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.46 -174.01 45.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.18 -147.47 16.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 6.8 p 174.16 -164.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 110.074 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.88 -10.33 6.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 78.1 t -109.92 -15.77 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 110.088 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 94.5 m95 -122.67 -9.15 8.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.6 -166.17 31.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 56' ' ' SER . 5.6 p -103.39 55.28 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -1.159 . . . . 0.0 110.096 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.46 96.51 45.82 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.52 87.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.771 2.314 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.4 ttt -55.64 139.82 67.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.928 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.29 142.51 86.27 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.633 2.222 . . . . 0.0 110.25 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.8 Cg_endo -63.17 165.99 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.647 2.231 . . . . 0.0 110.19 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 26.5 mm-40 -137.58 164.86 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -104.11 70.76 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -127.48 155.97 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.28 -0.888 . . . . 0.0 110.099 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -104.95 171.41 7.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' THR . 36.0 t0 -43.35 -53.43 5.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.032 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.23 -59.14 3.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.901 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -54.82 -41.09 70.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.585 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -59.31 -35.63 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.802 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 2.0 ttpm? -65.76 -51.71 56.96 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.423 -0.798 . . . . 0.0 110.009 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.68 -30.17 54.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.453 HD13 HG21 ' A' ' 46' ' ' ILE . 19.1 mt -70.26 -51.07 33.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.894 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.437 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -69.57 -31.62 69.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -75.46 -37.39 60.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.487 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.6 t90 -79.08 -37.78 37.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 109.847 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.546 HD11 ' CE1' ' A' ' 25' ' ' TYR . 79.0 mt -71.99 -40.33 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.84 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 29.5 mt -65.24 -45.26 85.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -60.22 -29.24 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.044 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.55 ' CG2' ' CD2' ' A' ' 16' ' ' LEU . 42.6 mt -64.9 109.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.072 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.424 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.5 m -88.36 -29.26 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -1.155 . . . . 0.0 109.998 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -59.21 -14.57 11.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.114 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -26.62 4.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.978 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.4 m -133.86 -36.08 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.957 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.439 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 88.5 m-70 -71.26 -179.32 2.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.27 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER 174.34 125.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.914 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.434 HD23 HG22 ' A' ' 79' ' ' ILE . 25.1 mt -42.43 -68.76 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -122.28 42.49 3.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -139.52 82.39 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.373 -0.829 . . . . 0.0 110.138 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -59.47 79.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -85.12 -90.57 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 27.2 t -96.0 -46.32 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 109.889 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.55 167.78 13.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.57 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -60.98 120.06 7.56 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.764 2.309 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.29 130.6 4.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 109.977 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CE1' HD11 ' A' ' 76' ' ' ILE . 4.9 m-85 -48.67 -32.22 7.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.69 -44.06 74.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.09 -49.38 76.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 39.8 t -57.3 -44.31 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.867 . . . . 0.0 110.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -51.55 -55.06 21.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.971 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -54.08 -46.37 72.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.53 -32.34 65.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 110.127 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CD2' HG11 ' A' ' 28' ' ' VAL . 24.3 m-85 -105.46 1.19 27.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.06 -29.01 67.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.039 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.12 16.3 48.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -115.47 139.02 50.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -1.161 . . . . 0.0 110.065 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -95.36 -16.53 22.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.068 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.71 12.69 21.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.464 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -53.46 -20.31 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.038 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 70' ' ' LYS . 41.3 t -68.62 -57.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.072 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.62 -52.77 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.05 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.422 ' OH ' ' HE3' ' A' ' 45' ' ' LYS . 86.6 t80 -52.61 -62.78 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 73' ' ' ALA . 45.4 mt -43.26 -74.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.61 -39.86 2.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.415 -0.803 . . . . 0.0 110.079 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.34 -36.78 70.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HE3' ' OH ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -92.1 -15.63 27.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -1.111 . . . . 0.0 110.076 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 49.7 mt -67.34 -44.59 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.096 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -82.56 6.95 15.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.46 -31.1 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 110.046 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.39 -160.32 49.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 100.24 -143.72 16.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.4 p 169.76 -172.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -1.157 . . . . 0.0 110.043 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.95 -9.25 5.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.13 -18.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -1.132 . . . . 0.0 110.081 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CD2' ' HG3' ' A' ' 23' ' ' PRO . 97.4 m95 -117.99 -26.89 6.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.081 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.47 -154.04 20.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.429 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -111.51 44.94 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.113 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.52 96.14 26.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.7 92.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.73 2.287 . . . . 0.0 110.292 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.2 ttt -62.67 138.84 96.9 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.513 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.47 142.15 83.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.616 2.21 . . . . 0.0 110.299 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.76 165.49 18.33 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.645 2.23 . . . . 0.0 110.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 26.5 mm-40 -134.67 163.43 29.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 16.4 p-10 -104.33 59.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.055 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.465 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.23 155.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.106 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -99.55 165.38 11.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 109.92 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 6.4 p-10 -43.36 -47.04 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.025 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.47 -61.09 2.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.883 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.41 -40.95 68.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.753 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . . . -59.45 -34.17 72.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.469 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -65.77 -52.1 53.7 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.401 -0.812 . . . . 0.0 110.053 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.75 -29.85 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.59 -49.84 43.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . . . -70.77 -31.05 67.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.381 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 4.4 mt-30 -76.03 -37.04 58.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.423 -0.798 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.478 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 23.6 t90 -80.35 -37.42 32.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.835 . . . . 0.0 109.765 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 25' ' ' TYR . 57.0 mt -72.35 -40.35 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.858 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 28.2 mt -66.83 -43.65 83.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.872 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.2 p -60.83 -30.22 69.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 75' ' ' TRP . 36.8 mt -67.85 107.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.069 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 m -92.22 -29.64 16.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 110.153 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.5 mmt -60.46 -13.53 14.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.58 -24.87 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.036 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.0 m -136.31 -36.57 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 89.6 m-70 -71.25 -179.71 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.393 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER 172.2 118.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.871 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.524 HD21 ' CG2' ' A' ' 79' ' ' ILE . 1.6 mt -41.71 -58.27 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.36 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.54 42.64 3.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -146.47 87.86 1.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -85.83 -143.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.3 t -51.48 -30.99 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.977 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.48 160.53 13.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.565 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.84 128.74 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.79 2.327 . . . . 0.0 110.317 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -50.3 122.6 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 76' ' ' ILE . 2.6 m-85 -43.64 -29.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HA ' HG23 ' A' ' 79' ' ' ILE . . . -71.97 -45.78 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 0.0 109.99 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.66 -49.04 79.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.606 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 37.5 t -56.37 -43.57 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.885 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' ILE . . . -52.24 -61.61 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.984 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -53.39 -40.75 65.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -33.53 71.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CB ' HD22 ' A' ' 77' ' ' LEU . 13.8 m-85 -106.67 4.58 28.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.095 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -69.99 -28.57 65.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 0.0 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.81 14.88 55.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.98 165.45 12.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.114 . . . . 0.0 110.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -115.65 -6.87 12.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 110.04 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -123.89 18.45 9.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -55.84 -23.24 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 21.5 t -67.13 -55.3 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.955 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.97 -51.64 68.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 42' ' ' LEU . 30.0 t80 -54.5 -67.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.064 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mt -43.05 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 110.131 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.5 -39.14 2.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.096 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -59.04 -42.78 97.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.25 -13.76 51.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -1.114 . . . . 0.0 110.003 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.512 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 40.7 mt -69.68 -47.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -81.64 -19.84 40.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 35.3 mttm -92.24 -30.85 15.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 110.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.3 -167.77 31.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.17 -143.02 15.82 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.9 t 169.71 -179.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -1.094 . . . . 0.0 110.08 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 136.79 -11.3 3.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.13 -29.61 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -1.161 . . . . 0.0 110.076 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 97.1 m95 -104.67 -22.98 13.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.76 -138.26 5.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.49 67.52 0.85 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -1.159 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 51' ' ' SER . 40.0 t -136.38 91.82 16.09 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.92 77.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.724 2.282 . . . . 0.0 110.285 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.6 ttt -45.62 141.21 4.04 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.991 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.03 143.23 90.45 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.674 2.249 . . . . 0.0 110.317 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.03 167.16 12.8 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.666 2.244 . . . . 0.0 110.128 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 25.3 mm-40 -139.69 166.39 24.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 110.073 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -105.31 68.1 0.8 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.419 HG23 HG23 ' A' ' 46' ' ' ILE . 3.5 m -114.77 155.93 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 p -103.55 167.52 9.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.93 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.45 -62.06 1.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.02 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.56 -55.75 5.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.901 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.79 -42.95 76.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.482 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -58.86 -35.81 73.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.825 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -66.33 -50.79 62.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.436 -0.79 . . . . 0.0 110.032 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.69 -29.24 59.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 77.8 mt -70.39 -49.47 48.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB3' HD11 ' A' ' 42' ' ' LEU . . . -70.51 -31.21 68.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.09 -37.57 58.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.467 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 23.3 t90 -79.64 -36.67 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.793 . . . . 0.0 109.796 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.567 HG12 ' CD1' ' A' ' 25' ' ' TYR . 25.2 mt -71.86 -39.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.884 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.493 HD22 ' CB ' ' A' ' 32' ' ' TYR . 18.1 mt -68.02 -42.44 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.1 t -62.04 -37.83 86.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.913 . . . . 0.0 109.962 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.524 ' CG2' HD21 ' A' ' 16' ' ' LEU . 19.5 mt -59.39 97.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.026 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.462 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -90.0 -28.99 18.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.079 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -14.01 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.123 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.66 -25.1 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.0 m -135.72 -36.83 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.498 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 88.8 m-70 -70.31 -179.45 2.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.44 124.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.904 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 79' ' ' ILE . 27.0 mt -42.46 -64.69 0.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 42.19 3.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 15' ' ' ASP . . . -146.3 84.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 110.147 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.88 64.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 16.4 mttm -62.57 -90.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.056 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 29.3 t -93.68 -44.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.49 166.27 13.24 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.05 7.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.754 2.302 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.29 132.66 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.498 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 6.8 m-85 -49.85 -32.4 14.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -44.67 76.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.935 . . . . 0.0 110.071 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -49.92 73.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.565 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 36.1 t -56.49 -43.48 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.993 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 76' ' ' ILE . . . -52.44 -57.24 10.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -43.76 64.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -36.41 67.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.525 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 14.1 m-85 -99.1 4.08 46.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.28 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.04 61.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.92 160.67 37.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -1.175 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -111.42 -26.94 8.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -84.65 9.21 14.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -60.79 -25.02 66.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.78 -53.87 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -54.07 50.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -51.82 -61.76 2.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 38' ' ' ALA . 8.2 mt -43.05 -73.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.79 -41.23 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.381 -0.825 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.22 73.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -90.93 -9.72 45.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -1.143 . . . . 0.0 109.991 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 41.0 mt -73.38 -47.74 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.02 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -4.75 47.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -5.12 10.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.928 . . . . 0.0 110.077 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 45.29 -134.73 7.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 82.83 -143.33 22.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 3.6 t 169.79 -178.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.416 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 142.75 -14.63 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 53' ' ' VAL . 96.4 t -106.67 -11.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -1.142 . . . . 0.0 110.072 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.565 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 96.7 m95 -120.37 -29.1 4.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.013 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.39 -142.14 6.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 65.6 m -120.57 45.82 2.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.235 -1.156 . . . . 0.0 110.123 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.7 t -111.58 94.99 25.21 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.04 77.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.695 2.263 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.8 ttt -46.62 140.39 5.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.92 144.99 94.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.623 2.216 . . . . 0.0 110.289 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.62 166.48 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.714 2.276 . . . . 0.0 110.205 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -137.74 165.2 27.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.095 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -105.14 60.85 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 HG11 ' OE1' ' A' ' 68' ' ' GLU . 3.6 m -113.82 155.82 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -0.947 . . . . 0.0 110.153 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.11 167.8 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -43.46 -59.08 2.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.92 -56.66 5.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.907 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.428 ' OE1' HG11 ' A' ' 64' ' ' VAL . 4.1 mt-10 -55.29 -42.49 73.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 109.875 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . . . -58.17 -35.88 72.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 109.835 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -51.81 59.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -0.813 . . . . 0.0 110.001 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.95 -29.79 57.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 110.012 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.24 -50.59 38.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.855 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.73 -31.83 70.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.141 -0.974 . . . . 0.0 109.432 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -75.47 -37.34 60.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.338 -0.852 . . . . 0.0 109.504 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.475 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.5 t90 -79.15 -37.6 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 78.0 mt -72.43 -39.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 18.8 mt -66.13 -46.11 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.8 m -58.31 -31.55 67.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.981 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 75' ' ' TRP . 18.5 mt -67.26 128.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.038 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.103 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.8 m -93.0 -29.11 16.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -1.083 . . . . 0.0 110.012 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -16.06 10.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.09 -25.13 3.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 109.984 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.7 m -136.61 -36.01 0.72 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.2 m-70 -73.05 -179.62 3.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 170.07 121.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.78 . . . . 0.0 109.86 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.517 HD22 ' CG2' ' A' ' 79' ' ' ILE . 4.0 mp -41.93 -63.24 0.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.302 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.97 42.38 3.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -140.22 83.95 1.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -56.08 84.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.106 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -94.61 -143.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.048 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 42.1 t -52.18 -31.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 164.39 14.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.572 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.17 130.82 33.84 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.715 2.277 . . . . 0.0 110.241 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -51.3 126.89 18.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.019 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.55 ' CE1' HD11 ' A' ' 76' ' ' ILE . 2.8 m-85 -46.3 -37.68 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -61.45 -56.28 21.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.971 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.3 -34.07 71.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.073 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 34.1 t -60.89 -50.98 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -54.82 -46.72 74.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.871 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 2.2 mtpm? -59.25 -43.33 92.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.943 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -34.8 71.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -101.7 -1.79 31.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.082 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.26 -22.0 27.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.07 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.75 20.74 30.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 127.77 40.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -1.182 . . . . 0.0 110.097 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -38.66 69.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.49 40.82 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.21 -24.06 63.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.033 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 60.7 t -73.61 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.65 -51.07 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -52.33 -63.02 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.984 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 73' ' ' ALA . 28.6 mt -46.94 -74.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 110.119 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.39 -39.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 110.045 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -57.38 -40.61 92.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -87.8 -10.39 51.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.041 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.513 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 42.3 mt -73.4 -44.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 110.066 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.81 11.3 13.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.034 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -111.48 -45.24 3.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.46 179.24 52.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.81 -147.35 16.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.3 p 169.66 -168.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -1.073 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.96 -16.76 5.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -96.21 -23.82 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 110.139 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.572 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.8 m95 -112.58 -18.01 12.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.76 -153.17 23.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -111.68 66.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -1.115 . . . . 0.0 110.04 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.22 95.78 14.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.116 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.76 86.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.704 2.27 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.7 ttt -55.36 138.93 67.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 109.981 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.61 141.77 81.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.586 2.191 . . . . 0.0 110.332 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.39 169.73 9.13 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.62 2.214 . . . . 0.0 110.091 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.447 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 24.9 mm-40 -137.73 164.67 28.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.69 55.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.98 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.462 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 3.5 m -114.4 155.85 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.882 . . . . 0.0 110.099 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' ASP . 77.5 p -105.61 172.66 6.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 t0 -43.56 -50.34 7.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.036 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -48.76 -63.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 11.5 mt-10 -53.54 -39.97 65.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.237 -0.915 . . . . 0.0 109.768 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.548 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -60.19 -34.66 73.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.718 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 16.2 mttm -65.61 -51.55 58.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.808 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.96 -30.32 61.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.19 -49.76 47.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.853 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.29 -32.44 70.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 0.0 109.426 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 3.1 mm-40 -74.99 -36.82 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.483 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.477 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.6 t90 -79.51 -38.26 34.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -0.831 . . . . 0.0 109.898 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.55 HD11 ' CE1' ' A' ' 25' ' ' TYR . 50.5 mt -68.43 -36.54 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.931 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 29' ' ' ALA . 19.3 mt -69.94 -47.52 62.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 109.943 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 t -58.46 -23.46 57.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.517 ' CG2' HD22 ' A' ' 16' ' ' LEU . 36.6 mt -73.22 114.28 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 109.994 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.064 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.7 m -102.36 -28.82 12.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -1.152 . . . . 0.0 110.03 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.96 -16.17 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 110.138 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.14 -24.31 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 109.976 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.1 m -137.0 -37.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.034 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.402 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -70.75 -179.56 2.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 176.04 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.0 109.819 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' CD2' HD13 ' A' ' 79' ' ' ILE . 28.8 mt -42.48 -65.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -122.04 42.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 15' ' ' ASP . . . -146.97 82.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.78 71.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -71.89 -90.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.249 -0.907 . . . . 0.0 109.977 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 29.6 t -90.4 -40.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.883 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.11 165.34 12.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.529 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 121.16 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.608 2.206 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.25 129.95 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 110.02 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.479 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.5 m-85 -48.65 -31.69 7.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.41 -46.21 73.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -48.84 79.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 93.0 t -56.93 -44.41 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -51.73 -62.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.08 -39.99 63.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -60.01 -34.52 73.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.099 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 4.0 m-85 -96.26 4.57 52.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.105 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.86 -17.53 60.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.053 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 16.56 51.41 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.19 157.48 46.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -1.129 . . . . 0.0 110.063 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -104.68 -3.16 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.155 -0.965 . . . . 0.0 110.109 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -115.23 20.63 14.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -62.0 -21.65 65.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.077 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.67 -57.24 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.14 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -53.52 57.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.407 ' O ' ' C ' ' A' ' 42' ' ' LEU . 18.9 t80 -51.04 -63.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.522 HD13 ' CB ' ' A' ' 73' ' ' ALA . 22.4 mt -43.4 -73.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.537 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.32 -39.54 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.092 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.9 -42.66 92.47 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -84.75 -14.97 46.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.164 . . . . 0.0 109.971 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 28.8 mt -67.62 -46.25 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 110.014 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -16.62 43.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -95.36 -30.53 13.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.74 -157.76 29.74 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.4 -132.57 11.08 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.2 p 169.85 178.6 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 110.085 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 141.02 -20.32 2.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -105.75 -22.31 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -1.126 . . . . 0.0 110.084 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.487 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 80.3 m95 -119.53 -12.37 9.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.67 -145.95 10.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.461 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 3.7 m -122.92 -26.51 4.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 110.1 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . 21.9 t -41.6 102.04 0.26 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.7 88.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.654 2.236 . . . . 0.0 110.248 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.2 ttt -55.63 138.88 69.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.41 143.58 88.83 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.589 2.193 . . . . 0.0 110.332 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.426 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.86 169.32 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.757 2.304 . . . . 0.0 110.116 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 31.5 mm-40 -137.97 165.69 25.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.042 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -104.76 56.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 3.7 m -114.62 155.78 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.13 170.3 8.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.922 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -43.33 -53.63 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.983 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -49.32 -59.07 4.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.31 -40.82 68.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.889 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.537 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -59.02 -36.66 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.395 -0.815 . . . . 0.0 109.869 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 29.5 mttt -64.82 -51.03 64.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.38 -0.825 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.2 tm0? -55.05 -31.04 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 110.012 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HB3' HD12 ' A' ' 46' ' ' ILE . 8.1 mt -70.01 -50.34 42.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.824 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' CB ' HD13 ' A' ' 42' ' ' LEU . . . -68.7 -34.4 75.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.455 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.18 -37.89 66.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.434 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.472 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 17.3 t90 -76.78 -39.83 50.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 109.754 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.479 HG12 ' CD1' ' A' ' 25' ' ' TYR . 37.8 mt -68.13 -46.07 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 58.2 mt -61.08 -41.13 96.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.895 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.465 HD13 ' CD2' ' A' ' 16' ' ' LEU . 11.6 mt -59.23 100.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.5 m -69.75 -29.61 67.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -1.161 . . . . 0.0 110.094 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 mmt -60.58 -13.31 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.106 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.0 -36.39 60.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.6 m -126.73 -8.4 6.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.448 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 81.6 m-70 -101.67 -178.35 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 110.426 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 1.1 m-20 170.75 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 109.793 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 26.7 mt -42.53 -68.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 42.86 3.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.849 . . . . 0.0 110.057 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . . . -138.07 88.0 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -50.59 159.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.125 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 2.3 tptt 177.42 -147.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 109.916 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 72.1 t -49.65 -29.53 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -130.07 153.3 20.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.566 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.78 120.98 9.0 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.708 2.272 . . . . 0.0 110.323 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 136.47 3.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.543 ' CE1' HD11 ' A' ' 76' ' ' ILE . 7.2 m-85 -54.75 -33.65 61.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.01 -52.32 60.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 110.165 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.608 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -57.84 -46.03 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.995 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 76' ' ' ILE . . . -49.33 -66.84 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.918 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -53.08 -38.3 62.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.563 ' HD2' ' CZ2' ' A' ' 54' ' ' TRP . 7.5 ttmt -63.22 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -100.16 -5.48 27.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.84 -22.67 65.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.061 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.79 11.75 65.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.12 127.02 45.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.119 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -77.07 -29.19 54.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.081 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.51 18.23 10.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 42' ' ' LEU . . . -65.25 -23.83 67.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.085 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 61.5 t -70.79 -58.77 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.053 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.45 -51.31 69.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.2 t80 -52.26 -65.87 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 38' ' ' ALA . 15.9 mt -43.01 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB3' ' CB ' ' A' ' 69' ' ' ALA . . . -42.54 -40.11 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.077 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.61 -41.28 93.54 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -9.37 55.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.441 HD11 ' HA ' ' A' ' 43' ' ' ALA . 8.2 mt -73.96 -49.2 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.18 -2.89 20.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -120.28 -17.64 8.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.32 -153.93 26.37 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.68 -145.33 16.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 5.5 p 173.43 -170.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 110.058 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.48 -19.2 6.33 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.5 t -96.35 -22.64 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 94.6 m95 -112.92 -35.46 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.56 -140.83 4.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.416 ' C ' HG22 ' A' ' 57' ' ' VAL . 5.3 p -120.07 63.84 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -1.135 . . . . 0.0 110.026 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.416 HG22 ' C ' ' A' ' 56' ' ' SER . 57.2 t -131.52 95.82 22.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.042 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.74 86.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.693 2.262 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.408 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 9.0 ttt -55.12 139.88 63.7 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 2.9 Cg_endo -62.83 141.36 84.47 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.653 2.235 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.425 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 3.0 Cg_endo -63.08 168.83 10.1 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.687 2.258 . . . . 0.0 110.087 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 33.3 mm-40 -139.04 166.61 24.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -105.3 64.62 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.103 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.99 155.81 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 110.137 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.09 169.29 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.89 . . . . 0.0 109.958 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -43.47 -52.03 6.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.999 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.21 6.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -40.5 68.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.863 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . . . -58.79 -36.89 75.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.808 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.1 57.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.342 -0.849 . . . . 0.0 109.981 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.13 -29.5 45.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 110.036 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.5 mt -70.16 -51.69 29.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -69.41 -31.67 70.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.12 -36.93 61.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.558 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.514 ' CE2' HD12 ' A' ' 79' ' ' ILE . 21.4 t90 -79.49 -38.78 33.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.832 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.543 HD11 ' CE1' ' A' ' 25' ' ' TYR . 57.0 mt -70.49 -38.55 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 29' ' ' ALA . 24.1 mt -68.46 -41.47 80.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.961 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.31 -38.42 91.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.023 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.514 HD12 ' CE2' ' A' ' 75' ' ' TRP . 9.2 mt -60.3 120.01 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.998 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.419 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.121 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.462 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.7 m -86.73 -29.05 22.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -1.158 . . . . 0.0 109.983 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmt -56.88 -16.85 7.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.57 -22.27 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 15.0 m -138.47 -37.22 0.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 0.0 110.124 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.487 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 89.3 m-70 -72.56 -178.34 2.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 169.87 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.858 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.449 HD21 HG23 ' A' ' 79' ' ' ILE . 25.5 mt -42.15 -62.93 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 42.86 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -152.35 75.52 1.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.185 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.47 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.847 . . . . 0.0 110.205 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.6 mtpt -67.92 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.008 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 25.4 t -91.41 -31.82 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.935 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.4 167.75 13.37 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.82 8.75 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.738 2.292 . . . . 0.0 110.273 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.97 134.73 4.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CD1' HG12 ' A' ' 76' ' ' ILE . 5.9 m-85 -51.25 -32.36 24.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.78 -44.78 69.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.029 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.98 -47.84 84.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 32.5 t -56.83 -44.61 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' CB ' ' HA ' ' A' ' 77' ' ' LEU . . . -52.29 -59.15 4.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -55.12 -42.95 73.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 109.824 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 tptt -60.28 -33.39 72.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.049 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 42' ' ' LEU . 5.2 m-85 -90.46 5.74 46.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.84 -23.72 66.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.18 13.11 62.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -117.11 138.13 51.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -1.125 . . . . 0.0 110.068 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -90.82 -16.34 28.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.85 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.46 33.74 5.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.107 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.485 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -57.47 -21.46 37.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.071 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -69.72 -57.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.0 -54.79 42.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.2 t80 -51.64 -63.7 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.062 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.495 HD22 ' CE2' ' A' ' 32' ' ' TYR . 15.7 mt -43.14 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.51 -40.3 2.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.432 -0.793 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.38 -37.71 75.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' LEU . 3.4 mmtt -91.35 -7.98 49.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -1.157 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 53.5 mt -78.03 -37.28 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 0.0 110.062 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -90.75 4.49 51.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.081 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -119.89 -43.7 2.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.11 -164.98 40.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 104.9 -140.34 14.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.62 -176.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.9 -10.71 4.52 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -111.65 -6.29 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 110.116 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.497 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.0 m95 -135.52 4.37 3.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -153.54 23.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -116.78 48.82 1.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.15 . . . . 0.0 110.119 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.81 96.22 27.76 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -60.58 88.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 110.34 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.6 ttt -62.01 139.49 95.86 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.961 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.38 143.02 87.79 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.684 2.256 . . . . 0.0 110.364 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.8 Cg_endo -63.09 167.9 11.66 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.671 2.247 . . . . 0.0 110.151 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.45 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 26.3 mm-40 -138.14 165.1 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.25 62.07 0.68 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.006 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 46' ' ' ILE . 3.4 m -114.99 155.8 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.2 p -99.87 164.96 11.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.955 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -43.38 -51.66 6.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.947 . . . . 0.0 110.035 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.41 -58.05 6.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.77 -41.72 70.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -58.11 -35.12 70.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.43 -0.794 . . . . 0.0 109.804 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -52.76 48.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.85 . . . . 0.0 110.029 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.28 -29.62 47.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.2 mt -70.11 -50.87 36.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.919 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . . . -69.45 -32.22 71.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -74.94 -37.45 62.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.823 . . . . 0.0 109.524 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.474 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.7 t90 -78.81 -38.17 38.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.813 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.492 HG12 ' CD1' ' A' ' 25' ' ' TYR . 52.3 mt -70.08 -42.19 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.062 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.507 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.3 mt -64.23 -47.24 80.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -28.44 62.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 75' ' ' TRP . 29.4 mt -71.23 139.27 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.403 ' N ' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.058 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.425 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.6 m -103.75 -29.61 10.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -1.123 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.2 mmt -60.22 -13.84 14.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.35 -34.72 48.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.071 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -125.32 -26.0 3.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.87 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.5 m-70 -83.67 -179.65 7.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 110.467 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 168.23 125.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.463 -0.773 . . . . 0.0 109.688 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 79' ' ' ILE . 25.6 mt -42.14 -64.91 0.52 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 42.75 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 110.115 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -145.28 45.19 1.32 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.88 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 110.085 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 18' ' ' ALA . 9.6 mtmt -93.62 -90.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 30.7 t -80.02 -31.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.04 169.21 16.99 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 123.41 12.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.745 2.297 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -48.48 135.9 13.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.506 ' CE1' HD12 ' A' ' 76' ' ' ILE . 5.2 m-85 -50.51 -32.46 18.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.77 -49.54 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 110.044 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.57 -44.82 89.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.86 . . . . 0.0 109.977 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 84.5 t -57.46 -45.7 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.94 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -52.74 -52.69 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -54.23 -45.21 72.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.906 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 11.0 mttt -55.65 -36.83 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 110.104 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 12.2 m-85 -101.16 -4.09 27.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 110.089 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -62.3 -26.38 68.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.41 15.64 55.86 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.08 174.02 8.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.039 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -120.36 -22.26 6.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.123 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -100.62 20.32 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.081 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -60.01 -23.89 64.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.456 HG13 ' HD3' ' A' ' 70' ' ' LYS . 60.1 t -66.87 -53.66 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.59 -55.74 27.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.094 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 50.8 t80 -48.31 -64.7 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 110.048 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' A' ' 73' ' ' ALA . 18.5 mt -42.99 -73.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.62 -40.99 2.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.087 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.75 -38.44 72.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' CE ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -89.93 -16.54 29.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 110.039 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 45.1 mt -65.91 -45.07 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 110.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -81.64 -13.88 57.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -101.22 -43.75 5.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.095 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.84 -148.52 38.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 92.52 -135.47 12.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 175.95 -177.43 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 110.052 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.52 -22.01 5.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 53' ' ' VAL . 69.0 t -89.08 -21.55 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -1.164 . . . . 0.0 110.005 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.555 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.2 m95 -117.2 -39.34 3.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.27 -128.93 1.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 p -124.26 62.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 110.135 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.68 92.01 49.28 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.23 86.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.76 2.307 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.2 ttt -63.92 139.92 97.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 109.933 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.66 142.15 82.39 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 110.316 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.22 162.73 25.52 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.661 2.24 . . . . 0.0 110.12 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.447 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 21.9 mm-40 -134.91 163.8 29.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 110.097 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -104.58 65.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 46' ' ' ILE . 3.5 m -114.34 155.88 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 43.6 p -103.28 168.49 9.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 9.4 m-20 -43.39 -57.87 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.052 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.7 -59.02 3.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.939 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -41.59 70.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.899 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -36.15 75.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.825 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HD3' HG13 ' A' ' 39' ' ' VAL . 32.1 mmtt -67.2 -51.05 58.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.36 -29.66 49.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 72' ' ' LEU . 59.6 mt -70.11 -52.3 24.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.518 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -68.66 -33.49 74.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -73.45 -36.58 65.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.433 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.475 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 19.7 t90 -78.61 -40.72 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.851 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.506 HD12 ' CE1' ' A' ' 25' ' ' TYR . 51.2 mt -69.39 -39.65 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.971 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 29' ' ' ALA . 46.2 mt -66.51 -42.25 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.87 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -63.68 -43.07 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.521 HG21 ' CD2' ' A' ' 16' ' ' LEU . 25.8 mt -49.63 98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.059 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.434 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 18.0 m -80.83 -30.75 35.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.063 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -14.69 14.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.32 -26.97 5.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.8 m -133.8 -35.1 0.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.573 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 90.2 m-70 -73.82 179.95 3.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.439 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 171.46 119.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 4.7 mp -41.73 -60.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 110.35 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.74 42.75 3.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.219 -0.926 . . . . 0.0 110.07 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -143.12 85.86 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.114 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -57.83 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -92.19 -145.37 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.055 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.1 t -51.54 -31.41 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 110.066 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.02 163.96 13.19 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.572 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 131.82 38.7 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.743 2.295 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -53.14 123.9 13.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.573 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.5 m-85 -46.09 -31.51 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -69.22 -45.64 69.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.062 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.48 -45.0 92.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.895 . . . . 0.0 110.108 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 52.5 t -58.14 -46.74 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.036 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -52.49 -54.57 30.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.981 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -54.82 -43.62 73.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -35.41 70.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 110.085 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.52 1.65 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.01 -28.98 68.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.35 19.39 36.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -120.19 158.65 26.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.073 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 -19.54 13.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -103.12 18.8 20.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.13 -23.16 45.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 t -70.67 -54.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.079 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.04 -53.1 61.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.071 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' LEU . 51.8 t80 -52.95 -65.02 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 45' ' ' LYS . 26.4 mt -43.93 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -42.64 -37.64 1.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.397 -0.814 . . . . 0.0 110.102 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.05 65.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.7 tptp -101.41 -13.97 17.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.2 mt -72.49 -44.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.093 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -80.21 -5.43 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.44 -13.46 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.045 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 53.6 -149.93 13.48 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.69 -147.7 16.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.1 t 169.69 -178.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 110.099 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 133.84 -11.94 4.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.5 t -102.88 -27.33 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.067 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.572 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.8 m95 -107.05 -13.69 15.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.088 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.91 -147.85 16.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 56' ' ' SER . 3.6 p -116.35 50.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -1.14 . . . . 0.0 110.079 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.14 95.84 47.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.86 103.92 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.752 2.301 . . . . 0.0 110.336 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 6.8 ttt -75.54 139.7 71.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.907 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.37 138.76 67.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.67 2.246 . . . . 0.0 110.365 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.421 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.6 168.87 10.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.597 2.198 . . . . 0.0 110.173 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 30.2 mm-40 -138.17 165.56 26.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.937 . . . . 0.0 110.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -105.16 65.1 0.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.11 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.91 155.84 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -100.53 165.3 11.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.018 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 65' ' ' THR . 3.5 t0 -43.36 -55.51 4.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.4 -60.4 2.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.66 -41.3 69.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.751 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . . . -59.27 -34.21 71.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.845 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -52.24 50.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.414 -0.804 . . . . 0.0 110.039 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.17 -30.03 59.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 69' ' ' ALA . 76.3 mt -70.21 -50.24 41.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.884 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.88 -32.39 70.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -74.79 -37.29 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.478 ' CE2' HD12 ' A' ' 79' ' ' ILE . 20.9 t90 -79.02 -38.42 36.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.822 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' CE1' ' A' ' 25' ' ' TYR . 44.8 mt -72.47 -38.02 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.953 . . . . 0.0 109.961 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 17.0 mt -67.03 -44.5 80.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.916 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -61.27 -30.59 70.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 109.963 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.478 HD12 ' CE2' ' A' ' 75' ' ' TRP . 43.0 mt -62.76 101.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.019 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.463 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.067 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.7 m -73.07 -29.06 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.973 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 mmt -59.54 -15.91 21.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.107 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -23.66 2.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.223 -0.923 . . . . 0.0 109.978 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.446 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.7 m -136.88 -36.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.31 -0.869 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.502 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 88.1 m-70 -71.64 -179.57 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 110.468 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.38 122.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.505 -0.747 . . . . 0.0 109.669 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.51 ' CD2' HG21 ' A' ' 79' ' ' ILE . 32.1 mt -42.07 -65.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 110.313 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.5 42.6 3.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -155.16 45.52 0.5 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 6.4 pttt -45.69 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.2 tptt -79.68 -90.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.071 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 25.9 t -78.67 -31.7 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.074 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.39 174.78 16.31 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 147.49 95.3 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.744 2.296 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -71.28 129.81 39.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 109.979 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.55 ' CD1' HG12 ' A' ' 76' ' ' ILE . 3.4 m-85 -45.98 -30.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.105 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.69 -46.93 51.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.966 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -49.11 78.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 109.93 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.606 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 45.7 t -56.31 -43.4 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.91 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -52.23 -57.47 9.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 14.1 tttm -53.78 -44.7 70.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.907 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -34.0 69.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' HB2' ' CD2' ' A' ' 77' ' ' LEU . 28.2 m-85 -99.24 3.12 46.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' LYS . . . -67.79 -28.97 68.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.065 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.5 19.59 35.5 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.09 146.39 45.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -1.167 . . . . 0.0 110.058 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 37' ' ' ASP . 8.7 ptpt -96.09 -27.38 15.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 38.9 m-20 -105.34 29.07 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.061 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -59.21 -25.13 63.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG1' ' HG3' ' A' ' 70' ' ' LYS . 3.8 t -68.31 -54.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -58.61 -55.64 32.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.52 -66.18 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 0.0 110.083 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 38' ' ' ALA . 2.1 mt -43.13 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.77 -38.39 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 110.08 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -41.19 95.18 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -87.72 -9.18 54.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -1.168 . . . . 0.0 110.056 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 42.2 mt -74.17 -50.62 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 2.0 mtmt -73.69 -9.05 58.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.111 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -121.26 -7.4 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 44.35 -142.74 2.77 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.11 -137.46 13.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.75 -174.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.22 -10.33 7.77 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 53' ' ' VAL . 53.8 t -107.87 -16.5 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.26 -1.141 . . . . 0.0 110.15 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 95.7 m95 -121.38 -27.12 4.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.52 -141.47 6.26 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 m -120.85 69.86 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 110.09 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 59' ' ' MET . 55.6 t -139.19 95.22 9.42 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.026 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.01 75.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.737 2.291 . . . . 0.0 110.276 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' VAL . 7.2 ttt -43.87 140.44 2.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.74 145.05 94.85 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.688 2.259 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.65 167.75 11.18 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.2 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.427 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 37.1 mm-40 -138.66 166.23 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.074 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -105.74 62.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 46' ' ' ILE . 3.6 m -114.72 155.95 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 3.5 p -104.46 168.39 9.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.8 OUTLIER -43.39 -62.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.046 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.85 -57.57 3.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -55.24 -42.58 73.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . . . -58.71 -34.84 71.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.91 -51.4 58.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.26 -30.42 60.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.183 -0.948 . . . . 0.0 109.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.2 -50.56 38.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 109.862 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.61 -32.26 70.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 78' ' ' SER . 0.1 OUTLIER -74.91 -37.49 62.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 109.499 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.472 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.6 t90 -78.84 -38.15 38.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.55 HG12 ' CD1' ' A' ' 25' ' ' TYR . 47.4 mt -73.05 -41.83 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 38' ' ' ALA . 36.4 mt -64.79 -41.75 95.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.0 OUTLIER -62.53 -31.47 72.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.51 HG21 ' CD2' ' A' ' 16' ' ' LEU . 28.9 mt -66.7 98.37 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.994 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.048 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 5.9 m-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.241 0.543 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 1' ' ' ASN . 0.5 OUTLIER 68.2 -67.53 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.062 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -50.28 -23.4 2.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.87 . . . . 0.0 110.123 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.32 -54.48 36.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 110.018 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.548 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -49.92 -30.39 10.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -66.33 -55.94 13.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 110.074 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -25.33 4.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.081 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' HB3' HBB2 ' A' ' 81' ' ' HEC . 0.0 OUTLIER -93.98 -46.3 7.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 110.134 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.31 34.56 5.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 14.5 m -76.71 -28.86 56.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 110.0 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.57 -15.66 7.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -24.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.008 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.9 m -136.44 -37.05 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.002 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.407 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.6 m-70 -71.49 -179.66 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 110.344 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER 176.55 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.834 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 79' ' ' ILE . 26.6 mt -42.66 -67.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -121.98 42.37 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.349 -0.844 . . . . 0.0 110.041 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -139.0 87.39 2.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 110.117 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pttt -55.51 85.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 110.06 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -96.63 -143.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 36.4 t -51.96 -31.4 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.0 161.01 15.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.87 120.06 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.705 2.27 . . . . 0.0 110.262 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.51 130.16 5.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.98 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.594 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 6.7 m-85 -51.02 -33.25 24.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -66.14 -42.67 88.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.15 -52.37 59.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 53.6 t -56.37 -43.38 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.878 . . . . 0.0 109.973 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -51.5 -57.9 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -45.14 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.933 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 9.3 mttt -58.13 -34.83 70.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.87 4.01 31.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -68.48 -29.27 67.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.6 19.91 34.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -112.72 174.08 6.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.13 . . . . 0.0 110.16 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -122.26 -12.68 8.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.79 19.04 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.062 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.01 -21.02 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.07 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 19.6 t -71.38 -56.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.98 -52.72 64.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 109.993 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 45.2 t80 -52.18 -66.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.478 ' CD1' ' HB1' ' A' ' 73' ' ' ALA . 59.9 mt -43.21 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.577 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.54 -35.92 1.21 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.411 -0.805 . . . . 0.0 110.108 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.29 -35.98 81.01 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' CB ' ' O1A' ' A' ' 81' ' ' HEC . 0.4 OUTLIER -93.94 -11.87 30.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -1.17 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.503 HG12 ' CMA' ' A' ' 81' ' ' HEC . 13.6 mt -72.01 -44.26 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 110.07 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -102.1 -44.15 5.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.96 -162.01 48.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.45 -136.37 12.78 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.92 -170.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 0.0 110.074 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.4 -19.55 5.65 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 53' ' ' VAL . 98.8 t -101.5 -20.2 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -1.134 . . . . 0.0 110.078 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 86.8 m95 -121.77 -27.59 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.022 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.38 -136.65 2.28 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 22.5 p -129.53 -35.06 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.074 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG13 ' CMD' ' A' ' 81' ' ' HEC . 3.4 p -42.19 102.66 0.28 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.131 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.8 87.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.203 . . . . 0.0 110.27 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.502 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.5 ttt -45.02 139.87 3.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' CD ' HBC3 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.684 2.256 . . . . 0.0 110.281 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.22 162.93 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 110.172 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 22.0 mm-40 -134.56 163.54 29.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 110.096 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -103.81 72.75 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.436 HG23 HG23 ' A' ' 46' ' ' ILE . 3.6 m -124.31 155.89 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ASP . 66.7 p -104.14 169.92 8.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.948 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' THR . 14.0 t0 -43.43 -58.0 2.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.05 -58.92 3.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -54.4 -41.29 69.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.577 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -58.48 -35.49 72.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.815 . . . . 0.0 109.858 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -65.17 -52.08 57.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.9 -30.03 57.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.998 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.456 HD23 HMB1 ' A' ' 81' ' ' HEC . 24.0 mt -70.24 -50.69 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' CD1' ' A' ' 42' ' ' LEU . . . -70.13 -30.79 68.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.471 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.24 -37.09 58.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.459 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.548 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 22.8 t90 -80.28 -36.83 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.594 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 54.9 mt -74.34 -37.22 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 24.7 mt -68.36 -46.91 68.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -57.42 -25.99 60.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.989 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 75' ' ' TRP . 16.8 mt -75.44 130.59 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.025 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.107 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.522 ' CMB' HBB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.265 0.555 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.47 -23.43 24.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -50.66 -21.2 1.48 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.114 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.5 mt -77.59 -33.49 53.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 110.105 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.594 ' CB ' ' CH2' ' A' ' 75' ' ' TRP . . . -82.44 -27.0 32.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.023 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mtmm -74.67 -58.24 3.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.106 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -50.09 -25.45 3.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.457 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -82.53 -51.83 7.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.077 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.78 20.98 7.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 8' ' ' LYS . 11.8 m -72.47 -29.01 63.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -1.214 . . . . 0.0 109.962 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -16.38 9.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.94 -28.02 6.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' SG ' HMC1 ' A' ' 81' ' ' HEC . 14.4 m -132.27 -34.15 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.513 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 89.1 m-70 -75.51 -179.22 4.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 169.39 124.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.75 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.482 ' CD2' HG21 ' A' ' 79' ' ' ILE . 23.2 mt -42.25 -66.47 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 42.71 3.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.943 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -147.73 45.75 1.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.02 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 10.6 pttt -42.4 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -89.73 -89.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 t -82.11 -31.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.872 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.22 170.26 15.59 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 3.0 Cg_endo -61.28 127.54 22.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.715 2.277 . . . . 0.0 110.273 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -51.08 133.36 27.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.218 -0.926 . . . . 0.0 109.939 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.513 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 4.6 m-85 -49.54 -32.19 11.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.14 -45.93 62.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.55 -44.71 95.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.529 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 34.7 t -57.68 -45.83 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 77' ' ' LEU . . . -52.86 -53.12 53.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.886 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . 20.7 ttmt -55.27 -45.39 76.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.976 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.74 66.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 41.6 m-85 -102.99 -1.25 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.081 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.35 -29.93 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.74 15.37 52.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -126.02 153.6 44.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -1.133 . . . . 0.0 110.038 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -20.71 13.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.016 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -96.52 14.65 23.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -59.53 -21.89 60.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -68.8 -56.91 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.984 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -52.92 63.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.0 t80 -51.8 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.519 HD13 ' CB ' ' A' ' 73' ' ' ALA . 78.2 mt -43.08 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.913 . . . . 0.0 110.123 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.74 -41.83 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.036 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.69 -40.61 88.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HB3' HBA2 ' A' ' 81' ' ' HEC . 0.3 OUTLIER -87.08 -13.67 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.076 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 41.1 mt -69.24 -46.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.027 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -83.22 -12.51 56.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.066 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -96.21 -37.28 10.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.61 -162.18 54.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 95.29 -141.09 15.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.76 -175.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -1.146 . . . . 0.0 110.05 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.43 -12.33 3.5 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 53' ' ' VAL . 98.8 t -105.1 -23.53 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.105 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' CZ2' HG21 ' A' ' 28' ' ' VAL . 92.4 m95 -112.3 -24.77 9.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.89 28.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -110.09 54.4 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HB ' HMD2 ' A' ' 81' ' ' HEC . 17.9 t -120.24 96.82 49.23 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.047 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.51 88.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.325 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.499 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.9 ttt -60.08 139.41 91.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.872 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.477 ' CD ' HBC3 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.16 144.09 91.44 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.652 2.235 . . . . 0.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.66 165.42 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.69 2.26 . . . . 0.0 110.151 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.459 ' CG ' HBB2 ' A' ' 81' ' ' HEC . 31.1 mm-40 -136.62 164.58 27.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.82 62.1 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.451 HG22 HG21 ' A' ' 46' ' ' ILE . 3.7 m -114.34 155.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.9 p -103.67 169.02 8.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 109.967 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 25.3 t0 -43.38 -58.23 2.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -47.97 -55.38 10.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.85 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.45 -42.63 74.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.911 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.491 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -57.78 -34.87 70.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.845 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 1.6 mtmt -65.6 -52.59 50.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.19 -30.1 48.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.999 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.05 -51.39 32.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.892 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 42' ' ' LEU . . . -69.59 -31.8 70.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.418 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.27 -36.55 61.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.594 ' CH2' ' CB ' ' A' ' 5' ' ' ALA . 21.0 t90 -79.76 -38.31 33.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.835 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.484 HG12 ' CD1' ' A' ' 25' ' ' TYR . 79.1 mt -70.72 -39.7 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 14.8 mt -67.54 -44.62 77.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.041 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -31.86 70.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG21 ' CD2' ' A' ' 16' ' ' LEU . 39.5 mt -67.84 114.99 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.086 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.519 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.407 ' HB2' HD13 ' A' ' 4' ' ' LEU . 87.7 m-20 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.275 0.56 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -105.17 -50.05 3.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.109 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -47.15 -25.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 1' ' ' ASN . 10.6 mt -62.28 -42.37 99.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.143 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.573 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . . . -57.56 -42.9 83.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.061 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -52.77 62.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.079 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.63 -24.83 6.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.203 -0.935 . . . . 0.0 110.04 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -91.95 -46.17 7.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.11 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.3 51.96 1.4 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -103.36 -28.71 11.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.089 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.7 mmt -59.08 -14.5 10.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.13 -25.43 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.478 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -135.95 -36.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.8 m-70 -70.63 -179.14 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER 172.73 124.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.524 ' CD2' HG23 ' A' ' 79' ' ' ILE . 24.2 mt -42.15 -63.3 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.344 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 42.51 3.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.0 110.06 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -142.83 86.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -60.31 78.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.166 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 17.7 mttt -88.42 -141.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 110.011 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 38.9 t -50.17 -31.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.12 157.65 16.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.89 124.71 15.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.73 2.287 . . . . 0.0 110.271 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -45.01 132.91 6.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 109.952 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.2 m-85 -52.12 -32.26 34.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.57 -47.2 76.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.151 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -47.3 83.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 38.0 t -57.45 -45.25 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.999 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -53.15 -50.23 64.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -53.47 -44.74 69.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.055 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -38.08 65.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.034 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -100.85 -0.48 36.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.133 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.6 -26.46 67.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.049 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.26 24.27 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.33 154.13 47.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -1.193 . . . . 0.0 110.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -36.67 9.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.017 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.461 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 22.5 t70 -88.41 34.26 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.94 -24.57 67.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.02 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.86 -54.72 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.461 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -58.33 -55.97 28.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' LEU . 8.5 t80 -50.82 -65.19 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 73' ' ' ALA . 25.6 mt -43.01 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.584 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.25 -42.01 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 110.078 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.23 58.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HB2' ' CBA' ' A' ' 81' ' ' HEC . 1.6 mmtp -97.43 -7.61 31.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.524 HG12 ' CMA' ' A' ' 81' ' ' HEC . 49.5 mt -75.98 -47.91 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 110.067 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -73.8 -15.24 61.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.05 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 44.06 -144.01 2.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 94.6 -134.0 11.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.3 p 169.75 -170.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -1.184 . . . . 0.0 110.013 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.21 6.56 6.24 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.34 -11.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.496 ' HB2' ' CGD' ' A' ' 81' ' ' HEC . 96.3 m95 -124.72 -9.14 7.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.56 -128.58 2.37 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.87 51.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.452 ' HB ' HMD3 ' A' ' 81' ' ' HEC . 76.2 t -114.01 94.94 36.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.041 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.431 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 3.0 Cg_exo -60.86 87.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.776 2.317 . . . . 0.0 110.281 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.503 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.6 ttt -59.17 139.42 88.0 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.95 141.03 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.636 2.224 . . . . 0.0 110.301 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.35 164.94 18.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.669 2.246 . . . . 0.0 110.065 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' HG3' HBB3 ' A' ' 81' ' ' HEC . 26.9 mm-40 -134.8 163.19 30.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.132 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -104.4 57.05 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 110.005 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 3.5 m -114.33 155.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.232 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -107.13 174.58 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.896 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -43.66 -50.37 7.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.001 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.31 -63.26 1.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 0.0 109.906 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 6.2 mt-10 -53.88 -39.79 66.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.786 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.584 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -60.31 -34.45 73.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.63 57.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 110.005 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.8 -30.62 61.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.996 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 46' ' ' ILE . 19.8 mt -70.01 -49.82 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.36 -32.13 69.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.105 -0.997 . . . . 0.0 109.398 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -75.24 -36.88 61.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.573 ' CH2' ' HB3' ' A' ' 5' ' ' ALA . 21.9 t90 -79.79 -37.95 34.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.815 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.15 -40.42 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.0 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 29' ' ' ALA . 21.7 mt -68.84 -39.96 79.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.933 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -64.66 -28.63 69.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.855 . . . . 0.0 110.035 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.524 HG23 ' CD2' ' A' ' 16' ' ' LEU . 28.5 mt -69.67 116.79 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.003 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.054 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.524 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.458 ' O ' ' NE1' ' A' ' 75' ' ' TRP . 14.4 m-80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.258 0.552 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 6' ' ' LYS . 2.2 pp20? -118.82 -11.32 9.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.072 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -50.04 -22.62 1.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 110.051 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 mt -74.93 -44.84 46.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.925 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.5 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . . . -78.57 -29.42 46.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -63.15 -68.46 0.34 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -49.4 -25.14 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 4.1 tptt -73.16 -53.38 11.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.036 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.52 20.55 5.41 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 10.6 m -79.23 -29.08 42.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -1.15 . . . . 0.0 110.018 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.08 -15.64 14.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.928 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.5 m -127.83 -30.24 2.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.505 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -80.27 -179.37 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.06 123.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.449 -0.782 . . . . 0.0 109.785 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.506 ' CD2' HG22 ' A' ' 79' ' ' ILE . 2.0 mt -42.01 -64.12 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -122.85 42.77 3.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 109.991 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -148.3 45.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.016 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.87 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.343 -0.848 . . . . 0.0 110.224 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 5.6 mtpt -91.6 -89.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 28.3 t -80.58 -31.54 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.903 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.79 169.22 15.92 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.574 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -60.98 126.98 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.759 2.306 . . . . 0.0 110.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -51.19 131.45 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.897 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.505 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.36 -32.22 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.135 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.56 -45.45 68.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -48.86 79.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 37.7 t -56.53 -43.5 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 77' ' ' LEU . . . -52.55 -54.53 31.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.952 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -46.1 69.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -55.55 -35.3 65.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 31.8 m-85 -101.42 0.21 36.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.927 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -63.43 -25.87 68.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.05 16.8 54.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -139.43 153.62 47.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -1.165 . . . . 0.0 110.185 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -105.47 -29.02 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 0.0 110.111 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -76.69 1.81 16.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 110.117 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.516 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -55.93 -24.19 36.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.022 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 96.1 t -67.62 -55.53 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.71 -54.83 42.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -52.32 -63.16 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.063 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 38' ' ' ALA . 50.5 mt -43.24 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 110.087 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.67 -41.04 2.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -56.83 -41.11 90.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' CB ' ' O1A' ' A' ' 81' ' ' HEC . 0.0 OUTLIER -86.26 -15.38 40.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.524 HG12 ' CMA' ' A' ' 81' ' ' HEC . 39.7 mt -67.28 -46.83 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.878 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 5.46 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -123.82 -6.64 7.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.103 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 44.24 -149.04 0.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.41 -146.72 18.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.506 ' HB2' ' CBD' ' A' ' 81' ' ' HEC . 0.3 OUTLIER 169.69 177.05 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -1.119 . . . . 0.0 110.106 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.54 -14.8 3.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.79 -30.8 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.03 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.574 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.3 m95 -107.89 -26.21 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' N ' ' O2D' ' A' ' 81' ' ' HEC . . . 172.08 -155.94 24.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 t -108.05 57.39 0.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -1.15 . . . . 0.0 110.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' HMD3 ' A' ' 81' ' ' HEC . 25.7 t -117.59 96.26 49.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.61 78.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.741 2.294 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.5 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.2 ttt -52.15 138.98 35.81 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.68 142.24 82.63 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.627 2.218 . . . . 0.0 110.383 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.423 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.8 Cg_endo -63.83 161.92 30.72 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.649 2.233 . . . . 0.0 110.17 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 27.1 mm-40 -135.04 163.57 29.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 110.104 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.09 69.1 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.002 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.457 HG23 HG22 ' A' ' 46' ' ' ILE . 3.3 m -114.7 155.8 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.1 m -101.28 165.09 11.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.915 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 4.5 m-20 -43.41 -57.75 2.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.008 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.21 -55.11 11.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.51 -43.05 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' CB ' ' HB1' ' A' ' 43' ' ' ALA . . . -57.4 -36.63 71.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.825 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -65.28 -52.32 55.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -0.833 . . . . 0.0 110.026 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -53.94 -28.97 40.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 HD11 HG23 ' A' ' 46' ' ' ILE . 17.3 mt -70.19 -52.05 26.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.935 . . . . 0.0 109.822 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.445 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -69.29 -31.38 69.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 0.0 109.38 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.23 -37.06 61.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.5 ' CH2' ' HB3' ' A' ' 5' ' ' ALA . 20.5 t90 -79.57 -38.44 34.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.78 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.482 HG12 ' CD1' ' A' ' 25' ' ' TYR . 47.2 mt -70.6 -42.4 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 24.5 mt -65.41 -42.82 92.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 109.99 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.3 t -61.95 -33.09 73.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 110.031 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.506 HG22 ' CD2' ' A' ' 16' ' ' LEU . 42.0 mt -64.63 103.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.146 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.524 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.188 0.518 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -175.69 -55.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.873 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -50.27 -24.69 3.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.025 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.433 HD21 ' OE1' ' A' ' 71' ' ' GLN . 3.3 mt -69.07 -48.46 62.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.575 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . . . -65.7 -37.0 85.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 110.108 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -69.64 -55.16 10.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 110.111 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -50.1 -24.86 2.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 110.102 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -92.96 -47.06 7.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.07 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.14 45.69 0.85 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 16.6 m -97.6 -30.42 12.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -1.164 . . . . 0.0 110.134 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.9 mmt -61.16 -12.61 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.64 58.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.473 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 m -123.86 -19.01 5.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.7 m-70 -91.26 -179.18 5.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.948 . . . . 0.0 110.343 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.52 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 170.66 122.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.916 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -42.52 -64.23 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.16 41.9 3.2 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -139.42 86.06 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.45 -0.781 . . . . 0.0 110.073 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 3.7 ptpt -55.24 86.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 18' ' ' ALA . 2.8 tptt -95.01 -147.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.02 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 35.9 t -50.89 -31.28 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 109.924 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -120.07 166.14 13.58 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.573 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.15 129.35 28.22 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.776 2.317 . . . . 0.0 110.252 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -50.76 127.16 17.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.9 m-85 -47.95 -33.55 7.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.004 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -68.12 -44.44 76.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -49.53 76.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.051 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.621 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 61.9 t -56.97 -44.72 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -51.21 -62.51 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.943 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -40.92 67.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.788 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -61.63 -32.06 72.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CB ' HD21 ' A' ' 77' ' ' LEU . 6.5 m-85 -91.64 2.07 56.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.17 -25.4 61.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.082 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.71 -3.88 68.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -118.26 164.67 14.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -1.135 . . . . 0.0 110.045 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 -11.01 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.67 21.78 16.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.033 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -59.37 -15.81 18.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 49.2 t -73.77 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.033 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.87 -51.4 69.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.2 -64.34 0.84 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 109.997 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 73' ' ' ALA . 55.8 mt -43.52 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . . . -42.53 -37.62 1.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.494 -0.754 . . . . 0.0 110.095 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.73 -41.13 93.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 49' ' ' GLY . 4.7 mmtp -87.9 -9.47 53.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.517 HG12 ' CMA' ' A' ' 81' ' ' HEC . 25.7 mt -73.49 -51.52 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.004 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -17.5 62.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.03 -18.18 13.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 55.53 -140.32 40.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 92.35 -139.44 14.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.484 ' HB3' ' CBD' ' A' ' 81' ' ' HEC . 2.7 p 169.92 -170.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -1.142 . . . . 0.0 110.034 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.23 4.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.83 -21.32 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -1.145 . . . . 0.0 110.131 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.621 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 93.0 m95 -115.81 -28.39 6.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 110.096 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 -155.85 25.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.9 p -107.89 65.34 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.039 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 51' ' ' SER . 60.4 t -129.97 96.33 26.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.59 87.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.736 2.291 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.49 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.9 ttt -59.43 140.28 88.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.508 ' CD ' HBC1 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.28 141.5 82.26 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.577 2.185 . . . . 0.0 110.375 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.8 163.91 23.3 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.571 2.181 . . . . 0.0 110.029 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 20.0 mm-40 -134.95 163.33 30.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -0.982 . . . . 0.0 110.064 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -104.83 64.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.953 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -113.83 155.72 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 p -100.06 166.78 10.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 109.901 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.36 -55.29 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.069 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.79 -57.95 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.47 -40.99 68.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.9 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -58.58 -35.47 72.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.811 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HE3' HG11 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.56 -52.25 53.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.339 -0.85 . . . . 0.0 110.088 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.52 -30.19 52.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 110.082 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.7 mt -70.24 -50.33 40.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.87 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.39 -30.99 68.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.253 -0.905 . . . . 0.0 109.455 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -76.27 -36.56 58.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.56 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 5' ' ' ALA . 23.7 t90 -80.79 -36.97 31.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 109.835 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.487 HG12 ' CD1' ' A' ' 25' ' ' TYR . 47.6 mt -74.13 -34.87 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.947 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.522 HD21 ' CB ' ' A' ' 32' ' ' TYR . 20.1 mt -72.34 -41.88 66.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.4 t -64.14 -27.78 69.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 75' ' ' TRP . 37.8 mt -69.65 100.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.018 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.051 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.517 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.203 0.525 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.447 ' O ' ' HB1' ' A' ' 5' ' ' ALA . 12.8 mt-10 -64.04 -10.71 23.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.086 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 4' ' ' LEU . 2.6 mm-40 -51.09 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 110.115 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -42.57 -27.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 0.0 110.142 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.575 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -69.17 -36.85 77.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.847 . . . . 0.0 110.015 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 3' ' ' GLN . 37.2 tttt -84.57 -49.87 8.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.036 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -50.67 -24.66 3.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.073 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.64 -49.05 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 110.071 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.65 25.09 5.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.457 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 13.6 m -73.04 -28.99 62.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 0.0 109.991 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.7 mmt -59.39 -14.33 11.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.197 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.28 -25.31 3.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 110.106 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 9.7 m -135.76 -36.82 0.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.023 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -69.47 -178.84 1.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 175.63 129.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.75 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.522 ' CD1' HG23 ' A' ' 79' ' ' ILE . 3.9 mm? -42.75 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.137 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.26 42.55 3.12 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 110.009 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.41 87.76 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.12 156.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.061 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 178.73 -145.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 55.1 t -50.15 -29.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 0.0 109.848 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.81 20.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.567 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.67 121.37 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.745 2.296 . . . . 0.0 110.316 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 135.06 3.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.937 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.556 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.4 m-85 -53.07 -31.87 44.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.42 -47.2 67.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.85 -46.14 91.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 36.3 t -57.51 -45.47 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.975 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 76' ' ' ILE . . . -52.34 -57.25 10.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.9 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -54.51 -43.29 71.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.59 -34.95 71.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.057 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 6.3 m-85 -102.44 4.68 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.9 -23.42 59.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.22 10.58 60.63 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 167.69 14.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.098 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -113.62 -10.67 13.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -110.81 28.79 8.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.075 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -70.8 -24.81 62.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG12 ' HD3' ' A' ' 70' ' ' LYS . 83.9 t -68.89 -56.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 110.045 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 1.3 m-20 -59.18 -53.2 61.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.0 t80 -51.32 -63.05 1.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 HD11 ' CB ' ' A' ' 73' ' ' ALA . 56.8 mt -43.17 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.046 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.62 -41.09 2.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.14 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.48 -39.67 84.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 6.8 mmpt? -88.57 -16.62 32.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -1.155 . . . . 0.0 110.093 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.527 HG12 ' CMA' ' A' ' 81' ' ' HEC . 44.5 mt -65.65 -47.68 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.883 . . . . 0.0 110.063 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 2.9 ttmm -80.09 6.2 12.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.82 -28.97 4.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.2 -156.95 33.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.75 -129.67 9.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.517 ' OG ' ' CBD' ' A' ' 81' ' ' HEC . 0.3 OUTLIER 169.82 -170.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -1.172 . . . . 0.0 110.028 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -2.29 8.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 ' CD1' ' A' ' 54' ' ' TRP . 37.6 t -119.95 -14.84 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.148 . . . . 0.0 110.094 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.567 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.5 m95 -133.79 9.45 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.32 -149.78 20.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 21.5 m -118.13 51.42 1.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -1.194 . . . . 0.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.454 ' O ' ' OG ' ' A' ' 51' ' ' SER . 49.6 t -110.26 95.13 20.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.922 . . . . 0.0 110.098 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.86 72.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.798 2.332 . . . . 0.0 110.286 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.503 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.1 ttt -43.98 139.41 3.02 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.883 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.85 141.23 83.85 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.642 2.228 . . . . 0.0 110.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.35 160.21 36.24 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.615 2.21 . . . . 0.0 110.135 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 23.5 mm-40 -133.01 162.92 30.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.072 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -103.93 68.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 46' ' ' ILE . 3.4 m -115.13 155.94 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.132 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.6 p -101.91 167.93 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' THR . 8.8 t0 -43.39 -61.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.082 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.47 -54.98 6.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.41 -43.23 75.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.853 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.504 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . . . -57.56 -36.28 71.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.784 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HD3' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.26 -52.19 55.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 110.046 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.07 -29.37 44.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.929 . . . . 0.0 110.019 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.452 HD13 ' CMB' ' A' ' 81' ' ' HEC . 20.2 mt -70.12 -51.73 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' A' ' 42' ' ' LEU . . . -69.31 -31.54 70.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -0.988 . . . . 0.0 109.39 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.12 -37.27 61.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.843 . . . . 0.0 109.619 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.575 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 20.4 t90 -79.33 -38.21 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.803 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.556 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.8 mt -71.48 -41.66 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.962 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 21.7 mt -64.53 -46.68 81.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 109.96 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -56.65 -27.95 59.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 109.977 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.522 HG23 ' CD1' ' A' ' 16' ' ' LEU . 6.8 mt -75.46 121.82 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.096 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.527 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.176 0.512 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.24 -31.67 14.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.081 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.49 -24.9 3.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.31 -51.78 61.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.037 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.98 -36.5 60.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -63.33 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 110.084 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -50.71 -24.83 3.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.86 -49.0 7.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.075 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.01 40.93 4.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.452 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 13.5 m -95.06 -28.83 14.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 109.988 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -16.18 6.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.872 . . . . 0.0 110.117 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -23.57 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.186 -0.946 . . . . 0.0 109.945 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m -137.51 -38.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.424 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 89.2 m-70 -70.01 -179.53 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 110.33 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 173.31 123.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.827 . . . . 0.0 109.802 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.456 HD21 HG22 ' A' ' 79' ' ' ILE . 31.6 mt -42.52 -66.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -122.47 42.63 3.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -141.46 84.11 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.17 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -61.7 76.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 110.111 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -79.21 -90.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.028 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 34.6 t -99.44 -39.51 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.989 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.93 166.45 12.3 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.576 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.82 118.61 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.785 2.323 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.35 128.79 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.571 ' CE1' HD11 ' A' ' 76' ' ' ILE . 5.5 m-85 -48.34 -35.7 12.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -63.32 -41.87 98.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.08 -48.38 71.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 32' ' ' TYR . 98.1 t -58.13 -46.3 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -51.88 -53.94 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -45.48 73.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.949 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.546 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 6.1 mttp -56.66 -34.43 67.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 110.048 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.569 ' CE2' HG13 ' A' ' 28' ' ' VAL . 19.3 m-85 -103.96 -1.36 27.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.59 -28.56 60.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.31 19.55 34.95 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG3' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -128.23 149.5 50.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.156 . . . . 0.0 110.023 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.52 -14.57 15.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 35' ' ' ARG . 7.1 p-10 -102.55 4.37 38.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.085 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -54.38 -20.89 8.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.04 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.508 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 72.7 t -69.66 -54.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.049 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.4 -53.63 55.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.092 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 70.4 t80 -50.88 -64.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 73' ' ' ALA . 72.3 mt -43.18 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . . . -42.35 -41.63 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.73 -39.24 75.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HG2' ' CGA' ' A' ' 81' ' ' HEC . 0.1 OUTLIER -89.76 -5.96 56.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.052 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.515 HG12 ' CMA' ' A' ' 81' ' ' HEC . 31.2 mt -78.02 -47.68 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -9.1 58.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -100.37 -42.58 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.033 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.43 -169.03 52.2 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.38 -138.37 13.83 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER 169.7 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 110.07 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.84 3.22 5.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -121.69 -18.05 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 110.02 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 93.8 m95 -120.01 -11.72 9.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.46 -141.02 7.61 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.03 60.01 1.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -1.201 . . . . 0.0 110.061 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' HMD3 ' A' ' 81' ' ' HEC . 22.8 t -122.82 96.37 45.31 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.915 . . . . 0.0 110.106 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.55 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.697 2.265 . . . . 0.0 110.279 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.485 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.1 ttt -49.77 138.39 17.57 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.16 143.47 90.09 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.685 2.256 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.43 165.68 17.07 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.716 2.277 . . . . 0.0 110.145 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 27.8 mm-40 -135.08 163.89 28.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.117 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -104.34 64.25 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.058 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.61 155.82 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.109 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.54 167.42 10.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 m-20 -43.36 -59.01 2.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.117 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.5 -56.35 7.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.897 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -54.87 -41.87 71.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.235 -0.916 . . . . 0.0 109.92 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.519 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -57.95 -37.74 74.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -64.7 -51.82 60.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -53.92 -29.26 41.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.016 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.451 HD11 HG21 ' A' ' 46' ' ' ILE . 45.2 mt -70.1 -52.75 21.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 39' ' ' VAL . . . -68.55 -32.47 72.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.496 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.12 -36.93 64.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.475 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 19.0 t90 -78.64 -40.06 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.817 . . . . 0.0 109.74 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.571 HD11 ' CE1' ' A' ' 25' ' ' TYR . 20.9 mt -71.11 -43.77 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.93 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 20.6 mt -62.22 -44.68 96.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 t -59.58 -36.02 75.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 75' ' ' TRP . 26.2 mt -59.6 108.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.964 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.04 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.527 ' CMB' HBB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.258 0.551 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -154.73 -68.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 110.095 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -49.32 -24.12 1.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.03 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' O ' ' CG ' ' A' ' 8' ' ' LYS . 13.0 mt -68.81 -54.66 14.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.09 -30.19 71.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.11 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -66.38 -66.48 0.55 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.084 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -50.61 -25.2 3.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 110.067 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 18.9 mmtm -80.07 -53.81 6.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 110.052 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.35 51.66 1.55 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.455 ' SG ' HMB3 ' A' ' 81' ' ' HEC . 13.8 m -106.55 -29.13 9.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 110.017 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mmt -58.51 -14.99 9.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.27 -24.75 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.982 . . . . 0.0 109.988 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' HG12 ' A' ' 21' ' ' VAL . 11.2 m -136.15 -36.91 0.73 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.577 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.7 m-70 -71.73 -179.9 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 110.378 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.06 121.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.873 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 15' ' ' ASP . 1.6 mp -42.13 -62.31 0.96 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.303 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.13 42.37 3.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.36 -0.838 . . . . 0.0 110.038 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 20' ' ' LYS . . . -147.05 45.76 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -47.49 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.134 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -96.54 -89.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 0.0 109.954 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 13' ' ' CYS . 35.4 t -78.12 -31.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 109.901 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.15 168.32 18.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.566 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.04 124.73 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.728 2.285 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -49.32 127.57 15.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 109.893 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.594 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 3.3 m-85 -45.97 -31.22 2.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.081 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.31 -44.47 75.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.035 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -63.59 -49.12 74.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 39.7 t -57.8 -45.79 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 77' ' ' LEU . . . -51.21 -63.72 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.29 -38.67 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -60.24 -35.65 75.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.881 . . . . 0.0 110.042 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.61 2.89 26.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.033 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -65.87 -26.62 67.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.024 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.71 16.71 49.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.39 154.51 36.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.064 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -100.54 -14.34 18.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' CG ' ' OD2' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -108.7 29.37 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.451 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.07 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.524 HG13 ' CE ' ' A' ' 70' ' ' LYS . 22.0 t -73.31 -61.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD2' ' CG ' ' A' ' 37' ' ' ASP . 3.2 p-10 -59.27 -50.33 74.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -51.75 -58.23 7.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.047 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 73' ' ' ALA . 45.5 mt -48.3 -73.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 110.125 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.67 -43.07 3.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.25 -41.23 86.4 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.5 OUTLIER -86.68 -9.88 54.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.123 . . . . 0.0 110.042 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.526 ' CG1' HMA1 ' A' ' 81' ' ' HEC . 34.0 mt -73.21 -50.55 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.51 -11.57 60.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.053 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -100.83 -13.67 18.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 45.31 -165.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 108.0 -137.39 14.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.85 -172.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.146 . . . . 0.0 110.101 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.12 -10.59 5.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 53' ' ' VAL . 82.1 t -106.72 -22.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -1.144 . . . . 0.0 110.047 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.566 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.6 m95 -120.37 -22.12 6.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.53 -169.61 42.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -98.14 46.36 1.01 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.095 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -111.39 96.24 30.41 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 59' ' ' MET . 3.0 Cg_exo -60.75 76.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 0.0 110.346 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.467 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.5 ttt -43.24 139.59 2.34 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.523 ' CD ' HBC1 ' A' ' 81' ' ' HEC . 3.0 Cg_endo -62.64 142.59 90.22 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.674 2.25 . . . . 0.0 110.309 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.8 Cg_endo -63.27 166.8 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.626 2.217 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 29.8 mm-40 -136.03 164.64 27.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 110.075 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -104.62 58.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.6 155.96 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.014 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.8 p -100.39 168.53 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.995 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 56.5 t0 -43.32 -53.31 5.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.41 -58.77 4.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -54.27 -40.71 68.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.781 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.548 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -58.69 -36.38 74.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' HG13 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.71 -51.86 60.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 110.0 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.0 -29.7 57.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.473 HD13 ' CMB' ' A' ' 81' ' ' HEC . 62.4 mt -70.21 -50.28 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.72 -30.3 66.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 109.398 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.5 mt-30 -76.63 -37.2 56.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.507 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.473 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 24.7 t90 -80.6 -36.45 32.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.842 . . . . 0.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.594 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 55.6 mt -74.64 -33.65 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.914 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 21.9 mt -71.61 -45.39 62.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -60.64 -25.81 66.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 75' ' ' TRP . 39.1 mt -71.3 119.84 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.107 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.526 HMA1 ' CG1' ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.1 m120 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.207 0.527 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 pm0 -106.12 -2.24 22.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.153 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.36 -23.73 0.64 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.053 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.455 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 1.4 mt -73.97 -44.73 53.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 110.041 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.428 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.2 -30.49 67.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.942 . . . . 0.0 110.107 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -62.53 -66.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -50.41 -29.72 10.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.092 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -65.38 -60.0 3.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.912 . . . . 0.0 110.043 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.95 49.32 0.58 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 13.0 m -99.13 -28.86 13.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -1.182 . . . . 0.0 110.078 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.6 mmt -54.89 -17.46 3.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.34 -23.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.967 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 14.1 m -138.63 -37.75 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.897 . . . . 0.0 110.041 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.452 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.6 m-70 -70.12 -179.25 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.852 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 170.77 126.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 79' ' ' ILE . 28.8 mt -42.17 -67.85 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 42.77 3.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 110.019 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -139.44 83.6 1.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -62.33 74.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 57.2 mmtt -77.68 -90.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 26.5 t -97.67 -45.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.97 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.7 167.52 14.03 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.07 119.28 6.35 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.68 2.254 . . . . 0.0 110.242 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 134.58 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.607 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 5.0 m-85 -50.49 -32.07 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 79' ' ' ILE . . . -67.72 -44.88 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.017 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.59 -48.83 79.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 71.4 t -57.16 -44.51 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.993 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -51.69 -59.7 3.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.904 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.75 -43.07 72.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -34.04 73.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 110.048 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' HB3' HD22 ' A' ' 77' ' ' LEU . 16.6 m-85 -94.5 -12.76 27.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -52.12 -28.77 19.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 0.0 110.009 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.63 17.25 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -122.86 121.98 37.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.106 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -72.97 -31.06 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.034 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.67 37.01 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 110.054 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.463 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.37 -25.11 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.62 -50.91 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.099 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -55.67 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 110.076 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.7 t80 -50.61 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.066 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' CD2' HMA1 ' A' ' 81' ' ' HEC . 1.4 mt -43.27 -73.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.079 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 69' ' ' ALA . . . -42.19 -41.75 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.805 . . . . 0.0 110.058 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.5 -41.89 89.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HE2' ' O1A' ' A' ' 81' ' ' HEC . 0.8 OUTLIER -84.98 -16.91 39.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.521 HG12 ' CMA' ' A' ' 81' ' ' HEC . 32.8 mt -65.21 -49.46 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 10.3 tttt -80.83 -0.06 37.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -7.01 10.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 47.77 -155.86 1.06 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.9 -149.64 16.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.52 ' HB3' ' CBD' ' A' ' 81' ' ' HEC . 1.3 p 169.68 -167.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.15 . . . . 0.0 110.071 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -18.08 7.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 53' ' ' VAL . 64.2 t -100.03 -3.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.571 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 99.6 m95 -137.88 6.45 2.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.44 -153.06 23.8 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -118.37 52.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.108 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.459 HG12 HMD3 ' A' ' 81' ' ' HEC . 64.2 t -113.91 96.2 40.57 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.069 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.65 80.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.689 2.259 . . . . 0.0 110.225 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.496 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.4 ttt -51.48 138.58 29.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.95 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.528 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.75 144.84 90.04 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.682 2.255 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.96 168.19 10.97 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.693 2.262 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.457 ' CG ' HBB2 ' A' ' 81' ' ' HEC . 33.7 mm-40 -137.06 164.83 27.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.155 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.05 60.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.027 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.66 155.89 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -103.77 170.59 7.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.001 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' THR . 13.1 m-20 -43.35 -57.27 3.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.993 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.83 -57.96 4.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -41.02 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' CB ' ' HB1' ' A' ' 43' ' ' ALA . . . -59.46 -34.77 72.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -65.41 -51.24 61.64 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -56.2 -30.69 62.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.078 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HB3' HD12 ' A' ' 46' ' ' ILE . 38.1 mt -70.41 -48.9 53.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -71.22 -29.6 65.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -37.43 48.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.495 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.471 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 25.3 t90 -81.03 -34.21 32.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.607 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 56.6 mt -76.84 -35.74 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 24.4 mt -71.36 -45.38 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.973 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 t -59.06 -33.42 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.008 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 75' ' ' TRP . 14.1 mt -69.29 95.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.979 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 6.2 mmmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.017 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.528 HBC2 ' CD ' ' A' ' 60' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.471 ' O ' ' CE2' ' A' ' 75' ' ' TRP . 8.8 p-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.278 0.561 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -119.87 -43.61 2.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.06 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -50.35 -21.91 1.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.082 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.9 mt -77.16 -25.28 51.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.062 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.627 ' CB ' ' CH2' ' A' ' 75' ' ' TRP . . . -89.27 -41.4 12.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.06 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -33.19 63.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.066 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -49.38 -24.32 1.88 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.094 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.507 ' HE3' ' CG1' ' A' ' 64' ' ' VAL . 7.7 mmtt -106.45 -39.89 5.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 110.054 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.91 36.39 2.2 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.455 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 13.3 m -73.7 -28.98 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -1.182 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.66 -13.3 13.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.34 -35.51 51.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 m -125.15 -25.49 3.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.55 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.99 -179.25 7.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.463 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 169.48 122.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.784 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.55 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 1.2 mp -41.84 -64.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.7 42.69 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 110.072 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -136.54 82.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.83 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.46 113.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.046 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -134.51 -143.55 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 t -50.98 -30.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.61 158.91 19.23 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.67 122.54 11.41 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.769 2.313 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 126.35 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 109.981 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.55 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.6 m-85 -46.29 -37.27 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.085 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -61.05 -50.72 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.02 92.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.041 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 90.6 t -57.08 -45.45 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 77' ' ' LEU . . . -53.04 -58.97 5.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -55.77 -40.93 73.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.756 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -34.25 74.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -100.7 1.8 40.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.17 62.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 17.79 44.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -132.17 147.62 52.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 110.096 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -90.75 -33.83 15.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -91.12 28.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 42' ' ' LEU . . . -62.72 -20.24 64.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.29 -57.45 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -57.64 -56.59 19.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' A' ' 42' ' ' LEU . 42.8 t80 -49.45 -63.98 0.94 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.98 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.437 HD12 ' CB ' ' A' ' 73' ' ' ALA . 10.7 mt -43.11 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.585 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.45 -38.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -56.93 -39.96 89.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -89.18 -7.52 55.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 110.059 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 46.2 mt -77.78 -39.48 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -3.52 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -102.51 -34.77 9.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.46 -174.01 45.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.18 -147.47 16.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 6.8 p 174.16 -164.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 110.074 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.88 -10.33 6.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 78.1 t -109.92 -15.77 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 110.088 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 94.5 m95 -122.67 -9.15 8.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.6 -166.17 31.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 56' ' ' SER . 5.6 p -103.39 55.28 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -1.159 . . . . 0.0 110.096 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.46 96.51 45.82 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.52 87.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.771 2.314 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.495 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.4 ttt -55.64 139.82 67.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.928 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.29 142.51 86.27 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.633 2.222 . . . . 0.0 110.25 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.8 Cg_endo -63.17 165.99 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.647 2.231 . . . . 0.0 110.19 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 26.5 mm-40 -137.58 164.86 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -104.11 70.76 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.507 ' CG1' ' HE3' ' A' ' 8' ' ' LYS . 3.8 m -127.48 155.97 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.28 -0.888 . . . . 0.0 110.099 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -104.95 171.41 7.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' THR . 36.0 t0 -43.35 -53.43 5.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.032 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.23 -59.14 3.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.901 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -54.82 -41.09 70.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.585 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -59.31 -35.63 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.802 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 2.0 ttpm? -65.76 -51.71 56.96 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.423 -0.798 . . . . 0.0 110.009 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.68 -30.17 54.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.453 HD13 HG21 ' A' ' 46' ' ' ILE . 19.1 mt -70.26 -51.07 33.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.894 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.437 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -69.57 -31.62 69.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -75.46 -37.39 60.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.627 ' CH2' ' CB ' ' A' ' 5' ' ' ALA . 21.6 t90 -79.08 -37.78 37.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 109.847 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.546 HD11 ' CE1' ' A' ' 25' ' ' TYR . 79.0 mt -71.99 -40.33 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.84 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 29.5 mt -65.24 -45.26 85.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -60.22 -29.24 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.044 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.55 ' CG2' ' CD2' ' A' ' 16' ' ' LEU . 42.6 mt -64.9 109.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.072 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.517 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.263 0.554 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -119.6 -11.14 9.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.073 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -45.51 -25.62 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 110.051 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 14.0 mt -73.03 -30.52 63.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 110.009 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.566 ' CB ' ' CH2' ' A' ' 75' ' ' TRP . . . -84.4 -43.0 15.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 110.094 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -60.73 2.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.022 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 13.0 pt20 -50.03 -30.37 10.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 110.075 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 9.5 tppt? -68.82 -56.61 7.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.108 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.94 25.35 2.31 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.455 ' SG ' HMB3 ' A' ' 81' ' ' HEC . 13.5 m -88.36 -29.26 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -1.155 . . . . 0.0 109.998 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -59.21 -14.57 11.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.114 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -26.62 4.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.978 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.4 m -133.86 -36.08 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.957 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.439 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 88.5 m-70 -71.26 -179.32 2.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.27 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER 174.34 125.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.914 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.434 HD23 HG22 ' A' ' 79' ' ' ILE . 25.1 mt -42.43 -68.76 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -122.28 42.49 3.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -139.52 82.39 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.373 -0.829 . . . . 0.0 110.138 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -59.47 79.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -85.12 -90.57 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 27.2 t -96.0 -46.32 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 109.889 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.55 167.78 13.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.57 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -60.98 120.06 7.56 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.764 2.309 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.29 130.6 4.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 109.977 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CE1' HD11 ' A' ' 76' ' ' ILE . 4.9 m-85 -48.67 -32.22 7.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.69 -44.06 74.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.09 -49.38 76.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 39.8 t -57.3 -44.31 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.867 . . . . 0.0 110.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -51.55 -55.06 21.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.971 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -54.08 -46.37 72.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.53 -32.34 65.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 110.127 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CD2' HG11 ' A' ' 28' ' ' VAL . 24.3 m-85 -105.46 1.19 27.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.06 -29.01 67.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.039 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.12 16.3 48.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.4 mmm-85 -115.47 139.02 50.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -1.161 . . . . 0.0 110.065 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -95.36 -16.53 22.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.068 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.71 12.69 21.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.464 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -53.46 -20.31 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.038 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 70' ' ' LYS . 41.3 t -68.62 -57.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.072 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.62 -52.77 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.05 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.422 ' OH ' ' HE3' ' A' ' 45' ' ' LYS . 86.6 t80 -52.61 -62.78 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 73' ' ' ALA . 45.4 mt -43.26 -74.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.61 -39.86 2.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.415 -0.803 . . . . 0.0 110.079 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.34 -36.78 70.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.2 OUTLIER -92.1 -15.63 27.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -1.111 . . . . 0.0 110.076 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 49.7 mt -67.34 -44.59 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.096 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -82.56 6.95 15.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.46 -31.1 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 110.046 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.39 -160.32 49.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 100.24 -143.72 16.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.4 p 169.76 -172.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -1.157 . . . . 0.0 110.043 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.95 -9.25 5.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.13 -18.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -1.132 . . . . 0.0 110.081 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CD2' ' HG3' ' A' ' 23' ' ' PRO . 97.4 m95 -117.99 -26.89 6.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.081 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.47 -154.04 20.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.429 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -111.51 44.94 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.113 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.52 96.14 26.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.7 92.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.73 2.287 . . . . 0.0 110.292 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.484 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.2 ttt -62.67 138.84 96.9 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.523 ' CD ' HBC1 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.47 142.15 83.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.616 2.21 . . . . 0.0 110.299 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.76 165.49 18.33 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.645 2.23 . . . . 0.0 110.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 26.5 mm-40 -134.67 163.43 29.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 16.4 p-10 -104.33 59.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.055 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.465 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.23 155.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.106 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -99.55 165.38 11.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 109.92 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 6.4 p-10 -43.36 -47.04 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.025 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.47 -61.09 2.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.883 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.41 -40.95 68.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.753 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 43' ' ' ALA . . . -59.45 -34.17 72.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.469 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -65.77 -52.1 53.7 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.401 -0.812 . . . . 0.0 110.053 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.75 -29.85 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.522 HD12 ' CMB' ' A' ' 81' ' ' HEC . 16.2 mt -70.59 -49.84 43.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.815 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . . . -70.77 -31.05 67.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.381 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 4.4 mt-30 -76.03 -37.04 58.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.423 -0.798 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.566 ' CH2' ' CB ' ' A' ' 5' ' ' ALA . 23.6 t90 -80.35 -37.42 32.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.835 . . . . 0.0 109.765 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.529 HD11 ' CE1' ' A' ' 25' ' ' TYR . 57.0 mt -72.35 -40.35 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.858 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 28.2 mt -66.83 -43.65 83.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.872 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.2 p -60.83 -30.22 69.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 75' ' ' TRP . 36.8 mt -67.85 107.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.069 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.526 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.262 0.553 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -138.65 12.15 2.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.021 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.47 -27.13 5.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 110.045 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.512 HD22 ' NE2' ' A' ' 71' ' ' GLN . 3.2 pp -79.42 -28.61 41.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 110.005 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.42 -32.18 26.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.058 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -69.07 -57.31 5.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.023 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -51.92 -25.15 7.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 110.073 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -79.92 -54.12 6.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 110.079 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.61 41.09 0.75 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 21.4 m -92.22 -29.64 16.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.5 mmt -60.46 -13.53 14.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.58 -24.87 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.036 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.0 m -136.31 -36.57 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 89.6 m-70 -71.25 -179.71 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.393 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER 172.2 118.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.871 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.524 HD21 ' CG2' ' A' ' 79' ' ' ILE . 1.6 mt -41.71 -58.27 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.36 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.54 42.64 3.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -146.47 87.86 1.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -85.83 -143.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG13 ' HAC' ' A' ' 81' ' ' HEC . 39.3 t -51.48 -30.99 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.977 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.48 160.53 13.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.565 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.84 128.74 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.79 2.327 . . . . 0.0 110.317 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -50.3 122.6 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 76' ' ' ILE . 2.6 m-85 -43.64 -29.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HA ' HG23 ' A' ' 79' ' ' ILE . . . -71.97 -45.78 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 0.0 109.99 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.66 -49.04 79.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.606 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 37.5 t -56.37 -43.57 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.885 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' ILE . . . -52.24 -61.61 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.984 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -53.39 -40.75 65.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -33.53 71.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CB ' HD22 ' A' ' 77' ' ' LEU . 13.8 m-85 -106.67 4.58 28.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.095 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -69.99 -28.57 65.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 0.0 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.81 14.88 55.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.98 165.45 12.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.114 . . . . 0.0 110.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -115.65 -6.87 12.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 110.04 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -123.89 18.45 9.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -55.84 -23.24 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 21.5 t -67.13 -55.3 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.955 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.97 -51.64 68.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 42' ' ' LEU . 30.0 t80 -54.5 -67.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.064 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 73' ' ' ALA . 3.2 mt -43.05 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 110.131 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.5 -39.14 2.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.096 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -59.04 -42.78 97.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.505 ' HB2' ' CGA' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -84.25 -13.76 51.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -1.114 . . . . 0.0 110.003 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.524 HG12 ' CMA' ' A' ' 81' ' ' HEC . 40.7 mt -69.68 -47.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -81.64 -19.84 40.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 35.3 mttm -92.24 -30.85 15.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 110.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.3 -167.77 31.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.17 -143.02 15.82 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.9 t 169.71 -179.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -1.094 . . . . 0.0 110.08 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 136.79 -11.3 3.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.13 -29.61 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -1.161 . . . . 0.0 110.076 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 97.1 m95 -104.67 -22.98 13.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.76 -138.26 5.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.49 67.52 0.85 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -1.159 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' HB ' HMD3 ' A' ' 81' ' ' HEC . 40.0 t -136.38 91.82 16.09 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.92 77.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.724 2.282 . . . . 0.0 110.285 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.474 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.6 ttt -45.62 141.21 4.04 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.991 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.03 143.23 90.45 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.674 2.249 . . . . 0.0 110.317 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.03 167.16 12.8 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.666 2.244 . . . . 0.0 110.128 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 25.3 mm-40 -139.69 166.39 24.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 110.073 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -105.31 68.1 0.8 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.419 HG23 HG23 ' A' ' 46' ' ' ILE . 3.5 m -114.77 155.93 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 p -103.55 167.52 9.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.93 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.45 -62.06 1.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.02 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.56 -55.75 5.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.901 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.79 -42.95 76.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.482 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -58.86 -35.81 73.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.825 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -66.33 -50.79 62.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.436 -0.79 . . . . 0.0 110.032 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.512 ' NE2' HD22 ' A' ' 4' ' ' LEU . 1.4 tm0? -55.69 -29.24 59.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 77.8 mt -70.39 -49.47 48.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HB3' HD11 ' A' ' 42' ' ' LEU . . . -70.51 -31.21 68.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.09 -37.57 58.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.467 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 23.3 t90 -79.64 -36.67 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.793 . . . . 0.0 109.796 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.567 HG12 ' CD1' ' A' ' 25' ' ' TYR . 25.2 mt -71.86 -39.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.884 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.493 HD22 ' CB ' ' A' ' 32' ' ' TYR . 18.1 mt -68.02 -42.44 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.1 t -62.04 -37.83 86.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.913 . . . . 0.0 109.962 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.524 ' CG2' HD21 ' A' ' 16' ' ' LEU . 19.5 mt -59.39 97.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.026 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.524 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.285 0.564 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.18 -40.04 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.11 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -47.3 -24.41 0.74 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.957 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.434 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 12.8 mt -63.06 -42.28 99.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.02 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.43 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -91.37 -0.22 57.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.103 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -88.94 -58.54 2.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.12 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -48.76 -24.42 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.96 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.516 ' HE3' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -80.55 -53.96 6.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.083 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.85 46.35 0.97 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.462 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -90.0 -28.99 18.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.079 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -14.01 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.123 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.66 -25.1 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.457 ' SG ' HMC3 ' A' ' 81' ' ' HEC . 12.0 m -135.72 -36.83 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.498 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 88.8 m-70 -70.31 -179.45 2.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.44 124.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.904 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 79' ' ' ILE . 27.0 mt -42.46 -64.69 0.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 42.19 3.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 15' ' ' ASP . . . -146.3 84.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 110.147 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.88 64.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 16.4 mttm -62.57 -90.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.056 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 29.3 t -93.68 -44.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.49 166.27 13.24 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.05 7.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.754 2.302 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.29 132.66 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.498 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 6.8 m-85 -49.85 -32.4 14.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.85 -44.67 76.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.935 . . . . 0.0 110.071 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -49.92 73.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.565 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 36.1 t -56.49 -43.48 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.993 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 76' ' ' ILE . . . -52.44 -57.24 10.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -43.76 64.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -36.41 67.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 14.1 m-85 -99.1 4.08 46.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.28 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.04 61.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.92 160.67 37.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -1.175 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -111.42 -26.94 8.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -84.65 9.21 14.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -60.79 -25.02 66.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.78 -53.87 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -54.07 50.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -51.82 -61.76 2.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 38' ' ' ALA . 8.2 mt -43.05 -73.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.79 -41.23 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.381 -0.825 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.22 73.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CB ' ' O2A' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -90.93 -9.72 45.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -1.143 . . . . 0.0 109.991 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.523 HG12 ' CMA' ' A' ' 81' ' ' HEC . 41.0 mt -73.38 -47.74 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.02 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -4.75 47.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -5.12 10.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.928 . . . . 0.0 110.077 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 45.29 -134.73 7.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 82.83 -143.33 22.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 3.6 t 169.79 -178.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.416 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 142.75 -14.63 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.412 ' O ' HG11 ' A' ' 53' ' ' VAL . 96.4 t -106.67 -11.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -1.142 . . . . 0.0 110.072 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.565 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 96.7 m95 -120.37 -29.1 4.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.013 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.39 -142.14 6.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 65.6 m -120.57 45.82 2.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.235 -1.156 . . . . 0.0 110.123 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.465 HG13 ' CMD' ' A' ' 81' ' ' HEC . 85.7 t -111.58 94.99 25.21 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.04 77.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.695 2.263 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.468 ' CE ' ' NB ' ' A' ' 81' ' ' HEC . 7.8 ttt -46.62 140.39 5.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.92 144.99 94.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.623 2.216 . . . . 0.0 110.289 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.62 166.48 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.714 2.276 . . . . 0.0 110.205 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.466 ' CG ' HBB3 ' A' ' 81' ' ' HEC . 37.4 mm-40 -137.74 165.2 27.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.095 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -105.14 60.85 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG11 ' OE1' ' A' ' 68' ' ' GLU . 3.6 m -113.82 155.82 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -0.947 . . . . 0.0 110.153 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.11 167.8 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -43.46 -59.08 2.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.92 -56.66 5.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.907 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.428 ' OE1' HG11 ' A' ' 64' ' ' VAL . 4.1 mt-10 -55.29 -42.49 73.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 109.875 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . . . -58.17 -35.88 72.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 109.835 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -51.81 59.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -0.813 . . . . 0.0 110.001 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.95 -29.79 57.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 110.012 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.24 -50.59 38.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.855 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.73 -31.83 70.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.141 -0.974 . . . . 0.0 109.432 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -75.47 -37.34 60.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.338 -0.852 . . . . 0.0 109.504 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.475 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.5 t90 -79.15 -37.6 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.48 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 78.0 mt -72.43 -39.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 18.8 mt -66.13 -46.11 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.8 m -58.31 -31.55 67.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.981 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 75' ' ' TRP . 18.5 mt -67.26 128.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.038 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.103 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.523 ' O2A' ' CB ' ' A' ' 45' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 2.1 m120 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.246 0.545 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 1' ' ' ASN . 1.3 mm-40 -150.68 -60.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 110.115 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -48.54 -24.35 1.28 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.176 -0.953 . . . . 0.0 110.022 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.37 -63.09 1.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 110.083 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -56.43 -31.82 64.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.032 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -62.42 1.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 110.063 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -50.43 -24.8 3.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 0.0 110.037 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -77.5 -53.51 7.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 110.114 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.15 38.68 2.62 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.8 m -93.0 -29.11 16.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -1.083 . . . . 0.0 110.012 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -16.06 10.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB3' HMC2 ' A' ' 81' ' ' HEC . . . -50.09 -25.13 3.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 109.984 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.7 m -136.61 -36.01 0.72 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.2 m-70 -73.05 -179.62 3.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 170.07 121.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.78 . . . . 0.0 109.86 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.517 HD22 ' CG2' ' A' ' 79' ' ' ILE . 4.0 mp -41.93 -63.24 0.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.302 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.97 42.38 3.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.522 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -140.22 83.95 1.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -56.08 84.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.106 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -94.61 -143.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.048 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.467 HG13 ' HAC' ' A' ' 81' ' ' HEC . 42.1 t -52.18 -31.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 164.39 14.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.572 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.17 130.82 33.84 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.715 2.277 . . . . 0.0 110.241 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -51.3 126.89 18.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.019 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.55 ' CE1' HD11 ' A' ' 76' ' ' ILE . 2.8 m-85 -46.3 -37.68 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -61.45 -56.28 21.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.971 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.3 -34.07 71.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.073 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 34.1 t -60.89 -50.98 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -54.82 -46.72 74.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.871 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 2.2 mtpm? -59.25 -43.33 92.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.943 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -34.8 71.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -101.7 -1.79 31.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.082 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.26 -22.0 27.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.07 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.75 20.74 30.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 127.77 40.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -1.182 . . . . 0.0 110.097 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -38.66 69.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.49 40.82 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.21 -24.06 63.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.033 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 60.7 t -73.61 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.65 -51.07 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -52.33 -63.02 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.984 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 73' ' ' ALA . 28.6 mt -46.94 -74.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 110.119 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.39 -39.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 110.045 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -57.38 -40.61 92.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HB3' HBA2 ' A' ' 81' ' ' HEC . 3.1 mttt -87.8 -10.39 51.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.041 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.514 HG12 ' CMA' ' A' ' 81' ' ' HEC . 42.3 mt -73.4 -44.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 110.066 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.81 11.3 13.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.034 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -111.48 -45.24 3.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.46 179.24 52.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.81 -147.35 16.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.3 p 169.66 -168.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -1.073 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.96 -16.76 5.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -96.21 -23.82 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 110.139 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.572 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.8 m95 -112.58 -18.01 12.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.76 -153.17 23.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -111.68 66.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -1.115 . . . . 0.0 110.04 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.22 95.78 14.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.116 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.76 86.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.704 2.27 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.499 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.7 ttt -55.36 138.93 67.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 109.981 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.481 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.61 141.77 81.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.586 2.191 . . . . 0.0 110.332 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.39 169.73 9.13 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.62 2.214 . . . . 0.0 110.091 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.455 ' HG3' HBB1 ' A' ' 81' ' ' HEC . 24.9 mm-40 -137.73 164.67 28.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.69 55.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.98 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.462 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 3.5 m -114.4 155.85 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.882 . . . . 0.0 110.099 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' ASP . 77.5 p -105.61 172.66 6.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 t0 -43.56 -50.34 7.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.036 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -48.76 -63.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 11.5 mt-10 -53.54 -39.97 65.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.237 -0.915 . . . . 0.0 109.768 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.548 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -60.19 -34.66 73.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.718 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 16.2 mttm -65.61 -51.55 58.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.808 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.96 -30.32 61.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.19 -49.76 47.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.853 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.29 -32.44 70.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 0.0 109.426 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 3.1 mm-40 -74.99 -36.82 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.483 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.529 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 21.6 t90 -79.51 -38.26 34.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -0.831 . . . . 0.0 109.898 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.55 HD11 ' CE1' ' A' ' 25' ' ' TYR . 50.5 mt -68.43 -36.54 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.931 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 29' ' ' ALA . 19.3 mt -69.94 -47.52 62.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 109.943 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 t -58.46 -23.46 57.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.517 ' CG2' HD22 ' A' ' 16' ' ' LEU . 36.6 mt -73.22 114.28 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 109.994 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.064 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.514 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.8 m120 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.213 0.53 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.84 -29.2 70.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.088 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -51.84 -26.08 9.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 110.064 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.05 -44.89 91.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.06 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.501 ' HB1' ' CH2' ' A' ' 75' ' ' TRP . . . -55.2 -41.88 72.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.084 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -69.7 -56.45 7.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.983 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -24.48 3.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.108 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -88.89 -48.31 7.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.328 -0.857 . . . . 0.0 110.07 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.04 45.78 1.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' HMB3 ' A' ' 81' ' ' HEC . 13.7 m -102.36 -28.82 12.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -1.152 . . . . 0.0 110.03 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.96 -16.17 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 110.138 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HB3' HMC1 ' A' ' 81' ' ' HEC . . . -49.14 -24.31 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 109.976 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.1 m -137.0 -37.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.034 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.402 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -70.75 -179.56 2.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.523 ' CB ' ' O ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 176.04 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.0 109.819 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' CD2' HD13 ' A' ' 79' ' ' ILE . 28.8 mt -42.48 -65.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -122.04 42.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 15' ' ' ASP . . . -146.97 82.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.78 71.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -71.89 -90.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.249 -0.907 . . . . 0.0 109.977 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 29.6 t -90.4 -40.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.883 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.11 165.34 12.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.529 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 121.16 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.608 2.206 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.25 129.95 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 110.02 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.479 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.5 m-85 -48.65 -31.69 7.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.41 -46.21 73.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -48.84 79.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 93.0 t -56.93 -44.41 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -51.73 -62.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.08 -39.99 63.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -60.01 -34.52 73.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.099 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 4.0 m-85 -96.26 4.57 52.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.105 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.86 -17.53 60.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.053 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 16.56 51.41 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.19 157.48 46.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -1.129 . . . . 0.0 110.063 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -104.68 -3.16 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.155 -0.965 . . . . 0.0 110.109 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -115.23 20.63 14.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -62.0 -21.65 65.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.077 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.67 -57.24 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.14 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -53.52 57.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.407 ' O ' ' C ' ' A' ' 42' ' ' LEU . 18.9 t80 -51.04 -63.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.522 HD13 ' CB ' ' A' ' 73' ' ' ALA . 22.4 mt -43.4 -73.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.537 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.32 -39.54 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.092 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.9 -42.66 92.47 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.483 ' HB2' ' CBA' ' A' ' 81' ' ' HEC . 4.5 mtpt -84.75 -14.97 46.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.164 . . . . 0.0 109.971 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.515 HG12 ' CMA' ' A' ' 81' ' ' HEC . 28.8 mt -67.62 -46.25 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 110.014 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -16.62 43.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -95.36 -30.53 13.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.74 -157.76 29.74 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.4 -132.57 11.08 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.2 p 169.85 178.6 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 110.085 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 141.02 -20.32 2.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -105.75 -22.31 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -1.126 . . . . 0.0 110.084 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.487 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 80.3 m95 -119.53 -12.37 9.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' O1D' ' A' ' 81' ' ' HEC . . . 164.67 -145.95 10.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.461 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 3.7 m -122.92 -26.51 4.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 110.1 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . 21.9 t -41.6 102.04 0.26 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.7 88.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.654 2.236 . . . . 0.0 110.248 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.498 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.2 ttt -55.63 138.88 69.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.518 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.41 143.58 88.83 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.589 2.193 . . . . 0.0 110.332 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.426 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.86 169.32 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.757 2.304 . . . . 0.0 110.116 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 31.5 mm-40 -137.97 165.69 25.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.042 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -104.76 56.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 3.7 m -114.62 155.78 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.13 170.3 8.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.922 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -43.33 -53.63 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.983 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -49.32 -59.07 4.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.31 -40.82 68.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.889 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.537 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -59.02 -36.66 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.395 -0.815 . . . . 0.0 109.869 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 29.5 mttt -64.82 -51.03 64.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.38 -0.825 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.2 tm0? -55.05 -31.04 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 110.012 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.471 HD23 ' CMB' ' A' ' 81' ' ' HEC . 8.1 mt -70.01 -50.34 42.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.824 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' CB ' HD13 ' A' ' 42' ' ' LEU . . . -68.7 -34.4 75.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.455 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.18 -37.89 66.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.434 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.501 ' CH2' ' HB1' ' A' ' 5' ' ' ALA . 17.3 t90 -76.78 -39.83 50.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 109.754 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.479 HG12 ' CD1' ' A' ' 25' ' ' TYR . 37.8 mt -68.13 -46.07 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 58.2 mt -61.08 -41.13 96.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.895 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.465 HD13 ' CD2' ' A' ' 16' ' ' LEU . 11.6 mt -59.23 100.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.518 HBC2 ' CD ' ' A' ' 60' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 p30 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.221 0.534 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -158.66 -58.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.132 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -24.62 2.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.091 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mt -58.01 -57.4 12.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.54 -18.51 56.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.034 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -68.46 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.044 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.24 -25.38 2.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.108 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.05 -52.77 7.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 110.087 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.56 24.64 6.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' SG ' HMB3 ' A' ' 81' ' ' HEC . 14.5 m -69.75 -29.61 67.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -1.161 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 mmt -60.58 -13.31 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.106 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.0 -36.39 60.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.6 m -126.73 -8.4 6.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.448 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 81.6 m-70 -101.67 -178.35 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 110.426 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 1.1 m-20 170.75 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 109.793 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.504 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 26.7 mt -42.53 -68.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 42.86 3.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.849 . . . . 0.0 110.057 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . . . -138.07 88.0 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -50.59 159.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.125 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 2.3 tptt 177.42 -147.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 109.916 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.463 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 72.1 t -49.65 -29.53 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -130.07 153.3 20.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.566 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.78 120.98 9.0 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.708 2.272 . . . . 0.0 110.323 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 136.47 3.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.543 ' CE1' HD11 ' A' ' 76' ' ' ILE . 7.2 m-85 -54.75 -33.65 61.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.01 -52.32 60.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 110.165 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.608 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -57.84 -46.03 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.995 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 76' ' ' ILE . . . -49.33 -66.84 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.918 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -53.08 -38.3 62.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.563 ' HD2' ' CZ2' ' A' ' 54' ' ' TRP . 7.5 ttmt -63.22 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -100.16 -5.48 27.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.84 -22.67 65.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.061 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.79 11.75 65.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.12 127.02 45.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.119 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -77.07 -29.19 54.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.081 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.51 18.23 10.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' HD13 ' A' ' 42' ' ' LEU . . . -65.25 -23.83 67.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.085 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 61.5 t -70.79 -58.77 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.053 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.45 -51.31 69.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.2 t80 -52.26 -65.87 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 38' ' ' ALA . 15.9 mt -43.01 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB3' ' CB ' ' A' ' 69' ' ' ALA . . . -42.54 -40.11 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.077 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.61 -41.28 93.54 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -9.37 55.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.519 HG12 ' CMA' ' A' ' 81' ' ' HEC . 8.2 mt -73.96 -49.2 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.18 -2.89 20.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -120.28 -17.64 8.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.32 -153.93 26.37 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.68 -145.33 16.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.49 ' HA ' ' CGD' ' A' ' 81' ' ' HEC . 5.5 p 173.43 -170.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 110.058 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.48 -19.2 6.33 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.5 t -96.35 -22.64 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 94.6 m95 -112.92 -35.46 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.56 -140.83 4.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.416 ' C ' HG22 ' A' ' 57' ' ' VAL . 5.3 p -120.07 63.84 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -1.135 . . . . 0.0 110.026 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.416 HG22 ' C ' ' A' ' 56' ' ' SER . 57.2 t -131.52 95.82 22.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.042 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.74 86.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.693 2.262 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.484 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 9.0 ttt -55.12 139.88 63.7 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -62.83 141.36 84.47 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.653 2.235 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.425 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 3.0 Cg_endo -63.08 168.83 10.1 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.687 2.258 . . . . 0.0 110.087 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 33.3 mm-40 -139.04 166.61 24.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -105.3 64.62 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.103 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.99 155.81 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 110.137 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.09 169.29 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.89 . . . . 0.0 109.958 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -43.47 -52.03 6.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.999 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.21 6.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -40.5 68.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.863 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . . . -58.79 -36.89 75.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.808 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.1 57.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.342 -0.849 . . . . 0.0 109.981 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.13 -29.5 45.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 110.036 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.5 mt -70.16 -51.69 29.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -69.41 -31.67 70.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.12 -36.93 61.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.558 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.514 ' CE2' HD12 ' A' ' 79' ' ' ILE . 21.4 t90 -79.49 -38.78 33.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.832 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.543 HD11 ' CE1' ' A' ' 25' ' ' TYR . 57.0 mt -70.49 -38.55 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 29' ' ' ALA . 24.1 mt -68.46 -41.47 80.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.961 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.31 -38.42 91.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.023 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.514 HD12 ' CE2' ' A' ' 75' ' ' TRP . 9.2 mt -60.3 120.01 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.998 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.419 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.121 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.519 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.5 t30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.277 0.561 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' OE1' ' HG3' ' A' ' 6' ' ' LYS . 2.3 tt0 -91.08 -24.61 19.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.06 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 3.3 tt0 -49.65 -24.99 2.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.075 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.5 mt -69.46 -51.95 31.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.079 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.03 -28.75 57.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.079 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HG3' ' OE1' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -54.79 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 110.123 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 3.9 pt20 -50.81 -29.82 12.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.045 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -64.34 -56.25 15.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.24 37.94 1.73 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.462 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.7 m -86.73 -29.05 22.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -1.158 . . . . 0.0 109.983 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmt -56.88 -16.85 7.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.57 -22.27 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 15.0 m -138.47 -37.22 0.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 0.0 110.124 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.487 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 89.3 m-70 -72.56 -178.34 2.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 169.87 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.858 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.449 HD21 HG23 ' A' ' 79' ' ' ILE . 25.5 mt -42.15 -62.93 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 42.86 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -152.35 75.52 1.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.185 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.47 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.847 . . . . 0.0 110.205 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.6 mtpt -67.92 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.008 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 25.4 t -91.41 -31.82 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.935 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.4 167.75 13.37 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.82 8.75 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.738 2.292 . . . . 0.0 110.273 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -43.97 134.73 4.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.492 ' CD1' HG12 ' A' ' 76' ' ' ILE . 5.9 m-85 -51.25 -32.36 24.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.78 -44.78 69.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.029 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.98 -47.84 84.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 32.5 t -56.83 -44.61 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' CB ' ' HA ' ' A' ' 77' ' ' LEU . . . -52.29 -59.15 4.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -55.12 -42.95 73.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 109.824 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 tptt -60.28 -33.39 72.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.049 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 42' ' ' LEU . 5.2 m-85 -90.46 5.74 46.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.84 -23.72 66.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.18 13.11 62.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -117.11 138.13 51.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -1.125 . . . . 0.0 110.068 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -90.82 -16.34 28.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.85 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.46 33.74 5.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.107 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.485 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -57.47 -21.46 37.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.071 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -69.72 -57.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.0 -54.79 42.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.2 t80 -51.64 -63.7 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.062 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.495 HD22 ' CE2' ' A' ' 32' ' ' TYR . 15.7 mt -43.14 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 69' ' ' ALA . . . -42.51 -40.3 2.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.432 -0.793 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.38 -37.71 75.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' LEU . 3.4 mmtt -91.35 -7.98 49.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -1.157 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.524 ' CG1' HMA1 ' A' ' 81' ' ' HEC . 53.5 mt -78.03 -37.28 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 0.0 110.062 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -90.75 4.49 51.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.081 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -119.89 -43.7 2.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.11 -164.98 40.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 104.9 -140.34 14.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.62 -176.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.9 -10.71 4.52 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -111.65 -6.29 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 110.116 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.497 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.0 m95 -135.52 4.37 3.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -153.54 23.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -116.78 48.82 1.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.15 . . . . 0.0 110.119 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG12 HMD2 ' A' ' 81' ' ' HEC . 58.8 t -110.81 96.22 27.76 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -60.58 88.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 110.34 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.495 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.6 ttt -62.01 139.49 95.86 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.961 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' CD ' HBC3 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.38 143.02 87.79 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.684 2.256 . . . . 0.0 110.364 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.8 Cg_endo -63.09 167.9 11.66 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.671 2.247 . . . . 0.0 110.151 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 26.3 mm-40 -138.14 165.1 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.25 62.07 0.68 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.006 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 46' ' ' ILE . 3.4 m -114.99 155.8 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.2 p -99.87 164.96 11.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.955 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -43.38 -51.66 6.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.947 . . . . 0.0 110.035 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.41 -58.05 6.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.77 -41.72 70.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 43' ' ' ALA . . . -58.11 -35.12 70.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.43 -0.794 . . . . 0.0 109.804 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -52.76 48.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.85 . . . . 0.0 110.029 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.28 -29.62 47.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.2 mt -70.11 -50.87 36.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.919 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . . . -69.45 -32.22 71.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -74.94 -37.45 62.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.823 . . . . 0.0 109.524 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.474 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.7 t90 -78.81 -38.17 38.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.813 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.492 HG12 ' CD1' ' A' ' 25' ' ' TYR . 52.3 mt -70.08 -42.19 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.062 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.507 ' HA ' ' CB ' ' A' ' 29' ' ' ALA . 31.3 mt -64.23 -47.24 80.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -28.44 62.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 75' ' ' TRP . 29.4 mt -71.23 139.27 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.403 ' N ' HG21 ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.058 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.524 HMA1 ' CG1' ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 14.2 p-10 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.221 0.534 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 0.7 OUTLIER 179.7 -43.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.035 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -51.13 -21.61 2.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.069 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 3.8 pp -74.44 -32.83 62.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 110.084 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.501 ' CB ' ' CH2' ' A' ' 75' ' ' TRP . . . -69.74 -39.4 76.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -75.8 -52.14 11.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 110.013 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -51.17 -25.85 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.09 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -78.13 -54.51 6.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 110.07 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.69 43.26 0.42 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.455 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 12.6 m -103.75 -29.61 10.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -1.123 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.2 mmt -60.22 -13.84 14.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.35 -34.72 48.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.071 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -125.32 -26.0 3.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.87 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.5 m-70 -83.67 -179.65 7.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 110.467 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 168.23 125.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.463 -0.773 . . . . 0.0 109.688 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.521 ' CD2' HG21 ' A' ' 79' ' ' ILE . 25.6 mt -42.14 -64.91 0.52 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 42.75 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 110.115 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -145.28 45.19 1.32 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.88 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 110.085 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 18' ' ' ALA . 9.6 mtmt -93.62 -90.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 30.7 t -80.02 -31.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.04 169.21 16.99 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 123.41 12.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.745 2.297 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -48.48 135.9 13.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.506 ' CE1' HD12 ' A' ' 76' ' ' ILE . 5.2 m-85 -50.51 -32.46 18.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.77 -49.54 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 110.044 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.57 -44.82 89.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.86 . . . . 0.0 109.977 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 84.5 t -57.46 -45.7 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.94 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -52.74 -52.69 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -54.23 -45.21 72.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.906 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 11.0 mttt -55.65 -36.83 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 110.104 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 12.2 m-85 -101.16 -4.09 27.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 110.089 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -62.3 -26.38 68.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.41 15.64 55.86 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.08 174.02 8.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.039 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -120.36 -22.26 6.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.123 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -100.62 20.32 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.081 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -60.01 -23.89 64.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.456 HG13 ' HD3' ' A' ' 70' ' ' LYS . 60.1 t -66.87 -53.66 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.59 -55.74 27.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.094 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 50.8 t80 -48.31 -64.7 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 110.048 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' A' ' 73' ' ' ALA . 18.5 mt -42.99 -73.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.62 -40.99 2.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.087 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.75 -38.44 72.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' CE ' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -89.93 -16.54 29.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 110.039 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.527 HG12 ' CMA' ' A' ' 81' ' ' HEC . 45.1 mt -65.91 -45.07 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 110.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -81.64 -13.88 57.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -101.22 -43.75 5.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.095 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.84 -148.52 38.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 92.52 -135.47 12.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 175.95 -177.43 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 110.052 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.52 -22.01 5.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 53' ' ' VAL . 69.0 t -89.08 -21.55 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -1.164 . . . . 0.0 110.005 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.555 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.2 m95 -117.2 -39.34 3.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.27 -128.93 1.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 p -124.26 62.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 110.135 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.523 ' HB ' ' CMD' ' A' ' 81' ' ' HEC . 4.1 t -122.68 92.01 49.28 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.23 86.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.76 2.307 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.496 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.2 ttt -63.92 139.92 97.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 109.933 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.66 142.15 82.39 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 110.316 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.22 162.73 25.52 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.661 2.24 . . . . 0.0 110.12 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 21.9 mm-40 -134.91 163.8 29.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 110.097 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -104.58 65.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 46' ' ' ILE . 3.5 m -114.34 155.88 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 43.6 p -103.28 168.49 9.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 9.4 m-20 -43.39 -57.87 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.052 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.7 -59.02 3.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.939 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -41.59 70.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.899 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.55 -36.15 75.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.825 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HD3' HG13 ' A' ' 39' ' ' VAL . 32.1 mmtt -67.2 -51.05 58.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.36 -29.66 49.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 72' ' ' LEU . 59.6 mt -70.11 -52.3 24.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.518 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -68.66 -33.49 74.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -73.45 -36.58 65.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.433 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.501 ' CH2' ' CB ' ' A' ' 5' ' ' ALA . 19.7 t90 -78.61 -40.72 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.851 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.506 HD12 ' CE1' ' A' ' 25' ' ' TYR . 51.2 mt -69.39 -39.65 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.971 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 29' ' ' ALA . 46.2 mt -66.51 -42.25 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.87 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -63.68 -43.07 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.521 HG21 ' CD2' ' A' ' 16' ' ' LEU . 25.8 mt -49.63 98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.059 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.527 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.185 0.517 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 28.6 tt0 -172.28 -73.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.121 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 4.5 mm-40 -45.94 -25.36 0.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.088 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' HB3' ' OE1' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -65.46 -54.98 20.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.13 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.5 -9.72 55.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.901 . . . . 0.0 110.113 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 2.1 tttt -75.97 -64.93 0.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.117 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 10.3 pt20 -45.3 -30.34 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 109.973 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB3' HBB2 ' A' ' 81' ' ' HEC . 0.0 OUTLIER -68.55 -58.74 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 110.006 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.88 40.3 1.32 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.452 ' SG ' HMB3 ' A' ' 81' ' ' HEC . 18.0 m -80.83 -30.75 35.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.063 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -14.69 14.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HB3' HMC2 ' A' ' 81' ' ' HEC . . . -50.32 -26.97 5.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.8 m -133.8 -35.1 0.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.573 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 90.2 m-70 -73.82 179.95 3.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.439 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 171.46 119.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.496 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 4.7 mp -41.73 -60.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 110.35 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.74 42.75 3.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.219 -0.926 . . . . 0.0 110.07 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -143.12 85.86 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.114 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -57.83 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -92.19 -145.37 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.055 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.1 t -51.54 -31.41 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 110.066 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.02 163.96 13.19 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.572 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 131.82 38.7 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.743 2.295 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -53.14 123.9 13.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.573 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.5 m-85 -46.09 -31.51 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -69.22 -45.64 69.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.062 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.48 -45.0 92.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.895 . . . . 0.0 110.108 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 52.5 t -58.14 -46.74 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.036 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -52.49 -54.57 30.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.981 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -54.82 -43.62 73.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -35.41 70.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 110.085 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.52 1.65 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.01 -28.98 68.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.35 19.39 36.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -120.19 158.65 26.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.073 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 -19.54 13.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -103.12 18.8 20.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.13 -23.16 45.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 t -70.67 -54.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.079 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.04 -53.1 61.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.071 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' LEU . 51.8 t80 -52.95 -65.02 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 45' ' ' LYS . 26.4 mt -43.93 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -42.64 -37.64 1.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.397 -0.814 . . . . 0.0 110.102 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.05 65.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' HB3' ' CBA' ' A' ' 81' ' ' HEC . 1.7 tptp -101.41 -13.97 17.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.515 HG12 ' CMA' ' A' ' 81' ' ' HEC . 27.2 mt -72.49 -44.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.093 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -80.21 -5.43 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.44 -13.46 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.045 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 53.6 -149.93 13.48 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.69 -147.7 16.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.1 t 169.69 -178.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 110.099 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 133.84 -11.94 4.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.5 t -102.88 -27.33 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.067 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.572 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.8 m95 -107.05 -13.69 15.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.088 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.91 -147.85 16.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 56' ' ' SER . 3.6 p -116.35 50.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -1.14 . . . . 0.0 110.079 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.14 95.84 47.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.86 103.92 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.752 2.301 . . . . 0.0 110.336 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.487 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 6.8 ttt -75.54 139.7 71.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.907 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.37 138.76 67.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.67 2.246 . . . . 0.0 110.365 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.6 168.87 10.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.597 2.198 . . . . 0.0 110.173 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 30.2 mm-40 -138.17 165.56 26.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.937 . . . . 0.0 110.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -105.16 65.1 0.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.11 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.91 155.84 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -100.53 165.3 11.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.018 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 65' ' ' THR . 3.5 t0 -43.36 -55.51 4.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.4 -60.4 2.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.66 -41.3 69.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.751 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . . . -59.27 -34.21 71.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.845 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -52.24 50.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.414 -0.804 . . . . 0.0 110.039 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.17 -30.03 59.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 69' ' ' ALA . 76.3 mt -70.21 -50.24 41.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.884 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.88 -32.39 70.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -74.79 -37.29 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.478 ' CE2' HD12 ' A' ' 79' ' ' ILE . 20.9 t90 -79.02 -38.42 36.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.822 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.553 HD11 ' CE1' ' A' ' 25' ' ' TYR . 44.8 mt -72.47 -38.02 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.953 . . . . 0.0 109.961 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 17.0 mt -67.03 -44.5 80.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.916 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -61.27 -30.59 70.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 109.963 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.478 HD12 ' CE2' ' A' ' 75' ' ' TRP . 43.0 mt -62.76 101.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.019 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.463 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.067 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.515 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 3' ' ' GLN . 1.1 t-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.237 0.542 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 4.5 mt-10 64.75 -68.98 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 0.0 110.136 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -50.75 -24.62 3.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 110.043 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.0 mt -65.3 -54.14 33.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 110.12 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.401 ' HB1' ' CH2' ' A' ' 75' ' ' TRP . . . -56.59 -36.89 69.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.951 . . . . 0.0 110.015 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -65.15 -54.02 36.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.122 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -25.67 4.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 110.09 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -48.46 9.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 110.073 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.59 24.52 4.96 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 13.7 m -73.07 -29.06 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.973 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 mmt -59.54 -15.91 21.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.107 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -23.66 2.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.223 -0.923 . . . . 0.0 109.978 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' HMC1 ' A' ' 81' ' ' HEC . 13.7 m -136.88 -36.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.31 -0.869 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.502 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 88.1 m-70 -71.64 -179.57 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 110.468 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.38 122.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.505 -0.747 . . . . 0.0 109.669 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.51 ' CD2' HG21 ' A' ' 79' ' ' ILE . 32.1 mt -42.07 -65.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 110.313 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.5 42.6 3.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -155.16 45.52 0.5 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 6.4 pttt -45.69 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.2 tptt -79.68 -90.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.071 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 25.9 t -78.67 -31.7 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.074 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.39 174.78 16.31 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 147.49 95.3 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.744 2.296 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -71.28 129.81 39.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 109.979 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.55 ' CD1' HG12 ' A' ' 76' ' ' ILE . 3.4 m-85 -45.98 -30.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.105 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.69 -46.93 51.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.966 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -49.11 78.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 109.93 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.606 ' CG2' ' CZ2' ' A' ' 54' ' ' TRP . 45.7 t -56.31 -43.4 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.91 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -52.23 -57.47 9.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 14.1 tttm -53.78 -44.7 70.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.907 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -34.0 69.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' HB2' ' CD2' ' A' ' 77' ' ' LEU . 28.2 m-85 -99.24 3.12 46.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' LYS . . . -67.79 -28.97 68.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.065 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.5 19.59 35.5 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.09 146.39 45.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -1.167 . . . . 0.0 110.058 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 37' ' ' ASP . 8.7 ptpt -96.09 -27.38 15.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 38.9 m-20 -105.34 29.07 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.061 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . . . -59.21 -25.13 63.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG1' ' HG3' ' A' ' 70' ' ' LYS . 3.8 t -68.31 -54.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -58.61 -55.64 32.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.52 -66.18 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 0.0 110.083 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 38' ' ' ALA . 2.1 mt -43.13 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -42.77 -38.39 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 110.08 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -41.19 95.18 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -87.72 -9.18 54.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -1.168 . . . . 0.0 110.056 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.505 ' CG1' HMA3 ' A' ' 81' ' ' HEC . 42.2 mt -74.17 -50.62 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 2.0 mtmt -73.69 -9.05 58.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.111 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -121.26 -7.4 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 44.35 -142.74 2.77 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.11 -137.46 13.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.75 -174.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.22 -10.33 7.77 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 53' ' ' VAL . 53.8 t -107.87 -16.5 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.26 -1.141 . . . . 0.0 110.15 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CZ2' ' CG2' ' A' ' 28' ' ' VAL . 95.7 m95 -121.38 -27.12 4.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.52 -141.47 6.26 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 m -120.85 69.86 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 110.09 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG12 ' CMD' ' A' ' 81' ' ' HEC . 55.6 t -139.19 95.22 9.42 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.026 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.01 75.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.737 2.291 . . . . 0.0 110.276 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.476 ' CE ' ' NB ' ' A' ' 81' ' ' HEC . 7.2 ttt -43.87 140.44 2.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.74 145.05 94.85 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.688 2.259 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.65 167.75 11.18 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.2 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.453 ' CG ' HBB1 ' A' ' 81' ' ' HEC . 37.1 mm-40 -138.66 166.23 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.074 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -105.74 62.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 46' ' ' ILE . 3.6 m -114.72 155.95 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 3.5 p -104.46 168.39 9.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.8 OUTLIER -43.39 -62.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.046 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.85 -57.57 3.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -55.24 -42.58 73.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . . . -58.71 -34.84 71.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.91 -51.4 58.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.26 -30.42 60.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.183 -0.948 . . . . 0.0 109.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.519 HD11 ' CMB' ' A' ' 81' ' ' HEC . 14.9 mt -70.2 -50.56 38.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 109.862 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.61 -32.26 70.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 78' ' ' SER . 0.1 OUTLIER -74.91 -37.49 62.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 109.499 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.472 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.6 t90 -78.84 -38.15 38.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG12 ' CD1' ' A' ' 25' ' ' TYR . 47.4 mt -73.05 -41.83 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 38' ' ' ALA . 36.4 mt -64.79 -41.75 95.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.0 OUTLIER -62.53 -31.47 72.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.51 HG21 ' CD2' ' A' ' 16' ' ' LEU . 28.9 mt -66.7 98.37 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.994 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.048 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.52 ' CMD' HG12 ' A' ' 57' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.5 m -76.71 -28.86 56.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 110.0 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.57 -15.66 7.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -24.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.008 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.9 m -136.44 -37.05 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.002 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 56.1 m80 -71.49 -179.66 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 110.344 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.804 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 176.55 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.834 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.591 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 26.6 mt -42.66 -67.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.477 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -121.98 42.37 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.349 -0.844 . . . . 0.0 110.041 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.804 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -139.0 87.39 2.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 110.117 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pttt -55.51 85.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 110.06 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -96.63 -143.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 36.4 t -51.96 -31.4 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.0 161.01 15.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.582 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.87 120.06 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.705 2.27 . . . . 0.0 110.262 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.51 130.16 5.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.98 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.751 ' CE1' HD13 ' A' ' 76' ' ' ILE . 6.7 m-85 -51.02 -33.25 24.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -66.14 -42.67 88.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.15 -52.37 59.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.041 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 53.6 t -56.37 -43.38 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.878 . . . . 0.0 109.973 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.782 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.5 -57.9 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -45.14 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.933 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 9.3 mttt -58.13 -34.83 70.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.87 4.01 31.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -68.48 -29.27 67.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.6 19.91 34.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -112.72 174.08 6.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.13 . . . . 0.0 110.16 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -122.26 -12.68 8.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.79 19.04 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.062 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.51 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -55.01 -21.02 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 19.6 t -71.38 -56.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.98 -52.72 64.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 109.993 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 45.2 t80 -52.18 -66.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.476 HD12 ' HB1' ' A' ' 73' ' ' ALA . 59.9 mt -43.21 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.099 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.54 -35.92 1.21 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.411 -0.805 . . . . 0.0 110.108 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.29 -35.98 81.01 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -93.94 -11.87 30.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -1.17 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 72' ' ' LEU . 13.6 mt -72.01 -44.26 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 110.07 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -102.1 -44.15 5.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.96 -162.01 48.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.45 -136.37 12.78 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.92 -170.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 0.0 110.074 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.4 -19.55 5.65 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG21 ' OH ' ' A' ' 41' ' ' TYR . 98.8 t -101.5 -20.2 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -1.134 . . . . 0.0 110.078 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 1.041 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 86.8 m95 -121.77 -27.59 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.022 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.38 -136.65 2.28 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 22.5 p -129.53 -35.06 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.074 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.4 p -42.19 102.66 0.28 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.131 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.8 87.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.203 . . . . 0.0 110.27 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.5 ttt -45.02 139.87 3.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 2.9 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.684 2.256 . . . . 0.0 110.281 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.22 162.93 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 110.172 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 22.0 mm-40 -134.56 163.54 29.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 110.096 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -103.81 72.75 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 46' ' ' ILE . 3.6 m -124.31 155.89 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ASP . 66.7 p -104.14 169.92 8.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.948 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' THR . 14.0 t0 -43.43 -58.0 2.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.05 -58.92 3.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -54.4 -41.29 69.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.099 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.48 -35.49 72.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.815 . . . . 0.0 109.858 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -65.17 -52.08 57.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.9 -30.03 57.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.998 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.664 HD13 HD13 ' A' ' 46' ' ' ILE . 24.0 mt -70.24 -50.69 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.13 -30.79 68.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.471 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.24 -37.09 58.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.459 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 22.8 t90 -80.28 -36.83 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.751 HD13 ' CE1' ' A' ' 25' ' ' TYR . 54.9 mt -74.34 -37.22 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.7 mt -68.36 -46.91 68.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -57.42 -25.99 60.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.989 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 16' ' ' LEU . 16.8 mt -75.44 130.59 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.025 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.107 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 11.8 m -72.47 -29.01 63.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -1.214 . . . . 0.0 109.962 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -16.38 9.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.94 -28.02 6.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 14.4 m -132.27 -34.15 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 55.5 m80 -75.51 -179.22 4.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.653 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 169.39 124.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.75 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 79' ' ' ILE . 23.2 mt -42.25 -66.47 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 42.71 3.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.943 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -147.73 45.75 1.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.02 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 10.6 pttt -42.4 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -89.73 -89.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 t -82.11 -31.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.872 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.22 170.26 15.59 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.622 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -61.28 127.54 22.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.715 2.277 . . . . 0.0 110.273 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.08 133.36 27.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.218 -0.926 . . . . 0.0 109.939 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 4.6 m-85 -49.54 -32.19 11.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -71.14 -45.93 62.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.55 -44.71 95.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 34.7 t -57.68 -45.83 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.86 -53.12 53.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.886 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -55.27 -45.39 76.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.976 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.74 66.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 41.6 m-85 -102.99 -1.25 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.081 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.35 -29.93 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.74 15.37 52.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -126.02 153.6 44.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -1.133 . . . . 0.0 110.038 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -20.71 13.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.016 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -96.52 14.65 23.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -59.53 -21.89 60.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 39' ' ' VAL . 4.5 t -68.8 -56.91 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.984 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -52.92 63.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.0 t80 -51.8 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.446 HD12 ' HB1' ' A' ' 73' ' ' ALA . 78.2 mt -43.08 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.913 . . . . 0.0 110.123 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.74 -41.83 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.036 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.69 -40.61 88.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.08 -13.67 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.076 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 43' ' ' ALA . 41.1 mt -69.24 -46.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.027 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -83.22 -12.51 56.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.066 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -96.21 -37.28 10.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.61 -162.18 54.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 95.29 -141.09 15.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.76 -175.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -1.146 . . . . 0.0 110.05 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.43 -12.33 3.5 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.1 -23.53 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.105 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.66 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 92.4 m95 -112.3 -24.77 9.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.89 28.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -110.09 54.4 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.24 96.82 49.23 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.047 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.51 88.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.325 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.9 ttt -60.08 139.41 91.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.872 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 144.09 91.44 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.652 2.235 . . . . 0.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.66 165.42 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.69 2.26 . . . . 0.0 110.151 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 31.1 mm-40 -136.62 164.58 27.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.82 62.1 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.34 155.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.9 p -103.67 169.02 8.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 109.967 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 25.3 t0 -43.38 -58.23 2.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -47.97 -55.38 10.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.85 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.45 -42.63 74.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.911 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.738 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -57.78 -34.87 70.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.845 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 1.6 mtmt -65.6 -52.59 50.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.19 -30.1 48.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.999 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.05 -51.39 32.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.892 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -69.59 -31.8 70.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.418 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.27 -36.55 61.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.578 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.0 t90 -79.76 -38.31 33.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.835 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 79.1 mt -70.72 -39.7 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 29' ' ' ALA . 14.8 mt -67.54 -44.62 77.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.041 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -31.86 70.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.96 HG21 HD22 ' A' ' 16' ' ' LEU . 39.5 mt -67.84 114.99 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.086 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -103.36 -28.71 11.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.089 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.7 mmt -59.08 -14.5 10.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.13 -25.43 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -135.95 -36.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.8 m-70 -70.63 -179.14 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.862 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 172.73 124.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.009 HD22 HG21 ' A' ' 79' ' ' ILE . 24.2 mt -42.15 -63.3 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.344 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 42.51 3.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.0 110.06 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.862 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -142.83 86.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -60.31 78.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.166 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 17.7 mttt -88.42 -141.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 110.011 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 38.9 t -50.17 -31.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.12 157.65 16.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.89 124.71 15.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.73 2.287 . . . . 0.0 110.271 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -45.01 132.91 6.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 109.952 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.2 m-85 -52.12 -32.26 34.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.57 -47.2 76.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.151 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -47.3 83.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 23' ' ' PRO . 38.0 t -57.45 -45.25 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.999 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -53.15 -50.23 64.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.47 -44.74 69.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.055 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -38.08 65.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.034 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -100.85 -0.48 36.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.133 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.6 -26.46 67.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.049 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.26 24.27 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.33 154.13 47.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -1.193 . . . . 0.0 110.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -36.67 9.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.017 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 22.5 t70 -88.41 34.26 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -62.94 -24.57 67.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.02 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.86 -54.72 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -58.33 -55.97 28.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' LEU . 8.5 t80 -50.82 -65.19 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 38' ' ' ALA . 25.6 mt -43.01 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.971 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . . . -42.25 -42.01 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 110.078 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.23 58.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' LEU . 1.6 mmtp -97.43 -7.61 31.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 43' ' ' ALA . 49.5 mt -75.98 -47.91 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 110.067 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -73.8 -15.24 61.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.05 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 44.06 -144.01 2.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 94.6 -134.0 11.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.3 p 169.75 -170.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -1.184 . . . . 0.0 110.013 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.21 6.56 6.24 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.34 -11.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.62 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 96.3 m95 -124.72 -9.14 7.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.56 -128.58 2.37 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.87 51.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.2 t -114.01 94.94 36.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.041 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 3.0 Cg_exo -60.86 87.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.776 2.317 . . . . 0.0 110.281 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.447 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.6 ttt -59.17 139.42 88.0 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 2.9 Cg_endo -63.95 141.03 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.636 2.224 . . . . 0.0 110.301 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.35 164.94 18.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.669 2.246 . . . . 0.0 110.065 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -134.8 163.19 30.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.132 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -104.4 57.05 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 110.005 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.467 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 3.5 m -114.33 155.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.232 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -107.13 174.58 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.896 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -43.66 -50.37 7.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.001 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.31 -63.26 1.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 0.0 109.906 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 6.2 mt-10 -53.88 -39.79 66.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.786 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.971 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -60.31 -34.45 73.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.63 57.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 110.005 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.8 -30.62 61.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.996 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.8 mt -70.01 -49.82 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.36 -32.13 69.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.105 -0.997 . . . . 0.0 109.398 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -75.24 -36.88 61.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.9 t90 -79.79 -37.95 34.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.815 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.15 -40.42 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.0 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 21.7 mt -68.84 -39.96 79.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.933 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -64.66 -28.63 69.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.855 . . . . 0.0 110.035 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.009 HG21 HD22 ' A' ' 16' ' ' LEU . 28.5 mt -69.67 116.79 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.003 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.054 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 10.6 m -79.23 -29.08 42.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -1.15 . . . . 0.0 110.018 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.08 -15.64 14.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.928 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.5 m -127.83 -30.24 2.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.521 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 53.7 m80 -80.27 -179.37 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.652 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.06 123.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.449 -0.782 . . . . 0.0 109.785 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.881 HD23 HG21 ' A' ' 79' ' ' ILE . 2.0 mt -42.01 -64.12 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -122.85 42.77 3.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 109.991 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -148.3 45.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.016 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.87 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.343 -0.848 . . . . 0.0 110.224 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 5.6 mtpt -91.6 -89.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 28.3 t -80.58 -31.54 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.903 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.79 169.22 15.92 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.674 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -60.98 126.98 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.759 2.306 . . . . 0.0 110.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.19 131.45 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.897 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.36 -32.22 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.135 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.56 -45.45 68.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -48.86 79.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.988 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 37.7 t -56.53 -43.5 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.836 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.55 -54.53 31.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.952 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -46.1 69.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -55.55 -35.3 65.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 31.8 m-85 -101.42 0.21 36.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.927 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -63.43 -25.87 68.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.05 16.8 54.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -139.43 153.62 47.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -1.165 . . . . 0.0 110.185 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -105.47 -29.02 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 0.0 110.111 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -76.69 1.81 16.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 110.117 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -55.93 -24.19 36.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.022 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 96.1 t -67.62 -55.53 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.71 -54.83 42.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -52.32 -63.16 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.063 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 38' ' ' ALA . 50.5 mt -43.24 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 110.087 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.886 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.67 -41.04 2.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -56.83 -41.11 90.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.26 -15.38 40.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.886 HD12 ' HA ' ' A' ' 43' ' ' ALA . 39.7 mt -67.28 -46.83 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.878 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 5.46 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -123.82 -6.64 7.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.103 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 44.24 -149.04 0.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.41 -146.72 18.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.69 177.05 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -1.119 . . . . 0.0 110.106 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.54 -14.8 3.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.79 -30.8 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.03 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.988 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.3 m95 -107.89 -26.21 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.08 -155.94 24.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 t -108.05 57.39 0.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -1.15 . . . . 0.0 110.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.7 t -117.59 96.26 49.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.61 78.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.741 2.294 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.2 ttt -52.15 138.98 35.81 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.68 142.24 82.63 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.627 2.218 . . . . 0.0 110.383 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.83 161.92 30.72 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.649 2.233 . . . . 0.0 110.17 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 27.1 mm-40 -135.04 163.57 29.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 110.104 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.09 69.1 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.002 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 46' ' ' ILE . 3.3 m -114.7 155.8 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.1 m -101.28 165.09 11.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.915 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 4.5 m-20 -43.41 -57.75 2.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.008 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.21 -55.11 11.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.51 -43.05 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.828 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.4 -36.63 71.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.825 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -65.28 -52.32 55.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -0.833 . . . . 0.0 110.026 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -53.94 -28.97 40.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 72' ' ' LEU . 17.3 mt -70.19 -52.05 26.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.935 . . . . 0.0 109.822 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -69.29 -31.38 69.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 0.0 109.38 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.23 -37.06 61.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.6 ' CE2' HD11 ' A' ' 79' ' ' ILE . 20.5 t90 -79.57 -38.44 34.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.78 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.2 mt -70.6 -42.4 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.836 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.5 mt -65.41 -42.82 92.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 109.99 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.3 t -61.95 -33.09 73.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 110.031 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.881 HG21 HD23 ' A' ' 16' ' ' LEU . 42.0 mt -64.63 103.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.146 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 16.6 m -97.6 -30.42 12.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -1.164 . . . . 0.0 110.134 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.9 mmt -61.16 -12.61 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.64 58.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.48 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 m -123.86 -19.01 5.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 50.1 m80 -91.26 -179.18 5.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.948 . . . . 0.0 110.343 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.896 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 170.66 122.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.916 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.772 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -42.52 -64.23 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.16 41.9 3.2 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.896 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -139.42 86.06 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.45 -0.781 . . . . 0.0 110.073 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 3.7 ptpt -55.24 86.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 18' ' ' ALA . 2.8 tptt -95.01 -147.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.02 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 35.9 t -50.89 -31.28 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 109.924 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.07 166.14 13.58 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.15 129.35 28.22 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.776 2.317 . . . . 0.0 110.252 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -50.76 127.16 17.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.9 m-85 -47.95 -33.55 7.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.004 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.12 -44.44 76.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -49.53 76.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.051 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.145 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 61.9 t -56.97 -44.72 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 76' ' ' ILE . . . -51.21 -62.51 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.943 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -40.92 67.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.788 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -61.63 -32.06 72.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 6.5 m-85 -91.64 2.07 56.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.17 -25.4 61.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.082 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.71 -3.88 68.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -118.26 164.67 14.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -1.135 . . . . 0.0 110.045 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 -11.01 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.67 21.78 16.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.033 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -59.37 -15.81 18.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.539 HG12 ' NZ ' ' A' ' 70' ' ' LYS . 49.2 t -73.77 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.033 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.87 -51.4 69.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.2 -64.34 0.84 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 109.997 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 38' ' ' ALA . 55.8 mt -43.52 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.53 -37.62 1.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.494 -0.754 . . . . 0.0 110.095 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.73 -41.13 93.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 49' ' ' GLY . 4.7 mmtp -87.9 -9.47 53.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.7 mt -73.49 -51.52 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.004 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -17.5 62.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.03 -18.18 13.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 55.53 -140.32 40.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 92.35 -139.44 14.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.7 p 169.92 -170.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -1.142 . . . . 0.0 110.034 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.23 4.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.83 -21.32 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -1.145 . . . . 0.0 110.131 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 1.145 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 93.0 m95 -115.81 -28.39 6.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 110.096 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 -155.85 25.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.9 p -107.89 65.34 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.039 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 51' ' ' SER . 60.4 t -129.97 96.33 26.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.59 87.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.736 2.291 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.433 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 8.9 ttt -59.43 140.28 88.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.28 141.5 82.26 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.577 2.185 . . . . 0.0 110.375 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.8 163.91 23.3 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.571 2.181 . . . . 0.0 110.029 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 20.0 mm-40 -134.95 163.33 30.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -0.982 . . . . 0.0 110.064 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -104.83 64.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.953 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -113.83 155.72 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 p -100.06 166.78 10.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 109.901 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -43.36 -55.29 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.79 -57.95 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.47 -40.99 68.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.9 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.58 -35.47 72.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.811 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' NZ ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.56 -52.25 53.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.339 -0.85 . . . . 0.0 110.088 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.52 -30.19 52.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 110.082 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 76' ' ' ILE . 26.7 mt -70.24 -50.33 40.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.87 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.39 -30.99 68.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.253 -0.905 . . . . 0.0 109.455 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -76.27 -36.56 58.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.56 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.533 ' CE2' HD11 ' A' ' 79' ' ' ILE . 23.7 t90 -80.79 -36.97 31.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 109.835 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.6 mt -74.13 -34.87 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.947 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 29' ' ' ALA . 20.1 mt -72.34 -41.88 66.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.4 t -64.14 -27.78 69.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.61 HG23 HD23 ' A' ' 16' ' ' LEU . 37.8 mt -69.65 100.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.018 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.051 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.6 m -73.04 -28.99 62.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 0.0 109.991 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.7 mmt -59.39 -14.33 11.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.197 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.28 -25.31 3.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 110.106 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 21' ' ' VAL . 9.7 m -135.76 -36.82 0.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.023 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -69.47 -178.84 1.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.617 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 175.63 129.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.75 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.049 HD11 HD13 ' A' ' 79' ' ' ILE . 3.9 mm? -42.75 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.137 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.26 42.55 3.12 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 110.009 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -137.41 87.76 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.12 156.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.061 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 178.73 -145.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 13' ' ' CYS . 55.1 t -50.15 -29.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 0.0 109.848 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.81 20.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.623 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.67 121.37 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.745 2.296 . . . . 0.0 110.316 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 135.06 3.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.937 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.4 m-85 -53.07 -31.87 44.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.42 -47.2 67.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.85 -46.14 91.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 23' ' ' PRO . 36.3 t -57.51 -45.47 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.975 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.837 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.34 -57.25 10.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.9 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -54.51 -43.29 71.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HE2' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.59 -34.95 71.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.057 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.537 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 6.3 m-85 -102.44 4.68 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.9 -23.42 59.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.22 10.58 60.63 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 167.69 14.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.098 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -113.62 -10.67 13.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -110.81 28.79 8.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.075 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.58 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.8 -24.81 62.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 83.9 t -68.89 -56.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 110.045 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 1.3 m-20 -59.18 -53.2 61.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.0 t80 -51.32 -63.05 1.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 38' ' ' ALA . 56.8 mt -43.17 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.046 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.921 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.62 -41.09 2.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.14 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.48 -39.67 84.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -88.57 -16.62 32.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -1.155 . . . . 0.0 110.093 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 43' ' ' ALA . 44.5 mt -65.65 -47.68 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.883 . . . . 0.0 110.063 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 2.9 ttmm -80.09 6.2 12.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.82 -28.97 4.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.2 -156.95 33.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.75 -129.67 9.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.82 -170.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -1.172 . . . . 0.0 110.028 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -2.29 8.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 54' ' ' TRP . 37.6 t -119.95 -14.84 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.148 . . . . 0.0 110.094 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.5 m95 -133.79 9.45 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.32 -149.78 20.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 21.5 m -118.13 51.42 1.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -1.194 . . . . 0.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 59' ' ' MET . 49.6 t -110.26 95.13 20.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.922 . . . . 0.0 110.098 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.86 72.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.798 2.332 . . . . 0.0 110.286 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 57' ' ' VAL . 8.1 ttt -43.98 139.41 3.02 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.883 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.85 141.23 83.85 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.642 2.228 . . . . 0.0 110.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.35 160.21 36.24 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.615 2.21 . . . . 0.0 110.135 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 23.5 mm-40 -133.01 162.92 30.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.072 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -103.93 68.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.13 155.94 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.132 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.6 p -101.91 167.93 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' THR . 8.8 t0 -43.39 -61.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.082 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.47 -54.98 6.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.41 -43.23 75.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.853 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.921 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.56 -36.28 71.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.784 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 -52.19 55.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 110.046 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.07 -29.37 44.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.929 . . . . 0.0 110.019 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 76' ' ' ILE . 20.2 mt -70.12 -51.73 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.31 -31.54 70.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -0.988 . . . . 0.0 109.39 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.12 -37.27 61.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.843 . . . . 0.0 109.619 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.4 t90 -79.33 -38.21 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.803 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.549 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.8 mt -71.48 -41.66 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.962 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 29' ' ' ALA . 21.7 mt -64.53 -46.68 81.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 109.96 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -56.65 -27.95 59.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 109.977 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.049 HD13 HD11 ' A' ' 16' ' ' LEU . 6.8 mt -75.46 121.82 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.096 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 m -95.06 -28.83 14.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -16.18 6.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.872 . . . . 0.0 110.117 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -23.57 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.186 -0.946 . . . . 0.0 109.945 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m -137.51 -38.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 56.1 m80 -70.01 -179.53 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 110.33 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.768 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 173.31 123.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.827 . . . . 0.0 109.802 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.684 HD22 HG21 ' A' ' 79' ' ' ILE . 31.6 mt -42.52 -66.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -122.47 42.63 3.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -141.46 84.11 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.17 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -61.7 76.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 110.111 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -79.21 -90.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.028 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 34.6 t -99.44 -39.51 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.989 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.93 166.45 12.3 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.82 118.61 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.785 2.323 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.35 128.79 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CD1' HG12 ' A' ' 76' ' ' ILE . 5.5 m-85 -48.34 -35.7 12.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -63.32 -41.87 98.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.08 -48.38 71.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.982 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -58.13 -46.3 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.88 -53.94 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -45.48 73.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.949 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 6.1 mttp -56.66 -34.43 67.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 110.048 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 19.3 m-85 -103.96 -1.36 27.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.59 -28.56 60.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.31 19.55 34.95 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.427 ' HG3' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -128.23 149.5 50.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.156 . . . . 0.0 110.023 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.52 -14.57 15.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 35' ' ' ARG . 7.1 p-10 -102.55 4.37 38.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.085 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -54.38 -20.89 8.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.04 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.599 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 72.7 t -69.66 -54.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.049 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.4 -53.63 55.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.092 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 70.4 t80 -50.88 -64.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' ALA . 72.3 mt -43.18 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.04 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.35 -41.63 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.73 -39.24 75.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -89.76 -5.96 56.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.052 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 43' ' ' ALA . 31.2 mt -78.02 -47.68 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -9.1 58.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -100.37 -42.58 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.033 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.43 -169.03 52.2 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.38 -138.37 13.83 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER 169.7 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 110.07 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.84 3.22 5.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -121.69 -18.05 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 110.02 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.982 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 93.8 m95 -120.01 -11.72 9.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.46 -141.02 7.61 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.03 60.01 1.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -1.201 . . . . 0.0 110.061 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 59' ' ' MET . 22.8 t -122.82 96.37 45.31 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.915 . . . . 0.0 110.106 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.55 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.697 2.265 . . . . 0.0 110.279 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.423 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.1 ttt -49.77 138.39 17.57 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.511 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 143.47 90.09 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.685 2.256 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.43 165.68 17.07 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.716 2.277 . . . . 0.0 110.145 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 27.8 mm-40 -135.08 163.89 28.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.117 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -104.34 64.25 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.058 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.61 155.82 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.109 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.54 167.42 10.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 m-20 -43.36 -59.01 2.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.117 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.5 -56.35 7.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.897 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -54.87 -41.87 71.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.235 -0.916 . . . . 0.0 109.92 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.04 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.95 -37.74 74.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -64.7 -51.82 60.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -53.92 -29.26 41.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.016 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 76' ' ' ILE . 45.2 mt -70.1 -52.75 21.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -68.55 -32.47 72.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.496 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.12 -36.93 64.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.497 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 19.0 t90 -78.64 -40.06 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.817 . . . . 0.0 109.74 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.692 HD12 ' O ' ' A' ' 72' ' ' LEU . 20.9 mt -71.11 -43.77 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.93 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 29' ' ' ALA . 20.6 mt -62.22 -44.68 96.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 t -59.58 -36.02 75.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.684 HG21 HD22 ' A' ' 16' ' ' LEU . 26.2 mt -59.6 108.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.964 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.04 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.8 m -106.55 -29.13 9.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 110.017 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mmt -58.51 -14.99 9.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.27 -24.75 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.982 . . . . 0.0 109.988 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -136.15 -36.91 0.73 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 56.0 m80 -71.73 -179.9 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 110.378 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 169.06 121.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.873 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.864 HD23 HG23 ' A' ' 79' ' ' ILE . 1.6 mp -42.13 -62.31 0.96 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.303 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.13 42.37 3.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.36 -0.838 . . . . 0.0 110.038 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.759 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -147.05 45.76 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -47.49 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.134 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -96.54 -89.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 0.0 109.954 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 35.4 t -78.12 -31.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 109.901 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.15 168.32 18.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.669 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -61.04 124.73 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.728 2.285 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -49.32 127.57 15.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 109.893 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.3 m-85 -45.97 -31.22 2.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.081 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.31 -44.47 75.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.035 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -63.59 -49.12 74.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.904 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 39.7 t -57.8 -45.79 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.84 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.21 -63.72 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.29 -38.67 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -60.24 -35.65 75.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.881 . . . . 0.0 110.042 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.61 2.89 26.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.033 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -65.87 -26.62 67.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.024 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.71 16.71 49.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.39 154.51 36.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.064 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -100.54 -14.34 18.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' CG ' ' OD2' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -108.7 29.37 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.07 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.47 HG12 ' CE ' ' A' ' 70' ' ' LYS . 22.0 t -73.31 -61.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD2' ' CG ' ' A' ' 37' ' ' ASP . 3.2 p-10 -59.27 -50.33 74.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -51.75 -58.23 7.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.047 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.658 HD12 ' HB1' ' A' ' 73' ' ' ALA . 45.5 mt -48.3 -73.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 110.125 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.939 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.67 -43.07 3.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.25 -41.23 86.4 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.68 -9.88 54.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.123 . . . . 0.0 110.042 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.879 HD12 ' HA ' ' A' ' 43' ' ' ALA . 34.0 mt -73.21 -50.55 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.51 -11.57 60.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.053 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -100.83 -13.67 18.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 45.31 -165.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 108.0 -137.39 14.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.85 -172.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.146 . . . . 0.0 110.101 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.12 -10.59 5.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 82.1 t -106.72 -22.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -1.144 . . . . 0.0 110.047 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.904 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.6 m95 -120.37 -22.12 6.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.53 -169.61 42.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -98.14 46.36 1.01 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.095 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -111.39 96.24 30.41 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.75 76.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 0.0 110.346 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' PRO . 7.5 ttt -43.24 139.59 2.34 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 3.0 Cg_endo -62.64 142.59 90.22 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.674 2.25 . . . . 0.0 110.309 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.27 166.8 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.626 2.217 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 29.8 mm-40 -136.03 164.64 27.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 110.075 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -104.62 58.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.6 155.96 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.014 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.8 p -100.39 168.53 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.995 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 56.5 t0 -43.32 -53.31 5.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.41 -58.77 4.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -54.27 -40.71 68.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.781 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.939 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.69 -36.38 74.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' CE ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.71 -51.86 60.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 110.0 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -55.0 -29.7 57.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 69' ' ' ALA . 62.4 mt -70.21 -50.28 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.658 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.72 -30.3 66.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 109.398 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.5 mt-30 -76.63 -37.2 56.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.507 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 24.7 t90 -80.6 -36.45 32.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.842 . . . . 0.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 55.6 mt -74.64 -33.65 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.914 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.84 HD23 ' HA ' ' A' ' 29' ' ' ALA . 21.9 mt -71.61 -45.39 62.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -60.64 -25.81 66.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.864 HG23 HD23 ' A' ' 16' ' ' LEU . 39.1 mt -71.3 119.84 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.107 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 m -99.13 -28.86 13.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -1.182 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.6 mmt -54.89 -17.46 3.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.34 -23.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.967 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.1 m -138.63 -37.75 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.897 . . . . 0.0 110.041 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.452 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.6 m-70 -70.12 -179.25 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.852 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.821 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER 170.77 126.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.564 ' CD2' HD13 ' A' ' 79' ' ' ILE . 28.8 mt -42.17 -67.85 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 42.77 3.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 110.019 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -139.44 83.6 1.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -62.33 74.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 57.2 mmtt -77.68 -90.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 26.5 t -97.67 -45.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.97 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.7 167.52 14.03 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.07 119.28 6.35 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.68 2.254 . . . . 0.0 110.242 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 134.58 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.607 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 5.0 m-85 -50.49 -32.07 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' ILE . . . -67.72 -44.88 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.017 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.59 -48.83 79.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.565 HG23 ' HB2' ' A' ' 23' ' ' PRO . 71.4 t -57.16 -44.51 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.993 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.738 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.69 -59.7 3.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.904 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.75 -43.07 72.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -34.04 73.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 110.048 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -94.5 -12.76 27.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -52.12 -28.77 19.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 0.0 110.009 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.63 17.25 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -122.86 121.98 37.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.106 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -72.97 -31.06 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.034 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.67 37.01 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 110.054 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.742 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.37 -25.11 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.62 -50.91 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.099 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -55.67 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 110.076 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.7 t80 -50.61 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.066 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 38' ' ' ALA . 1.4 mt -43.27 -73.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.079 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.879 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.19 -41.75 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.805 . . . . 0.0 110.058 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.5 -41.89 89.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.8 OUTLIER -84.98 -16.91 39.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 43' ' ' ALA . 32.8 mt -65.21 -49.46 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 10.3 tttt -80.83 -0.06 37.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -7.01 10.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 47.77 -155.86 1.06 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.9 -149.64 16.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.3 p 169.68 -167.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.15 . . . . 0.0 110.071 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -18.08 7.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 53' ' ' VAL . 64.2 t -100.03 -3.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.596 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 99.6 m95 -137.88 6.45 2.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.44 -153.06 23.8 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -118.37 52.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.108 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.91 96.2 40.57 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.069 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.65 80.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.689 2.259 . . . . 0.0 110.225 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.4 ttt -51.48 138.58 29.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.95 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.75 144.84 90.04 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.682 2.255 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -62.96 168.19 10.97 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.693 2.262 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.427 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 33.7 mm-40 -137.06 164.83 27.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.155 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.05 60.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.027 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.461 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.66 155.89 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -103.77 170.59 7.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.001 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' THR . 13.1 m-20 -43.35 -57.27 3.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.993 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.83 -57.96 4.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -41.02 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.879 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.46 -34.77 72.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -65.41 -51.24 61.64 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -56.2 -30.69 62.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.078 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 76' ' ' ILE . 38.1 mt -70.41 -48.9 53.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -71.22 -29.6 65.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -37.43 48.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.495 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 25.3 t90 -81.03 -34.21 32.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 56.6 mt -76.84 -35.74 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.4 mt -71.36 -45.38 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.973 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 t -59.06 -33.42 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.008 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.564 HD13 ' CD2' ' A' ' 16' ' ' LEU . 14.1 mt -69.29 95.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.979 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.564 ' OXT' ' HB3' ' A' ' 29' ' ' ALA . 6.2 mmmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.017 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.3 m -73.7 -28.98 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -1.182 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.66 -13.3 13.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.34 -35.51 51.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 m -125.15 -25.49 3.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.99 -179.25 7.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.463 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.896 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 169.48 122.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.784 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.0 HD23 HG23 ' A' ' 79' ' ' ILE . 1.2 mp -41.84 -64.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.7 42.69 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 110.072 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.896 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -136.54 82.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.83 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.46 113.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.046 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -134.51 -143.55 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 t -50.98 -30.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.61 158.91 19.23 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.582 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.67 122.54 11.41 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.769 2.313 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 126.35 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 109.981 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.6 m-85 -46.29 -37.27 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.085 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -61.05 -50.72 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.02 92.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.041 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 90.6 t -57.08 -45.45 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.837 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -53.04 -58.97 5.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -55.77 -40.93 73.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.756 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -34.25 74.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -100.7 1.8 40.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.17 62.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 17.79 44.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -132.17 147.62 52.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 110.096 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -90.75 -33.83 15.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -91.12 28.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.806 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -62.72 -20.24 64.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.29 -57.45 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -57.64 -56.59 19.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' A' ' 42' ' ' LEU . 42.8 t80 -49.45 -63.98 0.94 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.98 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 38' ' ' ALA . 10.7 mt -43.11 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.908 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.45 -38.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -56.93 -39.96 89.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -89.18 -7.52 55.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 110.059 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.908 HD12 ' HA ' ' A' ' 43' ' ' ALA . 46.2 mt -77.78 -39.48 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -3.52 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -102.51 -34.77 9.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.46 -174.01 45.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.18 -147.47 16.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 6.8 p 174.16 -164.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 110.074 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.88 -10.33 6.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 78.1 t -109.92 -15.77 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 110.088 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.5 m95 -122.67 -9.15 8.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.6 -166.17 31.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 56' ' ' SER . 5.6 p -103.39 55.28 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -1.159 . . . . 0.0 110.096 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.46 96.51 45.82 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.52 87.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.771 2.314 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.4 ttt -55.64 139.82 67.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.928 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.29 142.51 86.27 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.633 2.222 . . . . 0.0 110.25 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.17 165.99 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.647 2.231 . . . . 0.0 110.19 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 26.5 mm-40 -137.58 164.86 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -104.11 70.76 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -127.48 155.97 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.28 -0.888 . . . . 0.0 110.099 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -104.95 171.41 7.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' THR . 36.0 t0 -43.35 -53.43 5.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.032 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.23 -59.14 3.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.901 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -54.82 -41.09 70.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -59.31 -35.63 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.802 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 2.0 ttpm? -65.76 -51.71 56.96 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.423 -0.798 . . . . 0.0 110.009 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.68 -30.17 54.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.26 -51.07 33.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -69.57 -31.62 69.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -75.46 -37.39 60.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.487 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.6 t90 -79.08 -37.78 37.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 109.847 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' A' ' 79' ' ' ILE . 79.0 mt -71.99 -40.33 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.84 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 29' ' ' ALA . 29.5 mt -65.24 -45.26 85.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -60.22 -29.24 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.044 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.0 HG23 HD23 ' A' ' 16' ' ' LEU . 42.6 mt -64.9 109.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.072 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.5 m -88.36 -29.26 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -1.155 . . . . 0.0 109.998 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -59.21 -14.57 11.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.114 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -26.62 4.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.978 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.4 m -133.86 -36.08 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.957 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 55.2 m80 -71.26 -179.32 2.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.27 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.777 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.34 125.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.914 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.603 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 25.1 mt -42.43 -68.76 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -122.28 42.49 3.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -139.52 82.39 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.373 -0.829 . . . . 0.0 110.138 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -59.47 79.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -85.12 -90.57 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 27.2 t -96.0 -46.32 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 109.889 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.55 167.78 13.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -60.98 120.06 7.56 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.764 2.309 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -43.29 130.6 4.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 109.977 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.67 -32.22 7.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.69 -44.06 74.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.09 -49.38 76.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.958 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 39.8 t -57.3 -44.31 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.867 . . . . 0.0 110.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.848 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.55 -55.06 21.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.971 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -54.08 -46.37 72.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.53 -32.34 65.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 110.127 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CE2' HG13 ' A' ' 28' ' ' VAL . 24.3 m-85 -105.46 1.19 27.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.06 -29.01 67.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.039 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.12 16.3 48.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.503 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 11.4 mmm-85 -115.47 139.02 50.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -1.161 . . . . 0.0 110.065 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -95.36 -16.53 22.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.068 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.71 12.69 21.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.576 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -53.46 -20.31 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.038 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 70' ' ' LYS . 41.3 t -68.62 -57.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.072 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.62 -52.77 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.05 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' OH ' ' HE3' ' A' ' 45' ' ' LYS . 86.6 t80 -52.61 -62.78 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 38' ' ' ALA . 45.4 mt -43.26 -74.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.892 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.61 -39.86 2.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.415 -0.803 . . . . 0.0 110.079 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.34 -36.78 70.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -92.1 -15.63 27.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -1.111 . . . . 0.0 110.076 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 43' ' ' ALA . 49.7 mt -67.34 -44.59 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.096 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -82.56 6.95 15.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.46 -31.1 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 110.046 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.39 -160.32 49.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 100.24 -143.72 16.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.4 p 169.76 -172.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -1.157 . . . . 0.0 110.043 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.95 -9.25 5.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.13 -18.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -1.132 . . . . 0.0 110.081 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.958 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.4 m95 -117.99 -26.89 6.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.081 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.47 -154.04 20.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -111.51 44.94 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.113 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.52 96.14 26.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.7 92.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.73 2.287 . . . . 0.0 110.292 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.426 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.2 ttt -62.67 138.84 96.9 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.513 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.47 142.15 83.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.616 2.21 . . . . 0.0 110.299 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.76 165.49 18.33 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.645 2.23 . . . . 0.0 110.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 26.5 mm-40 -134.67 163.43 29.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 16.4 p-10 -104.33 59.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.055 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.455 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.23 155.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.106 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -99.55 165.38 11.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 109.92 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 6.4 p-10 -43.36 -47.04 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.025 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.47 -61.09 2.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.883 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.41 -40.95 68.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.753 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -59.45 -34.17 72.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -65.77 -52.1 53.7 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.401 -0.812 . . . . 0.0 110.053 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.75 -29.85 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.59 -49.84 43.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.77 -31.05 67.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.381 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 2.6 mt-30 -76.03 -37.04 58.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.423 -0.798 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.498 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 23.6 t90 -80.35 -37.42 32.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.835 . . . . 0.0 109.765 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.581 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 57.0 mt -72.35 -40.35 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.858 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.848 HD23 ' HA ' ' A' ' 29' ' ' ALA . 28.2 mt -66.83 -43.65 83.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.872 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.2 p -60.83 -30.22 69.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.592 HD13 ' CD2' ' A' ' 16' ' ' LEU . 36.8 mt -67.85 107.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.069 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 m -92.22 -29.64 16.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 110.153 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.5 mmt -60.46 -13.53 14.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.58 -24.87 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.036 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.0 m -136.31 -36.57 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 89.6 m-70 -71.25 -179.71 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.393 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.963 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 172.2 118.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.871 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.748 HD23 ' CG2' ' A' ' 79' ' ' ILE . 1.6 mt -41.71 -58.27 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.36 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.54 42.64 3.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.963 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.47 87.86 1.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -85.83 -143.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.3 t -51.48 -30.99 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.977 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.48 160.53 13.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.84 128.74 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.79 2.327 . . . . 0.0 110.317 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -50.3 122.6 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.568 ' CD1' HG12 ' A' ' 76' ' ' ILE . 2.6 m-85 -43.64 -29.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -71.97 -45.78 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 0.0 109.99 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.66 -49.04 79.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.108 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 37.5 t -56.37 -43.57 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.885 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.936 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.24 -61.61 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.984 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -53.39 -40.75 65.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -33.53 71.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.676 ' HB2' HD21 ' A' ' 77' ' ' LEU . 13.8 m-85 -106.67 4.58 28.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.095 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -69.99 -28.57 65.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 0.0 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.81 14.88 55.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.98 165.45 12.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.114 . . . . 0.0 110.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -115.65 -6.87 12.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 110.04 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -123.89 18.45 9.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -55.84 -23.24 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.13 -55.3 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.97 -51.64 68.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.559 ' OH ' HG21 ' A' ' 53' ' ' VAL . 30.0 t80 -54.5 -67.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.064 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 38' ' ' ALA . 3.2 mt -43.05 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 110.131 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.897 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.5 -39.14 2.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.096 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -59.04 -42.78 97.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.25 -13.76 51.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -1.114 . . . . 0.0 110.003 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.897 HD12 ' HA ' ' A' ' 43' ' ' ALA . 40.7 mt -69.68 -47.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -81.64 -19.84 40.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 35.3 mttm -92.24 -30.85 15.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 110.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.3 -167.77 31.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.17 -143.02 15.82 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.9 t 169.71 -179.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -1.094 . . . . 0.0 110.08 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 136.79 -11.3 3.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG21 ' OH ' ' A' ' 41' ' ' TYR . 45.3 t -99.13 -29.61 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -1.161 . . . . 0.0 110.076 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 1.108 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.1 m95 -104.67 -22.98 13.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.76 -138.26 5.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.49 67.52 0.85 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -1.159 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 51' ' ' SER . 40.0 t -136.38 91.82 16.09 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.92 77.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.724 2.282 . . . . 0.0 110.285 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.6 ttt -45.62 141.21 4.04 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.991 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.03 143.23 90.45 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.674 2.249 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.03 167.16 12.8 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.666 2.244 . . . . 0.0 110.128 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 25.3 mm-40 -139.69 166.39 24.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 110.073 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -105.31 68.1 0.8 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.525 HG21 HG22 ' A' ' 46' ' ' ILE . 3.5 m -114.77 155.93 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 p -103.55 167.52 9.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.93 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.45 -62.06 1.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.02 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.56 -55.75 5.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.901 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.79 -42.95 76.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.882 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.86 -35.81 73.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.825 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -66.33 -50.79 62.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.436 -0.79 . . . . 0.0 110.032 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -55.69 -29.24 59.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 76' ' ' ILE . 77.8 mt -70.39 -49.47 48.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.51 -31.21 68.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.09 -37.57 58.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.532 ' CE2' HD11 ' A' ' 79' ' ' ILE . 23.3 t90 -79.64 -36.67 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.793 . . . . 0.0 109.796 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.841 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 25.2 mt -71.86 -39.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.884 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.936 HD23 ' HA ' ' A' ' 29' ' ' ALA . 18.1 mt -68.02 -42.44 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.1 t -62.04 -37.83 86.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.913 . . . . 0.0 109.962 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.748 ' CG2' HD23 ' A' ' 16' ' ' LEU . 19.5 mt -59.39 97.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.026 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.484 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -90.0 -28.99 18.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.079 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -14.01 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.123 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.66 -25.1 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.0 m -135.72 -36.83 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.498 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 55.6 m80 -70.31 -179.45 2.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.766 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.44 124.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.904 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 79' ' ' ILE . 27.0 mt -42.46 -64.69 0.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 42.19 3.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.766 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.3 84.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 110.147 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.88 64.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 16.4 mttm -62.57 -90.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.056 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 29.3 t -93.68 -44.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.49 166.27 13.24 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.724 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.05 7.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.754 2.302 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.29 132.66 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.498 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 6.8 m-85 -49.85 -32.4 14.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -67.85 -44.67 76.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.935 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -49.92 73.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.08 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 36.1 t -56.49 -43.48 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.993 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.901 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.44 -57.24 10.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -43.76 64.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -36.41 67.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.725 ' HB2' HD21 ' A' ' 77' ' ' LEU . 14.1 m-85 -99.1 4.08 46.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.28 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.04 61.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.92 160.67 37.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -1.175 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -111.42 -26.94 8.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -84.65 9.21 14.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -60.79 -25.02 66.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.78 -53.87 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -54.07 50.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -51.82 -61.76 2.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 38' ' ' ALA . 8.2 mt -43.05 -73.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.877 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.79 -41.23 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.381 -0.825 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.22 73.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.93 -9.72 45.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -1.143 . . . . 0.0 109.991 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 43' ' ' ALA . 41.0 mt -73.38 -47.74 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.02 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -4.75 47.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -5.12 10.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.928 . . . . 0.0 110.077 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 45.29 -134.73 7.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . 82.83 -143.33 22.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 3.6 t 169.79 -178.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.416 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 142.75 -14.63 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.67 -11.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -1.142 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 1.08 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 96.7 m95 -120.37 -29.1 4.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.013 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.39 -142.14 6.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 65.6 m -120.57 45.82 2.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.235 -1.156 . . . . 0.0 110.123 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.7 t -111.58 94.99 25.21 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.04 77.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.695 2.263 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.8 ttt -46.62 140.39 5.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.92 144.99 94.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.623 2.216 . . . . 0.0 110.289 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.62 166.48 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.714 2.276 . . . . 0.0 110.205 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -137.74 165.2 27.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.095 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -105.14 60.85 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.63 HG12 ' OE1' ' A' ' 68' ' ' GLU . 3.6 m -113.82 155.82 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -0.947 . . . . 0.0 110.153 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.11 167.8 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -43.46 -59.08 2.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.92 -56.66 5.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.907 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.63 ' OE1' HG12 ' A' ' 64' ' ' VAL . 4.1 mt-10 -55.29 -42.49 73.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 109.875 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.17 -35.88 72.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 109.835 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -51.81 59.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -0.813 . . . . 0.0 110.001 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.95 -29.79 57.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 110.012 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.24 -50.59 38.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.855 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.73 -31.83 70.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.141 -0.974 . . . . 0.0 109.432 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -75.47 -37.34 60.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.338 -0.852 . . . . 0.0 109.504 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.497 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.5 t90 -79.15 -37.6 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 78.0 mt -72.43 -39.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 29' ' ' ALA . 18.8 mt -66.13 -46.11 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.8 m -58.31 -31.55 67.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.981 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 16' ' ' LEU . 18.5 mt -67.26 128.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.038 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.103 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.8 m -93.0 -29.11 16.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -1.083 . . . . 0.0 110.012 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -16.06 10.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.09 -25.13 3.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 109.984 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.7 m -136.61 -36.01 0.72 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.2 m-70 -73.05 -179.62 3.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.893 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 170.07 121.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.78 . . . . 0.0 109.86 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.0 mp -41.93 -63.24 0.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.302 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.97 42.38 3.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -140.22 83.95 1.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -56.08 84.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.106 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -94.61 -143.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.048 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.1 t -52.18 -31.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 164.39 14.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.17 130.82 33.84 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.715 2.277 . . . . 0.0 110.241 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.3 126.89 18.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.019 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 2.8 m-85 -46.3 -37.68 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -61.45 -56.28 21.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.971 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.3 -34.07 71.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.073 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 34.1 t -60.89 -50.98 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 77' ' ' LEU . . . -54.82 -46.72 74.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.871 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -59.25 -43.33 92.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.943 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -34.8 71.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -101.7 -1.79 31.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.082 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.26 -22.0 27.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.07 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.75 20.74 30.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 127.77 40.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -1.182 . . . . 0.0 110.097 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -38.66 69.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.49 40.82 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -69.21 -24.06 63.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.61 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.65 -51.07 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -52.33 -63.02 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.984 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 38' ' ' ALA . 28.6 mt -46.94 -74.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 110.119 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.991 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.39 -39.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 110.045 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -57.38 -40.61 92.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -87.8 -10.39 51.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.041 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 43' ' ' ALA . 42.3 mt -73.4 -44.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 110.066 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.81 11.3 13.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.034 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -111.48 -45.24 3.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.46 179.24 52.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.81 -147.35 16.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.3 p 169.66 -168.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -1.073 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.96 -16.76 5.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -96.21 -23.82 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 110.139 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.596 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.8 m95 -112.58 -18.01 12.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.76 -153.17 23.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -111.68 66.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -1.115 . . . . 0.0 110.04 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.22 95.78 14.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.116 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.76 86.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.704 2.27 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.434 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.7 ttt -55.36 138.93 67.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 109.981 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.61 141.77 81.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.586 2.191 . . . . 0.0 110.332 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.39 169.73 9.13 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.62 2.214 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 24.9 mm-40 -137.73 164.67 28.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.69 55.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.98 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.5 m -114.4 155.85 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.882 . . . . 0.0 110.099 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' ASP . 77.5 p -105.61 172.66 6.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 t0 -43.56 -50.34 7.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.036 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -48.76 -63.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 11.5 mt-10 -53.54 -39.97 65.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.237 -0.915 . . . . 0.0 109.768 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.991 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -60.19 -34.66 73.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.718 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 16.2 mttm -65.61 -51.55 58.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.808 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.96 -30.32 61.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.19 -49.76 47.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.853 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.29 -32.44 70.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 0.0 109.426 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 3.1 mm-40 -74.99 -36.82 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.483 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.62 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.6 t90 -79.51 -38.26 34.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -0.831 . . . . 0.0 109.898 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 25' ' ' TYR . 50.5 mt -68.43 -36.54 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.931 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.571 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 19.3 mt -69.94 -47.52 62.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 109.943 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 t -58.46 -23.46 57.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.62 HD11 ' CE2' ' A' ' 75' ' ' TRP . 36.6 mt -73.22 114.28 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 109.994 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.064 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.7 m -102.36 -28.82 12.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -1.152 . . . . 0.0 110.03 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.96 -16.17 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 110.138 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.14 -24.31 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 109.976 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.1 m -137.0 -37.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.034 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 55.5 m80 -70.75 -179.56 2.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.849 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 176.04 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.0 109.819 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.532 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 28.8 mt -42.48 -65.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -122.04 42.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.849 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.97 82.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.78 71.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -71.89 -90.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.249 -0.907 . . . . 0.0 109.977 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 29.6 t -90.4 -40.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.883 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.11 165.34 12.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.537 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 121.16 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.608 2.206 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -43.25 129.95 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 110.02 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.5 m-85 -48.65 -31.69 7.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.41 -46.21 73.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -48.84 79.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 93.0 t -56.93 -44.41 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.931 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.73 -62.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.08 -39.99 63.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -60.01 -34.52 73.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.099 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.627 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 4.0 m-85 -96.26 4.57 52.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.105 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.86 -17.53 60.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.053 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 16.56 51.41 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.19 157.48 46.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -1.129 . . . . 0.0 110.063 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -104.68 -3.16 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.155 -0.965 . . . . 0.0 110.109 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -115.23 20.63 14.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.627 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -62.0 -21.65 65.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.077 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 39' ' ' VAL . 4.4 t -69.67 -57.24 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -53.52 57.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' OH ' HG21 ' A' ' 53' ' ' VAL . 18.9 t80 -51.04 -63.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 43' ' ' ALA . 22.4 mt -43.4 -73.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.893 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.32 -39.54 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.092 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.9 -42.66 92.47 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -84.75 -14.97 46.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.164 . . . . 0.0 109.971 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.823 HD12 ' HA ' ' A' ' 43' ' ' ALA . 28.8 mt -67.62 -46.25 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 110.014 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -16.62 43.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -95.36 -30.53 13.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.74 -157.76 29.74 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.4 -132.57 11.08 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.2 p 169.85 178.6 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 110.085 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 141.02 -20.32 2.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.412 HG21 ' OH ' ' A' ' 41' ' ' TYR . 41.3 t -105.75 -22.31 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -1.126 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.656 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 80.3 m95 -119.53 -12.37 9.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.67 -145.95 10.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 3.7 m -122.92 -26.51 4.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 110.1 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . 21.9 t -41.6 102.04 0.26 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.7 88.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.654 2.236 . . . . 0.0 110.248 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.2 ttt -55.63 138.88 69.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.41 143.58 88.83 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.589 2.193 . . . . 0.0 110.332 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -62.86 169.32 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.757 2.304 . . . . 0.0 110.116 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.426 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 31.5 mm-40 -137.97 165.69 25.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.042 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -104.76 56.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 3.7 m -114.62 155.78 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.13 170.3 8.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.922 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -43.33 -53.63 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.983 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -49.32 -59.07 4.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.31 -40.82 68.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.889 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.893 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.02 -36.66 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.395 -0.815 . . . . 0.0 109.869 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 29.5 mttt -64.82 -51.03 64.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.38 -0.825 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -55.05 -31.04 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 110.012 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 76' ' ' ILE . 8.1 mt -70.01 -50.34 42.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.824 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -68.7 -34.4 75.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.455 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.18 -37.89 66.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.434 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.492 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 17.3 t90 -76.78 -39.83 50.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 109.754 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 37.8 mt -68.13 -46.07 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 29' ' ' ALA . 58.2 mt -61.08 -41.13 96.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.895 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG21 HD22 ' A' ' 16' ' ' LEU . 11.6 mt -59.23 100.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.5 m -69.75 -29.61 67.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -1.161 . . . . 0.0 110.094 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 mmt -60.58 -13.31 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.106 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.0 -36.39 60.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.6 m -126.73 -8.4 6.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.448 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 81.6 m-70 -101.67 -178.35 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 110.426 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.802 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 1.1 m-20 170.75 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 109.793 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 26.7 mt -42.53 -68.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 42.86 3.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.849 . . . . 0.0 110.057 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.802 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -138.07 88.0 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -50.59 159.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.125 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.3 tptt 177.42 -147.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 109.916 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 72.1 t -49.65 -29.53 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -130.07 153.3 20.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.589 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.78 120.98 9.0 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.708 2.272 . . . . 0.0 110.323 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 136.47 3.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 7.2 m-85 -54.75 -33.65 61.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.01 -52.32 60.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 110.165 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.149 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -57.84 -46.03 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.995 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.916 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -49.33 -66.84 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.918 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -53.08 -38.3 62.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HD2' ' CZ2' ' A' ' 54' ' ' TRP . 7.5 ttmt -63.22 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.546 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 13.6 m-85 -100.16 -5.48 27.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.84 -22.67 65.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.061 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.79 11.75 65.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.12 127.02 45.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.119 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -77.07 -29.19 54.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.081 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.51 18.23 10.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.716 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -65.25 -23.83 67.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.085 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.485 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 61.5 t -70.79 -58.77 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.053 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.45 -51.31 69.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.2 t80 -52.26 -65.87 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 38' ' ' ALA . 15.9 mt -43.01 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.068 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.54 -40.11 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.077 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.61 -41.28 93.54 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -9.37 55.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 43' ' ' ALA . 8.2 mt -73.96 -49.2 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.18 -2.89 20.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -120.28 -17.64 8.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.32 -153.93 26.37 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.68 -145.33 16.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 5.5 p 173.43 -170.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 110.058 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.48 -19.2 6.33 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.5 t -96.35 -22.64 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 1.149 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 94.6 m95 -112.92 -35.46 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.56 -140.83 4.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -120.07 63.84 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -1.135 . . . . 0.0 110.026 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.52 95.82 22.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.042 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.74 86.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.693 2.262 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.431 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 9.0 ttt -55.12 139.88 63.7 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -62.83 141.36 84.47 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.653 2.235 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 3.0 Cg_endo -63.08 168.83 10.1 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.687 2.258 . . . . 0.0 110.087 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.425 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 33.3 mm-40 -139.04 166.61 24.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -105.3 64.62 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.103 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 4.0 m -118.99 155.81 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 110.137 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.09 169.29 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.89 . . . . 0.0 109.958 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -43.47 -52.03 6.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.999 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.21 6.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.37 -40.5 68.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.863 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.068 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.79 -36.89 75.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.808 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.1 57.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.342 -0.849 . . . . 0.0 109.981 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -54.13 -29.5 45.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 110.036 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 72' ' ' LEU . 61.5 mt -70.16 -51.69 29.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -69.41 -31.67 70.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.12 -36.93 61.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.558 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.4 t90 -79.49 -38.78 33.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.832 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 57.0 mt -70.49 -38.55 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.916 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.1 mt -68.46 -41.47 80.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.961 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.31 -38.42 91.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.023 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 16' ' ' LEU . 9.2 mt -60.3 120.01 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.998 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.121 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.485 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.7 m -86.73 -29.05 22.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -1.158 . . . . 0.0 109.983 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmt -56.88 -16.85 7.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.57 -22.27 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.487 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 15.0 m -138.47 -37.22 0.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 0.0 110.124 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 55.7 m80 -72.56 -178.34 2.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.652 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 169.87 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.858 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.773 HD22 HG21 ' A' ' 79' ' ' ILE . 25.5 mt -42.15 -62.93 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 42.86 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.555 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -152.35 75.52 1.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.185 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.47 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.847 . . . . 0.0 110.205 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.6 mtpt -67.92 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.008 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.487 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 25.4 t -91.41 -31.82 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.935 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.4 167.75 13.37 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.687 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.82 8.75 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.738 2.292 . . . . 0.0 110.273 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.97 134.73 4.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 5.9 m-85 -51.25 -32.36 24.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.78 -44.78 69.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.029 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.98 -47.84 84.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.695 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 32.5 t -56.83 -44.61 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.29 -59.15 4.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -55.12 -42.95 73.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 109.824 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 tptt -60.28 -33.39 72.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.049 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -90.46 5.74 46.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.84 -23.72 66.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.18 13.11 62.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -117.11 138.13 51.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -1.125 . . . . 0.0 110.068 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -90.82 -16.34 28.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.85 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.46 33.74 5.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.107 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.844 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.47 -21.46 37.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.071 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 39' ' ' VAL . 6.4 t -69.72 -57.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.0 -54.79 42.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.2 t80 -51.64 -63.7 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.062 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 38' ' ' ALA . 15.7 mt -43.14 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.887 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . . . -42.51 -40.3 2.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.432 -0.793 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.38 -37.71 75.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' LEU . 3.4 mmtt -91.35 -7.98 49.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -1.157 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 43' ' ' ALA . 53.5 mt -78.03 -37.28 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 0.0 110.062 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.75 4.49 51.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.081 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -119.89 -43.7 2.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.11 -164.98 40.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 104.9 -140.34 14.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.62 -176.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.9 -10.71 4.52 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 53' ' ' VAL . 52.1 t -111.65 -6.29 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 110.116 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.0 m95 -135.52 4.37 3.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -153.54 23.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -116.78 48.82 1.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.15 . . . . 0.0 110.119 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.81 96.22 27.76 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -60.58 88.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 110.34 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.6 ttt -62.01 139.49 95.86 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.961 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.38 143.02 87.79 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.684 2.256 . . . . 0.0 110.364 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.09 167.9 11.66 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.671 2.247 . . . . 0.0 110.151 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 26.3 mm-40 -138.14 165.1 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.25 62.07 0.68 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.006 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 46' ' ' ILE . 3.4 m -114.99 155.8 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.2 p -99.87 164.96 11.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.955 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -43.38 -51.66 6.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.947 . . . . 0.0 110.035 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.41 -58.05 6.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.77 -41.72 70.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -58.11 -35.12 70.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.43 -0.794 . . . . 0.0 109.804 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -52.76 48.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.85 . . . . 0.0 110.029 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.28 -29.62 47.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 69' ' ' ALA . 30.2 mt -70.11 -50.87 36.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.919 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.45 -32.22 71.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -74.94 -37.45 62.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.823 . . . . 0.0 109.524 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.7 t90 -78.81 -38.17 38.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.813 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.488 HG12 ' CD1' ' A' ' 25' ' ' TYR . 52.3 mt -70.08 -42.19 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.062 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.851 HD23 ' HA ' ' A' ' 29' ' ' ALA . 31.3 mt -64.23 -47.24 80.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -28.44 62.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.773 HG21 HD22 ' A' ' 16' ' ' LEU . 29.4 mt -71.23 139.27 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.058 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.6 m -103.75 -29.61 10.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -1.123 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.2 mmt -60.22 -13.84 14.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.35 -34.72 48.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.071 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -125.32 -26.0 3.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.87 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.495 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.67 -179.65 7.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 110.467 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 168.23 125.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.463 -0.773 . . . . 0.0 109.688 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 79' ' ' ILE . 25.6 mt -42.14 -64.91 0.52 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 42.75 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 110.115 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -145.28 45.19 1.32 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.88 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 110.085 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 18' ' ' ALA . 9.6 mtmt -93.62 -90.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 30.7 t -80.02 -31.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.04 169.21 16.99 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.577 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 123.41 12.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.745 2.297 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -48.48 135.9 13.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 5.2 m-85 -50.51 -32.46 18.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -67.77 -49.54 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 110.044 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.57 -44.82 89.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.86 . . . . 0.0 109.977 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.673 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 84.5 t -57.46 -45.7 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.94 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.792 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.74 -52.69 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -54.23 -45.21 72.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.906 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 11.0 mttt -55.65 -36.83 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 110.104 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 12.2 m-85 -101.16 -4.09 27.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 110.089 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -62.3 -26.38 68.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.41 15.64 55.86 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.08 174.02 8.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.039 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -120.36 -22.26 6.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.123 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -100.62 20.32 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.081 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.819 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -60.01 -23.89 64.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' HD3' ' A' ' 70' ' ' LYS . 60.1 t -66.87 -53.66 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.59 -55.74 27.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.094 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 50.8 t80 -48.31 -64.7 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 110.048 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 38' ' ' ALA . 18.5 mt -42.99 -73.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.62 -40.99 2.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.087 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.75 -38.44 72.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -16.54 29.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 43' ' ' ALA . 45.1 mt -65.91 -45.07 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 110.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -81.64 -13.88 57.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -101.22 -43.75 5.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.095 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.84 -148.52 38.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 92.52 -135.47 12.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 175.95 -177.43 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 110.052 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.52 -22.01 5.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.0 t -89.08 -21.55 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -1.164 . . . . 0.0 110.005 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.673 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.2 m95 -117.2 -39.34 3.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.27 -128.93 1.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 p -124.26 62.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 110.135 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.68 92.01 49.28 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.23 86.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.76 2.307 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.427 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.2 ttt -63.92 139.92 97.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 109.933 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.66 142.15 82.39 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 110.316 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.22 162.73 25.52 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.661 2.24 . . . . 0.0 110.12 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 21.9 mm-40 -134.91 163.8 29.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 110.097 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -104.58 65.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 46' ' ' ILE . 3.5 m -114.34 155.88 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 43.6 p -103.28 168.49 9.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 9.4 m-20 -43.39 -57.87 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.052 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.7 -59.02 3.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.939 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -41.59 70.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.899 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.753 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.55 -36.15 75.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.825 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HD3' HG12 ' A' ' 39' ' ' VAL . 32.1 mmtt -67.2 -51.05 58.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -54.36 -29.66 49.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 72' ' ' LEU . 59.6 mt -70.11 -52.3 24.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -68.66 -33.49 74.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -73.45 -36.58 65.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.433 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.589 ' CE2' HD11 ' A' ' 79' ' ' ILE . 19.7 t90 -78.61 -40.72 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.851 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 51.2 mt -69.39 -39.65 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.971 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 29' ' ' ALA . 46.2 mt -66.51 -42.25 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.87 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -63.68 -43.07 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.93 HG21 HD22 ' A' ' 16' ' ' LEU . 25.8 mt -49.63 98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.059 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 18.0 m -80.83 -30.75 35.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.063 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -14.69 14.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.32 -26.97 5.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.8 m -133.8 -35.1 0.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 56.7 m80 -73.82 179.95 3.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.439 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.938 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 171.46 119.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.732 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.7 mp -41.73 -60.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 110.35 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.74 42.75 3.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.219 -0.926 . . . . 0.0 110.07 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.938 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -143.12 85.86 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.114 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -57.83 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -92.19 -145.37 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.055 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.1 t -51.54 -31.41 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 110.066 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.02 163.96 13.19 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 131.82 38.7 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.743 2.295 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -53.14 123.9 13.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.5 m-85 -46.09 -31.51 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.22 -45.64 69.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.062 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.48 -45.0 92.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.895 . . . . 0.0 110.108 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.023 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 52.5 t -58.14 -46.74 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.036 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.49 -54.57 30.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.981 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -54.82 -43.62 73.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -35.41 70.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 110.085 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.52 1.65 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.01 -28.98 68.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.35 19.39 36.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -120.19 158.65 26.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.073 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 -19.54 13.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -103.12 18.8 20.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.769 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.13 -23.16 45.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 39' ' ' VAL . 8.0 t -70.67 -54.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.079 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.04 -53.1 61.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.071 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' LEU . 51.8 t80 -52.95 -65.02 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 38' ' ' ALA . 26.4 mt -43.93 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.64 -37.64 1.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.397 -0.814 . . . . 0.0 110.102 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.05 65.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.7 tptp -101.41 -13.97 17.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 27.2 mt -72.49 -44.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.093 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -80.21 -5.43 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.44 -13.46 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.045 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 53.6 -149.93 13.48 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.69 -147.7 16.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.1 t 169.69 -178.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 110.099 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 133.84 -11.94 4.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.5 t -102.88 -27.33 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.067 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 1.023 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.8 m95 -107.05 -13.69 15.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.088 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.91 -147.85 16.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 56' ' ' SER . 3.6 p -116.35 50.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -1.14 . . . . 0.0 110.079 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.14 95.84 47.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.86 103.92 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.752 2.301 . . . . 0.0 110.336 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.432 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 6.8 ttt -75.54 139.7 71.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.907 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 2.9 Cg_endo -63.37 138.76 67.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.67 2.246 . . . . 0.0 110.365 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.421 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.6 168.87 10.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.597 2.198 . . . . 0.0 110.173 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 30.2 mm-40 -138.17 165.56 26.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.937 . . . . 0.0 110.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -105.16 65.1 0.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.11 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.91 155.84 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -100.53 165.3 11.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.018 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 65' ' ' THR . 3.5 t0 -43.36 -55.51 4.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.4 -60.4 2.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.66 -41.3 69.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.751 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.27 -34.21 71.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.845 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -52.24 50.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.414 -0.804 . . . . 0.0 110.039 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -55.17 -30.03 59.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 110.02 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 69' ' ' ALA . 76.3 mt -70.21 -50.24 41.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.884 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.88 -32.39 70.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -74.79 -37.29 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.9 t90 -79.02 -38.42 36.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.822 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.553 ' HA ' HD12 ' A' ' 79' ' ' ILE . 44.8 mt -72.47 -38.02 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.953 . . . . 0.0 109.961 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 29' ' ' ALA . 17.0 mt -67.03 -44.5 80.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.916 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -61.27 -30.59 70.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 109.963 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 76' ' ' ILE . 43.0 mt -62.76 101.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.019 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.7 m -73.07 -29.06 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.973 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 mmt -59.54 -15.91 21.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.107 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -23.66 2.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.223 -0.923 . . . . 0.0 109.978 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.7 m -136.88 -36.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.31 -0.869 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.524 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 54.8 m80 -71.64 -179.57 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 110.468 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.628 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.38 122.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.505 -0.747 . . . . 0.0 109.669 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.872 HD22 HG21 ' A' ' 79' ' ' ILE . 32.1 mt -42.07 -65.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 110.313 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.5 42.6 3.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -155.16 45.52 0.5 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 6.4 pttt -45.69 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.2 tptt -79.68 -90.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.071 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 25.9 t -78.67 -31.7 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.074 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.39 174.78 16.31 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.599 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 147.49 95.3 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.744 2.296 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -71.28 129.81 39.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 109.979 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CD1' HG12 ' A' ' 76' ' ' ILE . 3.4 m-85 -45.98 -30.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.105 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -72.69 -46.93 51.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.966 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -49.11 78.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 109.93 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.119 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 45.7 t -56.31 -43.4 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.91 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.941 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.23 -57.47 9.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -53.78 -44.7 70.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -34.0 69.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.596 ' HB2' HD21 ' A' ' 77' ' ' LEU . 28.2 m-85 -99.24 3.12 46.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.79 -28.97 68.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.065 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.5 19.59 35.5 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -119.09 146.39 45.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -1.167 . . . . 0.0 110.058 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 37' ' ' ASP . 8.7 ptpt -96.09 -27.38 15.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 38.9 m-20 -105.34 29.07 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.061 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.809 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -59.21 -25.13 63.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG1' ' HG3' ' A' ' 70' ' ' LYS . 3.8 t -68.31 -54.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -58.61 -55.64 32.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.52 -66.18 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 0.0 110.083 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 38' ' ' ALA . 2.1 mt -43.13 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.859 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.77 -38.39 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 110.08 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -41.19 95.18 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -87.72 -9.18 54.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -1.168 . . . . 0.0 110.056 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 43' ' ' ALA . 42.2 mt -74.17 -50.62 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 2.0 mtmt -73.69 -9.05 58.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.111 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -121.26 -7.4 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 44.35 -142.74 2.77 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.11 -137.46 13.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.75 -174.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.22 -10.33 7.77 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.87 -16.5 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.26 -1.141 . . . . 0.0 110.15 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 1.119 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.7 m95 -121.38 -27.12 4.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.52 -141.47 6.26 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 m -120.85 69.86 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 110.09 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 59' ' ' MET . 55.6 t -139.19 95.22 9.42 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.026 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.01 75.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.737 2.291 . . . . 0.0 110.276 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' VAL . 7.2 ttt -43.87 140.44 2.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.74 145.05 94.85 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.688 2.259 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.65 167.75 11.18 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.2 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.427 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 37.1 mm-40 -138.66 166.23 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.074 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -105.74 62.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.72 155.95 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 3.5 p -104.46 168.39 9.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.8 OUTLIER -43.39 -62.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.046 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.85 -57.57 3.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -55.24 -42.58 73.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -58.71 -34.84 71.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.51 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.91 -51.4 58.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.26 -30.42 60.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.183 -0.948 . . . . 0.0 109.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 76' ' ' ILE . 14.9 mt -70.2 -50.56 38.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 109.862 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.61 -32.26 70.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 78' ' ' SER . 0.1 OUTLIER -74.91 -37.49 62.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 109.499 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.6 t90 -78.84 -38.15 38.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.4 mt -73.05 -41.83 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.941 HD23 ' HA ' ' A' ' 29' ' ' ALA . 36.4 mt -64.79 -41.75 95.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.0 OUTLIER -62.53 -31.47 72.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.872 HG21 HD22 ' A' ' 16' ' ' LEU . 28.9 mt -66.7 98.37 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.994 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.048 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 1.9 m120 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.241 0.543 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 1' ' ' ASN . 0.5 OUTLIER 68.2 -67.53 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.062 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 1' ' ' ASN . 1.3 tp-100 -50.28 -23.4 2.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.87 . . . . 0.0 110.123 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.483 HD13 ' OE1' ' A' ' 71' ' ' GLN . 11.8 mt -63.32 -54.48 36.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 110.018 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.819 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -49.92 -30.39 10.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 3' ' ' GLN . 12.1 tttt -66.33 -55.94 13.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 110.074 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -25.33 4.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.081 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -93.98 -46.3 7.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 110.134 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.31 34.56 5.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 8' ' ' LYS . 14.5 m -76.71 -28.86 56.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 110.0 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.57 -15.66 7.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -24.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.008 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.9 m -136.44 -37.05 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.002 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.6 m-70 -71.49 -179.66 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 110.344 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.804 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 176.55 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.834 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.591 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 26.6 mt -42.66 -67.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.477 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -121.98 42.37 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.349 -0.844 . . . . 0.0 110.041 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.804 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -139.0 87.39 2.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 110.117 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pttt -55.51 85.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 110.06 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -96.63 -143.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 36.4 t -51.96 -31.4 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.0 161.01 15.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.582 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.87 120.06 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.705 2.27 . . . . 0.0 110.262 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.51 130.16 5.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.98 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.751 ' CE1' HD13 ' A' ' 76' ' ' ILE . 6.7 m-85 -51.02 -33.25 24.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -66.14 -42.67 88.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.15 -52.37 59.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.041 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 53.6 t -56.37 -43.38 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.878 . . . . 0.0 109.973 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.782 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.5 -57.9 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -45.14 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.933 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 9.3 mttt -58.13 -34.83 70.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.87 4.01 31.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -68.48 -29.27 67.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.6 19.91 34.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -112.72 174.08 6.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.13 . . . . 0.0 110.16 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -122.26 -12.68 8.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.79 19.04 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.062 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.51 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -55.01 -21.02 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 19.6 t -71.38 -56.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.98 -52.72 64.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 109.993 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 45.2 t80 -52.18 -66.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.476 HD12 ' HB1' ' A' ' 73' ' ' ALA . 59.9 mt -43.21 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.099 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.54 -35.92 1.21 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.411 -0.805 . . . . 0.0 110.108 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.29 -35.98 81.01 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' CB ' ' O1A' ' A' ' 81' ' ' HEC . 0.4 OUTLIER -93.94 -11.87 30.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -1.17 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 72' ' ' LEU . 13.6 mt -72.01 -44.26 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 110.07 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -102.1 -44.15 5.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.96 -162.01 48.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.45 -136.37 12.78 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.92 -170.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 0.0 110.074 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.4 -19.55 5.65 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.414 HG21 ' OH ' ' A' ' 41' ' ' TYR . 98.8 t -101.5 -20.2 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -1.134 . . . . 0.0 110.078 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 1.041 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 86.8 m95 -121.77 -27.59 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.022 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.4 ' N ' ' O2D' ' A' ' 81' ' ' HEC . . . -174.38 -136.65 2.28 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 22.5 p -129.53 -35.06 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.074 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.664 HG13 HMD2 ' A' ' 81' ' ' HEC . 3.4 p -42.19 102.66 0.28 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.131 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.8 87.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.203 . . . . 0.0 110.27 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.493 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.5 ttt -45.02 139.87 3.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.684 2.256 . . . . 0.0 110.281 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.22 162.93 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 110.172 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.416 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 22.0 mm-40 -134.56 163.54 29.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 110.096 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -103.81 72.75 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 46' ' ' ILE . 3.6 m -124.31 155.89 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ASP . 66.7 p -104.14 169.92 8.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.948 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' THR . 14.0 t0 -43.43 -58.0 2.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.05 -58.92 3.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -54.4 -41.29 69.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.099 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.48 -35.49 72.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.815 . . . . 0.0 109.858 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -65.17 -52.08 57.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.9 -30.03 57.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.998 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.664 HD13 HD13 ' A' ' 46' ' ' ILE . 24.0 mt -70.24 -50.69 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.13 -30.79 68.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.471 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.24 -37.09 58.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.459 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.819 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 22.8 t90 -80.28 -36.83 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.751 HD13 ' CE1' ' A' ' 25' ' ' TYR . 54.9 mt -74.34 -37.22 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.7 mt -68.36 -46.91 68.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -57.42 -25.99 60.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.989 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 16' ' ' LEU . 16.8 mt -75.44 130.59 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.025 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.107 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.692 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.265 0.555 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.47 -23.43 24.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -50.66 -21.2 1.48 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.114 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.448 HD13 ' OE1' ' A' ' 71' ' ' GLN . 16.5 mt -77.59 -33.49 53.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 110.105 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.762 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -82.44 -27.0 32.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.023 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mtmm -74.67 -58.24 3.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.106 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -50.09 -25.45 3.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -82.53 -51.83 7.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.077 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.78 20.98 7.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 8' ' ' LYS . 11.8 m -72.47 -29.01 63.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -1.214 . . . . 0.0 109.962 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -16.38 9.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.94 -28.02 6.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 14.4 m -132.27 -34.15 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.1 m-70 -75.51 -179.22 4.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.653 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 169.39 124.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.75 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 79' ' ' ILE . 23.2 mt -42.25 -66.47 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 42.71 3.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.943 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -147.73 45.75 1.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.02 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 10.6 pttt -42.4 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -89.73 -89.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 t -82.11 -31.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.872 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.22 170.26 15.59 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.622 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -61.28 127.54 22.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.715 2.277 . . . . 0.0 110.273 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.08 133.36 27.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.218 -0.926 . . . . 0.0 109.939 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 4.6 m-85 -49.54 -32.19 11.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -71.14 -45.93 62.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.55 -44.71 95.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 34.7 t -57.68 -45.83 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.86 -53.12 53.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.886 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -55.27 -45.39 76.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.976 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.74 66.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 41.6 m-85 -102.99 -1.25 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.081 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.35 -29.93 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.74 15.37 52.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -126.02 153.6 44.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -1.133 . . . . 0.0 110.038 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -20.71 13.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.016 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -96.52 14.65 23.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -59.53 -21.89 60.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 39' ' ' VAL . 4.5 t -68.8 -56.91 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.984 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -52.92 63.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.0 t80 -51.8 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.722 HD23 ' O2A' ' A' ' 81' ' ' HEC . 78.2 mt -43.08 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.913 . . . . 0.0 110.123 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.74 -41.83 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.036 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.69 -40.61 88.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HB3' HBA2 ' A' ' 81' ' ' HEC . 0.3 OUTLIER -87.08 -13.67 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.076 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 43' ' ' ALA . 41.1 mt -69.24 -46.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.027 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -83.22 -12.51 56.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.066 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -96.21 -37.28 10.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.61 -162.18 54.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 95.29 -141.09 15.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.76 -175.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -1.146 . . . . 0.0 110.05 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.43 -12.33 3.5 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.1 -23.53 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.105 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.66 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 92.4 m95 -112.3 -24.77 9.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.89 28.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -110.09 54.4 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.24 96.82 49.23 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.047 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.51 88.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.325 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.492 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.9 ttt -60.08 139.41 91.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.872 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 144.09 91.44 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.652 2.235 . . . . 0.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.66 165.42 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.69 2.26 . . . . 0.0 110.151 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.516 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 31.1 mm-40 -136.62 164.58 27.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.82 62.1 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.34 155.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.9 p -103.67 169.02 8.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 109.967 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 25.3 t0 -43.38 -58.23 2.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -47.97 -55.38 10.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.85 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.45 -42.63 74.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.911 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.738 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -57.78 -34.87 70.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.845 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 1.6 mtmt -65.6 -52.59 50.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.19 -30.1 48.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.999 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.05 -51.39 32.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.892 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -69.59 -31.8 70.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.418 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.27 -36.55 61.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.762 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 21.0 t90 -79.76 -38.31 33.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.835 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 79.1 mt -70.72 -39.7 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 29' ' ' ALA . 14.8 mt -67.54 -44.62 77.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.041 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -31.86 70.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.96 HG21 HD22 ' A' ' 16' ' ' LEU . 39.5 mt -67.84 114.99 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.086 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.722 ' O2A' HD23 ' A' ' 42' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.413 ' HB2' HD12 ' A' ' 4' ' ' LEU . 87.7 m-20 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.275 0.56 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -105.17 -50.05 3.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.109 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -47.15 -25.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.476 HD13 ' HG3' ' A' ' 71' ' ' GLN . 10.6 mt -62.28 -42.37 99.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.143 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.55 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -57.56 -42.9 83.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.061 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -52.77 62.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.079 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.63 -24.83 6.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.203 -0.935 . . . . 0.0 110.04 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -91.95 -46.17 7.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.11 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.3 51.96 1.4 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -103.36 -28.71 11.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.089 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.7 mmt -59.08 -14.5 10.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' HB3' HMC3 ' A' ' 81' ' ' HEC . . . -50.13 -25.43 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.071 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -135.95 -36.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.8 m-70 -70.63 -179.14 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.862 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 172.73 124.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.009 HD22 HG21 ' A' ' 79' ' ' ILE . 24.2 mt -42.15 -63.3 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.344 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 42.51 3.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.0 110.06 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.862 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -142.83 86.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -60.31 78.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.166 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 17.7 mttt -88.42 -141.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 110.011 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 38.9 t -50.17 -31.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.12 157.65 16.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.89 124.71 15.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.73 2.287 . . . . 0.0 110.271 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -45.01 132.91 6.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 109.952 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.2 m-85 -52.12 -32.26 34.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.57 -47.2 76.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.151 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -47.3 83.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 23' ' ' PRO . 38.0 t -57.45 -45.25 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.999 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -53.15 -50.23 64.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.47 -44.74 69.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.055 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -38.08 65.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.034 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -100.85 -0.48 36.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.133 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.6 -26.46 67.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.049 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.26 24.27 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.33 154.13 47.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -1.193 . . . . 0.0 110.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -36.67 9.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.017 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 22.5 t70 -88.41 34.26 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -62.94 -24.57 67.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.02 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.86 -54.72 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -58.33 -55.97 28.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' LEU . 8.5 t80 -50.82 -65.19 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 38' ' ' ALA . 25.6 mt -43.01 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.971 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . . . -42.25 -42.01 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 110.078 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.23 58.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HB2' ' CBA' ' A' ' 81' ' ' HEC . 1.6 mmtp -97.43 -7.61 31.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 43' ' ' ALA . 49.5 mt -75.98 -47.91 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 110.067 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -73.8 -15.24 61.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.05 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 44.06 -144.01 2.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 94.6 -134.0 11.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.3 p 169.75 -170.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -1.184 . . . . 0.0 110.013 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.21 6.56 6.24 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.34 -11.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.62 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 96.3 m95 -124.72 -9.14 7.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.56 -128.58 2.37 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.87 51.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.586 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 76.2 t -114.01 94.94 36.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.041 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 3.0 Cg_exo -60.86 87.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.776 2.317 . . . . 0.0 110.281 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.496 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.6 ttt -59.17 139.42 88.0 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.95 141.03 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.636 2.224 . . . . 0.0 110.301 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.35 164.94 18.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.669 2.246 . . . . 0.0 110.065 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.53 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 26.9 mm-40 -134.8 163.19 30.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.132 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -104.4 57.05 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 110.005 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.467 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 3.5 m -114.33 155.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.232 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -107.13 174.58 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.896 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -43.66 -50.37 7.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.001 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.31 -63.26 1.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 0.0 109.906 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 6.2 mt-10 -53.88 -39.79 66.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.786 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.971 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -60.31 -34.45 73.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.63 57.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 110.005 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.8 -30.62 61.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.996 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.577 HD22 HMB3 ' A' ' 81' ' ' HEC . 19.8 mt -70.01 -49.82 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.36 -32.13 69.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.105 -0.997 . . . . 0.0 109.398 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -75.24 -36.88 61.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.9 t90 -79.79 -37.95 34.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.815 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.15 -40.42 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.0 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 21.7 mt -68.84 -39.96 79.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.933 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -64.66 -28.63 69.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.855 . . . . 0.0 110.035 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.009 HG21 HD22 ' A' ' 16' ' ' LEU . 28.5 mt -69.67 116.79 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.003 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.054 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.742 HMA1 HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.458 ' O ' ' NE1' ' A' ' 75' ' ' TRP . 14.4 m-80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.258 0.552 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 6' ' ' LYS . 2.2 pp20? -118.82 -11.32 9.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.072 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -50.04 -22.62 1.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 110.051 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 mt -74.93 -44.84 46.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.925 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.633 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -78.57 -29.42 46.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -63.15 -68.46 0.34 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -49.4 -25.14 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.447 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 4.1 tptt -73.16 -53.38 11.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.036 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.52 20.55 5.41 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 10.6 m -79.23 -29.08 42.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -1.15 . . . . 0.0 110.018 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.08 -15.64 14.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.928 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.5 m -127.83 -30.24 2.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.521 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -80.27 -179.37 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.652 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.06 123.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.449 -0.782 . . . . 0.0 109.785 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.881 HD23 HG21 ' A' ' 79' ' ' ILE . 2.0 mt -42.01 -64.12 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -122.85 42.77 3.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 109.991 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -148.3 45.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.016 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.87 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.343 -0.848 . . . . 0.0 110.224 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 5.6 mtpt -91.6 -89.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 28.3 t -80.58 -31.54 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.903 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.79 169.22 15.92 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.674 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -60.98 126.98 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.759 2.306 . . . . 0.0 110.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.19 131.45 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.897 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.36 -32.22 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.135 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.56 -45.45 68.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -48.86 79.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.988 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 37.7 t -56.53 -43.5 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.836 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.55 -54.53 31.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.952 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -46.1 69.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -55.55 -35.3 65.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 31.8 m-85 -101.42 0.21 36.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.927 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -63.43 -25.87 68.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.05 16.8 54.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -139.43 153.62 47.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -1.165 . . . . 0.0 110.185 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -105.47 -29.02 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 0.0 110.111 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -76.69 1.81 16.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 110.117 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -55.93 -24.19 36.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.022 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 96.1 t -67.62 -55.53 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.71 -54.83 42.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -52.32 -63.16 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.063 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 38' ' ' ALA . 50.5 mt -43.24 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 110.087 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.886 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.67 -41.04 2.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -56.83 -41.11 90.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' CB ' ' O1A' ' A' ' 81' ' ' HEC . 0.0 OUTLIER -86.26 -15.38 40.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.886 HD12 ' HA ' ' A' ' 43' ' ' ALA . 39.7 mt -67.28 -46.83 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.878 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 5.46 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -123.82 -6.64 7.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.103 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 44.24 -149.04 0.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.41 -146.72 18.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.494 ' HB2' ' CBD' ' A' ' 81' ' ' HEC . 0.3 OUTLIER 169.69 177.05 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -1.119 . . . . 0.0 110.106 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.54 -14.8 3.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.79 -30.8 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.03 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.988 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.3 m95 -107.89 -26.21 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' N ' ' O2D' ' A' ' 81' ' ' HEC . . . 172.08 -155.94 24.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 t -108.05 57.39 0.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -1.15 . . . . 0.0 110.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 25.7 t -117.59 96.26 49.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.61 78.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.741 2.294 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.494 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.2 ttt -52.15 138.98 35.81 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.68 142.24 82.63 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.627 2.218 . . . . 0.0 110.383 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.83 161.92 30.72 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.649 2.233 . . . . 0.0 110.17 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.631 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 27.1 mm-40 -135.04 163.57 29.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 110.104 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.09 69.1 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.002 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 46' ' ' ILE . 3.3 m -114.7 155.8 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.1 m -101.28 165.09 11.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.915 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 4.5 m-20 -43.41 -57.75 2.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.008 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.21 -55.11 11.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.51 -43.05 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.828 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.4 -36.63 71.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.825 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -65.28 -52.32 55.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -0.833 . . . . 0.0 110.026 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -53.94 -28.97 40.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 72' ' ' LEU . 17.3 mt -70.19 -52.05 26.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.935 . . . . 0.0 109.822 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -69.29 -31.38 69.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 0.0 109.38 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.23 -37.06 61.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.633 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 20.5 t90 -79.57 -38.44 34.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.78 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.2 mt -70.6 -42.4 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.836 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.5 mt -65.41 -42.82 92.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 109.99 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.3 t -61.95 -33.09 73.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 110.031 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.881 HG21 HD23 ' A' ' 16' ' ' LEU . 42.0 mt -64.63 103.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.146 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.699 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.188 0.518 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -175.69 -55.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.873 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -50.27 -24.69 3.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.025 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.444 HD22 ' OE1' ' A' ' 71' ' ' GLN . 3.3 mt -69.07 -48.46 62.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.583 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -65.7 -37.0 85.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 110.108 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -69.64 -55.16 10.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 110.111 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -50.1 -24.86 2.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 110.102 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -92.96 -47.06 7.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.07 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.14 45.69 0.85 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 16.6 m -97.6 -30.42 12.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -1.164 . . . . 0.0 110.134 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.9 mmt -61.16 -12.61 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.64 58.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.48 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 m -123.86 -19.01 5.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.7 m-70 -91.26 -179.18 5.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.948 . . . . 0.0 110.343 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.896 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 170.66 122.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.916 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.772 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -42.52 -64.23 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.16 41.9 3.2 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.896 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -139.42 86.06 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.45 -0.781 . . . . 0.0 110.073 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 3.7 ptpt -55.24 86.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 18' ' ' ALA . 2.8 tptt -95.01 -147.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.02 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 35.9 t -50.89 -31.28 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 109.924 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.07 166.14 13.58 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.15 129.35 28.22 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.776 2.317 . . . . 0.0 110.252 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -50.76 127.16 17.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.9 m-85 -47.95 -33.55 7.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.004 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.12 -44.44 76.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -49.53 76.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.051 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.145 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 61.9 t -56.97 -44.72 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 76' ' ' ILE . . . -51.21 -62.51 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.943 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -40.92 67.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.788 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -61.63 -32.06 72.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 6.5 m-85 -91.64 2.07 56.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.17 -25.4 61.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.082 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.71 -3.88 68.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -118.26 164.67 14.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -1.135 . . . . 0.0 110.045 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 -11.01 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.67 21.78 16.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.033 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -59.37 -15.81 18.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.539 HG12 ' NZ ' ' A' ' 70' ' ' LYS . 49.2 t -73.77 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.033 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.87 -51.4 69.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.2 -64.34 0.84 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 109.997 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 38' ' ' ALA . 55.8 mt -43.52 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.53 -37.62 1.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.494 -0.754 . . . . 0.0 110.095 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.73 -41.13 93.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 49' ' ' GLY . 4.7 mmtp -87.9 -9.47 53.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.7 mt -73.49 -51.52 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.004 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -17.5 62.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.03 -18.18 13.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 55.53 -140.32 40.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 92.35 -139.44 14.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CBD' ' A' ' 81' ' ' HEC . 2.7 p 169.92 -170.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -1.142 . . . . 0.0 110.034 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.23 4.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.83 -21.32 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -1.145 . . . . 0.0 110.131 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 1.145 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 93.0 m95 -115.81 -28.39 6.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 110.096 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 -155.85 25.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.9 p -107.89 65.34 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.039 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 51' ' ' SER . 60.4 t -129.97 96.33 26.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.59 87.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.736 2.291 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.483 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.9 ttt -59.43 140.28 88.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.28 141.5 82.26 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.577 2.185 . . . . 0.0 110.375 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.8 163.91 23.3 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.571 2.181 . . . . 0.0 110.029 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.532 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 20.0 mm-40 -134.95 163.33 30.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -0.982 . . . . 0.0 110.064 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -104.83 64.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.953 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -113.83 155.72 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 p -100.06 166.78 10.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 109.901 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -43.36 -55.29 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.79 -57.95 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.47 -40.99 68.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.9 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.58 -35.47 72.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.811 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' NZ ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.56 -52.25 53.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.339 -0.85 . . . . 0.0 110.088 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.52 -30.19 52.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 110.082 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 76' ' ' ILE . 26.7 mt -70.24 -50.33 40.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.87 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.39 -30.99 68.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.253 -0.905 . . . . 0.0 109.455 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -76.27 -36.56 58.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.56 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.583 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 23.7 t90 -80.79 -36.97 31.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 109.835 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.6 mt -74.13 -34.87 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.947 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 29' ' ' ALA . 20.1 mt -72.34 -41.88 66.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.4 t -64.14 -27.78 69.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.61 HG23 HD23 ' A' ' 16' ' ' LEU . 37.8 mt -69.65 100.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.018 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.051 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.76 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.203 0.525 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 12.8 mt-10 -64.04 -10.71 23.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.086 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 4' ' ' LEU . 2.6 mm-40 -51.09 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 110.115 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -42.57 -27.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 0.0 110.142 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.711 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -69.17 -36.85 77.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.847 . . . . 0.0 110.015 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 3' ' ' GLN . 37.2 tttt -84.57 -49.87 8.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.036 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -50.67 -24.66 3.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.073 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.64 -49.05 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 110.071 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.65 25.09 5.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 8' ' ' LYS . 13.6 m -73.04 -28.99 62.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 0.0 109.991 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.7 mmt -59.39 -14.33 11.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.197 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.28 -25.31 3.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 110.106 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 21' ' ' VAL . 9.7 m -135.76 -36.82 0.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.023 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -69.47 -178.84 1.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.617 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 175.63 129.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.75 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.049 HD11 HD13 ' A' ' 79' ' ' ILE . 3.9 mm? -42.75 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.137 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.26 42.55 3.12 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 110.009 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -137.41 87.76 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.12 156.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.061 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 178.73 -145.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 13' ' ' CYS . 55.1 t -50.15 -29.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 0.0 109.848 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.81 20.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.623 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.67 121.37 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.745 2.296 . . . . 0.0 110.316 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 135.06 3.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.937 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.4 m-85 -53.07 -31.87 44.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.42 -47.2 67.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.85 -46.14 91.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 23' ' ' PRO . 36.3 t -57.51 -45.47 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.975 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.837 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.34 -57.25 10.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.9 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -54.51 -43.29 71.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HE2' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.59 -34.95 71.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.057 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.537 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 6.3 m-85 -102.44 4.68 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.9 -23.42 59.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.22 10.58 60.63 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 167.69 14.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.098 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -113.62 -10.67 13.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -110.81 28.79 8.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.075 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.58 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.8 -24.81 62.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 83.9 t -68.89 -56.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 110.045 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 1.3 m-20 -59.18 -53.2 61.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.0 t80 -51.32 -63.05 1.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 38' ' ' ALA . 56.8 mt -43.17 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.046 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.921 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.62 -41.09 2.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.14 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.48 -39.67 84.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 6.8 mmpt? -88.57 -16.62 32.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -1.155 . . . . 0.0 110.093 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 43' ' ' ALA . 44.5 mt -65.65 -47.68 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.883 . . . . 0.0 110.063 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 2.9 ttmm -80.09 6.2 12.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.82 -28.97 4.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.2 -156.95 33.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.75 -129.67 9.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.517 ' OG ' ' CBD' ' A' ' 81' ' ' HEC . 0.3 OUTLIER 169.82 -170.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -1.172 . . . . 0.0 110.028 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -2.29 8.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 54' ' ' TRP . 37.6 t -119.95 -14.84 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.148 . . . . 0.0 110.094 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.5 m95 -133.79 9.45 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.32 -149.78 20.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 21.5 m -118.13 51.42 1.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -1.194 . . . . 0.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 59' ' ' MET . 49.6 t -110.26 95.13 20.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.922 . . . . 0.0 110.098 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.86 72.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.798 2.332 . . . . 0.0 110.286 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.496 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.1 ttt -43.98 139.41 3.02 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.883 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.85 141.23 83.85 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.642 2.228 . . . . 0.0 110.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.35 160.21 36.24 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.615 2.21 . . . . 0.0 110.135 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 23.5 mm-40 -133.01 162.92 30.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.072 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -103.93 68.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.13 155.94 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.132 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.6 p -101.91 167.93 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' THR . 8.8 t0 -43.39 -61.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.082 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.47 -54.98 6.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.41 -43.23 75.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.853 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.921 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.56 -36.28 71.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.784 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 -52.19 55.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 110.046 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.07 -29.37 44.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.929 . . . . 0.0 110.019 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 76' ' ' ILE . 20.2 mt -70.12 -51.73 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.31 -31.54 70.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -0.988 . . . . 0.0 109.39 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.12 -37.27 61.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.843 . . . . 0.0 109.619 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.711 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 20.4 t90 -79.33 -38.21 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.803 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.549 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.8 mt -71.48 -41.66 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.962 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 29' ' ' ALA . 21.7 mt -64.53 -46.68 81.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 109.96 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -56.65 -27.95 59.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 109.977 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.049 HD13 HD11 ' A' ' 16' ' ' LEU . 6.8 mt -75.46 121.82 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.096 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.695 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.176 0.512 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.24 -31.67 14.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.081 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.49 -24.9 3.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.74 HD13 ' CD ' ' A' ' 71' ' ' GLN . 17.6 mt -64.31 -51.78 61.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.037 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.605 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -52.98 -36.5 60.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.089 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -63.33 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 110.084 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -50.71 -24.83 3.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.86 -49.0 7.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.075 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.01 40.93 4.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 m -95.06 -28.83 14.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -16.18 6.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.872 . . . . 0.0 110.117 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -23.57 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.186 -0.946 . . . . 0.0 109.945 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m -137.51 -38.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.2 m-70 -70.01 -179.53 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 110.33 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.768 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 173.31 123.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.827 . . . . 0.0 109.802 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.684 HD22 HG21 ' A' ' 79' ' ' ILE . 31.6 mt -42.52 -66.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -122.47 42.63 3.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -141.46 84.11 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.17 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -61.7 76.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 110.111 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -79.21 -90.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.028 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 34.6 t -99.44 -39.51 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.989 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.93 166.45 12.3 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.82 118.61 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.785 2.323 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.35 128.79 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CD1' HG12 ' A' ' 76' ' ' ILE . 5.5 m-85 -48.34 -35.7 12.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -63.32 -41.87 98.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.08 -48.38 71.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.982 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -58.13 -46.3 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.88 -53.94 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -45.48 73.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.949 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 6.1 mttp -56.66 -34.43 67.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 110.048 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 19.3 m-85 -103.96 -1.36 27.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.59 -28.56 60.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.31 19.55 34.95 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.427 ' HG3' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -128.23 149.5 50.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.156 . . . . 0.0 110.023 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.52 -14.57 15.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 35' ' ' ARG . 7.1 p-10 -102.55 4.37 38.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.085 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -54.38 -20.89 8.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.04 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.599 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 72.7 t -69.66 -54.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.049 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.4 -53.63 55.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.092 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 70.4 t80 -50.88 -64.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' ALA . 72.3 mt -43.18 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.04 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.35 -41.63 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.73 -39.24 75.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' CGA' ' A' ' 81' ' ' HEC . 0.1 OUTLIER -89.76 -5.96 56.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.052 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 43' ' ' ALA . 31.2 mt -78.02 -47.68 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -9.1 58.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -100.37 -42.58 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.033 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.43 -169.03 52.2 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.38 -138.37 13.83 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER 169.7 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 110.07 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.84 3.22 5.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -121.69 -18.05 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 110.02 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.982 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 93.8 m95 -120.01 -11.72 9.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.46 -141.02 7.61 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.03 60.01 1.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -1.201 . . . . 0.0 110.061 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.409 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 22.8 t -122.82 96.37 45.31 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.915 . . . . 0.0 110.106 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.55 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.697 2.265 . . . . 0.0 110.279 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.479 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.1 ttt -49.77 138.39 17.57 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.511 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 143.47 90.09 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.685 2.256 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.43 165.68 17.07 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.716 2.277 . . . . 0.0 110.145 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 27.8 mm-40 -135.08 163.89 28.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.117 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -104.34 64.25 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.058 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.61 155.82 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.109 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.54 167.42 10.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 m-20 -43.36 -59.01 2.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.117 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.5 -56.35 7.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.897 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -54.87 -41.87 71.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.235 -0.916 . . . . 0.0 109.92 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.04 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.95 -37.74 74.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -64.7 -51.82 60.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.74 ' CD ' HD13 ' A' ' 4' ' ' LEU . 1.4 tm0? -53.92 -29.26 41.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.016 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 76' ' ' ILE . 45.2 mt -70.1 -52.75 21.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -68.55 -32.47 72.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.496 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.12 -36.93 64.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.605 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 19.0 t90 -78.64 -40.06 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.817 . . . . 0.0 109.74 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.692 HD12 ' O ' ' A' ' 72' ' ' LEU . 20.9 mt -71.11 -43.77 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.93 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 29' ' ' ALA . 20.6 mt -62.22 -44.68 96.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 t -59.58 -36.02 75.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.684 HG21 HD22 ' A' ' 16' ' ' LEU . 26.2 mt -59.6 108.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.964 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.04 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.697 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.258 0.551 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -154.73 -68.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 110.095 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -49.32 -24.12 1.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.03 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' O ' ' CG ' ' A' ' 8' ' ' LYS . 13.0 mt -68.81 -54.66 14.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.553 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -63.09 -30.19 71.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.11 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -66.38 -66.48 0.55 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.084 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -50.61 -25.2 3.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 110.067 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 18.9 mmtm -80.07 -53.81 6.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 110.052 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.35 51.66 1.55 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.8 m -106.55 -29.13 9.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 110.017 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mmt -58.51 -14.99 9.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.27 -24.75 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.982 . . . . 0.0 109.988 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -136.15 -36.91 0.73 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.7 m-70 -71.73 -179.9 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 110.378 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 169.06 121.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.873 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.864 HD23 HG23 ' A' ' 79' ' ' ILE . 1.6 mp -42.13 -62.31 0.96 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.303 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.13 42.37 3.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.36 -0.838 . . . . 0.0 110.038 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.759 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -147.05 45.76 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -47.49 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.134 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -96.54 -89.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 0.0 109.954 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 35.4 t -78.12 -31.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 109.901 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.15 168.32 18.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.669 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -61.04 124.73 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.728 2.285 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -49.32 127.57 15.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 109.893 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.3 m-85 -45.97 -31.22 2.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.081 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.31 -44.47 75.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.035 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -63.59 -49.12 74.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.904 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 39.7 t -57.8 -45.79 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.84 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.21 -63.72 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.29 -38.67 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -60.24 -35.65 75.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.881 . . . . 0.0 110.042 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.61 2.89 26.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.033 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -65.87 -26.62 67.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.024 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.71 16.71 49.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.39 154.51 36.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.064 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -100.54 -14.34 18.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' CG ' ' OD2' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -108.7 29.37 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.07 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.47 HG12 ' CE ' ' A' ' 70' ' ' LYS . 22.0 t -73.31 -61.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD2' ' CG ' ' A' ' 37' ' ' ASP . 3.2 p-10 -59.27 -50.33 74.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -51.75 -58.23 7.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.047 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.658 HD12 ' HB1' ' A' ' 73' ' ' ALA . 45.5 mt -48.3 -73.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 110.125 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.939 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.67 -43.07 3.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.25 -41.23 86.4 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.5 OUTLIER -86.68 -9.88 54.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.123 . . . . 0.0 110.042 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.879 HD12 ' HA ' ' A' ' 43' ' ' ALA . 34.0 mt -73.21 -50.55 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.51 -11.57 60.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.053 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -100.83 -13.67 18.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 45.31 -165.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 108.0 -137.39 14.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.85 -172.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.146 . . . . 0.0 110.101 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.12 -10.59 5.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 82.1 t -106.72 -22.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -1.144 . . . . 0.0 110.047 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.904 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.6 m95 -120.37 -22.12 6.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.53 -169.61 42.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -98.14 46.36 1.01 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.095 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -111.39 96.24 30.41 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.75 76.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 0.0 110.346 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.498 ' HE3' ' C4B' ' A' ' 81' ' ' HEC . 7.5 ttt -43.24 139.59 2.34 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 3.0 Cg_endo -62.64 142.59 90.22 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.674 2.25 . . . . 0.0 110.309 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.27 166.8 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.626 2.217 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 29.8 mm-40 -136.03 164.64 27.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 110.075 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -104.62 58.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.6 155.96 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.014 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.8 p -100.39 168.53 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.995 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 56.5 t0 -43.32 -53.31 5.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.41 -58.77 4.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -54.27 -40.71 68.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.781 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.939 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.69 -36.38 74.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' CE ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.71 -51.86 60.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 110.0 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.0 -29.7 57.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 69' ' ' ALA . 62.4 mt -70.21 -50.28 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.658 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.72 -30.3 66.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 109.398 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.5 mt-30 -76.63 -37.2 56.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.507 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.553 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 24.7 t90 -80.6 -36.45 32.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.842 . . . . 0.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 55.6 mt -74.64 -33.65 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.914 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.84 HD23 ' HA ' ' A' ' 29' ' ' ALA . 21.9 mt -71.61 -45.39 62.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -60.64 -25.81 66.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.864 HG23 HD23 ' A' ' 16' ' ' LEU . 39.1 mt -71.3 119.84 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.107 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.681 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.207 0.527 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 pm0 -106.12 -2.24 22.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.153 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.36 -23.73 0.64 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.053 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.752 HD13 ' HG3' ' A' ' 71' ' ' GLN . 1.4 mt -73.97 -44.73 53.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 110.041 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.429 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.2 -30.49 67.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.942 . . . . 0.0 110.107 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -62.53 -66.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -50.41 -29.72 10.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.092 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -65.38 -60.0 3.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.912 . . . . 0.0 110.043 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.95 49.32 0.58 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 m -99.13 -28.86 13.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -1.182 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.6 mmt -54.89 -17.46 3.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.34 -23.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.967 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.1 m -138.63 -37.75 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.897 . . . . 0.0 110.041 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.452 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.6 m-70 -70.12 -179.25 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.852 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.821 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER 170.77 126.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.564 ' CD2' HD13 ' A' ' 79' ' ' ILE . 28.8 mt -42.17 -67.85 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 42.77 3.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 110.019 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -139.44 83.6 1.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -62.33 74.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 57.2 mmtt -77.68 -90.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 26.5 t -97.67 -45.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.97 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.7 167.52 14.03 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.07 119.28 6.35 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.68 2.254 . . . . 0.0 110.242 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 134.58 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.607 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 5.0 m-85 -50.49 -32.07 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' ILE . . . -67.72 -44.88 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.017 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.59 -48.83 79.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.565 HG23 ' HB2' ' A' ' 23' ' ' PRO . 71.4 t -57.16 -44.51 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.993 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.738 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.69 -59.7 3.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.904 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.75 -43.07 72.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -34.04 73.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 110.048 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -94.5 -12.76 27.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -52.12 -28.77 19.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 0.0 110.009 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.63 17.25 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -122.86 121.98 37.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.106 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -72.97 -31.06 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.034 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.67 37.01 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 110.054 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.742 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.37 -25.11 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.62 -50.91 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.099 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -55.67 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 110.076 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.7 t80 -50.61 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.066 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 38' ' ' ALA . 1.4 mt -43.27 -73.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.079 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.879 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.19 -41.75 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.805 . . . . 0.0 110.058 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.5 -41.89 89.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HE2' ' O1A' ' A' ' 81' ' ' HEC . 0.8 OUTLIER -84.98 -16.91 39.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 43' ' ' ALA . 32.8 mt -65.21 -49.46 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 10.3 tttt -80.83 -0.06 37.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -7.01 10.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 47.77 -155.86 1.06 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.9 -149.64 16.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.528 ' HB3' ' CBD' ' A' ' 81' ' ' HEC . 1.3 p 169.68 -167.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.15 . . . . 0.0 110.071 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -18.08 7.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 53' ' ' VAL . 64.2 t -100.03 -3.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.596 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 99.6 m95 -137.88 6.45 2.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.44 -153.06 23.8 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -118.37 52.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.108 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.91 96.2 40.57 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.069 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.65 80.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.689 2.259 . . . . 0.0 110.225 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.49 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.4 ttt -51.48 138.58 29.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.95 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.75 144.84 90.04 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.682 2.255 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -62.96 168.19 10.97 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.693 2.262 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.514 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 33.7 mm-40 -137.06 164.83 27.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.155 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.05 60.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.027 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.461 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.66 155.89 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -103.77 170.59 7.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.001 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' THR . 13.1 m-20 -43.35 -57.27 3.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.993 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.83 -57.96 4.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -41.02 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.879 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.46 -34.77 72.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -65.41 -51.24 61.64 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.752 ' HG3' HD13 ' A' ' 4' ' ' LEU . 1.5 tm0? -56.2 -30.69 62.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.078 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 76' ' ' ILE . 38.1 mt -70.41 -48.9 53.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -71.22 -29.6 65.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -37.43 48.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.495 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 25.3 t90 -81.03 -34.21 32.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 56.6 mt -76.84 -35.74 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.4 mt -71.36 -45.38 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.973 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 t -59.06 -33.42 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.008 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.564 HD13 ' CD2' ' A' ' 16' ' ' LEU . 14.1 mt -69.29 95.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.979 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.564 ' OXT' ' HB3' ' A' ' 29' ' ' ALA . 6.2 mmmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.017 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.741 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.471 ' O ' ' CE2' ' A' ' 75' ' ' TRP . 8.8 p-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.278 0.561 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -119.87 -43.61 2.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.06 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -50.35 -21.91 1.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.082 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.446 HD13 ' HG3' ' A' ' 71' ' ' GLN . 32.9 mt -77.16 -25.28 51.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.062 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.825 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -89.27 -41.4 12.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.06 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -33.19 63.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.066 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -49.38 -24.32 1.88 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.094 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.49 ' HE3' ' CG1' ' A' ' 64' ' ' VAL . 7.7 mmtt -106.45 -39.89 5.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 110.054 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.91 36.39 2.2 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.446 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 13.3 m -73.7 -28.98 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -1.182 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.66 -13.3 13.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.34 -35.51 51.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 m -125.15 -25.49 3.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.99 -179.25 7.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.463 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.896 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 169.48 122.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.784 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.0 HD23 HG23 ' A' ' 79' ' ' ILE . 1.2 mp -41.84 -64.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.7 42.69 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 110.072 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.896 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -136.54 82.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.83 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.46 113.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.046 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -134.51 -143.55 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 t -50.98 -30.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.61 158.91 19.23 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.582 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.67 122.54 11.41 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.769 2.313 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 126.35 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 109.981 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.6 m-85 -46.29 -37.27 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.085 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -61.05 -50.72 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.02 92.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.041 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 90.6 t -57.08 -45.45 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.837 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -53.04 -58.97 5.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -55.77 -40.93 73.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.756 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -34.25 74.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -100.7 1.8 40.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.17 62.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 17.79 44.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -132.17 147.62 52.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 110.096 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -90.75 -33.83 15.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -91.12 28.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.806 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -62.72 -20.24 64.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.29 -57.45 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -57.64 -56.59 19.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' A' ' 42' ' ' LEU . 42.8 t80 -49.45 -63.98 0.94 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.98 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 38' ' ' ALA . 10.7 mt -43.11 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.908 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.45 -38.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -56.93 -39.96 89.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -89.18 -7.52 55.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 110.059 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.908 HD12 ' HA ' ' A' ' 43' ' ' ALA . 46.2 mt -77.78 -39.48 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -3.52 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -102.51 -34.77 9.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.46 -174.01 45.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.18 -147.47 16.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 6.8 p 174.16 -164.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 110.074 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.88 -10.33 6.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 78.1 t -109.92 -15.77 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 110.088 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.5 m95 -122.67 -9.15 8.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.6 -166.17 31.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 56' ' ' SER . 5.6 p -103.39 55.28 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -1.159 . . . . 0.0 110.096 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.46 96.51 45.82 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.52 87.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.771 2.314 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.49 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.4 ttt -55.64 139.82 67.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.928 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.29 142.51 86.27 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.633 2.222 . . . . 0.0 110.25 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.17 165.99 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.647 2.231 . . . . 0.0 110.19 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.528 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 26.5 mm-40 -137.58 164.86 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -104.11 70.76 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.49 ' CG1' ' HE3' ' A' ' 8' ' ' LYS . 3.8 m -127.48 155.97 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.28 -0.888 . . . . 0.0 110.099 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -104.95 171.41 7.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' THR . 36.0 t0 -43.35 -53.43 5.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.032 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.23 -59.14 3.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.901 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -54.82 -41.09 70.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -59.31 -35.63 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.802 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 2.0 ttpm? -65.76 -51.71 56.96 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.423 -0.798 . . . . 0.0 110.009 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.68 -30.17 54.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.26 -51.07 33.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -69.57 -31.62 69.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -75.46 -37.39 60.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.825 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 21.6 t90 -79.08 -37.78 37.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 109.847 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' A' ' 79' ' ' ILE . 79.0 mt -71.99 -40.33 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.84 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 29' ' ' ALA . 29.5 mt -65.24 -45.26 85.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -60.22 -29.24 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.044 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.0 HG23 HD23 ' A' ' 16' ' ' LEU . 42.6 mt -64.9 109.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.072 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.723 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.263 0.554 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -119.6 -11.14 9.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.073 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -45.51 -25.62 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 110.051 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 14.0 mt -73.03 -30.52 63.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 110.009 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.844 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -84.4 -43.0 15.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 110.094 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -60.73 2.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.022 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 13.0 pt20 -50.03 -30.37 10.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 110.075 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 9.5 tppt? -68.82 -56.61 7.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.108 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.94 25.35 2.31 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.5 m -88.36 -29.26 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -1.155 . . . . 0.0 109.998 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -59.21 -14.57 11.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.114 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -26.62 4.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.978 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.4 m -133.86 -36.08 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.957 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 88.5 m-70 -71.26 -179.32 2.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.27 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.777 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.34 125.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.914 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.603 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 25.1 mt -42.43 -68.76 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -122.28 42.49 3.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -139.52 82.39 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.373 -0.829 . . . . 0.0 110.138 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -59.47 79.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -85.12 -90.57 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 27.2 t -96.0 -46.32 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 109.889 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.55 167.78 13.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -60.98 120.06 7.56 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.764 2.309 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -43.29 130.6 4.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 109.977 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.67 -32.22 7.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.69 -44.06 74.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.09 -49.38 76.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.958 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 39.8 t -57.3 -44.31 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.867 . . . . 0.0 110.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.848 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.55 -55.06 21.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.971 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -54.08 -46.37 72.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.53 -32.34 65.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 110.127 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CE2' HG13 ' A' ' 28' ' ' VAL . 24.3 m-85 -105.46 1.19 27.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.06 -29.01 67.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.039 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.12 16.3 48.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.503 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 11.4 mmm-85 -115.47 139.02 50.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -1.161 . . . . 0.0 110.065 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -95.36 -16.53 22.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.068 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.71 12.69 21.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.576 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -53.46 -20.31 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.038 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 70' ' ' LYS . 41.3 t -68.62 -57.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.072 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.62 -52.77 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.05 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.4 ' OH ' ' HE3' ' A' ' 45' ' ' LYS . 86.6 t80 -52.61 -62.78 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 38' ' ' ALA . 45.4 mt -43.26 -74.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.892 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.61 -39.86 2.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.415 -0.803 . . . . 0.0 110.079 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.34 -36.78 70.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.536 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.2 OUTLIER -92.1 -15.63 27.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -1.111 . . . . 0.0 110.076 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 43' ' ' ALA . 49.7 mt -67.34 -44.59 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.096 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -82.56 6.95 15.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.46 -31.1 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 110.046 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.39 -160.32 49.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 100.24 -143.72 16.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.4 p 169.76 -172.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -1.157 . . . . 0.0 110.043 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.95 -9.25 5.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.13 -18.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -1.132 . . . . 0.0 110.081 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.958 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.4 m95 -117.99 -26.89 6.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.081 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.47 -154.04 20.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -111.51 44.94 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.113 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.52 96.14 26.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.7 92.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.73 2.287 . . . . 0.0 110.292 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.479 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.2 ttt -62.67 138.84 96.9 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.513 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.47 142.15 83.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.616 2.21 . . . . 0.0 110.299 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.76 165.49 18.33 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.645 2.23 . . . . 0.0 110.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.588 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 26.5 mm-40 -134.67 163.43 29.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 16.4 p-10 -104.33 59.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.055 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.455 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.23 155.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.106 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -99.55 165.38 11.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 109.92 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 6.4 p-10 -43.36 -47.04 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.025 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.47 -61.09 2.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.883 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.41 -40.95 68.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.753 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -59.45 -34.17 72.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -65.77 -52.1 53.7 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.401 -0.812 . . . . 0.0 110.053 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.75 -29.85 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.59 -49.84 43.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.77 -31.05 67.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.381 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 2.6 mt-30 -76.03 -37.04 58.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.423 -0.798 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.844 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 23.6 t90 -80.35 -37.42 32.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.835 . . . . 0.0 109.765 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.581 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 57.0 mt -72.35 -40.35 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.858 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.848 HD23 ' HA ' ' A' ' 29' ' ' ALA . 28.2 mt -66.83 -43.65 83.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.872 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.2 p -60.83 -30.22 69.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.592 HD13 ' CD2' ' A' ' 16' ' ' LEU . 36.8 mt -67.85 107.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.069 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.711 HMA1 HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.262 0.553 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -138.65 12.15 2.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.021 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.47 -27.13 5.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 110.045 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 4' ' ' LEU . 3.2 pp -79.42 -28.61 41.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 110.005 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.42 -32.18 26.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.058 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -69.07 -57.31 5.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.023 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -51.92 -25.15 7.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 110.073 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -79.92 -54.12 6.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 110.079 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.61 41.09 0.75 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.457 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 21.4 m -92.22 -29.64 16.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.5 mmt -60.46 -13.53 14.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB3' HMC3 ' A' ' 81' ' ' HEC . . . -50.58 -24.87 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.036 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.0 m -136.31 -36.57 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 89.6 m-70 -71.25 -179.71 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.393 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.963 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 172.2 118.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.871 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.748 HD23 ' CG2' ' A' ' 79' ' ' ILE . 1.6 mt -41.71 -58.27 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.36 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.54 42.64 3.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.963 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.47 87.86 1.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -85.83 -143.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.3 t -51.48 -30.99 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.977 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.48 160.53 13.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.84 128.74 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.79 2.327 . . . . 0.0 110.317 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -50.3 122.6 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.568 ' CD1' HG12 ' A' ' 76' ' ' ILE . 2.6 m-85 -43.64 -29.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -71.97 -45.78 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 0.0 109.99 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.66 -49.04 79.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.108 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 37.5 t -56.37 -43.57 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.885 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.936 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.24 -61.61 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.984 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -53.39 -40.75 65.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -33.53 71.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.676 ' HB2' HD21 ' A' ' 77' ' ' LEU . 13.8 m-85 -106.67 4.58 28.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.095 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -69.99 -28.57 65.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 0.0 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.81 14.88 55.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.98 165.45 12.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.114 . . . . 0.0 110.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -115.65 -6.87 12.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 110.04 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -123.89 18.45 9.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -55.84 -23.24 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.13 -55.3 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.97 -51.64 68.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.559 ' OH ' HG21 ' A' ' 53' ' ' VAL . 30.0 t80 -54.5 -67.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.064 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 38' ' ' ALA . 3.2 mt -43.05 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 110.131 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.897 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.5 -39.14 2.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.096 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -59.04 -42.78 97.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HB2' ' CGA' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -84.25 -13.76 51.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -1.114 . . . . 0.0 110.003 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.897 HD12 ' HA ' ' A' ' 43' ' ' ALA . 40.7 mt -69.68 -47.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -81.64 -19.84 40.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 35.3 mttm -92.24 -30.85 15.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 110.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.3 -167.77 31.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.17 -143.02 15.82 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.9 t 169.71 -179.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -1.094 . . . . 0.0 110.08 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 136.79 -11.3 3.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG21 ' OH ' ' A' ' 41' ' ' TYR . 45.3 t -99.13 -29.61 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -1.161 . . . . 0.0 110.076 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 1.108 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.1 m95 -104.67 -22.98 13.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.76 -138.26 5.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.49 67.52 0.85 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -1.159 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 51' ' ' SER . 40.0 t -136.38 91.82 16.09 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.92 77.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.724 2.282 . . . . 0.0 110.285 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.494 ' HE3' ' C4B' ' A' ' 81' ' ' HEC . 7.6 ttt -45.62 141.21 4.04 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.991 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.03 143.23 90.45 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.674 2.249 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.03 167.16 12.8 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.666 2.244 . . . . 0.0 110.128 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.524 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 25.3 mm-40 -139.69 166.39 24.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 110.073 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -105.31 68.1 0.8 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.525 HG21 HG22 ' A' ' 46' ' ' ILE . 3.5 m -114.77 155.93 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 p -103.55 167.52 9.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.93 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.45 -62.06 1.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.02 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.56 -55.75 5.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.901 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.79 -42.95 76.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.882 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.86 -35.81 73.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.825 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -66.33 -50.79 62.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.436 -0.79 . . . . 0.0 110.032 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' CD ' HD22 ' A' ' 4' ' ' LEU . 1.4 tm0? -55.69 -29.24 59.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 76' ' ' ILE . 77.8 mt -70.39 -49.47 48.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.51 -31.21 68.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.09 -37.57 58.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.532 ' CE2' HD11 ' A' ' 79' ' ' ILE . 23.3 t90 -79.64 -36.67 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.793 . . . . 0.0 109.796 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.841 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 25.2 mt -71.86 -39.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.884 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.936 HD23 ' HA ' ' A' ' 29' ' ' ALA . 18.1 mt -68.02 -42.44 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.1 t -62.04 -37.83 86.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.913 . . . . 0.0 109.962 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.748 ' CG2' HD23 ' A' ' 16' ' ' LEU . 19.5 mt -59.39 97.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.026 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.654 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.285 0.564 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.18 -40.04 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.11 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -47.3 -24.41 0.74 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.957 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.603 HD13 ' HG3' ' A' ' 71' ' ' GLN . 12.8 mt -63.06 -42.28 99.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.02 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -91.37 -0.22 57.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.103 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -88.94 -58.54 2.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.12 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -48.76 -24.42 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.96 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HE3' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -80.55 -53.96 6.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.083 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.85 46.35 0.97 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.484 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -90.0 -28.99 18.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.079 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -14.01 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.123 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.66 -25.1 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.0 m -135.72 -36.83 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.498 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 88.8 m-70 -70.31 -179.45 2.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.766 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.44 124.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.904 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 79' ' ' ILE . 27.0 mt -42.46 -64.69 0.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 42.19 3.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.766 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.3 84.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 110.147 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.88 64.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 16.4 mttm -62.57 -90.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.056 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 29.3 t -93.68 -44.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.49 166.27 13.24 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.724 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.05 7.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.754 2.302 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.29 132.66 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.498 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 6.8 m-85 -49.85 -32.4 14.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -67.85 -44.67 76.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.935 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -49.92 73.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.08 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 36.1 t -56.49 -43.48 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.993 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.901 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.44 -57.24 10.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -43.76 64.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -36.41 67.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.725 ' HB2' HD21 ' A' ' 77' ' ' LEU . 14.1 m-85 -99.1 4.08 46.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.28 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.04 61.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.92 160.67 37.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -1.175 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -111.42 -26.94 8.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -84.65 9.21 14.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -60.79 -25.02 66.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.78 -53.87 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -54.07 50.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -51.82 -61.76 2.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 38' ' ' ALA . 8.2 mt -43.05 -73.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.877 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.79 -41.23 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.381 -0.825 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.22 73.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CB ' ' O2A' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -90.93 -9.72 45.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -1.143 . . . . 0.0 109.991 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 43' ' ' ALA . 41.0 mt -73.38 -47.74 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.02 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -4.75 47.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -5.12 10.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.928 . . . . 0.0 110.077 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 45.29 -134.73 7.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . 82.83 -143.33 22.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 3.6 t 169.79 -178.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.416 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 142.75 -14.63 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.67 -11.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -1.142 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 1.08 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 96.7 m95 -120.37 -29.1 4.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.013 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.39 -142.14 6.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 65.6 m -120.57 45.82 2.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.235 -1.156 . . . . 0.0 110.123 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 85.7 t -111.58 94.99 25.21 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.04 77.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.695 2.263 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.507 ' HE3' ' C4B' ' A' ' 81' ' ' HEC . 7.8 ttt -46.62 140.39 5.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -62.92 144.99 94.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.623 2.216 . . . . 0.0 110.289 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.62 166.48 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.714 2.276 . . . . 0.0 110.205 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.539 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 37.4 mm-40 -137.74 165.2 27.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.095 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -105.14 60.85 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.63 HG12 ' OE1' ' A' ' 68' ' ' GLU . 3.6 m -113.82 155.82 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -0.947 . . . . 0.0 110.153 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.11 167.8 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -43.46 -59.08 2.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.92 -56.66 5.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.907 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.63 ' OE1' HG12 ' A' ' 64' ' ' VAL . 4.1 mt-10 -55.29 -42.49 73.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 109.875 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.17 -35.88 72.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 109.835 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -51.81 59.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -0.813 . . . . 0.0 110.001 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.603 ' HG3' HD13 ' A' ' 4' ' ' LEU . 1.4 tm0? -54.95 -29.79 57.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 110.012 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.435 HD22 HMB3 ' A' ' 81' ' ' HEC . 17.6 mt -70.24 -50.59 38.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.855 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.73 -31.83 70.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.141 -0.974 . . . . 0.0 109.432 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -75.47 -37.34 60.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.338 -0.852 . . . . 0.0 109.504 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.497 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.5 t90 -79.15 -37.6 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 78.0 mt -72.43 -39.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 29' ' ' ALA . 18.8 mt -66.13 -46.11 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.8 m -58.31 -31.55 67.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.981 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 16' ' ' LEU . 18.5 mt -67.26 128.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.038 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.103 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.67 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 2.1 m120 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.246 0.545 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 1' ' ' ASN . 1.3 mm-40 -150.68 -60.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 110.115 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -48.54 -24.35 1.28 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.176 -0.953 . . . . 0.0 110.022 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 4' ' ' LEU . 13.0 mt -63.37 -63.09 1.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 110.083 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -56.43 -31.82 64.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.032 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -62.42 1.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 110.063 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -50.43 -24.8 3.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 0.0 110.037 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -77.5 -53.51 7.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 110.114 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.15 38.68 2.62 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.8 m -93.0 -29.11 16.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -1.083 . . . . 0.0 110.012 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -16.06 10.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB3' HMC3 ' A' ' 81' ' ' HEC . . . -50.09 -25.13 3.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 109.984 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.7 m -136.61 -36.01 0.72 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.2 m-70 -73.05 -179.62 3.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.893 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 170.07 121.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.78 . . . . 0.0 109.86 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.0 mp -41.93 -63.24 0.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.302 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.97 42.38 3.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -140.22 83.95 1.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -56.08 84.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.106 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -94.61 -143.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.048 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.1 t -52.18 -31.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 164.39 14.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.17 130.82 33.84 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.715 2.277 . . . . 0.0 110.241 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.3 126.89 18.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.019 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 2.8 m-85 -46.3 -37.68 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -61.45 -56.28 21.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.971 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.3 -34.07 71.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.073 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 34.1 t -60.89 -50.98 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 77' ' ' LEU . . . -54.82 -46.72 74.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.871 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -59.25 -43.33 92.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.943 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -34.8 71.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -101.7 -1.79 31.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.082 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.26 -22.0 27.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.07 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.75 20.74 30.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 127.77 40.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -1.182 . . . . 0.0 110.097 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -38.66 69.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.49 40.82 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -69.21 -24.06 63.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.61 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.65 -51.07 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -52.33 -63.02 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.984 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 38' ' ' ALA . 28.6 mt -46.94 -74.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 110.119 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.991 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.39 -39.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 110.045 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -57.38 -40.61 92.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HB3' HBA2 ' A' ' 81' ' ' HEC . 3.1 mttt -87.8 -10.39 51.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.041 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 43' ' ' ALA . 42.3 mt -73.4 -44.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 110.066 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.81 11.3 13.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.034 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -111.48 -45.24 3.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.46 179.24 52.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.81 -147.35 16.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.3 p 169.66 -168.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -1.073 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.96 -16.76 5.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -96.21 -23.82 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 110.139 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.596 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.8 m95 -112.58 -18.01 12.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.76 -153.17 23.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -111.68 66.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -1.115 . . . . 0.0 110.04 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.22 95.78 14.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.116 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.76 86.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.704 2.27 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.493 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.7 ttt -55.36 138.93 67.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 109.981 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.61 141.77 81.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.586 2.191 . . . . 0.0 110.332 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.39 169.73 9.13 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.62 2.214 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.52 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 24.9 mm-40 -137.73 164.67 28.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.69 55.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.98 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.5 m -114.4 155.85 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.882 . . . . 0.0 110.099 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' ASP . 77.5 p -105.61 172.66 6.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 t0 -43.56 -50.34 7.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.036 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -48.76 -63.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 11.5 mt-10 -53.54 -39.97 65.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.237 -0.915 . . . . 0.0 109.768 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.991 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -60.19 -34.66 73.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.718 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 16.2 mttm -65.61 -51.55 58.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.808 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.96 -30.32 61.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.527 HD22 HMB3 ' A' ' 81' ' ' HEC . 12.0 mt -70.19 -49.76 47.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.853 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.29 -32.44 70.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 0.0 109.426 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 3.1 mm-40 -74.99 -36.82 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.483 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.62 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.6 t90 -79.51 -38.26 34.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -0.831 . . . . 0.0 109.898 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 25' ' ' TYR . 50.5 mt -68.43 -36.54 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.931 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.571 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 19.3 mt -69.94 -47.52 62.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 109.943 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 t -58.46 -23.46 57.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.62 HD11 ' CE2' ' A' ' 75' ' ' TRP . 36.6 mt -73.22 114.28 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 109.994 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.064 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.683 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.8 m120 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.213 0.53 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.84 -29.2 70.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.088 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -51.84 -26.08 9.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 110.064 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.05 -44.89 91.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.06 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.915 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -55.2 -41.88 72.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.084 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -69.7 -56.45 7.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.983 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -24.48 3.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.108 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -88.89 -48.31 7.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.328 -0.857 . . . . 0.0 110.07 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.04 45.78 1.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 8' ' ' LYS . 13.7 m -102.36 -28.82 12.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -1.152 . . . . 0.0 110.03 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.96 -16.17 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 110.138 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.14 -24.31 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 109.976 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.1 m -137.0 -37.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.034 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -70.75 -179.56 2.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.849 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 176.04 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.0 109.819 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.532 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 28.8 mt -42.48 -65.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -122.04 42.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.849 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.97 82.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.78 71.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -71.89 -90.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.249 -0.907 . . . . 0.0 109.977 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 29.6 t -90.4 -40.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.883 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.11 165.34 12.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 121.16 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.608 2.206 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -43.25 129.95 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 110.02 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.5 m-85 -48.65 -31.69 7.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.41 -46.21 73.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -48.84 79.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 93.0 t -56.93 -44.41 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.931 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.73 -62.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.08 -39.99 63.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -60.01 -34.52 73.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.099 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.627 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 4.0 m-85 -96.26 4.57 52.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.105 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.86 -17.53 60.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.053 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 16.56 51.41 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.19 157.48 46.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -1.129 . . . . 0.0 110.063 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -104.68 -3.16 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.155 -0.965 . . . . 0.0 110.109 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -115.23 20.63 14.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.627 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -62.0 -21.65 65.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.077 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 39' ' ' VAL . 4.4 t -69.67 -57.24 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -53.52 57.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' OH ' HG21 ' A' ' 53' ' ' VAL . 18.9 t80 -51.04 -63.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 43' ' ' ALA . 22.4 mt -43.4 -73.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.893 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.32 -39.54 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.092 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.9 -42.66 92.47 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HB2' ' CBA' ' A' ' 81' ' ' HEC . 4.5 mtpt -84.75 -14.97 46.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.164 . . . . 0.0 109.971 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.823 HD12 ' HA ' ' A' ' 43' ' ' ALA . 28.8 mt -67.62 -46.25 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 110.014 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -16.62 43.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -95.36 -30.53 13.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.74 -157.76 29.74 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.4 -132.57 11.08 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.2 p 169.85 178.6 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 110.085 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 141.02 -20.32 2.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.412 HG21 ' OH ' ' A' ' 41' ' ' TYR . 41.3 t -105.75 -22.31 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -1.126 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.656 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 80.3 m95 -119.53 -12.37 9.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' O1D' ' A' ' 81' ' ' HEC . . . 164.67 -145.95 10.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 3.7 m -122.92 -26.51 4.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 110.1 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . 21.9 t -41.6 102.04 0.26 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.7 88.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.654 2.236 . . . . 0.0 110.248 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.2 ttt -55.63 138.88 69.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.41 143.58 88.83 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.589 2.193 . . . . 0.0 110.332 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -62.86 169.32 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.757 2.304 . . . . 0.0 110.116 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.535 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 31.5 mm-40 -137.97 165.69 25.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.042 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -104.76 56.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 3.7 m -114.62 155.78 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.13 170.3 8.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.922 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -43.33 -53.63 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.983 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -49.32 -59.07 4.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.31 -40.82 68.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.889 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.893 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.02 -36.66 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.395 -0.815 . . . . 0.0 109.869 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 29.5 mttt -64.82 -51.03 64.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.38 -0.825 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.2 tm0? -55.05 -31.04 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 110.012 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.645 HD22 HMB3 ' A' ' 81' ' ' HEC . 8.1 mt -70.01 -50.34 42.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.824 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -68.7 -34.4 75.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.455 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.18 -37.89 66.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.434 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.915 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 17.3 t90 -76.78 -39.83 50.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 109.754 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 37.8 mt -68.13 -46.07 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 29' ' ' ALA . 58.2 mt -61.08 -41.13 96.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.895 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG21 HD22 ' A' ' 16' ' ' LEU . 11.6 mt -59.23 100.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.723 HMA1 HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.221 0.534 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -158.66 -58.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.132 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -24.62 2.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.091 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.413 HD22 ' NE2' ' A' ' 71' ' ' GLN . 10.6 mt -58.01 -57.4 12.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.063 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.54 -18.51 56.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.034 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -68.46 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.044 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.24 -25.38 2.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.108 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.05 -52.77 7.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 110.087 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.56 24.64 6.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 14.5 m -69.75 -29.61 67.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -1.161 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 mmt -60.58 -13.31 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.106 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.0 -36.39 60.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.6 m -126.73 -8.4 6.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.448 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 81.6 m-70 -101.67 -178.35 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 110.426 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.802 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 1.1 m-20 170.75 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 109.793 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 26.7 mt -42.53 -68.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 42.86 3.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.849 . . . . 0.0 110.057 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.802 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -138.07 88.0 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -50.59 159.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.125 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.3 tptt 177.42 -147.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 109.916 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 72.1 t -49.65 -29.53 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -130.07 153.3 20.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.589 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.78 120.98 9.0 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.708 2.272 . . . . 0.0 110.323 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 136.47 3.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 7.2 m-85 -54.75 -33.65 61.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.01 -52.32 60.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 110.165 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.149 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -57.84 -46.03 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.995 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.916 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -49.33 -66.84 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.918 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -53.08 -38.3 62.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HD2' ' CZ2' ' A' ' 54' ' ' TRP . 7.5 ttmt -63.22 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 13.6 m-85 -100.16 -5.48 27.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.84 -22.67 65.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.061 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.79 11.75 65.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.12 127.02 45.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.119 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -77.07 -29.19 54.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.081 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.51 18.23 10.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.716 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -65.25 -23.83 67.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.085 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.485 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 61.5 t -70.79 -58.77 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.053 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.45 -51.31 69.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.2 t80 -52.26 -65.87 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 38' ' ' ALA . 15.9 mt -43.01 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.068 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.54 -40.11 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.077 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.61 -41.28 93.54 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -9.37 55.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.542 ' CG1' HMA2 ' A' ' 81' ' ' HEC . 8.2 mt -73.96 -49.2 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.18 -2.89 20.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -120.28 -17.64 8.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.32 -153.93 26.37 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.68 -145.33 16.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.504 ' HA ' ' CGD' ' A' ' 81' ' ' HEC . 5.5 p 173.43 -170.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 110.058 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.48 -19.2 6.33 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.5 t -96.35 -22.64 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 1.149 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 94.6 m95 -112.92 -35.46 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.56 -140.83 4.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -120.07 63.84 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -1.135 . . . . 0.0 110.026 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.52 95.82 22.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.042 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.74 86.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.693 2.262 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.483 ' CE ' ' NB ' ' A' ' 81' ' ' HEC . 9.0 ttt -55.12 139.88 63.7 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -62.83 141.36 84.47 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.653 2.235 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 3.0 Cg_endo -63.08 168.83 10.1 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.687 2.258 . . . . 0.0 110.087 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.531 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 33.3 mm-40 -139.04 166.61 24.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -105.3 64.62 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.103 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 4.0 m -118.99 155.81 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 110.137 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.09 169.29 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.89 . . . . 0.0 109.958 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -43.47 -52.03 6.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.999 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.21 6.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.37 -40.5 68.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.863 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.068 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.79 -36.89 75.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.808 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.1 57.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.342 -0.849 . . . . 0.0 109.981 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.6 OUTLIER -54.13 -29.5 45.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 110.036 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 72' ' ' LEU . 61.5 mt -70.16 -51.69 29.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -69.41 -31.67 70.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.12 -36.93 61.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.558 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.4 t90 -79.49 -38.78 33.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.832 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 57.0 mt -70.49 -38.55 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.916 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.1 mt -68.46 -41.47 80.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.961 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.31 -38.42 91.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.023 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 16' ' ' LEU . 9.2 mt -60.3 120.01 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.998 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.121 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.801 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.5 t30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.277 0.561 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' OE1' ' HG3' ' A' ' 6' ' ' LYS . 2.3 tt0 -91.08 -24.61 19.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.06 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 3.3 tt0 -49.65 -24.99 2.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.075 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.437 HD13 ' OE1' ' A' ' 71' ' ' GLN . 20.5 mt -69.46 -51.95 31.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.079 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.03 -28.75 57.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.079 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG3' ' OE1' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -54.79 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 110.123 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 9.9 pt20 -50.81 -29.82 12.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.045 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -64.34 -56.25 15.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.24 37.94 1.73 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.485 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.7 m -86.73 -29.05 22.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -1.158 . . . . 0.0 109.983 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmt -56.88 -16.85 7.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.57 -22.27 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.487 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 15.0 m -138.47 -37.22 0.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 0.0 110.124 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.3 m-70 -72.56 -178.34 2.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.652 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 169.87 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.858 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.773 HD22 HG21 ' A' ' 79' ' ' ILE . 25.5 mt -42.15 -62.93 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 42.86 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.555 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -152.35 75.52 1.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.185 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.47 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.847 . . . . 0.0 110.205 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.6 mtpt -67.92 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.008 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.487 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 25.4 t -91.41 -31.82 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.935 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.4 167.75 13.37 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.687 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.82 8.75 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.738 2.292 . . . . 0.0 110.273 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.97 134.73 4.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 5.9 m-85 -51.25 -32.36 24.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.78 -44.78 69.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.029 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.98 -47.84 84.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 32.5 t -56.83 -44.61 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.29 -59.15 4.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -55.12 -42.95 73.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 109.824 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 tptt -60.28 -33.39 72.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.049 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -90.46 5.74 46.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.84 -23.72 66.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.18 13.11 62.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -117.11 138.13 51.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -1.125 . . . . 0.0 110.068 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -90.82 -16.34 28.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.85 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.46 33.74 5.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.107 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.844 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.47 -21.46 37.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.071 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 39' ' ' VAL . 6.4 t -69.72 -57.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.0 -54.79 42.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.2 t80 -51.64 -63.7 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.062 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 38' ' ' ALA . 15.7 mt -43.14 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.887 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . . . -42.51 -40.3 2.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.432 -0.793 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.38 -37.71 75.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' LEU . 3.4 mmtt -91.35 -7.98 49.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -1.157 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 43' ' ' ALA . 53.5 mt -78.03 -37.28 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 0.0 110.062 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.75 4.49 51.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.081 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -119.89 -43.7 2.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.11 -164.98 40.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 104.9 -140.34 14.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.62 -176.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.9 -10.71 4.52 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 53' ' ' VAL . 52.1 t -111.65 -6.29 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 110.116 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.0 m95 -135.52 4.37 3.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -153.54 23.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -116.78 48.82 1.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.15 . . . . 0.0 110.119 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.81 96.22 27.76 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -60.58 88.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 110.34 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.6 ttt -62.01 139.49 95.86 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.961 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.38 143.02 87.79 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.684 2.256 . . . . 0.0 110.364 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.09 167.9 11.66 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.671 2.247 . . . . 0.0 110.151 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.523 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 26.3 mm-40 -138.14 165.1 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.25 62.07 0.68 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.006 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 46' ' ' ILE . 3.4 m -114.99 155.8 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.2 p -99.87 164.96 11.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.955 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -43.38 -51.66 6.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.947 . . . . 0.0 110.035 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.41 -58.05 6.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.77 -41.72 70.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -58.11 -35.12 70.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.43 -0.794 . . . . 0.0 109.804 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -52.76 48.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.85 . . . . 0.0 110.029 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.28 -29.62 47.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 69' ' ' ALA . 30.2 mt -70.11 -50.87 36.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.919 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.45 -32.22 71.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -74.94 -37.45 62.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.823 . . . . 0.0 109.524 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.7 t90 -78.81 -38.17 38.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.813 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.488 HG12 ' CD1' ' A' ' 25' ' ' TYR . 52.3 mt -70.08 -42.19 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.062 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.851 HD23 ' HA ' ' A' ' 29' ' ' ALA . 31.3 mt -64.23 -47.24 80.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -28.44 62.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.773 HG21 HD22 ' A' ' 16' ' ' LEU . 29.4 mt -71.23 139.27 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.058 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.714 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 14.2 p-10 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.221 0.534 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 0.7 OUTLIER 179.7 -43.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.035 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -51.13 -21.61 2.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.069 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 4' ' ' LEU . 3.8 pp -74.44 -32.83 62.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 110.084 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.711 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -69.74 -39.4 76.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -75.8 -52.14 11.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 110.013 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -51.17 -25.85 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.09 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -78.13 -54.51 6.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 110.07 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.69 43.26 0.42 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.6 m -103.75 -29.61 10.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -1.123 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.2 mmt -60.22 -13.84 14.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.35 -34.72 48.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.071 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -125.32 -26.0 3.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.87 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.495 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.67 -179.65 7.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 110.467 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 168.23 125.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.463 -0.773 . . . . 0.0 109.688 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 79' ' ' ILE . 25.6 mt -42.14 -64.91 0.52 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 42.75 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 110.115 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -145.28 45.19 1.32 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.88 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 110.085 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 18' ' ' ALA . 9.6 mtmt -93.62 -90.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 30.7 t -80.02 -31.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.04 169.21 16.99 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.577 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 123.41 12.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.745 2.297 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -48.48 135.9 13.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 5.2 m-85 -50.51 -32.46 18.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -67.77 -49.54 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 110.044 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.57 -44.82 89.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.86 . . . . 0.0 109.977 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.673 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 84.5 t -57.46 -45.7 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.94 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.792 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.74 -52.69 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -54.23 -45.21 72.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.906 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 11.0 mttt -55.65 -36.83 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 110.104 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 12.2 m-85 -101.16 -4.09 27.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 110.089 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -62.3 -26.38 68.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.41 15.64 55.86 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.08 174.02 8.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.039 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -120.36 -22.26 6.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.123 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -100.62 20.32 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.081 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.819 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -60.01 -23.89 64.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' HD3' ' A' ' 70' ' ' LYS . 60.1 t -66.87 -53.66 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.59 -55.74 27.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.094 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 50.8 t80 -48.31 -64.7 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 110.048 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 38' ' ' ALA . 18.5 mt -42.99 -73.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.62 -40.99 2.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.087 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.75 -38.44 72.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -16.54 29.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 43' ' ' ALA . 45.1 mt -65.91 -45.07 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 110.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -81.64 -13.88 57.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -101.22 -43.75 5.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.095 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.84 -148.52 38.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 92.52 -135.47 12.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 175.95 -177.43 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 110.052 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.52 -22.01 5.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.0 t -89.08 -21.55 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -1.164 . . . . 0.0 110.005 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.673 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.2 m95 -117.2 -39.34 3.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.27 -128.93 1.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 p -124.26 62.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 110.135 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' CMD' ' A' ' 81' ' ' HEC . 4.1 t -122.68 92.01 49.28 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.23 86.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.76 2.307 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.49 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.2 ttt -63.92 139.92 97.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 109.933 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.66 142.15 82.39 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 110.316 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.22 162.73 25.52 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.661 2.24 . . . . 0.0 110.12 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.516 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 21.9 mm-40 -134.91 163.8 29.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 110.097 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -104.58 65.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 46' ' ' ILE . 3.5 m -114.34 155.88 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 43.6 p -103.28 168.49 9.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 9.4 m-20 -43.39 -57.87 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.052 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.7 -59.02 3.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.939 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -41.59 70.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.899 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.753 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.55 -36.15 75.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.825 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HD3' HG12 ' A' ' 39' ' ' VAL . 32.1 mmtt -67.2 -51.05 58.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.36 -29.66 49.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 72' ' ' LEU . 59.6 mt -70.11 -52.3 24.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -68.66 -33.49 74.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -73.45 -36.58 65.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.433 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.589 ' CE2' HD11 ' A' ' 79' ' ' ILE . 19.7 t90 -78.61 -40.72 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.851 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 51.2 mt -69.39 -39.65 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.971 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 29' ' ' ALA . 46.2 mt -66.51 -42.25 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.87 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -63.68 -43.07 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.93 HG21 HD22 ' A' ' 16' ' ' LEU . 25.8 mt -49.63 98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.059 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.733 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.185 0.517 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 28.6 tt0 -172.28 -73.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.121 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 4.5 mm-40 -45.94 -25.36 0.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.088 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.543 HD22 ' OE1' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -65.46 -54.98 20.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.13 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.5 -9.72 55.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.901 . . . . 0.0 110.113 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 2.1 tttt -75.97 -64.93 0.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.117 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 10.3 pt20 -45.3 -30.34 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 109.973 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -68.55 -58.74 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 110.006 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.88 40.3 1.32 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 18.0 m -80.83 -30.75 35.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.063 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -14.69 14.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.32 -26.97 5.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.8 m -133.8 -35.1 0.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 90.2 m-70 -73.82 179.95 3.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.439 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.938 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 171.46 119.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.732 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.7 mp -41.73 -60.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 110.35 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.74 42.75 3.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.219 -0.926 . . . . 0.0 110.07 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.938 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -143.12 85.86 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.114 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -57.83 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -92.19 -145.37 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.055 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.1 t -51.54 -31.41 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 110.066 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.02 163.96 13.19 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 131.82 38.7 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.743 2.295 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -53.14 123.9 13.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.5 m-85 -46.09 -31.51 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.22 -45.64 69.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.062 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.48 -45.0 92.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.895 . . . . 0.0 110.108 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.023 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 52.5 t -58.14 -46.74 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.036 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.49 -54.57 30.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.981 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -54.82 -43.62 73.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -35.41 70.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 110.085 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.52 1.65 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.01 -28.98 68.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.35 19.39 36.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -120.19 158.65 26.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.073 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 -19.54 13.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -103.12 18.8 20.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.769 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.13 -23.16 45.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 39' ' ' VAL . 8.0 t -70.67 -54.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.079 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.04 -53.1 61.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.071 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' LEU . 51.8 t80 -52.95 -65.02 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 38' ' ' ALA . 26.4 mt -43.93 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.64 -37.64 1.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.397 -0.814 . . . . 0.0 110.102 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.05 65.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.527 ' HB3' ' CBA' ' A' ' 81' ' ' HEC . 1.7 tptp -101.41 -13.97 17.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.624 HG12 HMA1 ' A' ' 81' ' ' HEC . 27.2 mt -72.49 -44.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.093 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -80.21 -5.43 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.44 -13.46 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.045 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 53.6 -149.93 13.48 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.69 -147.7 16.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.1 t 169.69 -178.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 110.099 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 133.84 -11.94 4.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.5 t -102.88 -27.33 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.067 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 1.023 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.8 m95 -107.05 -13.69 15.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.088 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.91 -147.85 16.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 56' ' ' SER . 3.6 p -116.35 50.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -1.14 . . . . 0.0 110.079 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.14 95.84 47.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.86 103.92 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.752 2.301 . . . . 0.0 110.336 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.481 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 6.8 ttt -75.54 139.7 71.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.907 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 2.9 Cg_endo -63.37 138.76 67.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.67 2.246 . . . . 0.0 110.365 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.6 168.87 10.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.597 2.198 . . . . 0.0 110.173 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.568 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 30.2 mm-40 -138.17 165.56 26.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.937 . . . . 0.0 110.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -105.16 65.1 0.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.11 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.91 155.84 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -100.53 165.3 11.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.018 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 65' ' ' THR . 3.5 t0 -43.36 -55.51 4.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.4 -60.4 2.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.66 -41.3 69.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.751 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.27 -34.21 71.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.845 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -52.24 50.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.414 -0.804 . . . . 0.0 110.039 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.543 ' OE1' HD22 ' A' ' 4' ' ' LEU . 1.4 tm0? -55.17 -30.03 59.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 69' ' ' ALA . 76.3 mt -70.21 -50.24 41.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.884 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.88 -32.39 70.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -74.79 -37.29 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.9 t90 -79.02 -38.42 36.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.822 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.553 ' HA ' HD12 ' A' ' 79' ' ' ILE . 44.8 mt -72.47 -38.02 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.953 . . . . 0.0 109.961 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 29' ' ' ALA . 17.0 mt -67.03 -44.5 80.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.916 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -61.27 -30.59 70.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 109.963 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 76' ' ' ILE . 43.0 mt -62.76 101.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.019 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.676 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 3' ' ' GLN . 1.1 t-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.237 0.542 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 4.5 mt-10 64.75 -68.98 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 0.0 110.136 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -50.75 -24.62 3.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 110.043 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.486 HD13 ' OE1' ' A' ' 71' ' ' GLN . 12.0 mt -65.3 -54.14 33.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 110.12 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.681 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -56.59 -36.89 69.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.951 . . . . 0.0 110.015 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -65.15 -54.02 36.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.122 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -25.67 4.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 110.09 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -48.46 9.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 110.073 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.59 24.52 4.96 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.7 m -73.07 -29.06 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.973 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 mmt -59.54 -15.91 21.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.107 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -23.66 2.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.223 -0.923 . . . . 0.0 109.978 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.7 m -136.88 -36.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.31 -0.869 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.524 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 88.1 m-70 -71.64 -179.57 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 110.468 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.628 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.38 122.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.505 -0.747 . . . . 0.0 109.669 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.872 HD22 HG21 ' A' ' 79' ' ' ILE . 32.1 mt -42.07 -65.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 110.313 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.5 42.6 3.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -155.16 45.52 0.5 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 6.4 pttt -45.69 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.2 tptt -79.68 -90.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.071 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 25.9 t -78.67 -31.7 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.074 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.39 174.78 16.31 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.599 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 147.49 95.3 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.744 2.296 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -71.28 129.81 39.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 109.979 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CD1' HG12 ' A' ' 76' ' ' ILE . 3.4 m-85 -45.98 -30.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.105 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -72.69 -46.93 51.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.966 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -49.11 78.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 109.93 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.119 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 45.7 t -56.31 -43.4 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.91 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.941 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.23 -57.47 9.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -53.78 -44.7 70.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -34.0 69.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.596 ' HB2' HD21 ' A' ' 77' ' ' LEU . 28.2 m-85 -99.24 3.12 46.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.79 -28.97 68.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.065 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.5 19.59 35.5 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -119.09 146.39 45.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -1.167 . . . . 0.0 110.058 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 37' ' ' ASP . 8.7 ptpt -96.09 -27.38 15.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 38.9 m-20 -105.34 29.07 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.061 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.809 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -59.21 -25.13 63.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG1' ' HG3' ' A' ' 70' ' ' LYS . 3.8 t -68.31 -54.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -58.61 -55.64 32.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.52 -66.18 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 0.0 110.083 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 38' ' ' ALA . 2.1 mt -43.13 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.859 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.77 -38.39 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 110.08 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -41.19 95.18 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -87.72 -9.18 54.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -1.168 . . . . 0.0 110.056 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 43' ' ' ALA . 42.2 mt -74.17 -50.62 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 2.0 mtmt -73.69 -9.05 58.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.111 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -121.26 -7.4 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 44.35 -142.74 2.77 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.11 -137.46 13.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.75 -174.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.22 -10.33 7.77 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.87 -16.5 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.26 -1.141 . . . . 0.0 110.15 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 1.119 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.7 m95 -121.38 -27.12 4.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.52 -141.47 6.26 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 m -120.85 69.86 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 110.09 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.533 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 55.6 t -139.19 95.22 9.42 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.026 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.01 75.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.737 2.291 . . . . 0.0 110.276 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.476 ' CE ' ' NB ' ' A' ' 81' ' ' HEC . 7.2 ttt -43.87 140.44 2.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.74 145.05 94.85 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.688 2.259 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.65 167.75 11.18 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.2 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.521 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 37.1 mm-40 -138.66 166.23 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.074 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -105.74 62.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.72 155.95 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 3.5 p -104.46 168.39 9.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.8 OUTLIER -43.39 -62.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.046 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.85 -57.57 3.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -55.24 -42.58 73.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -58.71 -34.84 71.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.51 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.91 -51.4 58.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.26 -30.42 60.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.183 -0.948 . . . . 0.0 109.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 76' ' ' ILE . 14.9 mt -70.2 -50.56 38.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 109.862 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.61 -32.26 70.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 78' ' ' SER . 0.1 OUTLIER -74.91 -37.49 62.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 109.499 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.681 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 20.6 t90 -78.84 -38.15 38.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.4 mt -73.05 -41.83 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.941 HD23 ' HA ' ' A' ' 29' ' ' ALA . 36.4 mt -64.79 -41.75 95.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.0 OUTLIER -62.53 -31.47 72.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.872 HG21 HD22 ' A' ' 16' ' ' LEU . 28.9 mt -66.7 98.37 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.994 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.048 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.696 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.5 m -76.71 -28.86 56.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 110.0 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.57 -15.66 7.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -24.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.008 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.9 m -136.44 -37.05 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.002 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.6 m-70 -71.49 -179.66 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 110.344 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.804 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 176.55 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.834 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.591 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 26.6 mt -42.66 -67.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.477 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -121.98 42.37 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.349 -0.844 . . . . 0.0 110.041 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.804 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -139.0 87.39 2.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 110.117 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pttt -55.51 85.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 110.06 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -96.63 -143.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 36.4 t -51.96 -31.4 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.0 161.01 15.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.582 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.87 120.06 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.705 2.27 . . . . 0.0 110.262 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.51 130.16 5.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.98 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.751 ' CE1' HD13 ' A' ' 76' ' ' ILE . 6.7 m-85 -51.02 -33.25 24.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -66.14 -42.67 88.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.15 -52.37 59.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.041 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 53.6 t -56.37 -43.38 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.878 . . . . 0.0 109.973 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.782 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.5 -57.9 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -45.14 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.933 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 9.3 mttt -58.13 -34.83 70.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.87 4.01 31.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -68.48 -29.27 67.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.6 19.91 34.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -112.72 174.08 6.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.13 . . . . 0.0 110.16 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -122.26 -12.68 8.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.79 19.04 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.062 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.51 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -55.01 -21.02 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 19.6 t -71.38 -56.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.98 -52.72 64.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 109.993 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 45.2 t80 -52.18 -66.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.476 HD12 ' HB1' ' A' ' 73' ' ' ALA . 59.9 mt -43.21 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.099 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.54 -35.92 1.21 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.411 -0.805 . . . . 0.0 110.108 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.29 -35.98 81.01 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -93.94 -11.87 30.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -1.17 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 72' ' ' LEU . 13.6 mt -72.01 -44.26 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 110.07 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -102.1 -44.15 5.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.96 -162.01 48.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.45 -136.37 12.78 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.92 -170.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 0.0 110.074 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.4 -19.55 5.65 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG21 ' OH ' ' A' ' 41' ' ' TYR . 98.8 t -101.5 -20.2 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -1.134 . . . . 0.0 110.078 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 1.041 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 86.8 m95 -121.77 -27.59 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.022 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.38 -136.65 2.28 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 22.5 p -129.53 -35.06 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.074 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.4 p -42.19 102.66 0.28 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.131 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.8 87.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.203 . . . . 0.0 110.27 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.5 ttt -45.02 139.87 3.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 2.9 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.684 2.256 . . . . 0.0 110.281 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.22 162.93 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 110.172 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 22.0 mm-40 -134.56 163.54 29.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 110.096 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -103.81 72.75 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 46' ' ' ILE . 3.6 m -124.31 155.89 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ASP . 66.7 p -104.14 169.92 8.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.948 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' THR . 14.0 t0 -43.43 -58.0 2.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.05 -58.92 3.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -54.4 -41.29 69.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.099 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.48 -35.49 72.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.815 . . . . 0.0 109.858 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -65.17 -52.08 57.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.9 -30.03 57.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.998 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.664 HD13 HD13 ' A' ' 46' ' ' ILE . 24.0 mt -70.24 -50.69 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.13 -30.79 68.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.471 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.24 -37.09 58.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.459 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 22.8 t90 -80.28 -36.83 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.751 HD13 ' CE1' ' A' ' 25' ' ' TYR . 54.9 mt -74.34 -37.22 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.7 mt -68.36 -46.91 68.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -57.42 -25.99 60.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.989 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 16' ' ' LEU . 16.8 mt -75.44 130.59 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.025 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.107 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 11.8 m -72.47 -29.01 63.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -1.214 . . . . 0.0 109.962 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -16.38 9.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.94 -28.02 6.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 14.4 m -132.27 -34.15 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.1 m-70 -75.51 -179.22 4.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.653 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 169.39 124.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.75 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 79' ' ' ILE . 23.2 mt -42.25 -66.47 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 42.71 3.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.943 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -147.73 45.75 1.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.02 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 10.6 pttt -42.4 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -89.73 -89.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 t -82.11 -31.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.872 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.22 170.26 15.59 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.622 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -61.28 127.54 22.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.715 2.277 . . . . 0.0 110.273 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.08 133.36 27.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.218 -0.926 . . . . 0.0 109.939 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 4.6 m-85 -49.54 -32.19 11.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -71.14 -45.93 62.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.55 -44.71 95.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 34.7 t -57.68 -45.83 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.86 -53.12 53.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.886 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -55.27 -45.39 76.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.976 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.74 66.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 41.6 m-85 -102.99 -1.25 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.081 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.35 -29.93 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.74 15.37 52.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -126.02 153.6 44.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -1.133 . . . . 0.0 110.038 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -20.71 13.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.016 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -96.52 14.65 23.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -59.53 -21.89 60.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 39' ' ' VAL . 4.5 t -68.8 -56.91 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.984 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -52.92 63.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.0 t80 -51.8 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.446 HD12 ' HB1' ' A' ' 73' ' ' ALA . 78.2 mt -43.08 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.913 . . . . 0.0 110.123 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.74 -41.83 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.036 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.69 -40.61 88.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.08 -13.67 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.076 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 43' ' ' ALA . 41.1 mt -69.24 -46.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.027 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -83.22 -12.51 56.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.066 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -96.21 -37.28 10.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.61 -162.18 54.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 95.29 -141.09 15.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.76 -175.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -1.146 . . . . 0.0 110.05 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.43 -12.33 3.5 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.1 -23.53 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.105 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.66 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 92.4 m95 -112.3 -24.77 9.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.89 28.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -110.09 54.4 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.24 96.82 49.23 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.047 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.51 88.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.325 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.9 ttt -60.08 139.41 91.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.872 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 144.09 91.44 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.652 2.235 . . . . 0.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.66 165.42 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.69 2.26 . . . . 0.0 110.151 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 31.1 mm-40 -136.62 164.58 27.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.82 62.1 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.34 155.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.9 p -103.67 169.02 8.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 109.967 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 25.3 t0 -43.38 -58.23 2.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -47.97 -55.38 10.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.85 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.45 -42.63 74.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.911 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.738 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -57.78 -34.87 70.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.845 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 1.6 mtmt -65.6 -52.59 50.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.19 -30.1 48.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.999 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.05 -51.39 32.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.892 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -69.59 -31.8 70.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.418 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.27 -36.55 61.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.578 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.0 t90 -79.76 -38.31 33.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.835 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 79.1 mt -70.72 -39.7 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 29' ' ' ALA . 14.8 mt -67.54 -44.62 77.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.041 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -31.86 70.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.96 HG21 HD22 ' A' ' 16' ' ' LEU . 39.5 mt -67.84 114.99 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.086 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -103.36 -28.71 11.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.089 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.7 mmt -59.08 -14.5 10.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.13 -25.43 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.071 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -135.95 -36.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.8 m-70 -70.63 -179.14 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.862 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 172.73 124.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.009 HD22 HG21 ' A' ' 79' ' ' ILE . 24.2 mt -42.15 -63.3 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.344 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 42.51 3.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.0 110.06 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.862 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -142.83 86.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -60.31 78.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.166 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 17.7 mttt -88.42 -141.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 110.011 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 38.9 t -50.17 -31.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.12 157.65 16.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.89 124.71 15.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.73 2.287 . . . . 0.0 110.271 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -45.01 132.91 6.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 109.952 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.2 m-85 -52.12 -32.26 34.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.57 -47.2 76.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.151 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -47.3 83.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 23' ' ' PRO . 38.0 t -57.45 -45.25 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.999 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -53.15 -50.23 64.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.47 -44.74 69.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.055 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -38.08 65.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.034 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -100.85 -0.48 36.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.133 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.6 -26.46 67.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.049 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.26 24.27 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.33 154.13 47.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -1.193 . . . . 0.0 110.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -36.67 9.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.017 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 22.5 t70 -88.41 34.26 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -62.94 -24.57 67.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.02 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.86 -54.72 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -58.33 -55.97 28.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' LEU . 8.5 t80 -50.82 -65.19 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 38' ' ' ALA . 25.6 mt -43.01 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.971 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . . . -42.25 -42.01 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 110.078 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.23 58.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' LEU . 1.6 mmtp -97.43 -7.61 31.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 43' ' ' ALA . 49.5 mt -75.98 -47.91 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 110.067 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -73.8 -15.24 61.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.05 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 44.06 -144.01 2.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 94.6 -134.0 11.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.3 p 169.75 -170.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -1.184 . . . . 0.0 110.013 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.21 6.56 6.24 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.34 -11.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.62 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 96.3 m95 -124.72 -9.14 7.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.56 -128.58 2.37 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.87 51.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.2 t -114.01 94.94 36.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.041 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 3.0 Cg_exo -60.86 87.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.776 2.317 . . . . 0.0 110.281 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.447 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.6 ttt -59.17 139.42 88.0 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 2.9 Cg_endo -63.95 141.03 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.636 2.224 . . . . 0.0 110.301 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.35 164.94 18.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.669 2.246 . . . . 0.0 110.065 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -134.8 163.19 30.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.132 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -104.4 57.05 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 110.005 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.467 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 3.5 m -114.33 155.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.232 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -107.13 174.58 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.896 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -43.66 -50.37 7.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.001 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.31 -63.26 1.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 0.0 109.906 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 6.2 mt-10 -53.88 -39.79 66.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.786 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.971 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -60.31 -34.45 73.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.63 57.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 110.005 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.8 -30.62 61.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.996 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.8 mt -70.01 -49.82 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.915 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.36 -32.13 69.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.105 -0.997 . . . . 0.0 109.398 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -75.24 -36.88 61.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.9 t90 -79.79 -37.95 34.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.815 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.15 -40.42 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.0 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 21.7 mt -68.84 -39.96 79.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.933 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -64.66 -28.63 69.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.855 . . . . 0.0 110.035 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.009 HG21 HD22 ' A' ' 16' ' ' LEU . 28.5 mt -69.67 116.79 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.003 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.054 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 10.6 m -79.23 -29.08 42.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -1.15 . . . . 0.0 110.018 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.08 -15.64 14.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.928 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.5 m -127.83 -30.24 2.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.521 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -80.27 -179.37 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.652 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.06 123.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.449 -0.782 . . . . 0.0 109.785 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.881 HD23 HG21 ' A' ' 79' ' ' ILE . 2.0 mt -42.01 -64.12 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -122.85 42.77 3.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 109.991 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -148.3 45.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.016 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.87 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.343 -0.848 . . . . 0.0 110.224 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 5.6 mtpt -91.6 -89.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 28.3 t -80.58 -31.54 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.903 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.79 169.22 15.92 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.674 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -60.98 126.98 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.759 2.306 . . . . 0.0 110.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.19 131.45 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.897 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.36 -32.22 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.135 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.56 -45.45 68.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -48.86 79.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.988 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 37.7 t -56.53 -43.5 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.836 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.55 -54.53 31.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.952 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -46.1 69.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -55.55 -35.3 65.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 31.8 m-85 -101.42 0.21 36.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.927 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -63.43 -25.87 68.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.05 16.8 54.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -139.43 153.62 47.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -1.165 . . . . 0.0 110.185 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -105.47 -29.02 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 0.0 110.111 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -76.69 1.81 16.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 110.117 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -55.93 -24.19 36.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.022 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 96.1 t -67.62 -55.53 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.71 -54.83 42.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -52.32 -63.16 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.063 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 38' ' ' ALA . 50.5 mt -43.24 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 110.087 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.886 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.67 -41.04 2.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -56.83 -41.11 90.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.26 -15.38 40.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.886 HD12 ' HA ' ' A' ' 43' ' ' ALA . 39.7 mt -67.28 -46.83 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.878 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 5.46 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -123.82 -6.64 7.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.103 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 44.24 -149.04 0.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.41 -146.72 18.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.69 177.05 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -1.119 . . . . 0.0 110.106 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.54 -14.8 3.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.79 -30.8 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.03 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.988 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.3 m95 -107.89 -26.21 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.08 -155.94 24.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 t -108.05 57.39 0.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -1.15 . . . . 0.0 110.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.7 t -117.59 96.26 49.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.61 78.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.741 2.294 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.2 ttt -52.15 138.98 35.81 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.68 142.24 82.63 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.627 2.218 . . . . 0.0 110.383 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.83 161.92 30.72 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.649 2.233 . . . . 0.0 110.17 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 27.1 mm-40 -135.04 163.57 29.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 110.104 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.09 69.1 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.002 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 46' ' ' ILE . 3.3 m -114.7 155.8 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.1 m -101.28 165.09 11.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.915 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 4.5 m-20 -43.41 -57.75 2.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.008 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.21 -55.11 11.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.51 -43.05 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.828 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.4 -36.63 71.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.825 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -65.28 -52.32 55.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -0.833 . . . . 0.0 110.026 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -53.94 -28.97 40.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 72' ' ' LEU . 17.3 mt -70.19 -52.05 26.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.935 . . . . 0.0 109.822 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -69.29 -31.38 69.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 0.0 109.38 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.23 -37.06 61.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.6 ' CE2' HD11 ' A' ' 79' ' ' ILE . 20.5 t90 -79.57 -38.44 34.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.78 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.2 mt -70.6 -42.4 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.836 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.5 mt -65.41 -42.82 92.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 109.99 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.3 t -61.95 -33.09 73.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 110.031 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.881 HG21 HD23 ' A' ' 16' ' ' LEU . 42.0 mt -64.63 103.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.146 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 16.6 m -97.6 -30.42 12.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -1.164 . . . . 0.0 110.134 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.9 mmt -61.16 -12.61 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.64 58.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.48 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 m -123.86 -19.01 5.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.7 m-70 -91.26 -179.18 5.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.948 . . . . 0.0 110.343 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.896 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 170.66 122.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.916 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.772 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -42.52 -64.23 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.16 41.9 3.2 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.896 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -139.42 86.06 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.45 -0.781 . . . . 0.0 110.073 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 3.7 ptpt -55.24 86.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 18' ' ' ALA . 2.8 tptt -95.01 -147.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.02 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 35.9 t -50.89 -31.28 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 109.924 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.07 166.14 13.58 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.15 129.35 28.22 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.776 2.317 . . . . 0.0 110.252 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -50.76 127.16 17.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.9 m-85 -47.95 -33.55 7.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.004 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.12 -44.44 76.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -49.53 76.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.051 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.145 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 61.9 t -56.97 -44.72 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 76' ' ' ILE . . . -51.21 -62.51 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.943 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -40.92 67.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.788 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -61.63 -32.06 72.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 6.5 m-85 -91.64 2.07 56.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.17 -25.4 61.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.082 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.71 -3.88 68.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -118.26 164.67 14.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -1.135 . . . . 0.0 110.045 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 -11.01 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.67 21.78 16.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.033 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -59.37 -15.81 18.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.539 HG12 ' NZ ' ' A' ' 70' ' ' LYS . 49.2 t -73.77 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.033 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.87 -51.4 69.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.2 -64.34 0.84 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 109.997 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 38' ' ' ALA . 55.8 mt -43.52 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.53 -37.62 1.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.494 -0.754 . . . . 0.0 110.095 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.73 -41.13 93.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 49' ' ' GLY . 4.7 mmtp -87.9 -9.47 53.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.7 mt -73.49 -51.52 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.004 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -17.5 62.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.03 -18.18 13.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 55.53 -140.32 40.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 92.35 -139.44 14.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.7 p 169.92 -170.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -1.142 . . . . 0.0 110.034 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.23 4.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.83 -21.32 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -1.145 . . . . 0.0 110.131 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 1.145 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 93.0 m95 -115.81 -28.39 6.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 110.096 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 -155.85 25.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.9 p -107.89 65.34 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.039 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 51' ' ' SER . 60.4 t -129.97 96.33 26.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.59 87.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.736 2.291 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.433 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 8.9 ttt -59.43 140.28 88.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.28 141.5 82.26 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.577 2.185 . . . . 0.0 110.375 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.8 163.91 23.3 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.571 2.181 . . . . 0.0 110.029 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 20.0 mm-40 -134.95 163.33 30.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -0.982 . . . . 0.0 110.064 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -104.83 64.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.953 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -113.83 155.72 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 p -100.06 166.78 10.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 109.901 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -43.36 -55.29 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.79 -57.95 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.47 -40.99 68.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.9 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.58 -35.47 72.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.811 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' NZ ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.56 -52.25 53.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.339 -0.85 . . . . 0.0 110.088 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.52 -30.19 52.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 110.082 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 76' ' ' ILE . 26.7 mt -70.24 -50.33 40.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.87 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.39 -30.99 68.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.253 -0.905 . . . . 0.0 109.455 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -76.27 -36.56 58.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.56 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.533 ' CE2' HD11 ' A' ' 79' ' ' ILE . 23.7 t90 -80.79 -36.97 31.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 109.835 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.6 mt -74.13 -34.87 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.947 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 29' ' ' ALA . 20.1 mt -72.34 -41.88 66.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.4 t -64.14 -27.78 69.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.61 HG23 HD23 ' A' ' 16' ' ' LEU . 37.8 mt -69.65 100.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.018 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.051 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.6 m -73.04 -28.99 62.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 0.0 109.991 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.7 mmt -59.39 -14.33 11.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.197 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.28 -25.31 3.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 110.106 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 21' ' ' VAL . 9.7 m -135.76 -36.82 0.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.023 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -69.47 -178.84 1.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.617 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 175.63 129.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.75 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.049 HD11 HD13 ' A' ' 79' ' ' ILE . 3.9 mm? -42.75 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.137 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.26 42.55 3.12 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 110.009 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -137.41 87.76 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.12 156.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.061 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 178.73 -145.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 13' ' ' CYS . 55.1 t -50.15 -29.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 0.0 109.848 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.81 20.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.623 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.67 121.37 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.745 2.296 . . . . 0.0 110.316 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 135.06 3.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.937 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.4 m-85 -53.07 -31.87 44.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.42 -47.2 67.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.85 -46.14 91.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 23' ' ' PRO . 36.3 t -57.51 -45.47 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.975 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.837 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.34 -57.25 10.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.9 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -54.51 -43.29 71.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HE2' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.59 -34.95 71.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.057 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.537 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 6.3 m-85 -102.44 4.68 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.9 -23.42 59.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.22 10.58 60.63 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 167.69 14.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.098 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -113.62 -10.67 13.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -110.81 28.79 8.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.075 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.58 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.8 -24.81 62.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 83.9 t -68.89 -56.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 110.045 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 1.3 m-20 -59.18 -53.2 61.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.0 t80 -51.32 -63.05 1.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 38' ' ' ALA . 56.8 mt -43.17 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.046 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.921 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.62 -41.09 2.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.14 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.48 -39.67 84.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -88.57 -16.62 32.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -1.155 . . . . 0.0 110.093 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 43' ' ' ALA . 44.5 mt -65.65 -47.68 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.883 . . . . 0.0 110.063 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 2.9 ttmm -80.09 6.2 12.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.82 -28.97 4.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.2 -156.95 33.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.75 -129.67 9.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.82 -170.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -1.172 . . . . 0.0 110.028 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -2.29 8.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 54' ' ' TRP . 37.6 t -119.95 -14.84 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.148 . . . . 0.0 110.094 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.5 m95 -133.79 9.45 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.32 -149.78 20.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 21.5 m -118.13 51.42 1.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -1.194 . . . . 0.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 59' ' ' MET . 49.6 t -110.26 95.13 20.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.922 . . . . 0.0 110.098 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.86 72.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.798 2.332 . . . . 0.0 110.286 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 57' ' ' VAL . 8.1 ttt -43.98 139.41 3.02 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.883 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.85 141.23 83.85 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.642 2.228 . . . . 0.0 110.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.35 160.21 36.24 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.615 2.21 . . . . 0.0 110.135 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 23.5 mm-40 -133.01 162.92 30.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.072 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -103.93 68.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.13 155.94 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.132 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.6 p -101.91 167.93 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' THR . 8.8 t0 -43.39 -61.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.082 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.47 -54.98 6.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.41 -43.23 75.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.853 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.921 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.56 -36.28 71.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.784 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 -52.19 55.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 110.046 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.07 -29.37 44.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.929 . . . . 0.0 110.019 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 76' ' ' ILE . 20.2 mt -70.12 -51.73 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.31 -31.54 70.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -0.988 . . . . 0.0 109.39 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.12 -37.27 61.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.843 . . . . 0.0 109.619 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.489 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.4 t90 -79.33 -38.21 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.803 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.549 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.8 mt -71.48 -41.66 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.962 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 29' ' ' ALA . 21.7 mt -64.53 -46.68 81.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 109.96 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -56.65 -27.95 59.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 109.977 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.049 HD13 HD11 ' A' ' 16' ' ' LEU . 6.8 mt -75.46 121.82 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.096 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 m -95.06 -28.83 14.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -16.18 6.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.872 . . . . 0.0 110.117 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -23.57 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.186 -0.946 . . . . 0.0 109.945 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m -137.51 -38.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.2 m-70 -70.01 -179.53 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 110.33 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.768 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 173.31 123.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.827 . . . . 0.0 109.802 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.684 HD22 HG21 ' A' ' 79' ' ' ILE . 31.6 mt -42.52 -66.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -122.47 42.63 3.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -141.46 84.11 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.17 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -61.7 76.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 110.111 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -79.21 -90.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.028 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 34.6 t -99.44 -39.51 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.989 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.93 166.45 12.3 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.82 118.61 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.785 2.323 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.35 128.79 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CD1' HG12 ' A' ' 76' ' ' ILE . 5.5 m-85 -48.34 -35.7 12.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -63.32 -41.87 98.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.08 -48.38 71.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.982 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -58.13 -46.3 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.88 -53.94 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -45.48 73.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.949 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 6.1 mttp -56.66 -34.43 67.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 110.048 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 19.3 m-85 -103.96 -1.36 27.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.59 -28.56 60.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.31 19.55 34.95 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.427 ' HG3' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -128.23 149.5 50.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.156 . . . . 0.0 110.023 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.52 -14.57 15.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 35' ' ' ARG . 7.1 p-10 -102.55 4.37 38.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.085 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -54.38 -20.89 8.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.04 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.599 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 72.7 t -69.66 -54.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.049 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.4 -53.63 55.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.092 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 70.4 t80 -50.88 -64.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' ALA . 72.3 mt -43.18 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.04 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.35 -41.63 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.73 -39.24 75.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -89.76 -5.96 56.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.052 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 43' ' ' ALA . 31.2 mt -78.02 -47.68 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -9.1 58.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -100.37 -42.58 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.033 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.43 -169.03 52.2 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.38 -138.37 13.83 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER 169.7 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 110.07 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.84 3.22 5.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -121.69 -18.05 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 110.02 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.982 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 93.8 m95 -120.01 -11.72 9.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.46 -141.02 7.61 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.03 60.01 1.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -1.201 . . . . 0.0 110.061 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 59' ' ' MET . 22.8 t -122.82 96.37 45.31 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.915 . . . . 0.0 110.106 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.55 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.697 2.265 . . . . 0.0 110.279 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.423 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.1 ttt -49.77 138.39 17.57 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.511 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 143.47 90.09 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.685 2.256 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.43 165.68 17.07 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.716 2.277 . . . . 0.0 110.145 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 27.8 mm-40 -135.08 163.89 28.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.117 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -104.34 64.25 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.058 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.61 155.82 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.109 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.54 167.42 10.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 m-20 -43.36 -59.01 2.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.117 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.5 -56.35 7.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.897 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -54.87 -41.87 71.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.235 -0.916 . . . . 0.0 109.92 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.04 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.95 -37.74 74.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -64.7 -51.82 60.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -53.92 -29.26 41.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.016 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 76' ' ' ILE . 45.2 mt -70.1 -52.75 21.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -68.55 -32.47 72.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.496 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.12 -36.93 64.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.497 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 19.0 t90 -78.64 -40.06 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.817 . . . . 0.0 109.74 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.692 HD12 ' O ' ' A' ' 72' ' ' LEU . 20.9 mt -71.11 -43.77 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.93 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 29' ' ' ALA . 20.6 mt -62.22 -44.68 96.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 t -59.58 -36.02 75.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.684 HG21 HD22 ' A' ' 16' ' ' LEU . 26.2 mt -59.6 108.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.964 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.04 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.8 m -106.55 -29.13 9.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 110.017 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mmt -58.51 -14.99 9.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.27 -24.75 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.982 . . . . 0.0 109.988 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -136.15 -36.91 0.73 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.7 m-70 -71.73 -179.9 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 110.378 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 169.06 121.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.873 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.864 HD23 HG23 ' A' ' 79' ' ' ILE . 1.6 mp -42.13 -62.31 0.96 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.303 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.13 42.37 3.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.36 -0.838 . . . . 0.0 110.038 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.759 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -147.05 45.76 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -47.49 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.134 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -96.54 -89.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 0.0 109.954 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 35.4 t -78.12 -31.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 109.901 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.15 168.32 18.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.669 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -61.04 124.73 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.728 2.285 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -49.32 127.57 15.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 109.893 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.3 m-85 -45.97 -31.22 2.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.081 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.31 -44.47 75.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.035 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -63.59 -49.12 74.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.904 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 39.7 t -57.8 -45.79 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.84 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.21 -63.72 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.29 -38.67 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -60.24 -35.65 75.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.881 . . . . 0.0 110.042 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.61 2.89 26.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.033 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -65.87 -26.62 67.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.024 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.71 16.71 49.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.39 154.51 36.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.064 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -100.54 -14.34 18.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' CG ' ' OD2' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -108.7 29.37 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.07 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.47 HG12 ' CE ' ' A' ' 70' ' ' LYS . 22.0 t -73.31 -61.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD2' ' CG ' ' A' ' 37' ' ' ASP . 3.2 p-10 -59.27 -50.33 74.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -51.75 -58.23 7.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.047 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.658 HD12 ' HB1' ' A' ' 73' ' ' ALA . 45.5 mt -48.3 -73.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 110.125 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.939 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.67 -43.07 3.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.25 -41.23 86.4 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.68 -9.88 54.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.123 . . . . 0.0 110.042 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.879 HD12 ' HA ' ' A' ' 43' ' ' ALA . 34.0 mt -73.21 -50.55 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.51 -11.57 60.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.053 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -100.83 -13.67 18.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 45.31 -165.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 108.0 -137.39 14.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.85 -172.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.146 . . . . 0.0 110.101 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.12 -10.59 5.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 82.1 t -106.72 -22.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -1.144 . . . . 0.0 110.047 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.904 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.6 m95 -120.37 -22.12 6.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.53 -169.61 42.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -98.14 46.36 1.01 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.095 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -111.39 96.24 30.41 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.75 76.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 0.0 110.346 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' PRO . 7.5 ttt -43.24 139.59 2.34 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 3.0 Cg_endo -62.64 142.59 90.22 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.674 2.25 . . . . 0.0 110.309 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.27 166.8 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.626 2.217 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 29.8 mm-40 -136.03 164.64 27.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 110.075 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -104.62 58.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.6 155.96 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.014 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.8 p -100.39 168.53 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.995 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 56.5 t0 -43.32 -53.31 5.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.41 -58.77 4.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -54.27 -40.71 68.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.781 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.939 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.69 -36.38 74.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' CE ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.71 -51.86 60.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 110.0 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.0 -29.7 57.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 69' ' ' ALA . 62.4 mt -70.21 -50.28 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.658 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.72 -30.3 66.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 109.398 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.5 mt-30 -76.63 -37.2 56.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.507 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.494 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 24.7 t90 -80.6 -36.45 32.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.842 . . . . 0.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 55.6 mt -74.64 -33.65 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.914 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.84 HD23 ' HA ' ' A' ' 29' ' ' ALA . 21.9 mt -71.61 -45.39 62.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -60.64 -25.81 66.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.864 HG23 HD23 ' A' ' 16' ' ' LEU . 39.1 mt -71.3 119.84 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.107 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 m -99.13 -28.86 13.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -1.182 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.6 mmt -54.89 -17.46 3.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.34 -23.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.967 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.1 m -138.63 -37.75 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.897 . . . . 0.0 110.041 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.452 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.6 m-70 -70.12 -179.25 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.852 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.821 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER 170.77 126.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.564 ' CD2' HD13 ' A' ' 79' ' ' ILE . 28.8 mt -42.17 -67.85 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 42.77 3.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 110.019 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -139.44 83.6 1.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -62.33 74.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 57.2 mmtt -77.68 -90.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 26.5 t -97.67 -45.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.97 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.7 167.52 14.03 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.07 119.28 6.35 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.68 2.254 . . . . 0.0 110.242 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 134.58 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.607 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 5.0 m-85 -50.49 -32.07 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' ILE . . . -67.72 -44.88 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.017 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.59 -48.83 79.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.565 HG23 ' HB2' ' A' ' 23' ' ' PRO . 71.4 t -57.16 -44.51 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.993 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.738 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.69 -59.7 3.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.904 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.75 -43.07 72.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -34.04 73.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 110.048 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -94.5 -12.76 27.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -52.12 -28.77 19.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 0.0 110.009 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.63 17.25 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -122.86 121.98 37.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.106 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -72.97 -31.06 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.034 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.67 37.01 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 110.054 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.742 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.37 -25.11 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.62 -50.91 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.099 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -55.67 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 110.076 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.7 t80 -50.61 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.066 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 38' ' ' ALA . 1.4 mt -43.27 -73.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.079 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.879 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.19 -41.75 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.805 . . . . 0.0 110.058 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.5 -41.89 89.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.8 OUTLIER -84.98 -16.91 39.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 43' ' ' ALA . 32.8 mt -65.21 -49.46 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 10.3 tttt -80.83 -0.06 37.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -7.01 10.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 47.77 -155.86 1.06 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.9 -149.64 16.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.3 p 169.68 -167.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.15 . . . . 0.0 110.071 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -18.08 7.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 53' ' ' VAL . 64.2 t -100.03 -3.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.596 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 99.6 m95 -137.88 6.45 2.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.44 -153.06 23.8 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -118.37 52.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.108 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.91 96.2 40.57 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.069 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.65 80.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.689 2.259 . . . . 0.0 110.225 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.4 ttt -51.48 138.58 29.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.95 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.75 144.84 90.04 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.682 2.255 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -62.96 168.19 10.97 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.693 2.262 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.427 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 33.7 mm-40 -137.06 164.83 27.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.155 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.05 60.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.027 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.461 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.66 155.89 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -103.77 170.59 7.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.001 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' THR . 13.1 m-20 -43.35 -57.27 3.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.993 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.83 -57.96 4.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -41.02 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.879 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.46 -34.77 72.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -65.41 -51.24 61.64 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -56.2 -30.69 62.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.078 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 76' ' ' ILE . 38.1 mt -70.41 -48.9 53.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -71.22 -29.6 65.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -37.43 48.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.495 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 25.3 t90 -81.03 -34.21 32.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 56.6 mt -76.84 -35.74 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.4 mt -71.36 -45.38 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.973 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 t -59.06 -33.42 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.008 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.564 HD13 ' CD2' ' A' ' 16' ' ' LEU . 14.1 mt -69.29 95.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.979 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.564 ' OXT' ' HB3' ' A' ' 29' ' ' ALA . 6.2 mmmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.017 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.3 m -73.7 -28.98 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -1.182 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.66 -13.3 13.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.34 -35.51 51.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 m -125.15 -25.49 3.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.99 -179.25 7.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.463 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.896 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 169.48 122.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.784 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.0 HD23 HG23 ' A' ' 79' ' ' ILE . 1.2 mp -41.84 -64.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.7 42.69 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 110.072 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.896 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -136.54 82.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.83 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.46 113.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.046 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -134.51 -143.55 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 t -50.98 -30.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.61 158.91 19.23 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.582 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.67 122.54 11.41 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.769 2.313 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 126.35 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 109.981 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.6 m-85 -46.29 -37.27 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.085 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -61.05 -50.72 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.02 92.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.041 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 90.6 t -57.08 -45.45 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.837 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -53.04 -58.97 5.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -55.77 -40.93 73.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.756 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -34.25 74.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -100.7 1.8 40.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.17 62.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 17.79 44.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -132.17 147.62 52.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 110.096 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -90.75 -33.83 15.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -91.12 28.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.806 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -62.72 -20.24 64.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.29 -57.45 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -57.64 -56.59 19.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' A' ' 42' ' ' LEU . 42.8 t80 -49.45 -63.98 0.94 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.98 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 38' ' ' ALA . 10.7 mt -43.11 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.908 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.45 -38.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -56.93 -39.96 89.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -89.18 -7.52 55.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 110.059 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.908 HD12 ' HA ' ' A' ' 43' ' ' ALA . 46.2 mt -77.78 -39.48 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -3.52 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -102.51 -34.77 9.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.46 -174.01 45.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.18 -147.47 16.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 6.8 p 174.16 -164.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 110.074 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.88 -10.33 6.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 78.1 t -109.92 -15.77 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 110.088 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.5 m95 -122.67 -9.15 8.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.6 -166.17 31.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 56' ' ' SER . 5.6 p -103.39 55.28 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -1.159 . . . . 0.0 110.096 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.46 96.51 45.82 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.52 87.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.771 2.314 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.4 ttt -55.64 139.82 67.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.928 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.29 142.51 86.27 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.633 2.222 . . . . 0.0 110.25 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.17 165.99 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.647 2.231 . . . . 0.0 110.19 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 26.5 mm-40 -137.58 164.86 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -104.11 70.76 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.8 m -127.48 155.97 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.28 -0.888 . . . . 0.0 110.099 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -104.95 171.41 7.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' THR . 36.0 t0 -43.35 -53.43 5.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.032 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.23 -59.14 3.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.901 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -54.82 -41.09 70.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -59.31 -35.63 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.802 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 2.0 ttpm? -65.76 -51.71 56.96 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.423 -0.798 . . . . 0.0 110.009 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.68 -30.17 54.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.26 -51.07 33.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -69.57 -31.62 69.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -75.46 -37.39 60.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.487 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.6 t90 -79.08 -37.78 37.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 109.847 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' A' ' 79' ' ' ILE . 79.0 mt -71.99 -40.33 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.84 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 29' ' ' ALA . 29.5 mt -65.24 -45.26 85.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -60.22 -29.24 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.044 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.0 HG23 HD23 ' A' ' 16' ' ' LEU . 42.6 mt -64.9 109.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.072 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.5 m -88.36 -29.26 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -1.155 . . . . 0.0 109.998 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -59.21 -14.57 11.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.114 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -26.62 4.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.978 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.4 m -133.86 -36.08 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.957 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 88.5 m-70 -71.26 -179.32 2.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.27 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.777 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.34 125.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.914 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.603 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 25.1 mt -42.43 -68.76 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -122.28 42.49 3.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -139.52 82.39 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.373 -0.829 . . . . 0.0 110.138 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -59.47 79.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -85.12 -90.57 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 27.2 t -96.0 -46.32 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 109.889 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.55 167.78 13.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -60.98 120.06 7.56 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.764 2.309 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -43.29 130.6 4.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 109.977 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.67 -32.22 7.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.69 -44.06 74.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.09 -49.38 76.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.958 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 39.8 t -57.3 -44.31 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.867 . . . . 0.0 110.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.848 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.55 -55.06 21.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.971 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -54.08 -46.37 72.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.53 -32.34 65.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 110.127 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CE2' HG13 ' A' ' 28' ' ' VAL . 24.3 m-85 -105.46 1.19 27.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.06 -29.01 67.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.039 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.12 16.3 48.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.503 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 11.4 mmm-85 -115.47 139.02 50.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -1.161 . . . . 0.0 110.065 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -95.36 -16.53 22.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.068 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.71 12.69 21.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.576 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -53.46 -20.31 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.038 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 70' ' ' LYS . 41.3 t -68.62 -57.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.072 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.62 -52.77 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.05 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.4 ' OH ' ' HE3' ' A' ' 45' ' ' LYS . 86.6 t80 -52.61 -62.78 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 38' ' ' ALA . 45.4 mt -43.26 -74.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.892 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.61 -39.86 2.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.415 -0.803 . . . . 0.0 110.079 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.34 -36.78 70.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -92.1 -15.63 27.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -1.111 . . . . 0.0 110.076 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 43' ' ' ALA . 49.7 mt -67.34 -44.59 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.096 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -82.56 6.95 15.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.46 -31.1 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 110.046 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.39 -160.32 49.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 100.24 -143.72 16.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.4 p 169.76 -172.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -1.157 . . . . 0.0 110.043 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.95 -9.25 5.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.13 -18.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -1.132 . . . . 0.0 110.081 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.958 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.4 m95 -117.99 -26.89 6.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.081 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.47 -154.04 20.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -111.51 44.94 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.113 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.52 96.14 26.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.7 92.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.73 2.287 . . . . 0.0 110.292 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.426 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.2 ttt -62.67 138.84 96.9 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.513 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.47 142.15 83.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.616 2.21 . . . . 0.0 110.299 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.76 165.49 18.33 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.645 2.23 . . . . 0.0 110.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 26.5 mm-40 -134.67 163.43 29.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 16.4 p-10 -104.33 59.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.055 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.455 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.23 155.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.106 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -99.55 165.38 11.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 109.92 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 6.4 p-10 -43.36 -47.04 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.025 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.47 -61.09 2.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.883 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.41 -40.95 68.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.753 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -59.45 -34.17 72.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -65.77 -52.1 53.7 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.401 -0.812 . . . . 0.0 110.053 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.75 -29.85 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.59 -49.84 43.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.77 -31.05 67.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.381 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' NE2' ' HD2' ' A' ' 70' ' ' LYS . 4.4 mt-30 -76.03 -37.04 58.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.423 -0.798 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.498 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 23.6 t90 -80.35 -37.42 32.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.835 . . . . 0.0 109.765 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.581 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 57.0 mt -72.35 -40.35 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.858 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.848 HD23 ' HA ' ' A' ' 29' ' ' ALA . 28.2 mt -66.83 -43.65 83.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.872 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.2 p -60.83 -30.22 69.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.592 HD13 ' CD2' ' A' ' 16' ' ' LEU . 36.8 mt -67.85 107.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.069 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 m -92.22 -29.64 16.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 110.153 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.5 mmt -60.46 -13.53 14.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.58 -24.87 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.036 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.0 m -136.31 -36.57 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 89.6 m-70 -71.25 -179.71 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.393 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.963 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 172.2 118.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.871 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.748 HD23 ' CG2' ' A' ' 79' ' ' ILE . 1.6 mt -41.71 -58.27 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.36 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.54 42.64 3.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.963 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.47 87.86 1.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -85.83 -143.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.3 t -51.48 -30.99 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.977 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.48 160.53 13.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.84 128.74 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.79 2.327 . . . . 0.0 110.317 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -50.3 122.6 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.568 ' CD1' HG12 ' A' ' 76' ' ' ILE . 2.6 m-85 -43.64 -29.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -71.97 -45.78 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 0.0 109.99 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.66 -49.04 79.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.108 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 37.5 t -56.37 -43.57 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.885 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.936 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.24 -61.61 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.984 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -53.39 -40.75 65.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -33.53 71.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.676 ' HB2' HD21 ' A' ' 77' ' ' LEU . 13.8 m-85 -106.67 4.58 28.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.095 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -69.99 -28.57 65.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 0.0 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.81 14.88 55.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.98 165.45 12.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.114 . . . . 0.0 110.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -115.65 -6.87 12.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 110.04 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -123.89 18.45 9.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -55.84 -23.24 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.13 -55.3 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.97 -51.64 68.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.559 ' OH ' HG21 ' A' ' 53' ' ' VAL . 30.0 t80 -54.5 -67.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.064 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 38' ' ' ALA . 3.2 mt -43.05 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 110.131 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.897 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.5 -39.14 2.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.096 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -59.04 -42.78 97.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.25 -13.76 51.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -1.114 . . . . 0.0 110.003 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.897 HD12 ' HA ' ' A' ' 43' ' ' ALA . 40.7 mt -69.68 -47.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -81.64 -19.84 40.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 35.3 mttm -92.24 -30.85 15.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 110.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.3 -167.77 31.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.17 -143.02 15.82 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.9 t 169.71 -179.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -1.094 . . . . 0.0 110.08 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 136.79 -11.3 3.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG21 ' OH ' ' A' ' 41' ' ' TYR . 45.3 t -99.13 -29.61 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -1.161 . . . . 0.0 110.076 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 1.108 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.1 m95 -104.67 -22.98 13.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.76 -138.26 5.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.49 67.52 0.85 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -1.159 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 51' ' ' SER . 40.0 t -136.38 91.82 16.09 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.92 77.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.724 2.282 . . . . 0.0 110.285 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.6 ttt -45.62 141.21 4.04 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.991 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.03 143.23 90.45 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.674 2.249 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.03 167.16 12.8 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.666 2.244 . . . . 0.0 110.128 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 25.3 mm-40 -139.69 166.39 24.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 110.073 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -105.31 68.1 0.8 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.525 HG21 HG22 ' A' ' 46' ' ' ILE . 3.5 m -114.77 155.93 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 p -103.55 167.52 9.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.93 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.45 -62.06 1.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.02 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.56 -55.75 5.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.901 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.79 -42.95 76.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.882 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.86 -35.81 73.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.825 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -66.33 -50.79 62.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.436 -0.79 . . . . 0.0 110.032 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.69 -29.24 59.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 76' ' ' ILE . 77.8 mt -70.39 -49.47 48.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.51 -31.21 68.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.09 -37.57 58.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.532 ' CE2' HD11 ' A' ' 79' ' ' ILE . 23.3 t90 -79.64 -36.67 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.793 . . . . 0.0 109.796 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.841 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 25.2 mt -71.86 -39.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.884 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.936 HD23 ' HA ' ' A' ' 29' ' ' ALA . 18.1 mt -68.02 -42.44 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.1 t -62.04 -37.83 86.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.913 . . . . 0.0 109.962 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.748 ' CG2' HD23 ' A' ' 16' ' ' LEU . 19.5 mt -59.39 97.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.026 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.484 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -90.0 -28.99 18.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.079 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -14.01 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.123 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.66 -25.1 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.0 m -135.72 -36.83 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.498 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 88.8 m-70 -70.31 -179.45 2.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.766 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.44 124.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.904 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 79' ' ' ILE . 27.0 mt -42.46 -64.69 0.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 42.19 3.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.766 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.3 84.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 110.147 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.88 64.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 16.4 mttm -62.57 -90.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.056 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 29.3 t -93.68 -44.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.49 166.27 13.24 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.724 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.05 7.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.754 2.302 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.29 132.66 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.498 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 6.8 m-85 -49.85 -32.4 14.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -67.85 -44.67 76.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.935 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -49.92 73.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.08 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 36.1 t -56.49 -43.48 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.993 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.901 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.44 -57.24 10.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -43.76 64.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -36.41 67.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.725 ' HB2' HD21 ' A' ' 77' ' ' LEU . 14.1 m-85 -99.1 4.08 46.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.28 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.04 61.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.92 160.67 37.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -1.175 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -111.42 -26.94 8.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -84.65 9.21 14.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -60.79 -25.02 66.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.78 -53.87 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -54.07 50.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -51.82 -61.76 2.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 38' ' ' ALA . 8.2 mt -43.05 -73.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.877 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.79 -41.23 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.381 -0.825 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.22 73.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.93 -9.72 45.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -1.143 . . . . 0.0 109.991 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 43' ' ' ALA . 41.0 mt -73.38 -47.74 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.02 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -4.75 47.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -5.12 10.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.928 . . . . 0.0 110.077 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 45.29 -134.73 7.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . 82.83 -143.33 22.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 3.6 t 169.79 -178.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.416 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 142.75 -14.63 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.67 -11.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -1.142 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 1.08 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 96.7 m95 -120.37 -29.1 4.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.013 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.39 -142.14 6.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 65.6 m -120.57 45.82 2.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.235 -1.156 . . . . 0.0 110.123 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.7 t -111.58 94.99 25.21 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.04 77.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.695 2.263 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.8 ttt -46.62 140.39 5.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.92 144.99 94.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.623 2.216 . . . . 0.0 110.289 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.62 166.48 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.714 2.276 . . . . 0.0 110.205 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -137.74 165.2 27.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.095 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -105.14 60.85 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.63 HG12 ' OE1' ' A' ' 68' ' ' GLU . 3.6 m -113.82 155.82 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -0.947 . . . . 0.0 110.153 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.11 167.8 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -43.46 -59.08 2.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.92 -56.66 5.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.907 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.63 ' OE1' HG12 ' A' ' 64' ' ' VAL . 4.1 mt-10 -55.29 -42.49 73.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 109.875 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.17 -35.88 72.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 109.835 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -51.81 59.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -0.813 . . . . 0.0 110.001 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.95 -29.79 57.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 110.012 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.24 -50.59 38.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.855 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.73 -31.83 70.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.141 -0.974 . . . . 0.0 109.432 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -75.47 -37.34 60.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.338 -0.852 . . . . 0.0 109.504 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.497 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.5 t90 -79.15 -37.6 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 78.0 mt -72.43 -39.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 29' ' ' ALA . 18.8 mt -66.13 -46.11 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.8 m -58.31 -31.55 67.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.981 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 16' ' ' LEU . 18.5 mt -67.26 128.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.038 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.103 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.8 m -93.0 -29.11 16.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -1.083 . . . . 0.0 110.012 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -16.06 10.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.09 -25.13 3.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 109.984 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.7 m -136.61 -36.01 0.72 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.2 m-70 -73.05 -179.62 3.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.893 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 170.07 121.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.78 . . . . 0.0 109.86 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.0 mp -41.93 -63.24 0.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.302 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.97 42.38 3.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -140.22 83.95 1.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -56.08 84.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.106 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -94.61 -143.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.048 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.1 t -52.18 -31.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 164.39 14.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.17 130.82 33.84 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.715 2.277 . . . . 0.0 110.241 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.3 126.89 18.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.019 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 2.8 m-85 -46.3 -37.68 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -61.45 -56.28 21.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.971 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.3 -34.07 71.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.073 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 34.1 t -60.89 -50.98 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 77' ' ' LEU . . . -54.82 -46.72 74.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.871 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -59.25 -43.33 92.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.943 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -34.8 71.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -101.7 -1.79 31.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.082 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.26 -22.0 27.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.07 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.75 20.74 30.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 127.77 40.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -1.182 . . . . 0.0 110.097 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -38.66 69.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.49 40.82 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -69.21 -24.06 63.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.61 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.65 -51.07 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -52.33 -63.02 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.984 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 38' ' ' ALA . 28.6 mt -46.94 -74.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 110.119 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.991 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.39 -39.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 110.045 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -57.38 -40.61 92.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -87.8 -10.39 51.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.041 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 43' ' ' ALA . 42.3 mt -73.4 -44.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 110.066 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.81 11.3 13.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.034 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -111.48 -45.24 3.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.46 179.24 52.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.81 -147.35 16.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.3 p 169.66 -168.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -1.073 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.96 -16.76 5.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -96.21 -23.82 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 110.139 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.596 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.8 m95 -112.58 -18.01 12.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.76 -153.17 23.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -111.68 66.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -1.115 . . . . 0.0 110.04 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.22 95.78 14.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.116 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.76 86.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.704 2.27 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.434 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.7 ttt -55.36 138.93 67.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 109.981 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.61 141.77 81.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.586 2.191 . . . . 0.0 110.332 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.39 169.73 9.13 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.62 2.214 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 24.9 mm-40 -137.73 164.67 28.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.69 55.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.98 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.5 m -114.4 155.85 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.882 . . . . 0.0 110.099 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' ASP . 77.5 p -105.61 172.66 6.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 t0 -43.56 -50.34 7.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.036 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -48.76 -63.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 11.5 mt-10 -53.54 -39.97 65.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.237 -0.915 . . . . 0.0 109.768 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.991 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -60.19 -34.66 73.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.718 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 16.2 mttm -65.61 -51.55 58.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.808 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.96 -30.32 61.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.0 mt -70.19 -49.76 47.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.853 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.29 -32.44 70.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 0.0 109.426 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 3.1 mm-40 -74.99 -36.82 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.483 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.62 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.6 t90 -79.51 -38.26 34.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -0.831 . . . . 0.0 109.898 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 25' ' ' TYR . 50.5 mt -68.43 -36.54 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.931 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.571 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 19.3 mt -69.94 -47.52 62.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 109.943 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 t -58.46 -23.46 57.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.62 HD11 ' CE2' ' A' ' 75' ' ' TRP . 36.6 mt -73.22 114.28 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 109.994 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.064 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.7 m -102.36 -28.82 12.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -1.152 . . . . 0.0 110.03 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.96 -16.17 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 110.138 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.14 -24.31 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 109.976 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.1 m -137.0 -37.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.034 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -70.75 -179.56 2.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.849 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 176.04 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.0 109.819 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.532 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 28.8 mt -42.48 -65.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -122.04 42.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.849 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.97 82.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.78 71.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -71.89 -90.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.249 -0.907 . . . . 0.0 109.977 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 29.6 t -90.4 -40.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.883 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.11 165.34 12.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.537 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 121.16 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.608 2.206 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -43.25 129.95 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 110.02 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.5 m-85 -48.65 -31.69 7.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.41 -46.21 73.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -48.84 79.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 93.0 t -56.93 -44.41 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.931 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.73 -62.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.08 -39.99 63.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -60.01 -34.52 73.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.099 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.627 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 4.0 m-85 -96.26 4.57 52.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.105 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.86 -17.53 60.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.053 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 16.56 51.41 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.19 157.48 46.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -1.129 . . . . 0.0 110.063 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -104.68 -3.16 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.155 -0.965 . . . . 0.0 110.109 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -115.23 20.63 14.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.627 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -62.0 -21.65 65.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.077 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 39' ' ' VAL . 4.4 t -69.67 -57.24 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -53.52 57.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' OH ' HG21 ' A' ' 53' ' ' VAL . 18.9 t80 -51.04 -63.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 43' ' ' ALA . 22.4 mt -43.4 -73.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.893 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.32 -39.54 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.092 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.9 -42.66 92.47 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -84.75 -14.97 46.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.164 . . . . 0.0 109.971 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.823 HD12 ' HA ' ' A' ' 43' ' ' ALA . 28.8 mt -67.62 -46.25 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 110.014 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -16.62 43.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -95.36 -30.53 13.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.74 -157.76 29.74 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.4 -132.57 11.08 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.2 p 169.85 178.6 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 110.085 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 141.02 -20.32 2.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.412 HG21 ' OH ' ' A' ' 41' ' ' TYR . 41.3 t -105.75 -22.31 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -1.126 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.656 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 80.3 m95 -119.53 -12.37 9.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.67 -145.95 10.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 3.7 m -122.92 -26.51 4.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 110.1 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . 21.9 t -41.6 102.04 0.26 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.7 88.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.654 2.236 . . . . 0.0 110.248 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.2 ttt -55.63 138.88 69.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.41 143.58 88.83 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.589 2.193 . . . . 0.0 110.332 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -62.86 169.32 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.757 2.304 . . . . 0.0 110.116 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.426 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 31.5 mm-40 -137.97 165.69 25.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.042 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -104.76 56.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 3.7 m -114.62 155.78 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.13 170.3 8.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.922 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -43.33 -53.63 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.983 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -49.32 -59.07 4.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.31 -40.82 68.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.889 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.893 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.02 -36.66 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.395 -0.815 . . . . 0.0 109.869 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 29.5 mttt -64.82 -51.03 64.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.38 -0.825 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.2 tm0? -55.05 -31.04 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 110.012 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.434 ' O ' HD12 ' A' ' 76' ' ' ILE . 8.1 mt -70.01 -50.34 42.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.824 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -68.7 -34.4 75.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.455 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.18 -37.89 66.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.434 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.492 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 17.3 t90 -76.78 -39.83 50.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 109.754 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 37.8 mt -68.13 -46.07 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 29' ' ' ALA . 58.2 mt -61.08 -41.13 96.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.895 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG21 HD22 ' A' ' 16' ' ' LEU . 11.6 mt -59.23 100.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.5 m -69.75 -29.61 67.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -1.161 . . . . 0.0 110.094 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 mmt -60.58 -13.31 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.106 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.0 -36.39 60.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.6 m -126.73 -8.4 6.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.448 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 81.6 m-70 -101.67 -178.35 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 110.426 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.802 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 1.1 m-20 170.75 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 109.793 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 26.7 mt -42.53 -68.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 42.86 3.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.849 . . . . 0.0 110.057 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.802 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -138.07 88.0 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -50.59 159.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.125 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.3 tptt 177.42 -147.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 109.916 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 72.1 t -49.65 -29.53 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -130.07 153.3 20.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.589 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.78 120.98 9.0 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.708 2.272 . . . . 0.0 110.323 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 136.47 3.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 7.2 m-85 -54.75 -33.65 61.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.01 -52.32 60.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 110.165 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.149 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -57.84 -46.03 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.995 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.916 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -49.33 -66.84 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.918 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -53.08 -38.3 62.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HD2' ' CZ2' ' A' ' 54' ' ' TRP . 7.5 ttmt -63.22 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.546 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 13.6 m-85 -100.16 -5.48 27.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.84 -22.67 65.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.061 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.79 11.75 65.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.12 127.02 45.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.119 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -77.07 -29.19 54.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.081 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.51 18.23 10.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.716 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -65.25 -23.83 67.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.085 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.485 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 61.5 t -70.79 -58.77 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.053 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.45 -51.31 69.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.2 t80 -52.26 -65.87 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 38' ' ' ALA . 15.9 mt -43.01 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.068 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.54 -40.11 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.077 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.61 -41.28 93.54 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -9.37 55.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 43' ' ' ALA . 8.2 mt -73.96 -49.2 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.18 -2.89 20.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -120.28 -17.64 8.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.32 -153.93 26.37 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.68 -145.33 16.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 5.5 p 173.43 -170.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 110.058 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.48 -19.2 6.33 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.5 t -96.35 -22.64 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 1.149 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 94.6 m95 -112.92 -35.46 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.56 -140.83 4.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -120.07 63.84 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -1.135 . . . . 0.0 110.026 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.52 95.82 22.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.042 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.74 86.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.693 2.262 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.431 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 9.0 ttt -55.12 139.88 63.7 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -62.83 141.36 84.47 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.653 2.235 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 3.0 Cg_endo -63.08 168.83 10.1 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.687 2.258 . . . . 0.0 110.087 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.425 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 33.3 mm-40 -139.04 166.61 24.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -105.3 64.62 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.103 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 4.0 m -118.99 155.81 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 110.137 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.09 169.29 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.89 . . . . 0.0 109.958 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -43.47 -52.03 6.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.999 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.21 6.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.37 -40.5 68.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.863 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.068 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.79 -36.89 75.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.808 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.1 57.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.342 -0.849 . . . . 0.0 109.981 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.13 -29.5 45.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 110.036 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 72' ' ' LEU . 61.5 mt -70.16 -51.69 29.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -69.41 -31.67 70.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.12 -36.93 61.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.558 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.4 t90 -79.49 -38.78 33.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.832 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 57.0 mt -70.49 -38.55 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.916 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.1 mt -68.46 -41.47 80.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.961 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.31 -38.42 91.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.023 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 16' ' ' LEU . 9.2 mt -60.3 120.01 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.998 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.121 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.485 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.7 m -86.73 -29.05 22.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -1.158 . . . . 0.0 109.983 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmt -56.88 -16.85 7.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.57 -22.27 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.487 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 15.0 m -138.47 -37.22 0.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 0.0 110.124 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.3 m-70 -72.56 -178.34 2.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.652 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 169.87 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.858 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.773 HD22 HG21 ' A' ' 79' ' ' ILE . 25.5 mt -42.15 -62.93 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 42.86 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.555 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -152.35 75.52 1.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.185 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.47 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.847 . . . . 0.0 110.205 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.6 mtpt -67.92 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.008 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.487 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 25.4 t -91.41 -31.82 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.935 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.4 167.75 13.37 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.687 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.82 8.75 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.738 2.292 . . . . 0.0 110.273 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.97 134.73 4.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 5.9 m-85 -51.25 -32.36 24.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.78 -44.78 69.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.029 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.98 -47.84 84.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.695 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 32.5 t -56.83 -44.61 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.29 -59.15 4.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -55.12 -42.95 73.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 109.824 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 tptt -60.28 -33.39 72.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.049 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -90.46 5.74 46.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.84 -23.72 66.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.18 13.11 62.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -117.11 138.13 51.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -1.125 . . . . 0.0 110.068 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -90.82 -16.34 28.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.85 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.46 33.74 5.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.107 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.844 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.47 -21.46 37.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.071 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 39' ' ' VAL . 6.4 t -69.72 -57.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.0 -54.79 42.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.2 t80 -51.64 -63.7 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.062 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 38' ' ' ALA . 15.7 mt -43.14 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.887 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . . . -42.51 -40.3 2.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.432 -0.793 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.38 -37.71 75.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' LEU . 3.4 mmtt -91.35 -7.98 49.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -1.157 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 43' ' ' ALA . 53.5 mt -78.03 -37.28 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 0.0 110.062 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.75 4.49 51.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.081 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -119.89 -43.7 2.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.11 -164.98 40.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 104.9 -140.34 14.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.62 -176.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.9 -10.71 4.52 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 53' ' ' VAL . 52.1 t -111.65 -6.29 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 110.116 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.0 m95 -135.52 4.37 3.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -153.54 23.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -116.78 48.82 1.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.15 . . . . 0.0 110.119 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.81 96.22 27.76 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -60.58 88.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 110.34 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 7.6 ttt -62.01 139.49 95.86 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.961 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.38 143.02 87.79 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.684 2.256 . . . . 0.0 110.364 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.09 167.9 11.66 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.671 2.247 . . . . 0.0 110.151 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 26.3 mm-40 -138.14 165.1 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.25 62.07 0.68 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.006 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 46' ' ' ILE . 3.4 m -114.99 155.8 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.2 p -99.87 164.96 11.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.955 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -43.38 -51.66 6.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.947 . . . . 0.0 110.035 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.41 -58.05 6.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.77 -41.72 70.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -58.11 -35.12 70.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.43 -0.794 . . . . 0.0 109.804 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -52.76 48.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.85 . . . . 0.0 110.029 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.28 -29.62 47.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 69' ' ' ALA . 30.2 mt -70.11 -50.87 36.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.919 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.45 -32.22 71.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -74.94 -37.45 62.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.823 . . . . 0.0 109.524 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.7 t90 -78.81 -38.17 38.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.813 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.488 HG12 ' CD1' ' A' ' 25' ' ' TYR . 52.3 mt -70.08 -42.19 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.062 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.851 HD23 ' HA ' ' A' ' 29' ' ' ALA . 31.3 mt -64.23 -47.24 80.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -28.44 62.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.773 HG21 HD22 ' A' ' 16' ' ' LEU . 29.4 mt -71.23 139.27 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.058 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.6 m -103.75 -29.61 10.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -1.123 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.2 mmt -60.22 -13.84 14.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.35 -34.72 48.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.071 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -125.32 -26.0 3.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.87 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.495 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.67 -179.65 7.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 110.467 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 168.23 125.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.463 -0.773 . . . . 0.0 109.688 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 79' ' ' ILE . 25.6 mt -42.14 -64.91 0.52 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 42.75 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 110.115 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -145.28 45.19 1.32 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.88 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 110.085 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 18' ' ' ALA . 9.6 mtmt -93.62 -90.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 30.7 t -80.02 -31.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.04 169.21 16.99 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.577 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 123.41 12.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.745 2.297 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -48.48 135.9 13.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 5.2 m-85 -50.51 -32.46 18.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -67.77 -49.54 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 110.044 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.57 -44.82 89.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.86 . . . . 0.0 109.977 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.673 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 84.5 t -57.46 -45.7 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.94 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.792 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.74 -52.69 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -54.23 -45.21 72.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.906 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 11.0 mttt -55.65 -36.83 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 110.104 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 12.2 m-85 -101.16 -4.09 27.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 110.089 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -62.3 -26.38 68.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.41 15.64 55.86 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.08 174.02 8.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.039 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -120.36 -22.26 6.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.123 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -100.62 20.32 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.081 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.819 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -60.01 -23.89 64.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' HD3' ' A' ' 70' ' ' LYS . 60.1 t -66.87 -53.66 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.59 -55.74 27.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.094 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 50.8 t80 -48.31 -64.7 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 110.048 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 38' ' ' ALA . 18.5 mt -42.99 -73.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.62 -40.99 2.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.087 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.75 -38.44 72.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -16.54 29.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 43' ' ' ALA . 45.1 mt -65.91 -45.07 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 110.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -81.64 -13.88 57.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -101.22 -43.75 5.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.095 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.84 -148.52 38.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 92.52 -135.47 12.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 175.95 -177.43 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 110.052 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.52 -22.01 5.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.0 t -89.08 -21.55 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -1.164 . . . . 0.0 110.005 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.673 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.2 m95 -117.2 -39.34 3.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.27 -128.93 1.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 p -124.26 62.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 110.135 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.1 t -122.68 92.01 49.28 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.23 86.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.76 2.307 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.427 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.2 ttt -63.92 139.92 97.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 109.933 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.66 142.15 82.39 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 110.316 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.22 162.73 25.52 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.661 2.24 . . . . 0.0 110.12 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 21.9 mm-40 -134.91 163.8 29.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 110.097 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -104.58 65.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 46' ' ' ILE . 3.5 m -114.34 155.88 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 43.6 p -103.28 168.49 9.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 9.4 m-20 -43.39 -57.87 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.052 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.7 -59.02 3.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.939 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -41.59 70.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.899 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.753 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.55 -36.15 75.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.825 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HD3' HG12 ' A' ' 39' ' ' VAL . 32.1 mmtt -67.2 -51.05 58.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.36 -29.66 49.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 72' ' ' LEU . 59.6 mt -70.11 -52.3 24.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -68.66 -33.49 74.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -73.45 -36.58 65.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.433 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.589 ' CE2' HD11 ' A' ' 79' ' ' ILE . 19.7 t90 -78.61 -40.72 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.851 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 51.2 mt -69.39 -39.65 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.971 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 29' ' ' ALA . 46.2 mt -66.51 -42.25 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.87 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -63.68 -43.07 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.93 HG21 HD22 ' A' ' 16' ' ' LEU . 25.8 mt -49.63 98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.059 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 18.0 m -80.83 -30.75 35.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.063 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -14.69 14.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.32 -26.97 5.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.8 m -133.8 -35.1 0.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 90.2 m-70 -73.82 179.95 3.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.439 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.938 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 171.46 119.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.732 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.7 mp -41.73 -60.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 110.35 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.74 42.75 3.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.219 -0.926 . . . . 0.0 110.07 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.938 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -143.12 85.86 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.114 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -57.83 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -92.19 -145.37 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.055 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.1 t -51.54 -31.41 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 110.066 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.02 163.96 13.19 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 131.82 38.7 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.743 2.295 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -53.14 123.9 13.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.5 m-85 -46.09 -31.51 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.22 -45.64 69.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.062 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.48 -45.0 92.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.895 . . . . 0.0 110.108 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.023 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 52.5 t -58.14 -46.74 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.036 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.49 -54.57 30.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.981 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -54.82 -43.62 73.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -35.41 70.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 110.085 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.52 1.65 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.01 -28.98 68.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.35 19.39 36.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -120.19 158.65 26.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.073 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 -19.54 13.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -103.12 18.8 20.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.769 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.13 -23.16 45.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 39' ' ' VAL . 8.0 t -70.67 -54.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.079 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.04 -53.1 61.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.071 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' LEU . 51.8 t80 -52.95 -65.02 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 38' ' ' ALA . 26.4 mt -43.93 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.64 -37.64 1.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.397 -0.814 . . . . 0.0 110.102 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.05 65.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.7 tptp -101.41 -13.97 17.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 27.2 mt -72.49 -44.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.093 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -80.21 -5.43 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.44 -13.46 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.045 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 53.6 -149.93 13.48 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.69 -147.7 16.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.1 t 169.69 -178.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 110.099 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 133.84 -11.94 4.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.5 t -102.88 -27.33 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.067 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 1.023 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.8 m95 -107.05 -13.69 15.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.088 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.91 -147.85 16.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 56' ' ' SER . 3.6 p -116.35 50.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -1.14 . . . . 0.0 110.079 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.14 95.84 47.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.86 103.92 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.752 2.301 . . . . 0.0 110.336 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.432 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 6.8 ttt -75.54 139.7 71.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.907 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 2.9 Cg_endo -63.37 138.76 67.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.67 2.246 . . . . 0.0 110.365 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.421 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.6 168.87 10.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.597 2.198 . . . . 0.0 110.173 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 30.2 mm-40 -138.17 165.56 26.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.937 . . . . 0.0 110.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -105.16 65.1 0.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.11 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.91 155.84 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -100.53 165.3 11.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.018 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 65' ' ' THR . 3.5 t0 -43.36 -55.51 4.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.4 -60.4 2.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.66 -41.3 69.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.751 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.27 -34.21 71.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.845 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -52.24 50.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.414 -0.804 . . . . 0.0 110.039 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.17 -30.03 59.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 69' ' ' ALA . 76.3 mt -70.21 -50.24 41.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.884 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.88 -32.39 70.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -74.79 -37.29 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.9 t90 -79.02 -38.42 36.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.822 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.553 ' HA ' HD12 ' A' ' 79' ' ' ILE . 44.8 mt -72.47 -38.02 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.953 . . . . 0.0 109.961 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 29' ' ' ALA . 17.0 mt -67.03 -44.5 80.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.916 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -61.27 -30.59 70.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 109.963 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 76' ' ' ILE . 43.0 mt -62.76 101.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.019 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.7 m -73.07 -29.06 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.973 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 mmt -59.54 -15.91 21.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.107 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -23.66 2.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.223 -0.923 . . . . 0.0 109.978 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.7 m -136.88 -36.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.31 -0.869 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.524 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 88.1 m-70 -71.64 -179.57 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 110.468 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.628 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.38 122.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.505 -0.747 . . . . 0.0 109.669 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.872 HD22 HG21 ' A' ' 79' ' ' ILE . 32.1 mt -42.07 -65.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 110.313 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.5 42.6 3.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -155.16 45.52 0.5 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 6.4 pttt -45.69 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.2 tptt -79.68 -90.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.071 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 25.9 t -78.67 -31.7 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.074 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.39 174.78 16.31 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.599 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 147.49 95.3 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.744 2.296 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -71.28 129.81 39.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 109.979 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CD1' HG12 ' A' ' 76' ' ' ILE . 3.4 m-85 -45.98 -30.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.105 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -72.69 -46.93 51.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.966 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -49.11 78.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 109.93 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.119 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 45.7 t -56.31 -43.4 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.91 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.941 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.23 -57.47 9.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -53.78 -44.7 70.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -34.0 69.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.596 ' HB2' HD21 ' A' ' 77' ' ' LEU . 28.2 m-85 -99.24 3.12 46.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.79 -28.97 68.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.065 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.5 19.59 35.5 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -119.09 146.39 45.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -1.167 . . . . 0.0 110.058 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 37' ' ' ASP . 8.7 ptpt -96.09 -27.38 15.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 38.9 m-20 -105.34 29.07 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.061 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.809 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -59.21 -25.13 63.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG1' ' HG3' ' A' ' 70' ' ' LYS . 3.8 t -68.31 -54.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -58.61 -55.64 32.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.52 -66.18 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 0.0 110.083 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 38' ' ' ALA . 2.1 mt -43.13 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.859 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.77 -38.39 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 110.08 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -41.19 95.18 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -87.72 -9.18 54.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -1.168 . . . . 0.0 110.056 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 43' ' ' ALA . 42.2 mt -74.17 -50.62 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 2.0 mtmt -73.69 -9.05 58.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.111 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -121.26 -7.4 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 44.35 -142.74 2.77 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.11 -137.46 13.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.75 -174.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.22 -10.33 7.77 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.87 -16.5 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.26 -1.141 . . . . 0.0 110.15 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 1.119 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.7 m95 -121.38 -27.12 4.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.52 -141.47 6.26 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 m -120.85 69.86 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 110.09 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 59' ' ' MET . 55.6 t -139.19 95.22 9.42 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.026 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.01 75.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.737 2.291 . . . . 0.0 110.276 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' VAL . 7.2 ttt -43.87 140.44 2.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.74 145.05 94.85 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.688 2.259 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.65 167.75 11.18 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.2 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.427 ' CD ' ' O ' ' A' ' 61' ' ' PRO . 37.1 mm-40 -138.66 166.23 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.074 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -105.74 62.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.72 155.95 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 3.5 p -104.46 168.39 9.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.8 OUTLIER -43.39 -62.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.046 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.85 -57.57 3.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -55.24 -42.58 73.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -58.71 -34.84 71.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.51 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.91 -51.4 58.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.26 -30.42 60.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.183 -0.948 . . . . 0.0 109.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 76' ' ' ILE . 14.9 mt -70.2 -50.56 38.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 109.862 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.61 -32.26 70.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 78' ' ' SER . 0.1 OUTLIER -74.91 -37.49 62.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 109.499 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.6 t90 -78.84 -38.15 38.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.4 mt -73.05 -41.83 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.941 HD23 ' HA ' ' A' ' 29' ' ' ALA . 36.4 mt -64.79 -41.75 95.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.0 OUTLIER -62.53 -31.47 72.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.872 HG21 HD22 ' A' ' 16' ' ' LEU . 28.9 mt -66.7 98.37 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.994 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.048 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 5.9 m-80 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.241 0.543 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 1' ' ' ASN . 0.5 OUTLIER 68.2 -67.53 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.885 . . . . 0.0 110.062 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 1' ' ' ASN . 1.3 tp-100 -50.28 -23.4 2.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.87 . . . . 0.0 110.123 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.483 HD13 ' OE1' ' A' ' 71' ' ' GLN . 11.8 mt -63.32 -54.48 36.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 110.018 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.819 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -49.92 -30.39 10.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 110.081 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 3' ' ' GLN . 12.1 tttt -66.33 -55.94 13.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 110.074 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.7 -25.33 4.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 110.081 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -93.98 -46.3 7.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.942 . . . . 0.0 110.134 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.31 34.56 5.81 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 8' ' ' LYS . 14.5 m -76.71 -28.86 56.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -1.153 . . . . 0.0 110.0 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 mmt -57.57 -15.66 7.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.098 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -24.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.008 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.9 m -136.44 -37.05 0.7 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.002 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.6 m-70 -71.49 -179.66 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.331 -0.855 . . . . 0.0 110.344 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.804 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 176.55 125.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.834 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.591 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 26.6 mt -42.66 -67.31 0.28 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.238 -0.914 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.477 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -121.98 42.37 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.349 -0.844 . . . . 0.0 110.041 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.804 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -139.0 87.39 2.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 110.117 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pttt -55.51 85.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 110.06 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -96.63 -143.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.084 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 36.4 t -51.96 -31.4 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.996 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.0 161.01 15.17 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.582 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.87 120.06 7.57 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.705 2.27 . . . . 0.0 110.262 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.51 130.16 5.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.98 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.751 ' CE1' HD13 ' A' ' 76' ' ' ILE . 6.7 m-85 -51.02 -33.25 24.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 0.0 110.092 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -66.14 -42.67 88.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.15 -52.37 59.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 110.046 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.041 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 53.6 t -56.37 -43.38 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.878 . . . . 0.0 109.973 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.782 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.5 -57.9 7.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.999 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -45.14 69.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.933 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 9.3 mttt -58.13 -34.83 70.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -104.87 4.01 31.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.177 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -68.48 -29.27 67.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.936 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.6 19.91 34.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -112.72 174.08 6.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -1.13 . . . . 0.0 110.16 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -122.26 -12.68 8.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -118.79 19.04 13.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -0.923 . . . . 0.0 110.062 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.51 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -55.01 -21.02 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 19.6 t -71.38 -56.51 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.909 . . . . 0.0 110.086 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.98 -52.72 64.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 109.993 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 45.2 t80 -52.18 -66.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 110.104 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.476 HD12 ' HB1' ' A' ' 73' ' ' ALA . 59.9 mt -43.21 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.099 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.54 -35.92 1.21 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.411 -0.805 . . . . 0.0 110.108 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.29 -35.98 81.01 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' CB ' ' O1A' ' A' ' 81' ' ' HEC . 0.4 OUTLIER -93.94 -11.87 30.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -1.17 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.664 HD13 HD13 ' A' ' 72' ' ' LEU . 13.6 mt -72.01 -44.26 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -0.941 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.57 -14.18 57.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 110.07 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -102.1 -44.15 5.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.066 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.96 -162.01 48.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.45 -136.37 12.78 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.92 -170.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 0.0 110.074 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.4 -19.55 5.65 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.414 HG21 ' OH ' ' A' ' 41' ' ' TYR . 98.8 t -101.5 -20.2 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -1.134 . . . . 0.0 110.078 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 1.041 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 86.8 m95 -121.77 -27.59 4.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.022 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.4 ' N ' ' O2D' ' A' ' 81' ' ' HEC . . . -174.38 -136.65 2.28 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 22.5 p -129.53 -35.06 1.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.074 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.664 HG13 HMD2 ' A' ' 81' ' ' HEC . 3.4 p -42.19 102.66 0.28 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.131 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.8 87.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.604 2.203 . . . . 0.0 110.27 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.493 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.5 ttt -45.02 139.87 3.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.314 -0.866 . . . . 0.0 109.896 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.48 140.51 76.27 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.684 2.256 . . . . 0.0 110.281 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.22 162.93 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 110.172 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.416 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 22.0 mm-40 -134.56 163.54 29.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.154 -0.966 . . . . 0.0 110.096 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -103.81 72.75 1.13 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 46' ' ' ILE . 3.6 m -124.31 155.89 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.888 . . . . 0.0 110.13 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ASP . 66.7 p -104.14 169.92 8.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.948 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' THR . 14.0 t0 -43.43 -58.0 2.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.05 -58.92 3.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 109.895 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -54.4 -41.29 69.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.857 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.099 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.48 -35.49 72.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.397 -0.815 . . . . 0.0 109.858 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -65.17 -52.08 57.19 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.9 -30.03 57.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.998 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.664 HD13 HD13 ' A' ' 46' ' ' ILE . 24.0 mt -70.24 -50.69 37.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.884 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.13 -30.79 68.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.471 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.24 -37.09 58.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.408 -0.808 . . . . 0.0 109.459 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.819 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 22.8 t90 -80.28 -36.83 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.751 HD13 ' CE1' ' A' ' 25' ' ' TYR . 54.9 mt -74.34 -37.22 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.7 mt -68.36 -46.91 68.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -57.42 -25.99 60.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.886 . . . . 0.0 109.989 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 16' ' ' LEU . 16.8 mt -75.44 130.59 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.025 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.107 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.692 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.265 0.555 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.47 -23.43 24.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -50.66 -21.2 1.48 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 110.114 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.448 HD13 ' OE1' ' A' ' 71' ' ' GLN . 16.5 mt -77.59 -33.49 53.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 110.105 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.762 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -82.44 -27.0 32.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.023 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.3 mtmm -74.67 -58.24 3.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.106 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -50.09 -25.45 3.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -82.53 -51.83 7.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.077 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.78 20.98 7.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 8' ' ' LYS . 11.8 m -72.47 -29.01 63.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.137 -1.214 . . . . 0.0 109.962 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.41 -16.38 9.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 110.21 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.94 -28.02 6.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 0.0 110.04 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 14.4 m -132.27 -34.15 1.25 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 0.0 110.136 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.1 m-70 -75.51 -179.22 4.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.412 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.653 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 169.39 124.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.0 109.75 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 79' ' ' ILE . 23.2 mt -42.25 -66.47 0.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.306 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.8 42.71 3.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.943 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -147.73 45.75 1.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.02 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 10.6 pttt -42.4 94.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.39 -0.819 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -89.73 -89.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.004 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 20' ' ' LYS . 29.0 t -82.11 -31.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.872 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.22 170.26 15.59 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.622 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -61.28 127.54 22.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.715 2.277 . . . . 0.0 110.273 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.08 133.36 27.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.218 -0.926 . . . . 0.0 109.939 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 4.6 m-85 -49.54 -32.19 11.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -71.14 -45.93 62.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.55 -44.71 95.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.974 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 34.7 t -57.68 -45.83 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.86 -53.12 53.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.886 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -55.27 -45.39 76.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 109.976 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -33.74 66.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 41.6 m-85 -102.99 -1.25 29.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.081 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.35 -29.93 68.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.905 . . . . 0.0 110.041 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.74 15.37 52.47 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -126.02 153.6 44.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -1.133 . . . . 0.0 110.038 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -20.71 13.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.016 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -96.52 14.65 23.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.114 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -59.53 -21.89 60.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 39' ' ' VAL . 4.5 t -68.8 -56.91 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 109.984 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -52.92 63.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 110.086 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.0 t80 -51.8 -64.05 0.94 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.722 HD23 ' O2A' ' A' ' 81' ' ' HEC . 78.2 mt -43.08 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -0.913 . . . . 0.0 110.123 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.74 -41.83 3.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.036 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.69 -40.61 88.84 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HB3' HBA2 ' A' ' 81' ' ' HEC . 0.3 OUTLIER -87.08 -13.67 43.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.076 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 43' ' ' ALA . 41.1 mt -69.24 -46.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.225 -0.922 . . . . 0.0 110.027 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -83.22 -12.51 56.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.066 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -96.21 -37.28 10.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.61 -162.18 54.29 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 95.29 -141.09 15.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.5 p 169.76 -175.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -1.146 . . . . 0.0 110.05 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.43 -12.33 3.5 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.1 -23.53 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.105 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.66 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 92.4 m95 -112.3 -24.77 9.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.294 -0.879 . . . . 0.0 110.058 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.89 28.14 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -110.09 54.4 0.67 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -1.161 . . . . 0.0 110.053 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.9 t -120.24 96.82 49.23 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.047 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.51 88.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.325 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.492 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.9 ttt -60.08 139.41 91.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 109.872 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 144.09 91.44 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.652 2.235 . . . . 0.0 110.315 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.66 165.42 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.69 2.26 . . . . 0.0 110.151 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.516 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 31.1 mm-40 -136.62 164.58 27.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 110.149 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.82 62.1 0.7 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.34 155.88 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.142 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.9 p -103.67 169.02 8.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 109.967 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 25.3 t0 -43.38 -58.23 2.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -47.97 -55.38 10.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.85 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -55.45 -42.63 74.52 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 0.0 109.911 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.738 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -57.78 -34.87 70.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.845 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 1.6 mtmt -65.6 -52.59 50.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 110.035 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.19 -30.1 48.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.999 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.05 -51.39 32.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.892 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -69.59 -31.8 70.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.418 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.27 -36.55 61.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.762 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 21.0 t90 -79.76 -38.31 33.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.835 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 79.1 mt -70.72 -39.7 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 110.006 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 29' ' ' ALA . 14.8 mt -67.54 -44.62 77.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.041 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.32 -31.86 70.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.96 HG21 HD22 ' A' ' 16' ' ' LEU . 39.5 mt -67.84 114.99 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.086 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.722 ' O2A' HD23 ' A' ' 42' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.413 ' HB2' HD12 ' A' ' 4' ' ' LEU . 87.7 m-20 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.275 0.56 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -105.17 -50.05 3.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.109 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -47.15 -25.28 0.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.476 HD13 ' HG3' ' A' ' 71' ' ' GLN . 10.6 mt -62.28 -42.37 99.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.143 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.55 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -57.56 -42.9 83.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.204 -0.935 . . . . 0.0 110.061 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -52.77 62.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.079 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.63 -24.83 6.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.203 -0.935 . . . . 0.0 110.04 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -91.95 -46.17 7.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 110.11 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.3 51.96 1.4 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -103.36 -28.71 11.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -1.163 . . . . 0.0 110.089 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.7 mmt -59.08 -14.5 10.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.305 -0.872 . . . . 0.0 110.158 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' HB3' HMC3 ' A' ' 81' ' ' HEC . . . -50.13 -25.43 3.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.071 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.483 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -135.95 -36.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 0.0 110.119 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.43 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.8 m-70 -70.63 -179.14 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 110.431 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.862 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 172.73 124.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.411 -0.805 . . . . 0.0 109.828 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.009 HD22 HG21 ' A' ' 79' ' ' ILE . 24.2 mt -42.15 -63.3 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.344 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.17 42.51 3.12 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.309 -0.87 . . . . 0.0 110.06 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.862 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -142.83 86.41 1.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -60.31 78.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 110.166 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 18' ' ' ALA . 17.7 mttt -88.42 -141.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 110.011 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 38.9 t -50.17 -31.0 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.12 157.65 16.02 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.89 124.71 15.49 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.73 2.287 . . . . 0.0 110.271 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -45.01 132.91 6.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.897 . . . . 0.0 109.952 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.2 m-85 -52.12 -32.26 34.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 0.0 110.154 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.57 -47.2 76.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.933 . . . . 0.0 110.151 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -47.3 83.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' A' ' 23' ' ' PRO . 38.0 t -57.45 -45.25 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.999 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 33' ' ' ALA . . . -53.15 -50.23 64.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.47 -44.74 69.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.055 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -38.08 65.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.034 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -100.85 -0.48 36.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 110.133 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.6 -26.46 67.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.049 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.3 22.26 24.27 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.33 154.13 47.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -1.193 . . . . 0.0 110.136 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.56 -36.67 9.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.017 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 22.5 t70 -88.41 34.26 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -62.94 -24.57 67.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 110.02 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.86 -54.72 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -58.33 -55.97 28.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' LEU . 8.5 t80 -50.82 -65.19 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 110.143 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 38' ' ' ALA . 25.6 mt -43.01 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.23 -0.919 . . . . 0.0 110.11 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.971 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . . . -42.25 -42.01 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 110.078 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.23 58.22 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HB2' ' CBA' ' A' ' 81' ' ' HEC . 1.6 mmtp -97.43 -7.61 31.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 110.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 43' ' ' ALA . 49.5 mt -75.98 -47.91 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 110.067 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.084 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -73.8 -15.24 61.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.05 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 44.06 -144.01 2.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 94.6 -134.0 11.81 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.3 p 169.75 -170.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -1.184 . . . . 0.0 110.013 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.21 6.56 6.24 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.34 -11.36 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -1.178 . . . . 0.0 110.108 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.62 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 96.3 m95 -124.72 -9.14 7.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 110.051 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.56 -128.58 2.37 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.87 51.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -1.137 . . . . 0.0 110.145 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.586 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 76.2 t -114.01 94.94 36.31 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.041 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 3.0 Cg_exo -60.86 87.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.776 2.317 . . . . 0.0 110.281 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.496 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.6 ttt -59.17 139.42 88.0 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.95 141.03 75.76 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.636 2.224 . . . . 0.0 110.301 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.35 164.94 18.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.669 2.246 . . . . 0.0 110.065 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.53 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 26.9 mm-40 -134.8 163.19 30.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 0.0 110.132 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -104.4 57.05 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 110.005 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.467 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 3.5 m -114.33 155.85 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.232 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -107.13 174.58 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.896 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.3 OUTLIER -43.66 -50.37 7.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.204 -0.935 . . . . 0.0 110.001 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.31 -63.26 1.16 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 0.0 109.906 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 6.2 mt-10 -53.88 -39.79 66.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -0.878 . . . . 0.0 109.786 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.971 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -60.31 -34.45 73.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.374 -0.829 . . . . 0.0 109.678 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.63 57.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 110.005 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.8 -30.62 61.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.996 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.577 HD22 HMB3 ' A' ' 81' ' ' HEC . 19.8 mt -70.01 -49.82 47.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 109.915 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.36 -32.13 69.69 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.105 -0.997 . . . . 0.0 109.398 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -75.24 -36.88 61.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.612 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.9 t90 -79.79 -37.95 34.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.333 -0.854 . . . . 0.0 109.815 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.15 -40.42 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 110.0 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 21.7 mt -68.84 -39.96 79.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.933 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 t -64.66 -28.63 69.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.855 . . . . 0.0 110.035 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.009 HG21 HD22 ' A' ' 16' ' ' LEU . 28.5 mt -69.67 116.79 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 110.003 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.054 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.742 HMA1 HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.458 ' O ' ' NE1' ' A' ' 75' ' ' TRP . 14.4 m-80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.258 0.552 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 6' ' ' LYS . 2.2 pp20? -118.82 -11.32 9.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.072 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -50.04 -22.62 1.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 110.051 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.8 mt -74.93 -44.84 46.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.925 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.633 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -78.57 -29.42 46.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 2' ' ' GLU . 0.3 OUTLIER -63.15 -68.46 0.34 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.186 -0.946 . . . . 0.0 110.058 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -49.4 -25.14 2.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.166 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.447 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 4.1 tptt -73.16 -53.38 11.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.036 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.52 20.55 5.41 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 10.6 m -79.23 -29.08 42.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -1.15 . . . . 0.0 110.018 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.08 -15.64 14.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -0.928 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.44 22.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.5 m -127.83 -30.24 2.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.521 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -80.27 -179.37 7.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.652 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.06 123.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.449 -0.782 . . . . 0.0 109.785 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.881 HD23 HG21 ' A' ' 79' ' ' ILE . 2.0 mt -42.01 -64.12 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -122.85 42.77 3.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.388 -0.82 . . . . 0.0 109.991 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -148.3 45.5 1.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 110.016 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.521 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.87 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.343 -0.848 . . . . 0.0 110.224 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 5.6 mtpt -91.6 -89.87 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.934 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 28.3 t -80.58 -31.54 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.903 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.79 169.22 15.92 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.674 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -60.98 126.98 20.92 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.759 2.306 . . . . 0.0 110.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.19 131.45 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -0.93 . . . . 0.0 109.897 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.36 -32.22 7.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 110.135 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.56 -45.45 68.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -48.86 79.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.988 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 37.7 t -56.53 -43.5 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.836 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.55 -54.53 31.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.952 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.32 -46.1 69.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 109.964 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -55.55 -35.3 65.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 31.8 m-85 -101.42 0.21 36.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.218 -0.927 . . . . 0.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -63.43 -25.87 68.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.103 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.05 16.8 54.66 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -139.43 153.62 47.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -1.165 . . . . 0.0 110.185 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -105.47 -29.02 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 0.0 110.111 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -76.69 1.81 16.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 110.117 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.65 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -55.93 -24.19 36.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.022 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 96.1 t -67.62 -55.53 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 110.047 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.71 -54.83 42.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.337 -0.852 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -52.32 -63.16 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.063 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 38' ' ' ALA . 50.5 mt -43.24 -73.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 110.087 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.886 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.67 -41.04 2.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -56.83 -41.11 90.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' CB ' ' O1A' ' A' ' 81' ' ' HEC . 0.0 OUTLIER -86.26 -15.38 40.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -1.134 . . . . 0.0 109.963 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.886 HD12 ' HA ' ' A' ' 43' ' ' ALA . 39.7 mt -67.28 -46.83 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.878 . . . . 0.0 110.097 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 5.46 25.36 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.097 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -123.82 -6.64 7.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 110.103 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 44.24 -149.04 0.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.41 -146.72 18.39 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.494 ' HB2' ' CBD' ' A' ' 81' ' ' HEC . 0.3 OUTLIER 169.69 177.05 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -1.119 . . . . 0.0 110.106 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 139.54 -14.8 3.18 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.79 -30.8 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.03 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.988 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.3 m95 -107.89 -26.21 10.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.41 ' N ' ' O2D' ' A' ' 81' ' ' HEC . . . 172.08 -155.94 24.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.8 t -108.05 57.39 0.62 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -1.15 . . . . 0.0 110.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 25.7 t -117.59 96.26 49.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.61 78.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.741 2.294 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.494 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.2 ttt -52.15 138.98 35.81 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.68 142.24 82.63 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.627 2.218 . . . . 0.0 110.383 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.83 161.92 30.72 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.649 2.233 . . . . 0.0 110.17 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.631 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 27.1 mm-40 -135.04 163.57 29.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 110.104 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.09 69.1 0.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.002 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 46' ' ' ILE . 3.3 m -114.7 155.8 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.922 . . . . 0.0 110.133 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 1.1 m -101.28 165.09 11.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 109.915 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 4.5 m-20 -43.41 -57.75 2.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.889 . . . . 0.0 110.008 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.21 -55.11 11.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -55.51 -43.05 75.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.828 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.4 -36.63 71.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.825 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -65.28 -52.32 55.0 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.367 -0.833 . . . . 0.0 110.026 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -53.94 -28.97 40.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 72' ' ' LEU . 17.3 mt -70.19 -52.05 26.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.935 . . . . 0.0 109.822 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -69.29 -31.38 69.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 0.0 109.38 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.23 -37.06 61.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.441 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.633 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 20.5 t90 -79.57 -38.44 34.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.78 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.2 mt -70.6 -42.4 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.96 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.836 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.5 mt -65.41 -42.82 92.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.302 -0.873 . . . . 0.0 109.99 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.3 t -61.95 -33.09 73.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.837 . . . . 0.0 110.031 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.881 HG21 HD23 ' A' ' 16' ' ' LEU . 42.0 mt -64.63 103.97 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.005 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.146 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.699 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.188 0.518 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -175.69 -55.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.873 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -50.27 -24.69 3.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.025 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.444 HD22 ' OE1' ' A' ' 71' ' ' GLN . 3.3 mt -69.07 -48.46 62.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.136 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.583 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -65.7 -37.0 85.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 110.108 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -69.64 -55.16 10.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 110.111 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -50.1 -24.86 2.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 110.102 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -92.96 -47.06 7.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.07 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.14 45.69 0.85 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 16.6 m -97.6 -30.42 12.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -1.164 . . . . 0.0 110.134 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.9 mmt -61.16 -12.61 13.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.78 -36.64 58.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.48 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.2 m -123.86 -19.01 5.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 110.21 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.7 m-70 -91.26 -179.18 5.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.948 . . . . 0.0 110.343 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.896 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 170.66 122.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.916 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.772 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -42.52 -64.23 0.64 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 110.274 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.16 41.9 3.2 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.896 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -139.42 86.06 2.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.45 -0.781 . . . . 0.0 110.073 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 3.7 ptpt -55.24 86.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 110.189 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 18' ' ' ALA . 2.8 tptt -95.01 -147.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -0.906 . . . . 0.0 110.02 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 35.9 t -50.89 -31.28 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.185 -0.947 . . . . 0.0 109.924 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.07 166.14 13.58 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.15 129.35 28.22 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.776 2.317 . . . . 0.0 110.252 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -50.76 127.16 17.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 109.977 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.59 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.9 m-85 -47.95 -33.55 7.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 110.004 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.12 -44.44 76.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.956 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -49.53 76.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.0 110.051 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.145 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 61.9 t -56.97 -44.72 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 76' ' ' ILE . . . -51.21 -62.51 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.943 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -40.92 67.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.788 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -61.63 -32.06 72.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.334 -0.854 . . . . 0.0 110.11 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 6.5 m-85 -91.64 2.07 56.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.17 -25.4 61.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.082 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.71 -3.88 68.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -118.26 164.67 14.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -1.135 . . . . 0.0 110.045 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 -11.01 13.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 110.099 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.67 21.78 16.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.033 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -59.37 -15.81 18.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.539 HG12 ' NZ ' ' A' ' 70' ' ' LYS . 49.2 t -73.77 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 110.033 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.87 -51.4 69.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.316 -0.865 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.2 -64.34 0.84 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.94 . . . . 0.0 109.997 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 38' ' ' ALA . 55.8 mt -43.52 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.53 -37.62 1.7 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.494 -0.754 . . . . 0.0 110.095 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.73 -41.13 93.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 49' ' ' GLY . 4.7 mmtp -87.9 -9.47 53.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 110.07 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.7 mt -73.49 -51.52 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 110.004 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -17.5 62.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 110.176 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.03 -18.18 13.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.33 -0.856 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 55.53 -140.32 40.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 92.35 -139.44 14.67 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.488 ' HB3' ' CBD' ' A' ' 81' ' ' HEC . 2.7 p 169.92 -170.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -1.142 . . . . 0.0 110.034 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.9 -29.23 4.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.2 t -86.83 -21.32 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.254 -1.145 . . . . 0.0 110.131 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 1.145 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 93.0 m95 -115.81 -28.39 6.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 110.096 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 -155.85 25.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.9 p -107.89 65.34 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -1.167 . . . . 0.0 110.039 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 51' ' ' SER . 60.4 t -129.97 96.33 26.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 110.131 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.59 87.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.736 2.291 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.483 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.9 ttt -59.43 140.28 88.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.906 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.28 141.5 82.26 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.577 2.185 . . . . 0.0 110.375 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.8 163.91 23.3 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.571 2.181 . . . . 0.0 110.029 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.532 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 20.0 mm-40 -134.95 163.33 30.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.129 -0.982 . . . . 0.0 110.064 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -104.83 64.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.334 -0.854 . . . . 0.0 109.953 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -113.83 155.72 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.9 p -100.06 166.78 10.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 0.0 109.901 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -43.36 -55.29 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 110.069 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.79 -57.95 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.952 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.47 -40.99 68.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.217 -0.927 . . . . 0.0 109.9 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.826 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.58 -35.47 72.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.811 . . . . 0.0 109.865 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' NZ ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.56 -52.25 53.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.339 -0.85 . . . . 0.0 110.088 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -54.52 -30.19 52.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 110.082 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 76' ' ' ILE . 26.7 mt -70.24 -50.33 40.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.87 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.39 -30.99 68.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.253 -0.905 . . . . 0.0 109.455 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -76.27 -36.56 58.36 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.56 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.583 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 23.7 t90 -80.79 -36.97 31.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.398 -0.814 . . . . 0.0 109.835 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.878 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.6 mt -74.13 -34.87 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.172 -0.955 . . . . 0.0 109.947 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 29' ' ' ALA . 20.1 mt -72.34 -41.88 66.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.309 -0.869 . . . . 0.0 109.973 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.4 t -64.14 -27.78 69.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.61 HG23 HD23 ' A' ' 16' ' ' LEU . 37.8 mt -69.65 100.47 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 110.018 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.051 -179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.76 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.203 0.525 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 5' ' ' ALA . 12.8 mt-10 -64.04 -10.71 23.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.086 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 4' ' ' LEU . 2.6 mm-40 -51.09 -84.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 110.115 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -42.57 -27.07 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 0.0 110.142 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.711 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -69.17 -36.85 77.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.847 . . . . 0.0 110.015 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 3' ' ' GLN . 37.2 tttt -84.57 -49.87 8.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 110.036 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -50.67 -24.66 3.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.073 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.64 -49.05 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.26 -0.9 . . . . 0.0 110.071 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.65 25.09 5.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 8' ' ' LYS . 13.6 m -73.04 -28.99 62.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 0.0 109.991 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.7 mmt -59.39 -14.33 11.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 110.197 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.28 -25.31 3.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 110.106 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 21' ' ' VAL . 9.7 m -135.76 -36.82 0.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.023 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -69.47 -178.84 1.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.617 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 175.63 129.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.75 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.049 HD11 HD13 ' A' ' 79' ' ' ILE . 3.9 mm? -42.75 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.137 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.26 42.55 3.12 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.375 -0.828 . . . . 0.0 110.009 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -137.41 87.76 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.12 156.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.061 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER 178.73 -145.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.973 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 13' ' ' CYS . 55.1 t -50.15 -29.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 0.0 109.848 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.81 20.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.623 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.67 121.37 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.745 2.296 . . . . 0.0 110.316 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 135.06 3.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.937 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.4 m-85 -53.07 -31.87 44.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.128 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.42 -47.2 67.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.85 -46.14 91.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 23' ' ' PRO . 36.3 t -57.51 -45.47 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.975 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.837 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.34 -57.25 10.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.312 -0.867 . . . . 0.0 109.9 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 33.1 tttp -54.51 -43.29 71.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.882 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HE2' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -58.59 -34.95 71.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.057 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.537 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 6.3 m-85 -102.44 4.68 39.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -0.955 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.9 -23.42 59.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.22 10.58 60.63 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 167.69 14.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -1.098 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -113.62 -10.67 13.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.252 -0.905 . . . . 0.0 110.103 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -110.81 28.79 8.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.075 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.58 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.8 -24.81 62.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 110.116 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 83.9 t -68.89 -56.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 110.045 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 1.3 m-20 -59.18 -53.2 61.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.135 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.0 t80 -51.32 -63.05 1.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.271 -0.893 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 38' ' ' ALA . 56.8 mt -43.17 -73.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.046 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.921 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.62 -41.09 2.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.364 -0.835 . . . . 0.0 110.14 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.48 -39.67 84.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 6.8 mmpt? -88.57 -16.62 32.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -1.155 . . . . 0.0 110.093 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.895 HD12 ' HA ' ' A' ' 43' ' ' ALA . 44.5 mt -65.65 -47.68 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.288 -0.883 . . . . 0.0 110.063 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 2.9 ttmm -80.09 6.2 12.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.82 -28.97 4.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.2 -156.95 33.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.75 -129.67 9.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.517 ' OG ' ' CBD' ' A' ' 81' ' ' HEC . 0.3 OUTLIER 169.82 -170.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.207 -1.172 . . . . 0.0 110.028 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -2.29 8.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 54' ' ' TRP . 37.6 t -119.95 -14.84 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -1.148 . . . . 0.0 110.094 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 97.5 m95 -133.79 9.45 3.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.32 -149.78 20.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 21.5 m -118.13 51.42 1.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -1.194 . . . . 0.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 59' ' ' MET . 49.6 t -110.26 95.13 20.55 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.922 . . . . 0.0 110.098 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_endo -60.86 72.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.798 2.332 . . . . 0.0 110.286 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.496 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.1 ttt -43.98 139.41 3.02 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.883 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.85 141.23 83.85 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.642 2.228 . . . . 0.0 110.328 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.35 160.21 36.24 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.615 2.21 . . . . 0.0 110.135 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 60' ' ' PRO . 23.5 mm-40 -133.01 162.92 30.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 110.072 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -103.93 68.39 0.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.977 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.13 155.94 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.132 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.6 p -101.91 167.93 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.972 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 65' ' ' THR . 8.8 t0 -43.39 -61.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.082 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.47 -54.98 6.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.956 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.41 -43.23 75.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.853 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.921 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.56 -36.28 71.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.784 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.26 -52.19 55.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 110.046 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.07 -29.37 44.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.929 . . . . 0.0 110.019 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 76' ' ' ILE . 20.2 mt -70.12 -51.73 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.169 -0.957 . . . . 0.0 109.895 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.31 -31.54 70.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.119 -0.988 . . . . 0.0 109.39 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -75.12 -37.27 61.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.843 . . . . 0.0 109.619 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.711 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 20.4 t90 -79.33 -38.21 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.803 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.549 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.8 mt -71.48 -41.66 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.962 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 29' ' ' ALA . 21.7 mt -64.53 -46.68 81.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 109.96 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 m -56.65 -27.95 59.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 109.977 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.049 HD13 HD11 ' A' ' 16' ' ' LEU . 6.8 mt -75.46 121.82 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.902 . . . . 0.0 109.974 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.096 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.695 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.176 0.512 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -93.24 -31.67 14.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.081 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.49 -24.9 3.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 110.066 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.74 HD13 ' CD ' ' A' ' 71' ' ' GLN . 17.6 mt -64.31 -51.78 61.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.195 -0.941 . . . . 0.0 110.037 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.605 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -52.98 -36.5 60.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.089 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -63.33 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 110.084 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -50.71 -24.83 3.68 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.86 -49.0 7.38 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.075 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.01 40.93 4.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 m -95.06 -28.83 14.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -1.151 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -16.18 6.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.872 . . . . 0.0 110.117 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.29 -23.57 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.186 -0.946 . . . . 0.0 109.945 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m -137.51 -38.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.2 m-70 -70.01 -179.53 1.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.822 . . . . 0.0 110.33 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.768 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 173.31 123.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.827 . . . . 0.0 109.802 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.684 HD22 HG21 ' A' ' 79' ' ' ILE . 31.6 mt -42.52 -66.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 110.28 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -122.47 42.63 3.11 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.829 . . . . 0.0 110.085 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -141.46 84.11 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 110.17 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -61.7 76.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 110.111 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -79.21 -90.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 110.028 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 34.6 t -99.44 -39.51 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.989 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.93 166.45 12.3 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.82 118.61 5.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.785 2.323 . . . . 0.0 110.227 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.35 128.79 4.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.504 ' CD1' HG12 ' A' ' 76' ' ' ILE . 5.5 m-85 -48.34 -35.7 12.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -63.32 -41.87 98.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -0.915 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.08 -48.38 71.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.913 . . . . 0.0 110.079 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.982 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -58.13 -46.3 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.068 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.698 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.88 -53.94 34.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.325 -0.859 . . . . 0.0 110.016 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -45.48 73.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.949 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 6.1 mttp -56.66 -34.43 67.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 110.048 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 19.3 m-85 -103.96 -1.36 27.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 110.14 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.59 -28.56 60.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.31 19.55 34.95 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.427 ' HG3' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -128.23 149.5 50.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.156 . . . . 0.0 110.023 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.52 -14.57 15.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.427 ' OD1' ' HG3' ' A' ' 35' ' ' ARG . 7.1 p-10 -102.55 4.37 38.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 0.0 110.085 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -54.38 -20.89 8.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.04 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.599 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 72.7 t -69.66 -54.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.049 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.4 -53.63 55.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.294 -0.879 . . . . 0.0 110.092 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 70.4 t80 -50.88 -64.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' ALA . 72.3 mt -43.18 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 110.103 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.04 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.35 -41.63 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 110.11 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.73 -39.24 75.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' CGA' ' A' ' 81' ' ' HEC . 0.1 OUTLIER -89.76 -5.96 56.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -1.154 . . . . 0.0 110.052 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 43' ' ' ALA . 31.2 mt -78.02 -47.68 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -78.01 -9.1 58.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -100.37 -42.58 6.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.033 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.43 -169.03 52.2 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 101.38 -138.37 13.83 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER 169.7 -167.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 110.07 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.84 3.22 5.98 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -121.69 -18.05 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 110.02 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.982 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 93.8 m95 -120.01 -11.72 9.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 0.0 110.104 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.46 -141.02 7.61 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.03 60.01 1.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.158 -1.201 . . . . 0.0 110.061 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.409 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 22.8 t -122.82 96.37 45.31 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.915 . . . . 0.0 110.106 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.55 75.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.697 2.265 . . . . 0.0 110.279 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.479 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.1 ttt -49.77 138.39 17.57 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.511 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.16 143.47 90.09 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.685 2.256 . . . . 0.0 110.334 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.43 165.68 17.07 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.716 2.277 . . . . 0.0 110.145 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 27.8 mm-40 -135.08 163.89 28.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.932 . . . . 0.0 110.117 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -104.34 64.25 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.264 -0.897 . . . . 0.0 110.058 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.61 155.82 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.109 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.54 167.42 10.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 m-20 -43.36 -59.01 2.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.117 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.5 -56.35 7.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.897 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -54.87 -41.87 71.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.235 -0.916 . . . . 0.0 109.92 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.04 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -57.95 -37.74 74.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -64.7 -51.82 60.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.404 -0.81 . . . . 0.0 110.012 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.74 ' CD ' HD13 ' A' ' 4' ' ' LEU . 1.4 tm0? -53.92 -29.26 41.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.016 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 76' ' ' ILE . 45.2 mt -70.1 -52.75 21.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -68.55 -32.47 72.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.496 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.12 -36.93 64.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.605 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 19.0 t90 -78.64 -40.06 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.817 . . . . 0.0 109.74 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.692 HD12 ' O ' ' A' ' 72' ' ' LEU . 20.9 mt -71.11 -43.77 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.93 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 29' ' ' ALA . 20.6 mt -62.22 -44.68 96.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.02 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 t -59.58 -36.02 75.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.684 HG21 HD22 ' A' ' 16' ' ' LEU . 26.2 mt -59.6 108.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 109.964 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.04 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.697 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.258 0.551 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -154.73 -68.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 110.095 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -49.32 -24.12 1.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.03 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' O ' ' CG ' ' A' ' 8' ' ' LYS . 13.0 mt -68.81 -54.66 14.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.553 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -63.09 -30.19 71.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 110.11 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -66.38 -66.48 0.55 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 110.084 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -50.61 -25.2 3.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 110.067 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 4' ' ' LEU . 18.9 mmtm -80.07 -53.81 6.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 110.052 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.35 51.66 1.55 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.8 m -106.55 -29.13 9.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 110.017 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.4 mmt -58.51 -14.99 9.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.27 -24.75 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.128 -0.982 . . . . 0.0 109.988 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -136.15 -36.91 0.73 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.102 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.7 m-70 -71.73 -179.9 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 110.378 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 169.06 121.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.873 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.864 HD23 HG23 ' A' ' 79' ' ' ILE . 1.6 mp -42.13 -62.31 0.96 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 110.303 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.13 42.37 3.15 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.36 -0.838 . . . . 0.0 110.038 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.759 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -147.05 45.76 1.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -47.49 91.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 110.134 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' CD ' ' O ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -96.54 -89.38 0.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 0.0 109.954 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 35.4 t -78.12 -31.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.35 -0.844 . . . . 0.0 109.901 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.15 168.32 18.31 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.669 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -61.04 124.73 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.728 2.285 . . . . 0.0 110.316 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -49.32 127.57 15.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 109.893 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.597 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.3 m-85 -45.97 -31.22 2.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.081 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.31 -44.47 75.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.035 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -63.59 -49.12 74.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 110.147 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.904 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 39.7 t -57.8 -45.79 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -0.919 . . . . 0.0 109.973 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.84 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.21 -63.72 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.29 -38.67 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -60.24 -35.65 75.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.881 . . . . 0.0 110.042 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.61 2.89 26.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.033 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -65.87 -26.62 67.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.258 -0.901 . . . . 0.0 110.024 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.71 16.71 49.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.39 154.51 36.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -1.12 . . . . 0.0 110.064 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -100.54 -14.34 18.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.071 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' CG ' ' OD2' ' A' ' 40' ' ' ASP . 0.5 OUTLIER -108.7 29.37 7.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 110.084 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -75.43 -23.85 57.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 0.0 110.07 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.47 HG12 ' CE ' ' A' ' 70' ' ' LYS . 22.0 t -73.31 -61.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' OD2' ' CG ' ' A' ' 37' ' ' ASP . 3.2 p-10 -59.27 -50.33 74.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.063 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -51.75 -58.23 7.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.047 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.658 HD12 ' HB1' ' A' ' 73' ' ' ALA . 45.5 mt -48.3 -73.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.298 -0.876 . . . . 0.0 110.125 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.939 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.67 -43.07 3.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.25 -41.23 86.4 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.5 OUTLIER -86.68 -9.88 54.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -1.123 . . . . 0.0 110.042 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.879 HD12 ' HA ' ' A' ' 43' ' ' ALA . 34.0 mt -73.21 -50.55 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -74.51 -11.57 60.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.053 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -100.83 -13.67 18.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 45.31 -165.57 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 108.0 -137.39 14.03 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.85 -172.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -1.146 . . . . 0.0 110.101 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 130.12 -10.59 5.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 82.1 t -106.72 -22.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -1.144 . . . . 0.0 110.047 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.904 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.6 m95 -120.37 -22.12 6.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.53 -169.61 42.45 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -98.14 46.36 1.01 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.095 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -111.39 96.24 30.41 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.75 76.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.692 2.261 . . . . 0.0 110.346 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.498 ' HE3' ' C4B' ' A' ' 81' ' ' HEC . 7.5 ttt -43.24 139.59 2.34 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 3.0 Cg_endo -62.64 142.59 90.22 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.674 2.25 . . . . 0.0 110.309 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.27 166.8 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.626 2.217 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 29.8 mm-40 -136.03 164.64 27.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.92 . . . . 0.0 110.075 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -104.62 58.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.6 155.96 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.263 -0.898 . . . . 0.0 110.014 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.8 p -100.39 168.53 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.995 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 56.5 t0 -43.32 -53.31 5.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.184 -0.947 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.41 -58.77 4.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -54.27 -40.71 68.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.781 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.939 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.69 -36.38 74.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.854 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' CE ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.71 -51.86 60.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.423 -0.798 . . . . 0.0 110.0 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.0 -29.7 57.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 110.025 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.542 HD12 ' HA ' ' A' ' 69' ' ' ALA . 62.4 mt -70.21 -50.28 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.949 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.658 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.72 -30.3 66.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.094 -1.004 . . . . 0.0 109.398 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.5 mt-30 -76.63 -37.2 56.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.507 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.553 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 24.7 t90 -80.6 -36.45 32.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.354 -0.842 . . . . 0.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 55.6 mt -74.64 -33.65 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.914 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.84 HD23 ' HA ' ' A' ' 29' ' ' ALA . 21.9 mt -71.61 -45.39 62.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -60.64 -25.81 66.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.98 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.864 HG23 HD23 ' A' ' 16' ' ' LEU . 39.1 mt -71.3 119.84 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.107 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.681 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.1 m120 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.207 0.527 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 pm0 -106.12 -2.24 22.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.153 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.36 -23.73 0.64 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.053 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.752 HD13 ' HG3' ' A' ' 71' ' ' GLN . 1.4 mt -73.97 -44.73 53.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 110.041 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.429 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -70.2 -30.49 67.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.192 -0.942 . . . . 0.0 110.107 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.6 mttt -62.53 -66.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 110.146 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -50.41 -29.72 10.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 110.092 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -65.38 -60.0 3.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.912 . . . . 0.0 110.043 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.95 49.32 0.58 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 m -99.13 -28.86 13.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -1.182 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.6 mmt -54.89 -17.46 3.68 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.905 . . . . 0.0 110.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.34 -23.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.0 109.967 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 14.1 m -138.63 -37.75 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.897 . . . . 0.0 110.041 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.452 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 87.6 m-70 -70.12 -179.25 1.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.852 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.821 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER 170.77 126.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.564 ' CD2' HD13 ' A' ' 79' ' ' ILE . 28.8 mt -42.17 -67.85 0.23 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.2 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 42.77 3.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 110.019 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -139.44 83.6 1.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.405 -0.809 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -62.33 74.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 110.201 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 57.2 mmtt -77.68 -90.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 13' ' ' CYS . 26.5 t -97.67 -45.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.932 . . . . 0.0 109.97 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.7 167.52 14.03 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.07 119.28 6.35 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.68 2.254 . . . . 0.0 110.242 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.42 134.58 3.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.889 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.607 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 5.0 m-85 -50.49 -32.07 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' ILE . . . -67.72 -44.88 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 110.017 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.59 -48.83 79.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.924 . . . . 0.0 110.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.565 HG23 ' HB2' ' A' ' 23' ' ' PRO . 71.4 t -57.16 -44.51 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.993 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.738 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.69 -59.7 3.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.904 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.75 -43.07 72.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.826 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -34.04 73.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 110.048 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -94.5 -12.76 27.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.038 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -52.12 -28.77 19.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 0.0 110.009 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.63 17.25 45.77 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mtt85 -122.86 121.98 37.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.201 -1.176 . . . . 0.0 110.106 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -72.97 -31.06 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.034 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.67 37.01 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 110.054 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.742 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -70.37 -25.11 63.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.62 -50.91 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.919 . . . . 0.0 110.099 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -55.67 25.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 110.076 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.7 t80 -50.61 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 110.066 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 38' ' ' ALA . 1.4 mt -43.27 -73.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 0.0 110.079 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.879 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.19 -41.75 2.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.411 -0.805 . . . . 0.0 110.058 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.5 -41.89 89.19 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HE2' ' O1A' ' A' ' 81' ' ' HEC . 0.8 OUTLIER -84.98 -16.91 39.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 43' ' ' ALA . 32.8 mt -65.21 -49.46 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 110.005 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 10.3 tttt -80.83 -0.06 37.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.144 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.91 -7.01 10.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 47.77 -155.86 1.06 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.9 -149.64 16.74 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.528 ' HB3' ' CBD' ' A' ' 81' ' ' HEC . 1.3 p 169.68 -167.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.15 . . . . 0.0 110.071 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.48 -18.08 7.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 53' ' ' VAL . 64.2 t -100.03 -3.96 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.596 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 99.6 m95 -137.88 6.45 2.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.44 -153.06 23.8 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -118.37 52.24 1.04 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -1.137 . . . . 0.0 110.108 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 64.2 t -113.91 96.2 40.57 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 110.069 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.65 80.05 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.689 2.259 . . . . 0.0 110.225 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.49 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.4 ttt -51.48 138.58 29.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 109.95 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.75 144.84 90.04 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.682 2.255 . . . . 0.0 110.394 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -62.96 168.19 10.97 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.693 2.262 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.514 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 33.7 mm-40 -137.06 164.83 27.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.155 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.05 60.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.027 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.461 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.66 155.89 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 110.093 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -103.77 170.59 7.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 110.001 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' THR . 13.1 m-20 -43.35 -57.27 3.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.0 109.993 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.83 -57.96 4.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 109.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -41.02 70.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.879 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.46 -34.77 72.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.791 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -65.41 -51.24 61.64 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.334 -0.854 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.752 ' HG3' HD13 ' A' ' 4' ' ' LEU . 1.5 tm0? -56.2 -30.69 62.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.214 -0.929 . . . . 0.0 110.078 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' O ' ' HB ' ' A' ' 76' ' ' ILE . 38.1 mt -70.41 -48.9 53.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.26 -0.9 . . . . 0.0 109.832 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -71.22 -29.6 65.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.447 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -37.43 48.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.495 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 25.3 t90 -81.03 -34.21 32.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.869 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.656 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 56.6 mt -76.84 -35.74 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.4 mt -71.36 -45.38 63.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.973 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.9 t -59.06 -33.42 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 110.008 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.564 HD13 ' CD2' ' A' ' 16' ' ' LEU . 14.1 mt -69.29 95.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 109.979 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.564 ' OXT' ' HB3' ' A' ' 29' ' ' ALA . 6.2 mmmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.017 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.741 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.471 ' O ' ' CE2' ' A' ' 75' ' ' TRP . 8.8 p-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.278 0.561 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -119.87 -43.61 2.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 0.0 110.06 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -50.35 -21.91 1.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.082 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.446 HD13 ' HG3' ' A' ' 71' ' ' GLN . 32.9 mt -77.16 -25.28 51.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.286 -0.884 . . . . 0.0 110.062 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.825 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -89.27 -41.4 12.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.06 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.37 -33.19 63.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 110.066 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -49.38 -24.32 1.88 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.094 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.49 ' HE3' ' CG1' ' A' ' 64' ' ' VAL . 7.7 mmtt -106.45 -39.89 5.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 110.054 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.91 36.39 2.2 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.446 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 13.3 m -73.7 -28.98 62.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.19 -1.182 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.66 -13.3 13.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.34 -35.51 51.13 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 109.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 11.1 m -125.15 -25.49 3.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.99 -179.25 7.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 110.463 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.896 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 169.48 122.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.377 -0.827 . . . . 0.0 109.784 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.0 HD23 HG23 ' A' ' 79' ' ' ILE . 1.2 mp -41.84 -64.75 0.53 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.874 . . . . 0.0 110.367 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.7 42.69 3.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 110.072 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.896 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -136.54 82.92 1.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.83 . . . . 0.0 110.175 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.46 113.16 1.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.046 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -134.51 -143.55 0.21 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.476 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 t -50.98 -30.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.989 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -124.61 158.91 19.23 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.582 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_exo -60.67 122.54 11.41 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.769 2.313 . . . . 0.0 110.216 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 126.35 4.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.207 -0.933 . . . . 0.0 109.981 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.6 m-85 -46.29 -37.27 7.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.883 . . . . 0.0 110.085 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -61.05 -50.72 72.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.02 92.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -0.888 . . . . 0.0 110.041 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 90.6 t -57.08 -45.45 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.837 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -53.04 -58.97 5.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -55.77 -40.93 73.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.756 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -34.25 74.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -100.7 1.8 40.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.2 -17.17 62.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.255 -0.903 . . . . 0.0 110.057 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 17.79 44.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -132.17 147.62 52.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -1.154 . . . . 0.0 110.096 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -90.75 -33.83 15.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.116 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -91.12 28.29 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.806 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -62.72 -20.24 64.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 110.123 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.29 -57.45 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 110.09 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -57.64 -56.59 19.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' A' ' 42' ' ' LEU . 42.8 t80 -49.45 -63.98 0.94 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 109.98 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 38' ' ' ALA . 10.7 mt -43.11 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.074 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.908 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.45 -38.24 1.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.431 -0.793 . . . . 0.0 110.184 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -56.93 -39.96 89.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -89.18 -7.52 55.46 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -1.126 . . . . 0.0 110.059 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.908 HD12 ' HA ' ' A' ' 43' ' ' ALA . 46.2 mt -77.78 -39.48 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.069 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.06 -3.52 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.046 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -102.51 -34.77 9.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.46 -174.01 45.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.18 -147.47 16.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 6.8 p 174.16 -164.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -1.143 . . . . 0.0 110.074 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.88 -10.33 6.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 78.1 t -109.92 -15.77 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 110.088 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.582 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.5 m95 -122.67 -9.15 8.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.333 -0.855 . . . . 0.0 110.061 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.6 -166.17 31.7 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' ' OG ' ' A' ' 56' ' ' SER . 5.6 p -103.39 55.28 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -1.159 . . . . 0.0 110.096 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.46 96.51 45.82 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.52 87.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.771 2.314 . . . . 0.0 110.287 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.49 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.4 ttt -55.64 139.82 67.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.928 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.29 142.51 86.27 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.633 2.222 . . . . 0.0 110.25 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.17 165.99 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.647 2.231 . . . . 0.0 110.19 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.528 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 26.5 mm-40 -137.58 164.86 27.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 110.096 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -104.11 70.76 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.49 ' CG1' ' HE3' ' A' ' 8' ' ' LYS . 3.8 m -127.48 155.97 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.28 -0.888 . . . . 0.0 110.099 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -104.95 171.41 7.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 65' ' ' THR . 36.0 t0 -43.35 -53.43 5.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.032 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.23 -59.14 3.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.901 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -54.82 -41.09 70.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -59.31 -35.63 74.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.802 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 2.0 ttpm? -65.76 -51.71 56.96 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.423 -0.798 . . . . 0.0 110.009 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.68 -30.17 54.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.26 -51.07 33.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.169 -0.957 . . . . 0.0 109.894 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -69.57 -31.62 69.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.464 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -75.46 -37.39 60.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.491 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.825 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 21.6 t90 -79.08 -37.78 37.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.81 . . . . 0.0 109.847 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' A' ' 79' ' ' ILE . 79.0 mt -71.99 -40.33 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.84 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.837 HD23 ' HA ' ' A' ' 29' ' ' ALA . 29.5 mt -65.24 -45.26 85.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 t -60.22 -29.24 68.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 110.044 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.0 HG23 HD23 ' A' ' 16' ' ' LEU . 42.6 mt -64.9 109.62 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.072 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.723 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.263 0.554 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -119.6 -11.14 9.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.073 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -45.51 -25.62 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 110.051 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 14.0 mt -73.03 -30.52 63.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 110.009 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.844 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -84.4 -43.0 15.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 110.094 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -60.73 2.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.297 -0.877 . . . . 0.0 110.022 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 13.0 pt20 -50.03 -30.37 10.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.324 -0.86 . . . . 0.0 110.075 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 9.5 tppt? -68.82 -56.61 7.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.867 . . . . 0.0 110.108 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.94 25.35 2.31 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.5 m -88.36 -29.26 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -1.155 . . . . 0.0 109.998 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 mmt -59.21 -14.57 11.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -0.914 . . . . 0.0 110.114 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -26.62 4.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.278 -0.889 . . . . 0.0 109.978 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.4 m -133.86 -36.08 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.957 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 88.5 m-70 -71.26 -179.32 2.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.296 -0.878 . . . . 0.0 110.27 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.777 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.34 125.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.914 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.603 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 25.1 mt -42.43 -68.76 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 110.248 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -122.28 42.49 3.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -139.52 82.39 1.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.373 -0.829 . . . . 0.0 110.138 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -59.47 79.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.334 -0.854 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -85.12 -90.57 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.901 . . . . 0.0 110.006 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 27.2 t -96.0 -46.32 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 0.0 109.889 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.55 167.78 13.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 28' ' ' VAL . 3.0 Cg_endo -60.98 120.06 7.56 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.764 2.309 . . . . 0.0 110.228 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -43.29 130.6 4.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 109.977 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 4.9 m-85 -48.67 -32.22 7.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.69 -44.06 74.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -0.894 . . . . 0.0 110.075 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.09 -49.38 76.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 110.053 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.958 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 39.8 t -57.3 -44.31 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.867 . . . . 0.0 110.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.848 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.55 -55.06 21.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.971 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -54.08 -46.37 72.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 109.964 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.53 -32.34 65.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 110.127 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CE2' HG13 ' A' ' 28' ' ' VAL . 24.3 m-85 -105.46 1.19 27.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -59.06 -29.01 67.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.224 -0.923 . . . . 0.0 110.039 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.12 16.3 48.71 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.503 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 11.4 mmm-85 -115.47 139.02 50.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -1.161 . . . . 0.0 110.065 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.2 mttp -95.36 -16.53 22.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.068 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -111.71 12.69 21.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.576 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -53.46 -20.31 4.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.038 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 70' ' ' LYS . 41.3 t -68.62 -57.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 110.072 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.62 -52.77 64.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.05 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.4 ' OH ' ' HE3' ' A' ' 45' ' ' LYS . 86.6 t80 -52.61 -62.78 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 38' ' ' ALA . 45.4 mt -43.26 -74.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 110.077 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.892 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.61 -39.86 2.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.415 -0.803 . . . . 0.0 110.079 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.34 -36.78 70.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.536 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.2 OUTLIER -92.1 -15.63 27.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -1.111 . . . . 0.0 110.076 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 43' ' ' ALA . 49.7 mt -67.34 -44.59 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.096 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -82.56 6.95 15.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -0.907 . . . . 0.0 110.129 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.46 -31.1 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 110.046 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.39 -160.32 49.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 100.24 -143.72 16.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.4 p 169.76 -172.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -1.157 . . . . 0.0 110.043 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.95 -9.25 5.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.13 -18.66 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -1.132 . . . . 0.0 110.081 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.958 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.4 m95 -117.99 -26.89 6.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.927 . . . . 0.0 110.081 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.47 -154.04 20.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -111.51 44.94 1.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -1.15 . . . . 0.0 110.113 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.52 96.14 26.13 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 56' ' ' SER . 3.0 Cg_exo -60.7 92.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.73 2.287 . . . . 0.0 110.292 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.479 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.2 ttt -62.67 138.84 96.9 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.513 ' O ' ' NE2' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.47 142.15 83.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.616 2.21 . . . . 0.0 110.299 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.76 165.49 18.33 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.645 2.23 . . . . 0.0 110.07 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.588 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 26.5 mm-40 -134.67 163.43 29.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 16.4 p-10 -104.33 59.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.055 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.455 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 3.6 m -114.23 155.83 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.106 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -99.55 165.38 11.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 109.92 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 6.4 p-10 -43.36 -47.04 6.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.311 -0.868 . . . . 0.0 110.025 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.47 -61.09 2.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.883 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.41 -40.95 68.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.753 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -59.45 -34.17 72.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.367 -0.833 . . . . 0.0 109.791 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -65.77 -52.1 53.7 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.401 -0.812 . . . . 0.0 110.053 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -55.75 -29.85 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.59 -49.84 43.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.971 . . . . 0.0 109.815 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -70.77 -31.05 67.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.381 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' NE2' ' HD2' ' A' ' 70' ' ' LYS . 4.4 mt-30 -76.03 -37.04 58.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.423 -0.798 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.844 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 23.6 t90 -80.35 -37.42 32.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.835 . . . . 0.0 109.765 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.581 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 57.0 mt -72.35 -40.35 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.858 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.848 HD23 ' HA ' ' A' ' 29' ' ' ALA . 28.2 mt -66.83 -43.65 83.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.867 . . . . 0.0 109.872 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.2 p -60.83 -30.22 69.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.592 HD13 ' CD2' ' A' ' 16' ' ' LEU . 36.8 mt -67.85 107.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.069 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.711 HMA1 HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.262 0.553 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -138.65 12.15 2.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.021 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.47 -27.13 5.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 110.045 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 4' ' ' LEU . 3.2 pp -79.42 -28.61 41.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -0.857 . . . . 0.0 110.005 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.42 -32.18 26.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 110.058 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -69.07 -57.31 5.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 110.023 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -51.92 -25.15 7.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 110.073 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -79.92 -54.12 6.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 110.079 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.61 41.09 0.75 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.457 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 21.4 m -92.22 -29.64 16.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -1.152 . . . . 0.0 110.153 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 10.5 mmt -60.46 -13.53 14.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB3' HMC3 ' A' ' 81' ' ' HEC . . . -50.58 -24.87 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.036 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.0 m -136.31 -36.57 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 89.6 m-70 -71.25 -179.71 2.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 110.393 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.963 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 172.2 118.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.871 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.748 HD23 ' CG2' ' A' ' 79' ' ' ILE . 1.6 mt -41.71 -58.27 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.36 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.54 42.64 3.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.292 -0.88 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.963 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.47 87.86 1.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 110.041 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 110.144 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -85.83 -143.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 110.048 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.3 t -51.48 -30.99 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.977 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.48 160.53 13.91 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.643 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.84 128.74 26.48 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.79 2.327 . . . . 0.0 110.317 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -50.3 122.6 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.568 ' CD1' HG12 ' A' ' 76' ' ' ILE . 2.6 m-85 -43.64 -29.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.074 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -71.97 -45.78 59.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.332 -0.855 . . . . 0.0 109.99 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.66 -49.04 79.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.986 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.108 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 37.5 t -56.37 -43.57 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.885 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.936 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.24 -61.61 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.984 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -53.39 -40.75 65.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 109.858 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -33.53 71.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.096 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.676 ' HB2' HD21 ' A' ' 77' ' ' LEU . 13.8 m-85 -106.67 4.58 28.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.095 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -69.99 -28.57 65.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 0.0 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.81 14.88 55.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.98 165.45 12.33 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.305 -1.114 . . . . 0.0 110.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -115.65 -6.87 12.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 110.04 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -123.89 18.45 9.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.076 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 77' ' ' LEU . . . -55.84 -23.24 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 110.08 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.13 -55.3 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.955 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.97 -51.64 68.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 0.0 110.082 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.559 ' OH ' HG21 ' A' ' 53' ' ' VAL . 30.0 t80 -54.5 -67.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 110.064 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 38' ' ' ALA . 3.2 mt -43.05 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 110.131 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.897 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.5 -39.14 2.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.378 -0.826 . . . . 0.0 110.096 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -59.04 -42.78 97.13 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HB2' ' CGA' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -84.25 -13.76 51.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -1.114 . . . . 0.0 110.003 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.897 HD12 ' HA ' ' A' ' 43' ' ' ALA . 40.7 mt -69.68 -47.72 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -81.64 -19.84 40.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.095 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 35.3 mttm -92.24 -30.85 15.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 110.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.3 -167.77 31.46 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.17 -143.02 15.82 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 1.9 t 169.71 -179.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -1.094 . . . . 0.0 110.08 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 136.79 -11.3 3.96 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG21 ' OH ' ' A' ' 41' ' ' TYR . 45.3 t -99.13 -29.61 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -1.161 . . . . 0.0 110.076 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 1.108 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.1 m95 -104.67 -22.98 13.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 110.041 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.76 -138.26 5.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.49 67.52 0.85 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.23 -1.159 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 51' ' ' SER . 40.0 t -136.38 91.82 16.09 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 110.073 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.92 77.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.724 2.282 . . . . 0.0 110.285 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.494 ' HE3' ' C4B' ' A' ' 81' ' ' HEC . 7.6 ttt -45.62 141.21 4.04 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.991 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.03 143.23 90.45 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.674 2.249 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.03 167.16 12.8 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.666 2.244 . . . . 0.0 110.128 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.524 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 25.3 mm-40 -139.69 166.39 24.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -0.95 . . . . 0.0 110.073 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -105.31 68.1 0.8 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.525 HG21 HG22 ' A' ' 46' ' ' ILE . 3.5 m -114.77 155.93 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.31 -0.869 . . . . 0.0 110.033 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 p -103.55 167.52 9.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 109.93 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.45 -62.06 1.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.02 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.56 -55.75 5.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 0.0 109.901 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.79 -42.95 76.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.882 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.86 -35.81 73.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 0.0 109.825 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -66.33 -50.79 62.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.436 -0.79 . . . . 0.0 110.032 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' CD ' HD22 ' A' ' 4' ' ' LEU . 1.4 tm0? -55.69 -29.24 59.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.04 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.801 ' O ' HD12 ' A' ' 76' ' ' ILE . 77.8 mt -70.39 -49.47 48.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.894 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.51 -31.21 68.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.426 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -76.09 -37.57 58.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.355 -0.84 . . . . 0.0 109.504 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.532 ' CE2' HD11 ' A' ' 79' ' ' ILE . 23.3 t90 -79.64 -36.67 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.793 . . . . 0.0 109.796 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.841 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 25.2 mt -71.86 -39.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.884 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.936 HD23 ' HA ' ' A' ' 29' ' ' ALA . 18.1 mt -68.02 -42.44 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.1 t -62.04 -37.83 86.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.913 . . . . 0.0 109.962 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.748 ' CG2' HD23 ' A' ' 16' ' ' LEU . 19.5 mt -59.39 97.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.026 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.654 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.285 0.564 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.18 -40.04 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.11 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -47.3 -24.41 0.74 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.957 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.603 HD13 ' HG3' ' A' ' 71' ' ' GLN . 12.8 mt -63.06 -42.28 99.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.02 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -91.37 -0.22 57.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.103 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 ttmm -88.94 -58.54 2.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.12 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -48.76 -24.42 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.165 -0.96 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HE3' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -80.55 -53.96 6.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.083 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.85 46.35 0.97 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.484 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 15.2 m -90.0 -28.99 18.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -1.151 . . . . 0.0 110.079 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -14.01 13.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 110.123 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.66 -25.1 3.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.127 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.0 m -135.72 -36.83 0.76 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 110.108 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.498 ' CB ' ' CE2' ' A' ' 25' ' ' TYR . 88.8 m-70 -70.31 -179.45 2.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.375 -0.828 . . . . 0.0 110.306 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.766 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 174.44 124.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.904 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 79' ' ' ILE . 27.0 mt -42.46 -64.69 0.56 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 110.187 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 42.19 3.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.766 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.3 84.45 1.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.363 -0.836 . . . . 0.0 110.147 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.88 64.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ALA . 16.4 mttm -62.57 -90.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.906 . . . . 0.0 110.056 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 29.3 t -93.68 -44.37 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.49 166.27 13.24 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.724 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.05 7.56 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.754 2.302 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.29 132.66 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.498 ' CE2' ' CB ' ' A' ' 14' ' ' HIS . 6.8 m-85 -49.85 -32.4 14.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.143 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -67.85 -44.67 76.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.935 . . . . 0.0 110.071 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -49.92 73.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.031 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.08 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 36.1 t -56.49 -43.48 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.213 -0.93 . . . . 0.0 109.993 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.901 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.44 -57.24 10.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.992 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.22 -43.76 64.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.912 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -36.41 67.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 110.037 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.725 ' HB2' HD21 ' A' ' 77' ' ' LEU . 14.1 m-85 -99.1 4.08 46.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.19 -24.28 63.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.04 61.72 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.92 160.67 37.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -1.175 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -111.42 -26.94 8.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.88 . . . . 0.0 110.142 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -84.65 9.21 14.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -60.79 -25.02 66.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.228 -0.92 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.78 -53.87 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -54.07 50.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 110.055 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -51.82 -61.76 2.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.191 -0.943 . . . . 0.0 110.043 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 38' ' ' ALA . 8.2 mt -43.05 -73.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.877 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.79 -41.23 3.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.381 -0.825 . . . . 0.0 110.041 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.22 73.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CB ' ' O2A' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -90.93 -9.72 45.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -1.143 . . . . 0.0 109.991 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 43' ' ' ALA . 41.0 mt -73.38 -47.74 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 110.02 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -4.75 47.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.11 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.66 -5.12 10.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.928 . . . . 0.0 110.077 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 45.29 -134.73 7.89 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . 82.83 -143.33 22.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 3.6 t 169.79 -178.71 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.416 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 142.75 -14.63 2.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -106.67 -11.94 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.258 -1.142 . . . . 0.0 110.072 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 1.08 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 96.7 m95 -120.37 -29.1 4.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -0.891 . . . . 0.0 110.013 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.39 -142.14 6.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 65.6 m -120.57 45.82 2.14 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.235 -1.156 . . . . 0.0 110.123 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 85.7 t -111.58 94.99 25.21 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.102 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.04 77.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.695 2.263 . . . . 0.0 110.301 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.507 ' HE3' ' C4B' ' A' ' 81' ' ' HEC . 7.8 ttt -46.62 140.39 5.83 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' CD ' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -62.92 144.99 94.3 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.623 2.216 . . . . 0.0 110.289 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.62 166.48 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.714 2.276 . . . . 0.0 110.205 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.539 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 37.4 mm-40 -137.74 165.2 27.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.095 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -105.14 60.85 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 110.063 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.63 HG12 ' OE1' ' A' ' 68' ' ' GLU . 3.6 m -113.82 155.82 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.185 -0.947 . . . . 0.0 110.153 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.11 167.8 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.989 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -43.46 -59.08 2.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.92 -56.66 5.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.896 . . . . 0.0 109.907 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.63 ' OE1' HG12 ' A' ' 64' ' ' VAL . 4.1 mt-10 -55.29 -42.49 73.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.93 . . . . 0.0 109.875 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.699 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.17 -35.88 72.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.395 -0.815 . . . . 0.0 109.835 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -51.81 59.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -0.813 . . . . 0.0 110.001 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.603 ' HG3' HD13 ' A' ' 4' ' ' LEU . 1.4 tm0? -54.95 -29.79 57.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 110.012 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.435 HD22 HMB3 ' A' ' 81' ' ' HEC . 17.6 mt -70.24 -50.59 38.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.855 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.73 -31.83 70.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.141 -0.974 . . . . 0.0 109.432 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -75.47 -37.34 60.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.338 -0.852 . . . . 0.0 109.504 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.497 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.5 t90 -79.15 -37.6 38.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -0.863 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 78.0 mt -72.43 -39.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 29' ' ' ALA . 18.8 mt -66.13 -46.11 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.273 -0.892 . . . . 0.0 109.955 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.8 m -58.31 -31.55 67.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 109.981 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.573 HG21 HD22 ' A' ' 16' ' ' LEU . 18.5 mt -67.26 128.0 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.038 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.103 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.67 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 2.1 m120 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.246 0.545 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 1' ' ' ASN . 1.3 mm-40 -150.68 -60.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 110.115 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -48.54 -24.35 1.28 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.176 -0.953 . . . . 0.0 110.022 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 4' ' ' LEU . 13.0 mt -63.37 -63.09 1.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 110.083 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -56.43 -31.82 64.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.904 . . . . 0.0 110.032 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -62.42 1.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 110.063 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -50.43 -24.8 3.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 0.0 110.037 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -77.5 -53.51 7.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 110.114 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.15 38.68 2.62 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.8 m -93.0 -29.11 16.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -1.083 . . . . 0.0 110.012 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -16.06 10.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.181 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' HB3' HMC3 ' A' ' 81' ' ' HEC . . . -50.09 -25.13 3.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 109.984 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 12.7 m -136.61 -36.01 0.72 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.551 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 89.2 m-70 -73.05 -179.62 3.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.893 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 170.07 121.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.453 -0.78 . . . . 0.0 109.86 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.0 mp -41.93 -63.24 0.76 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.27 -0.894 . . . . 0.0 110.302 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.97 42.38 3.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.893 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -140.22 83.95 1.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.486 -0.759 . . . . 0.0 110.115 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -56.08 84.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.106 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -94.61 -143.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.048 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.1 t -52.18 -31.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 110.032 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 164.39 14.03 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 3.0 Cg_endo -61.17 130.82 33.84 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.715 2.277 . . . . 0.0 110.241 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -51.3 126.89 18.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.019 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 2.8 m-85 -46.3 -37.68 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -61.45 -56.28 21.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.971 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.3 -34.07 71.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.898 . . . . 0.0 110.073 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 23' ' ' PRO . 34.1 t -60.89 -50.98 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 77' ' ' LEU . . . -54.82 -46.72 74.59 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.871 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -59.25 -43.33 92.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.943 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -34.8 71.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 110.118 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -101.7 -1.79 31.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 110.082 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -56.26 -22.0 27.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.9 . . . . 0.0 110.07 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.75 20.74 30.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.93 127.77 40.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -1.182 . . . . 0.0 110.097 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.1 -38.66 69.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 110.055 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.49 40.82 0.91 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -69.21 -24.06 63.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.197 -0.939 . . . . 0.0 110.033 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.61 -61.09 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 110.075 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.65 -51.07 70.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.052 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -52.33 -63.02 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.984 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 38' ' ' ALA . 28.6 mt -46.94 -74.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 110.119 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.991 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.39 -39.08 2.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.409 -0.807 . . . . 0.0 110.045 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 48' ' ' LYS . . . -57.38 -40.61 92.31 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HB3' HBA2 ' A' ' 81' ' ' HEC . 3.1 mttt -87.8 -10.39 51.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.321 -1.105 . . . . 0.0 110.041 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' A' ' 43' ' ' ALA . 42.3 mt -73.4 -44.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 110.066 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -86.81 11.3 13.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.034 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -111.48 -45.24 3.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.46 179.24 52.89 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 107.81 -147.35 16.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.3 p 169.66 -168.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -1.073 . . . . 0.0 110.083 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.96 -16.76 5.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -96.21 -23.82 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -1.156 . . . . 0.0 110.139 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.596 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 94.8 m95 -112.58 -18.01 12.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.065 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.76 -153.17 23.65 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -111.68 66.73 0.64 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -1.115 . . . . 0.0 110.04 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -135.22 95.78 14.62 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 110.116 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.76 86.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.704 2.27 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.493 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.7 ttt -55.36 138.93 67.14 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 109.981 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.61 141.77 81.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.586 2.191 . . . . 0.0 110.332 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.39 169.73 9.13 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.62 2.214 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.52 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 24.9 mm-40 -137.73 164.67 28.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.925 . . . . 0.0 110.118 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.69 55.83 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.98 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 3.5 m -114.4 155.85 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.29 -0.882 . . . . 0.0 110.099 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 66' ' ' ASP . 77.5 p -105.61 172.66 6.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.946 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 65' ' ' THR . 1.1 t0 -43.56 -50.34 7.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.036 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -48.76 -63.98 0.93 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 109.868 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 64' ' ' VAL . 11.5 mt-10 -53.54 -39.97 65.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.237 -0.915 . . . . 0.0 109.768 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.991 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -60.19 -34.66 73.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.718 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 16.2 mttm -65.61 -51.55 58.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.808 . . . . 0.0 109.983 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.96 -30.32 61.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.527 HD22 HMB3 ' A' ' 81' ' ' HEC . 12.0 mt -70.19 -49.76 47.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.11 -0.994 . . . . 0.0 109.853 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -70.29 -32.44 70.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 0.0 109.426 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 3.1 mm-40 -74.99 -36.82 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.483 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.62 ' CE2' HD11 ' A' ' 79' ' ' ILE . 21.6 t90 -79.51 -38.26 34.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -0.831 . . . . 0.0 109.898 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 25' ' ' TYR . 50.5 mt -68.43 -36.54 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.931 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.571 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 19.3 mt -69.94 -47.52 62.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.891 . . . . 0.0 109.943 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 t -58.46 -23.46 57.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.013 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.62 HD11 ' CE2' ' A' ' 75' ' ' TRP . 36.6 mt -73.22 114.28 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.299 -0.876 . . . . 0.0 109.994 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.064 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.683 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.8 m120 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.213 0.53 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.84 -29.2 70.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 0.0 110.088 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -51.84 -26.08 9.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -0.939 . . . . 0.0 110.064 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.05 -44.89 91.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.06 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.915 ' HB2' ' CH2' ' A' ' 75' ' ' TRP . . . -55.2 -41.88 72.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.084 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -69.7 -56.45 7.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.983 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.9 -24.48 3.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.855 . . . . 0.0 110.108 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -88.89 -48.31 7.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.328 -0.857 . . . . 0.0 110.07 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.04 45.78 1.44 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 8' ' ' LYS . 13.7 m -102.36 -28.82 12.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -1.152 . . . . 0.0 110.03 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.96 -16.17 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -0.866 . . . . 0.0 110.138 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.14 -24.31 1.62 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 109.976 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 12.1 m -137.0 -37.69 0.65 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.034 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.0 m-70 -70.75 -179.56 2.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.228 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.849 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 176.04 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.0 109.819 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.532 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 28.8 mt -42.48 -65.34 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.225 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -122.04 42.51 3.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.356 -0.84 . . . . 0.0 110.079 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.849 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -146.97 82.29 1.56 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.841 . . . . 0.0 110.148 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.78 71.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -71.89 -90.92 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.249 -0.907 . . . . 0.0 109.977 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 29.6 t -90.4 -40.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 0.0 109.883 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.11 165.34 12.03 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 121.16 9.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.608 2.206 . . . . 0.0 110.241 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -43.25 129.95 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 110.02 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CD1' HG12 ' A' ' 76' ' ' ILE . 4.5 m-85 -48.65 -31.69 7.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.297 -0.877 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.41 -46.21 73.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 110.025 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.98 -48.84 79.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.339 -0.851 . . . . 0.0 110.089 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 93.0 t -56.93 -44.41 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.931 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.73 -62.49 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.08 -39.99 63.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.815 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -60.01 -34.52 73.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.099 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.627 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 4.0 m-85 -96.26 4.57 52.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.89 . . . . 0.0 110.105 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.86 -17.53 60.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.053 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.11 16.56 51.41 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.19 157.48 46.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -1.129 . . . . 0.0 110.063 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -104.68 -3.16 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.155 -0.965 . . . . 0.0 110.109 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -115.23 20.63 14.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.627 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -62.0 -21.65 65.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.237 -0.914 . . . . 0.0 110.077 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 39' ' ' VAL . 4.4 t -69.67 -57.24 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -53.52 57.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' OH ' HG21 ' A' ' 53' ' ' VAL . 18.9 t80 -51.04 -63.9 0.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 43' ' ' ALA . 22.4 mt -43.4 -73.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 0.0 110.108 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.893 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.32 -39.54 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.092 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.9 -42.66 92.47 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HB2' ' CBA' ' A' ' 81' ' ' HEC . 4.5 mtpt -84.75 -14.97 46.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.164 . . . . 0.0 109.971 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.823 HD12 ' HA ' ' A' ' 43' ' ' ALA . 28.8 mt -67.62 -46.25 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 110.014 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 -16.62 43.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.319 -0.863 . . . . 0.0 110.079 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -95.36 -30.53 13.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 60.74 -157.76 29.74 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 96.4 -132.57 11.08 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.2 p 169.85 178.6 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -1.145 . . . . 0.0 110.085 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 141.02 -20.32 2.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.412 HG21 ' OH ' ' A' ' 41' ' ' TYR . 41.3 t -105.75 -22.31 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -1.126 . . . . 0.0 110.084 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.656 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 80.3 m95 -119.53 -12.37 9.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.237 -0.914 . . . . 0.0 110.073 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' O1D' ' A' ' 81' ' ' HEC . . . 164.67 -145.95 10.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 3.7 m -122.92 -26.51 4.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 110.1 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 56' ' ' SER . 21.9 t -41.6 102.04 0.26 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 0.0 110.212 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -61.7 88.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.654 2.236 . . . . 0.0 110.248 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.2 ttt -55.63 138.88 69.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -63.41 143.58 88.83 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.589 2.193 . . . . 0.0 110.332 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -62.86 169.32 8.99 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.757 2.304 . . . . 0.0 110.116 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.535 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 31.5 mm-40 -137.97 165.69 25.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -0.977 . . . . 0.0 110.042 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -104.76 56.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 110.143 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 3.7 m -114.62 155.78 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.938 . . . . 0.0 110.128 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.13 170.3 8.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.9 . . . . 0.0 109.922 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -43.33 -53.63 5.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.983 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -49.32 -59.07 4.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.904 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.31 -40.82 68.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.889 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.893 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.02 -36.66 75.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.395 -0.815 . . . . 0.0 109.869 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 29.5 mttt -64.82 -51.03 64.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.38 -0.825 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.2 tm0? -55.05 -31.04 60.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 110.012 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.645 HD22 HMB3 ' A' ' 81' ' ' HEC . 8.1 mt -70.01 -50.34 42.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.824 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 42' ' ' LEU . . . -68.7 -34.4 75.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.145 -0.972 . . . . 0.0 109.455 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -73.18 -37.89 66.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 109.434 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.915 ' CH2' ' HB2' ' A' ' 5' ' ' ALA . 17.3 t90 -76.78 -39.83 50.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 109.754 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 37.8 mt -68.13 -46.07 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 29' ' ' ALA . 58.2 mt -61.08 -41.13 96.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.895 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.1 t -62.79 -38.47 90.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.964 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG21 HD22 ' A' ' 16' ' ' LEU . 11.6 mt -59.23 100.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.127 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.723 HMA1 HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 p30 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.221 0.534 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -158.66 -58.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 110.132 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -24.62 2.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.091 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mt -58.01 -57.4 12.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.54 -18.51 56.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.034 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -68.46 0.39 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.879 . . . . 0.0 110.044 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.24 -25.38 2.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.0 110.108 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.05 -52.77 7.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 110.087 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.56 24.64 6.64 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 14.5 m -69.75 -29.61 67.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -1.161 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.0 mmt -60.58 -13.31 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 110.106 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.0 -36.39 60.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.6 m -126.73 -8.4 6.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.192 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.448 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 81.6 m-70 -101.67 -178.35 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.16 -0.963 . . . . 0.0 110.426 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.802 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 1.1 m-20 170.75 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 109.793 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 26.7 mt -42.53 -68.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 42.86 3.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.849 . . . . 0.0 110.057 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.802 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -138.07 88.0 2.28 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -50.59 159.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 110.125 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 19' ' ' LYS . 2.3 tptt 177.42 -147.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.867 . . . . 0.0 109.916 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 72.1 t -49.65 -29.53 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 109.803 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . -130.07 153.3 20.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.589 ' HG3' ' CD2' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -60.78 120.98 9.0 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.708 2.272 . . . . 0.0 110.323 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.49 136.47 3.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.295 -0.878 . . . . 0.0 109.981 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 7.2 m-85 -54.75 -33.65 61.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 110.186 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -63.77 -43.82 95.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.01 -52.32 60.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 110.165 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.149 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 98.1 t -57.84 -46.03 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.995 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.916 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -49.33 -66.84 0.33 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.918 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -53.08 -38.3 62.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HD2' ' CZ2' ' A' ' 54' ' ' TRP . 7.5 ttmt -63.22 -31.11 72.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.295 -0.878 . . . . 0.0 110.096 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 13.6 m-85 -100.16 -5.48 27.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 110.129 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.84 -22.67 65.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.061 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.79 11.75 65.7 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.12 127.02 45.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -1.161 . . . . 0.0 110.119 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -77.07 -29.19 54.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.081 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.51 18.23 10.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 110.109 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.716 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -65.25 -23.83 67.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 110.085 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.485 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 61.5 t -70.79 -58.77 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 110.053 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.45 -51.31 69.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -0.888 . . . . 0.0 110.094 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 42' ' ' LEU . 11.2 t80 -52.26 -65.87 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.095 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 38' ' ' ALA . 15.9 mt -43.01 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.068 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.54 -40.11 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.077 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.61 -41.28 93.54 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -9.37 55.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 110.091 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.542 ' CG1' HMA2 ' A' ' 81' ' ' HEC . 8.2 mt -73.96 -49.2 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.104 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.18 -2.89 20.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -120.28 -17.64 8.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 110.107 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.32 -153.93 26.37 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 103.68 -145.33 16.13 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.504 ' HA ' ' CGD' ' A' ' 81' ' ' HEC . 5.5 p 173.43 -170.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 0.0 110.058 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 126.48 -19.2 6.33 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.5 t -96.35 -22.64 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -1.131 . . . . 0.0 110.17 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 1.149 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 94.6 m95 -112.92 -35.46 5.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.087 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.56 -140.83 4.47 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.3 p -120.07 63.84 0.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -1.135 . . . . 0.0 110.026 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.2 t -131.52 95.82 22.75 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 110.042 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.74 86.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.693 2.262 . . . . 0.0 110.361 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.483 ' CE ' ' NB ' ' A' ' 81' ' ' HEC . 9.0 ttt -55.12 139.88 63.7 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.904 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HD3' HBC2 ' A' ' 81' ' ' HEC . 2.9 Cg_endo -62.83 141.36 84.47 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.653 2.235 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 3.0 Cg_endo -63.08 168.83 10.1 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.687 2.258 . . . . 0.0 110.087 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.531 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 33.3 mm-40 -139.04 166.61 24.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.101 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -105.3 64.62 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.103 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 68' ' ' GLU . 4.0 m -118.99 155.81 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -0.929 . . . . 0.0 110.137 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -101.09 169.29 9.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.89 . . . . 0.0 109.958 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.4 OUTLIER -43.47 -52.03 6.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.999 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.7 -58.21 6.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -54.37 -40.5 68.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.863 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.068 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -58.79 -36.89 75.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.808 . . . . 0.0 109.832 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.1 57.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.342 -0.849 . . . . 0.0 109.981 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.13 -29.5 45.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 110.036 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 72' ' ' LEU . 61.5 mt -70.16 -51.69 29.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 109.941 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -69.41 -31.67 70.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.491 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.12 -36.93 61.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.558 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 21.4 t90 -79.49 -38.78 33.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.832 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 57.0 mt -70.49 -38.55 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.916 HD23 ' HA ' ' A' ' 29' ' ' ALA . 24.1 mt -68.46 -41.47 80.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.961 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.31 -38.42 91.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.023 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 16' ' ' LEU . 9.2 mt -60.3 120.01 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.998 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.121 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.801 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.5 t30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.277 0.561 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' OE1' ' HG3' ' A' ' 6' ' ' LYS . 2.3 tt0 -91.08 -24.61 19.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.06 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 3.3 tt0 -49.65 -24.99 2.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.075 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.437 HD13 ' OE1' ' A' ' 71' ' ' GLN . 20.5 mt -69.46 -51.95 31.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.079 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.03 -28.75 57.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.079 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG3' ' OE1' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -54.79 -66.75 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 110.123 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 3.9 pt20 -50.81 -29.82 12.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 110.045 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -64.34 -56.25 15.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.24 37.94 1.73 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.485 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.7 m -86.73 -29.05 22.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -1.158 . . . . 0.0 109.983 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmt -56.88 -16.85 7.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.57 -22.27 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 110.047 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.487 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 15.0 m -138.47 -37.22 0.56 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 0.0 110.124 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 89.3 m-70 -72.56 -178.34 2.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 110.346 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.652 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 169.87 124.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.858 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.773 HD22 HG21 ' A' ' 79' ' ' ILE . 25.5 mt -42.15 -62.93 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.284 -0.885 . . . . 0.0 110.301 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 42.86 3.1 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.555 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -152.35 75.52 1.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.377 -0.827 . . . . 0.0 110.185 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.47 76.23 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.847 . . . . 0.0 110.205 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 6.6 mtpt -67.92 -90.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.909 . . . . 0.0 110.008 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.487 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 25.4 t -91.41 -31.82 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.927 . . . . 0.0 109.935 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.4 167.75 13.37 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.687 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.86 120.82 8.75 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.738 2.292 . . . . 0.0 110.273 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -43.97 134.73 4.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.926 . . . . 0.0 109.925 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 5.9 m-85 -51.25 -32.36 24.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.78 -44.78 69.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.029 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.98 -47.84 84.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.254 -0.904 . . . . 0.0 110.054 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 32.5 t -56.83 -44.61 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.947 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.851 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.29 -59.15 4.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -55.12 -42.95 73.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.952 . . . . 0.0 109.824 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.3 tptt -60.28 -33.39 72.27 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 110.049 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -90.46 5.74 46.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.84 -23.72 66.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 110.101 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.18 13.11 62.48 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -117.11 138.13 51.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -1.125 . . . . 0.0 110.068 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -90.82 -16.34 28.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.339 -0.85 . . . . 0.0 110.089 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -121.46 33.74 5.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.107 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.844 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.47 -21.46 37.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 110.071 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 39' ' ' VAL . 6.4 t -69.72 -57.73 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.146 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.0 -54.79 42.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.885 . . . . 0.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' LEU . 16.2 t80 -51.64 -63.7 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.062 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 38' ' ' ALA . 15.7 mt -43.14 -73.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.069 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.887 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . . . -42.51 -40.3 2.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.432 -0.793 . . . . 0.0 110.064 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.38 -37.71 75.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' LEU . 3.4 mmtt -91.35 -7.98 49.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -1.157 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 43' ' ' ALA . 53.5 mt -78.03 -37.28 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.922 . . . . 0.0 110.062 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.75 4.49 51.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.895 . . . . 0.0 110.081 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -119.89 -43.7 2.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.11 -164.98 40.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 104.9 -140.34 14.97 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 169.62 -176.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 110.021 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 134.9 -10.71 4.52 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 53' ' ' VAL . 52.1 t -111.65 -6.29 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 110.116 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.695 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.0 m95 -135.52 4.37 3.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -153.54 23.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -116.78 48.82 1.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -1.15 . . . . 0.0 110.119 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.81 96.22 27.76 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 56' ' ' SER . 2.9 Cg_endo -60.58 88.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.678 2.252 . . . . 0.0 110.34 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 7.6 ttt -62.01 139.49 95.86 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 109.961 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.38 143.02 87.79 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.684 2.256 . . . . 0.0 110.364 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.8 Cg_endo -63.09 167.9 11.66 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.671 2.247 . . . . 0.0 110.151 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.523 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 26.3 mm-40 -138.14 165.1 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.114 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.25 62.07 0.68 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.006 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG21 HG22 ' A' ' 46' ' ' ILE . 3.4 m -114.99 155.8 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.161 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 66' ' ' ASP . 18.2 p -99.87 164.96 11.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.955 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -43.38 -51.66 6.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.947 . . . . 0.0 110.035 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.41 -58.05 6.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.77 -41.72 70.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -58.11 -35.12 70.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.43 -0.794 . . . . 0.0 109.804 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -52.76 48.99 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.85 . . . . 0.0 110.029 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.28 -29.62 47.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.052 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 69' ' ' ALA . 30.2 mt -70.11 -50.87 36.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.919 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.45 -32.22 71.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -74.94 -37.45 62.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -0.823 . . . . 0.0 109.524 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.7 t90 -78.81 -38.17 38.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.813 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.488 HG12 ' CD1' ' A' ' 25' ' ' TYR . 52.3 mt -70.08 -42.19 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 110.062 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.851 HD23 ' HA ' ' A' ' 29' ' ' ALA . 31.3 mt -64.23 -47.24 80.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.943 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -28.44 62.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -0.922 . . . . 0.0 109.968 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.773 HG21 HD22 ' A' ' 16' ' ' LEU . 29.4 mt -71.23 139.27 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 110.087 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.058 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.714 HBB3 HMB1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 14.2 p-10 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.221 0.534 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 0.7 OUTLIER 179.7 -43.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 110.035 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -51.13 -21.61 2.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.069 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 4' ' ' LEU . 3.8 pp -74.44 -32.83 62.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 110.084 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.711 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -69.74 -39.4 76.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.214 -0.929 . . . . 0.0 109.997 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tmtm? -75.8 -52.14 11.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.201 -0.937 . . . . 0.0 110.013 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -51.17 -25.85 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 0.0 110.09 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -78.13 -54.51 6.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.314 -0.866 . . . . 0.0 110.07 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.69 43.26 0.42 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.449 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 12.6 m -103.75 -29.61 10.93 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -1.123 . . . . 0.0 110.022 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.2 mmt -60.22 -13.84 14.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.35 -34.72 48.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.071 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -125.32 -26.0 3.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.87 . . . . 0.0 110.221 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.495 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 87.5 m-70 -83.67 -179.65 7.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 110.467 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.725 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 168.23 125.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.463 -0.773 . . . . 0.0 109.688 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 79' ' ' ILE . 25.6 mt -42.14 -64.91 0.52 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.93 42.75 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 110.115 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -145.28 45.19 1.32 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.018 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.88 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.317 -0.865 . . . . 0.0 110.085 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 18' ' ' ALA . 9.6 mtmt -93.62 -90.01 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 30.7 t -80.02 -31.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -0.926 . . . . 0.0 109.939 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.04 169.21 16.99 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.577 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 123.41 12.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.745 2.297 . . . . 0.0 110.285 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -48.48 135.9 13.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 109.961 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 5.2 m-85 -50.51 -32.46 18.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -67.77 -49.54 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.24 -0.912 . . . . 0.0 110.044 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.57 -44.82 89.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.86 . . . . 0.0 109.977 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.673 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 84.5 t -57.46 -45.7 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.94 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.792 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.74 -52.69 55.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -54.23 -45.21 72.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.906 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 11.0 mttt -55.65 -36.83 67.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 110.104 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 12.2 m-85 -101.16 -4.09 27.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 110.089 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -62.3 -26.38 68.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 0.0 110.054 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.41 15.64 55.86 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.08 174.02 8.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.039 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -120.36 -22.26 6.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.123 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -100.62 20.32 15.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 110.081 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.819 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -60.01 -23.89 64.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 0.0 110.087 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' HD3' ' A' ' 70' ' ' LYS . 60.1 t -66.87 -53.66 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.882 . . . . 0.0 110.125 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -61.59 -55.74 27.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.094 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' LEU . 50.8 t80 -48.31 -64.7 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 110.048 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 38' ' ' ALA . 18.5 mt -42.99 -73.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.891 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.62 -40.99 2.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.378 -0.826 . . . . 0.0 110.087 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.75 -38.44 72.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -16.54 29.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -1.162 . . . . 0.0 110.039 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.891 HD12 ' HA ' ' A' ' 43' ' ' ALA . 45.1 mt -65.91 -45.07 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 110.087 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -81.64 -13.88 57.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.059 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 mmtm -101.22 -43.75 5.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 110.095 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.84 -148.52 38.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 92.52 -135.47 12.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 175.95 -177.43 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -1.147 . . . . 0.0 110.052 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.52 -22.01 5.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.0 t -89.08 -21.55 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.221 -1.164 . . . . 0.0 110.005 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.673 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 97.2 m95 -117.2 -39.34 3.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.27 -128.93 1.25 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 p -124.26 62.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -1.125 . . . . 0.0 110.135 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' CMD' ' A' ' 81' ' ' HEC . 4.1 t -122.68 92.01 49.28 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.888 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.23 86.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.76 2.307 . . . . 0.0 110.225 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.49 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 8.2 ttt -63.92 139.92 97.75 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 109.933 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 2.9 Cg_endo -63.66 142.15 82.39 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.58 2.187 . . . . 0.0 110.316 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 2.9 Cg_endo -63.22 162.73 25.52 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.661 2.24 . . . . 0.0 110.12 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.516 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 21.9 mm-40 -134.91 163.8 29.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 110.097 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -104.58 65.71 0.77 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.885 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 46' ' ' ILE . 3.5 m -114.34 155.88 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 43.6 p -103.28 168.49 9.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 9.4 m-20 -43.39 -57.87 2.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 110.052 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.7 -59.02 3.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 109.939 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -41.59 70.67 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.899 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.753 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.55 -36.15 75.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.825 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HD3' HG12 ' A' ' 39' ' ' VAL . 32.1 mmtt -67.2 -51.05 58.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.351 -0.843 . . . . 0.0 110.044 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -54.36 -29.66 49.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 110.01 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 72' ' ' LEU . 59.6 mt -70.11 -52.3 24.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.846 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -68.66 -33.49 74.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -73.45 -36.58 65.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -0.828 . . . . 0.0 109.433 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.589 ' CE2' HD11 ' A' ' 79' ' ' ILE . 19.7 t90 -78.61 -40.72 33.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.851 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.468 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 51.2 mt -69.39 -39.65 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.971 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 29' ' ' ALA . 46.2 mt -66.51 -42.25 87.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.87 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -63.68 -43.07 97.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 110.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.93 HG21 HD22 ' A' ' 16' ' ' LEU . 25.8 mt -49.63 98.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.059 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.733 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.185 0.517 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 28.6 tt0 -172.28 -73.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.121 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 4.5 mm-40 -45.94 -25.36 0.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 110.088 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.543 HD22 ' OE1' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -65.46 -54.98 20.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 110.13 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.5 -9.72 55.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -0.901 . . . . 0.0 110.113 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 2.1 tttt -75.97 -64.93 0.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 110.117 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 10.3 pt20 -45.3 -30.34 1.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 109.973 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -68.55 -58.74 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 110.006 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.88 40.3 1.32 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 18.0 m -80.83 -30.75 35.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -1.144 . . . . 0.0 110.063 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -14.69 14.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.32 -26.97 5.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.026 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 11.8 m -133.8 -35.1 0.98 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 110.09 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 90.2 m-70 -73.82 179.95 3.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.439 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.938 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.4 OUTLIER 171.46 119.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.791 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.732 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.7 mp -41.73 -60.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 110.35 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.74 42.75 3.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.219 -0.926 . . . . 0.0 110.07 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.938 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -143.12 85.86 1.89 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.362 -0.836 . . . . 0.0 110.114 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -57.83 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 110.126 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -92.19 -145.37 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 110.055 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 39.1 t -51.54 -31.41 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 110.066 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.02 163.96 13.19 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 2.9 Cg_endo -61.1 131.82 38.7 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.743 2.295 . . . . 0.0 110.291 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -53.14 123.9 13.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.593 ' CD2' ' HB3' ' A' ' 14' ' ' HIS . 3.5 m-85 -46.09 -31.51 2.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -69.22 -45.64 69.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.062 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.48 -45.0 92.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -0.895 . . . . 0.0 110.108 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.023 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 52.5 t -58.14 -46.74 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 110.036 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.746 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.49 -54.57 30.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.981 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 tptp -54.82 -43.62 73.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.866 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -35.41 70.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 110.085 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -104.52 1.65 30.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 0.0 110.156 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' ALA . . . -60.01 -28.98 68.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 110.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.35 19.39 36.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -120.19 158.65 26.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -1.155 . . . . 0.0 110.073 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 -19.54 13.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.053 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -103.12 18.8 20.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.769 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -57.13 -23.16 45.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 39' ' ' VAL . 8.0 t -70.67 -54.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.079 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.04 -53.1 61.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.071 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' LEU . 51.8 t80 -52.95 -65.02 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 38' ' ' ALA . 26.4 mt -43.93 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.64 -37.64 1.77 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.397 -0.814 . . . . 0.0 110.102 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.39 -29.05 65.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.527 ' HB3' ' CBA' ' A' ' 81' ' ' HEC . 1.7 tptp -101.41 -13.97 17.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -1.141 . . . . 0.0 110.103 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.624 HG12 HMA1 ' A' ' 81' ' ' HEC . 27.2 mt -72.49 -44.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 110.093 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -80.21 -5.43 56.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.44 -13.46 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.045 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 53.6 -149.93 13.48 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 105.69 -147.7 16.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 2.1 t 169.69 -178.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -1.161 . . . . 0.0 110.099 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . 133.84 -11.94 4.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.5 t -102.88 -27.33 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.067 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 1.023 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.8 m95 -107.05 -13.69 15.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.088 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.91 -147.85 16.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 56' ' ' SER . 3.6 p -116.35 50.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -1.14 . . . . 0.0 110.079 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.14 95.84 47.97 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.076 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.86 103.92 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.752 2.301 . . . . 0.0 110.336 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.481 ' HG3' ' NC ' ' A' ' 81' ' ' HEC . 6.8 ttt -75.54 139.7 71.27 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 0.0 109.907 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 2.9 Cg_endo -63.37 138.76 67.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.67 2.246 . . . . 0.0 110.365 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -63.6 168.87 10.79 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.597 2.198 . . . . 0.0 110.173 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.568 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 30.2 mm-40 -138.17 165.56 26.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.937 . . . . 0.0 110.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -105.16 65.1 0.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.11 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -114.91 155.84 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -0.931 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -100.53 165.3 11.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.018 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 65' ' ' THR . 3.5 t0 -43.36 -55.51 4.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.4 -60.4 2.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.949 . . . . 0.0 109.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -54.66 -41.3 69.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.751 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -59.27 -34.21 71.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.845 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -52.24 50.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.414 -0.804 . . . . 0.0 110.039 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.543 ' OE1' HD22 ' A' ' 4' ' ' LEU . 1.4 tm0? -55.17 -30.03 59.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 110.02 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 69' ' ' ALA . 76.3 mt -70.21 -50.24 41.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.884 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.88 -32.39 70.71 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -74.79 -37.29 62.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 20.9 t90 -79.02 -38.42 36.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.0 109.822 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.553 ' HA ' HD12 ' A' ' 79' ' ' ILE . 44.8 mt -72.47 -38.02 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.953 . . . . 0.0 109.961 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 29' ' ' ALA . 17.0 mt -67.03 -44.5 80.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -0.891 . . . . 0.0 109.916 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -61.27 -30.59 70.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -0.879 . . . . 0.0 109.963 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' A' ' 76' ' ' ILE . 43.0 mt -62.76 101.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.019 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.676 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 3' ' ' GLN . 1.1 t-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.237 0.542 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 4.5 mt-10 64.75 -68.98 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 0.0 110.136 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 1' ' ' ASN . 0.1 OUTLIER -50.75 -24.62 3.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 110.043 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.486 HD13 ' OE1' ' A' ' 71' ' ' GLN . 12.0 mt -65.3 -54.14 33.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 110.12 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.681 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -56.59 -36.89 69.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.179 -0.951 . . . . 0.0 110.015 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -65.15 -54.02 36.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.122 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -25.67 4.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 110.09 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 -48.46 9.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 110.073 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.59 24.52 4.96 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 13.7 m -73.07 -29.06 62.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.973 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 mmt -59.54 -15.91 21.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 110.107 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.02 -23.66 2.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.223 -0.923 . . . . 0.0 109.978 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 13.7 m -136.88 -36.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.31 -0.869 . . . . 0.0 110.139 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.524 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 88.1 m-70 -71.64 -179.57 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.852 . . . . 0.0 110.468 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.628 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 169.38 122.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.505 -0.747 . . . . 0.0 109.669 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.872 HD22 HG21 ' A' ' 79' ' ' ILE . 32.1 mt -42.07 -65.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 110.313 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -122.5 42.6 3.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -155.16 45.52 0.5 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.077 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 6.4 pttt -45.69 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.362 -0.836 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.2 tptt -79.68 -90.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.263 -0.898 . . . . 0.0 110.071 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 25.9 t -78.67 -31.7 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 110.074 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.39 174.78 16.31 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.599 ' HB2' HG23 ' A' ' 28' ' ' VAL . 2.9 Cg_endo -60.9 147.49 95.3 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.744 2.296 . . . . 0.0 110.209 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -71.28 129.81 39.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 109.979 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.542 ' CD1' HG12 ' A' ' 76' ' ' ILE . 3.4 m-85 -45.98 -30.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 110.105 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -72.69 -46.93 51.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 109.966 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -49.11 78.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 109.93 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.119 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 45.7 t -56.31 -43.4 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.91 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.941 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.23 -57.47 9.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.916 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -53.78 -44.7 70.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -34.0 69.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.596 ' HB2' HD21 ' A' ' 77' ' ' LEU . 28.2 m-85 -99.24 3.12 46.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.79 -28.97 68.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.065 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.5 19.59 35.5 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.3 OUTLIER -119.09 146.39 45.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -1.167 . . . . 0.0 110.058 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' HG3' ' N ' ' A' ' 37' ' ' ASP . 8.7 ptpt -96.09 -27.38 15.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.05 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 36' ' ' LYS . 38.9 m-20 -105.34 29.07 6.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 110.061 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.809 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -59.21 -25.13 63.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -0.939 . . . . 0.0 110.102 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.51 ' CG1' ' HG3' ' A' ' 70' ' ' LYS . 3.8 t -68.31 -54.08 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -58.61 -55.64 32.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' C ' ' A' ' 42' ' ' LEU . 12.2 t80 -51.52 -66.18 0.43 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 0.0 110.083 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 38' ' ' ALA . 2.1 mt -43.13 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.138 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.859 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.77 -38.39 2.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 110.08 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -41.19 95.18 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -87.72 -9.18 54.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.214 -1.168 . . . . 0.0 110.056 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 43' ' ' ALA . 42.2 mt -74.17 -50.62 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.06 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 2.0 mtmt -73.69 -9.05 58.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 110.111 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -121.26 -7.4 9.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.956 . . . . 0.0 110.03 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . 44.35 -142.74 2.77 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . 102.11 -137.46 13.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER 169.75 -174.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 0.0 110.064 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 125.22 -10.33 7.77 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.87 -16.5 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.26 -1.141 . . . . 0.0 110.15 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 1.119 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 95.7 m95 -121.38 -27.12 4.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.071 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.52 -141.47 6.26 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.4 m -120.85 69.86 0.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -1.129 . . . . 0.0 110.09 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.533 ' CG1' HMD2 ' A' ' 81' ' ' HEC . 55.6 t -139.19 95.22 9.42 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 110.026 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.01 75.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.737 2.291 . . . . 0.0 110.276 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.476 ' CE ' ' NB ' ' A' ' 81' ' ' HEC . 7.2 ttt -43.87 140.44 2.61 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.74 145.05 94.85 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.688 2.259 . . . . 0.0 110.327 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' O ' ' CD ' ' A' ' 62' ' ' GLN . 2.9 Cg_endo -62.65 167.75 11.18 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.738 2.292 . . . . 0.0 110.2 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.521 ' CD ' HBB2 ' A' ' 81' ' ' HEC . 37.1 mm-40 -138.66 166.23 24.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.95 . . . . 0.0 110.074 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -105.74 62.66 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 110.123 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.72 155.95 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 66' ' ' ASP . 3.5 p -104.46 168.39 9.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.364 -0.835 . . . . 0.0 109.918 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.8 OUTLIER -43.39 -62.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.046 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.85 -57.57 3.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -55.24 -42.58 73.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.618 ' HB1' ' CB ' ' A' ' 43' ' ' ALA . . . -58.71 -34.84 71.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.51 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -65.91 -51.4 58.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.426 -0.796 . . . . 0.0 110.074 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.4 tm0? -55.26 -30.42 60.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.183 -0.948 . . . . 0.0 109.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 76' ' ' ILE . 14.9 mt -70.2 -50.56 38.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 109.862 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -69.61 -32.26 70.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.43 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 78' ' ' SER . 0.1 OUTLIER -74.91 -37.49 62.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.318 -0.864 . . . . 0.0 109.499 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.681 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 20.6 t90 -78.84 -38.15 38.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.371 -0.831 . . . . 0.0 109.819 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 47.4 mt -73.05 -41.83 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.908 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.941 HD23 ' HA ' ' A' ' 29' ' ' ALA . 36.4 mt -64.79 -41.75 95.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 1.0 OUTLIER -62.53 -31.47 72.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.97 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.872 HG21 HD22 ' A' ' 16' ' ' LEU . 28.9 mt -66.7 98.37 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 0.0 109.994 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.048 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.696 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_